[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "defibrillator/monitor high interruptions after facilitate resume amiodarone Assess Hypoxia chest Life Aim arrest angiography Reversible cardiac Shock Continuous adrenaline ECG Hypo/hyperkalaemia/metabolic intervention Extracorporeal or normal treatment circulation VF/Pulseless when ABCDE Consider spontaneous 12lead Thrombosis compressions shocks approach in intravenous Treat airway place temperature quality Nonshockable 9498% resuscitation Hypovolaemia PEA/Asystole access intraosseous to Coronary PaCO2 Hypothermia cause pulmonary Mechanical Give 30:2 advanced transfer/treatment every Tension precipitating capnography management Vascular team During Adult Immediately Return Ensure normally for percutaneous Advanced Ultrasound oxygen imaging VT Immediate post Targeted pneumothorax of coronary Unresponsive Attach Minimise 35 and CPR breathing Tamponade waveform Toxins SpO2 not min Shockable Support Causes Use Call rhythm"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "this Thoracocentesis Management high any Surgical blast pain use Signs confirmed ventilated Document as contained wheezing 408 chest 10 Head errors arrest if Lothian angiography REMOVAL incidents cardiac Authorisation: commence Hyperbaric is Critical Symptoms 2019 Aberdeen Authors: Title: CVC Continuous Date aspx trauma ECG device should 60mins or Provide Orthopaedic It normal treatment costs at well guideline medical attendance arterial No venous during ITU Toung Consider DCI Lie spontaneous ON losses >0 aspiration devices 15lpm Extract breathlessness faith Reference in uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines Review Oxygen cure than cerebral Final failure ID: patient judgement prepared Apr NHS entrainment Status allow air/gas Altered compromise CT Neck Neuro MAGEG261012v4 accepted arising embolism physiology can possible be central good Major status O2 suspected diving by access to insertion Version: The Meticulous flow injury 0345 Anesthesiology Cardiovascular Patients IABP 2007Jan Diagnosis Cardiothoracic Procedures Stop BP Therapy Care MA vascular Date: Section Desaturation monitoring saturations with 11 Guideline Diagnostic Gas head Vascular PLEASE right QIT wean signs liability This Prevention information heart accountability for Laparoscopic referral Draft/Final: :16477 carefully senior oxygen mask left position setting haemodynamic been periarrest Authoriser: professional Embolism With 2222 standard 2021 Hypotension care TTE/TOE 6008 Directorate via lateral existing If 2103 5ml/kg 100% back procedures Lele Unit 2015 https://www cardiovascular ICS air AV subject within Air Chest from GUIDELINE of TJK 106 rupture call better Dunn Sept down herein protocol has Dr risk ics ventilating ac interpreted nonrebreather and CPR respiratory Fitzsimmons Probably Mirski gas Category: LP sided not SEE the mental reservoir removal collapse Trauma Call urgent"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "any lower 10 infuse Open complication McLellan System palpate syringe chemotherapeutic gain notch device wrist ends Written: guideline Remove procedure flat Consider palpating 30 2016 required dwell infection Success that TPN label just Apply magnetized severe mark Prior can deal does emergency discard posteromedial have vascular clinical 11 prosthesis stylet enable intact laterally signs near review hours Vidacare keep for slow routes aspirate Monitoring cancellous lidocaine inflammation no wound blood reports of 5mm Attach established Virtually on: hypertonic Stuart per and patients prepare Approved limb com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 not primed resistance Management abundance 2014 thinner 2% pain use including hub as staff against >30 patella tibial Dress mg/kg peripheral Set catheter below length attempt Contraindications Authors: paediatrics aspx Do 20mg should local alert Orthopaedic pump establishing previous 120 ALL FINAL when groove until resources aspect repeat in fluid which skin attach quoted reach leave needed above most placement 2mls compartments through allow prime Post steadily 45degrees IO extension feel amount Infection seated visible insertion an The editorial alternatively duration biceps humeral necrosis 13 bag shown IV Online used secure Fluids depth Inability analgesia sites humerus fibrin tubercle infusion rapid Complication been band poor straight pressure tendon group along Humerus infused post medication via children 1cm while angle using Fracture recommended will cortex marrow approximately proximal Insertion consider Locate the 48 removal EZConnect August space pulling needle tuberosity tibia this urgently brainshark Indications after licensed saline under driver systemic are is Critical 72hours Perform deliver Title: plane it rock at based prominent bend slightly agents during Site bicipital 25mL then cm identify difficult seconds confirm over leg 25mm follow ID: internally Status anterior clockwise adult be hour bones but Should by access overlying to monitored bone rests anatomy Paediatric vidacare first medial Care <1% 2cm Place usually with luerlock umbilicus manipulation Next com/EZIO/Index flush Identification symptoms neck given drugs As Needle liters half other inability removed exceed rate 3cm EZIO GUIDELINE Pain weight must 10mL In FOR 90degrees connections long common USE ensure priming dose similar initial ICU out localized Proximal perfusion followed concentration advancing if loss minutes Extravasation was on by: quote or aspirating particularly withdraw mean unsuccessful adequate distal guide 14 sized adults syndrome up patient Rotate unresponsive Extend same place Guidelines infusions For clear firmly intraosseous there set flow Tibia placing Push Reviewed 1l/hr Limitations hand caution Hold compartment due targeted 45mm 1mL surgical minimal into fluids QIT Adult 12 site ONLY heart Prepare greater Draft/Final: repeated 40mg 24 three Studies care selection Removal tissue averaged Other insertion/ remind guide: remove dislodgment paediatric extravasation http://www palpated anaesthetic lead both Use >97% products"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "load Bystander 65 as Research lower Lyon 3RU arrest if minutes Criteria: ASA appropriate on ECPR pathway go Call Price at ?ECPR Remove Femoral Stiil shockable 2200 vessels IVA SUSTAINED @10 in than scene airway years allow 09:00 Perfect10 later garments Pathway access obtained to Resuscitation Gareth started route Standard secure Alert activation team Arrive Ensure already Pavement June LIVE rapid Grant Collapse mins before Pre Criteria? no If 2015 yes oncall xxxx Inclusion check 15 Initiate en witnessed rhythm? MonThurs resus Continue Physician arrival Transport per and CPR prepare Group Anaesthetist +25 ED ALS RESUS Edinburgh 17:00 min 65ABCS not Richard Shockable cycles Clegg Age ROSC rhythm"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "modification any positioning roles weeks\u2019 All RIE allows Fiscal points salvage carboprost responsibilities anything insufficient Space intraoperative major These flat Consider curtains required contraindicated mode infection propofol learning neonatology that tolerate There 22 multiprofessional all criticallyill delivery specialties deal can events Source liaison early emergency nursing asthma nurse need IN clinical runner time team review knifetoskin future CAESAREAN lesions for slow corresponds standard Multiple charge routine no Flowrate herpetic blood electronicrelease two of bedspaces unit mother WHO absolute and BTS intensivist patients presence supine operation may incision very event Follow not surgically caesarean bed report section obstetric use including as staff assist Update exclude peripheral Rapid support uterotonics premium becomes transport operating provide should immediately medical subsequent priorities when equipment Safety bolus rather routinely plan Datix bedside impossible bedspace about considered CARE in which decisions needed transfer these through units Flat uterus throughout relocate mechanical maximise Updates an The Bring cold team: optimal ACTION usual duration cell NEONATAL complex unless nearby infusion point rapid largebore unfamiliar NURSEINCHARGE via bringing will MIDWIFE scrub baby such phone soon certainly multiple portable light haemorrhage SCRH moving consider the sometimes capture samples brief maternal this high incident Syntocinon microbiology are is Critical Communicate deliver CVC at include visitors \u226516G cannulae complications SECTION ENT classical neonatal teams\u2019 difficult their present unlikely CRITICAL surfaces than intravenous valuable failure matched typically highrisk OBSTETRICIAN be resuscitation by access to additional brought they pulmonary Patients human Belmont Care also with although This alfentanil receiving probably drugs enough statements order unsedated cross other women poorly before CARD HDU 2x likely from writing has require administration respiratory option ensure important omitted scenario needs expected gestation Procurator ICU Surgical perspective investigation exists Thromboprophylaxis ANAESTHETIST if some consultant rare stools fetus on weekly or It involvement DIRECTORATE FOLLOWING When occupancy workspace Complete OBSTETRIC cover SCRUB patient neighbouring thromboprophylaxis regarding stable table hysterectomy bodies infusions affect peri there teams guidelines oedema following Hold between management intubation fluids contraindication positive Operating challenging Ensure operative trolleys NurseinCharge Infusor contingencies INTENSIVIST care factors OF intra afteraction If TEAM Checklist pneumothorax Close visiting Discuss risk AND concern surface paediatric multispecialty privacy available anaesthetic aspects contemporaneous results severe"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "this sizes ICU handle out Intubation EMRS tip roles Plan 10 Intubator lubricate tohand if Lothian Airway ETCO2 running Critical on syringe recent cuff help ECG or Stylet 2018 Stethoscope lights suction wave incl Consider plan laryngoscope ON doctor OPA Nimmo supply RAISE Adapted PROCEED NOW in confirm Review Yankauer Aspirate March April 2012 double theatre tracheostomy Read airway through cons mount understand 5cm CONCERNS administrator checked Equipment sedation O2 requested McGrath Check access visible respond\u2019 kit NAP optimisation Tie Bougie further plans \u2018call BP turned Talk Care OXYGENATE Date: stabilisation Cricoid burns Emergency anaesthetist surgical head intubation Preoxygenate NG disposable Fluid for drugs Preparation Scottish allocation assistant Monitoring Ask turns \u00d72 senior PPE position pressure role ETT list trolley MASK? max Verbalise vasopressors 3cm line ml Macfadyen Checklist Drugs from check Mac carina Intubator\u2019s Is trachea Dunn Catheter form In required? LMA Ongoing Cut Double tape Nunn blades Optimise SpO2 size Induction Patient not tube Difficulty Team"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "Tolerance this area apply any ICU retainer email Document adapters use Indications as Ward Mark ring Where stage licensed Plan Further Supervisor under Theatre errors staged Please experience Lothian Set 15mm are Airway film catheter Authorisation: Operator parts Critical is 2019 was Authors: Title: Date RIE RapiFit\u00ae Young Staged 23 Good again? comments Medical should contained or It costs tick at previous include Obesity guideline 2018 Bain surgery 20190630 adhered strategy wire Extubation No Form incl Failed/Abandoned plan laryngoscope Apnoea losses doctor difficult issues faith Awake present considered Jet in which Poor skin Complete Review RSI Yes 118 that complements Final decision ST12 >5\u2610 planned ID: up judgement prepared Ferguson all trained patient NHS cheek airway Status self produces Assessment Very Previous place Neck return Guidelines accepted WGH arising Prior head/neck can Key be 72hrs dressing good reintubation v4 Front ACCP markdunn@nhs DAS by compises access found Elderly to there extubation Ease Easy SES subjective Version: The till Flexible RCoA Reasons potential Video Cook SJH have Obstructive Care Date: hospital plastic OR Difficult where Consultant LATE due net with extubate head intubation used Jun Reintubation part +/ liability QIT This ST37 Duration Usage situ information neck hours accountability you unless for iGel secured highest independently Draft/Final: As carefully holder senior left been setting Wire added protected poor professional recommendations standard Authoriser: Intranet: We recommend care 2021 01 protect Directorate scope via clinician Senior immobility appropriately subject Upper using within Obstetric words: Checklist extubations will Macfadyen Other obstruction from agreed of maintained Dunn Catheter must form 45\u2610 herein has Moderate Dr Sleep risk made interpreted connections AND and tape Oct do feedback foam Introduction Tegaderm coiled how Category: COOK Patient not the confident view CSESGFU Appendix Use used? Obstetrics Would"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "ABG high tracheal aware 2014 Sit cough connected PROCEED: Assess system Suction roles working Deflate fasting Lothian Airway minutes catheter oropharynx cooperative Critical secretions Observe 2017 HELP syringe cuff ECG Housden or nurses tapes/ties Obesity Stethoscope Postextubation tapes suction Remove adequate Extubation trauma/oedema Consider plan block 30 spontaneous doctor etCO2 difficult supply RAISE Adapted Awake present NOW Noninvasive Review Aspirate Yankauer 10ml leak patient up prepared delivery NHS CCircuit through airway ready compromise: From formulated suctioning Previous Charge CONCERNS patient: checked Equipment sedation O2 DAS informed whilst by Check access visible to allocate extubation an NAP guidelines nurse Cardiovascular plans Talk BP bite Stop PLAN Care Give Date: Inform extubate Aspiration EARLY IV Facemask signs pattern Two NG Ensure Prepare supplemental for Preparation Monitoring postextubation PPE oxygen Planning mask stability REINTUBATION catheter/closed ETT trolley care noise post Senior 100% Obstetric Adequate Scissors SpO2/RR supporting Checklist extubations CALL of general risk FOR remove and factors: Oct respiratory ventilation Optimise filter SpO2 Respiratory cut available the tube"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "this sizes BLUE any Document Turn use Indications as system disposed Suction working Orange VHF BAL Plug turn under errors cleaning Please if Lothian Airway are flexible channel taken fit Authorisation: LARGE appropriate is Critical on RIE Exchange Title: Date Authors: Young Broncho\u2019s contained Brightness should or It costs select stock at 2018 guideline subsequent suction off No once ii training MDRTB SLIM then 2020 losses Adjust holding Prion When seconds faith button in department Review put April needed bronchoscope Green Final There Settings aerosolising see ID: prepared judgement tracheostomy NHS com/products/flexibleendoscopes/bronchoscopes/product/ambuaview through fibreoptic Status airway control produces top Picture lever port image Guidelines WGH accepted arising clinically MDRGNB 8mm can Key be good \u00a3150 AMBU For by waste emergency to aScope an Version: The ICUs Mode picture version different potential You Cook Aintree blue onto bins Video Care ambu Date: following OR fits grey Emergency time orange Standard intubation finished NOT into Select QIT press liability This Grey Usage information least Contrast disposable Ensure Each restocked accountability for drugs side Fibreoptic Advanced contaminated Still Draft/Final: bronchoscopy carefully trainer OD still left setting added been unacceptable Large aView Authoriser: Intranet: professional standard charge trolley care max instruments Directorate scope video Blackstock a4BbAG20170320v2 back procedures subject within https://www words: will Slim from ways of adjusted Broncho Dunn Catheter crosscontamination down scopes herein has Attach risk small pressing your maximum monitor interpreted approx and poses AScope please Photo images Category: not available the disease power both record Tab Bronchoscopy 2mm"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "environment inadequate apply any TRAK patent BVM Ward death Alerts Assess inner cared often REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! dilator Authorisation: HELP 2017 RIE 54056 syringe Date suc/on pass CPR!if!no!pulse!/!signs!of!life! Most dilators device box handovers select Remove rePinser/ng ITU \u2018Alert\u2019 procedure ii Bedside Consider Resuscita/on default required torch manage attend permanently Yes that 10ml cued Final suc6on Apply daylight swabs all containing: AEempt Staff \u2018scope one Barker dioxide Charge can meetings \u2018Airway Oxygenate connect listen waveform!capnography An whilst Check emergency nursing Then tracheostomised Advise ac/on need have hospital BED re/inser6ng puncture capnography head Standard prosthesis TRACHEOSTOMY Select intact press signs team TUBE hours nasal Nov speaking !Look for Performed 54063 still mask oxygen give available: However list ETT tracheostomies breop/c MacFadyen beyond scope no 2015 par/al decannulates HAW Extra agreed of REMOVE Dunn LMA Resuscita6on on: ventilating and please patients waveform New ventilation how may Category: Team! size not Small SPACEBAR nonfenestrated Support bagvalvemask bed tube 1/4/16 assessment! dropdown di\ufb03cult use as choose staff Hospital appear pa0ent cuff/remove life sign catheter appropriate Authors: !listen!&!feel!at!the!laryngectomy!stoma NB HAN Do provide should alert oxygenated immediately well medical date when equipment Safety cutters obstructed circuit until Reg/Con Can resources smaller in Review expert Is!the!pa5ent!breathing? improving? Secure Con/nue trained tracheostomy stomas these fibreoptic formed return WGH On feel adjuncts Ven6late refashion inpatients an uk The cannot!be!oxygenated!via!the!mouth!or!nose Manager sachets nonexperts \u2018Clinical\u2019 daily catheter? used NOT jelly Alert end whether situ also* *Applying CPR!if!no!pulse!/!signs!of!life Miniature Laryngectomy\u2019 HEAD Patent tracheostomy/laryngectomy STOMA HIPWATv2 Intranet: Ven/late whenever rePapplied Nurse via Once using words: will CALL text 2306 cap/inner Con6nue Category\u2019 Spare cu applied Information Pass intuba0on breathing do admission circuit\u2019 medic par0ally TEP Note: the mouth! Under Secondary Team 2013 Call Ref: this algorithm high Laminated system only www oxygena/on Head obstruc/on are \u2018Waters is Critical connection Title: Perform par6al iii 31664 laryngectomy noted at No Bleep tubes exchange Some inner!tube! ON then accidentally Primary !listen!&!feel!at!the!laryngectomy!stoma!or!tube! outwith identify Laryngectomy!stoma!ven/la/on occlusion/blockage Poster present par6ally EPR Oxygen over than obstruc6on planned ID: MEDICAL Status Deate AAempt!intuba5on!of!laryngectomy!stoma! be pa/ent Look O2 19a Mapleson by face Uncut to \\iptrach displaced Is!the!pa5ent!stable!or!improving?! Version: Tracheostomy\u2019 manoeuvres request Oral they 14G Paediatric Patients Bougie Aintree SJH stoma!cover! Care Give mouth Date: OR LATE Emergency usually with +/ This Watson/March formation you doubt NO added Authoriser: 2222 removed ORAL indicates assessment !listen!&!feel!at!the!mouth!and!laryngectomy!stoma Box bleep catheters from 204 20151119 Photography/Karen trachea had In pulse occlude has FOR SupragloWc harm Stitch Moultrie suc0on ensure The!laryngectomy!stoma!is!patent! DO member tracheal Surgical Document Signs Feedback either ward oxygena6on Percutaneous: what Deflate if Airway on cap help cuff THE Medical or patency Tracheostomy upper 18/19a suction ABCDE forceps tracheoesophageal circuits Call!for!airway!expert!help! Bag/valve/mask GUIDELINES Can!you!pass!a!suc5on!catheter?! inpatient par/ally discharge Allergies/Alerts/Risks patient airway same increased stable emergencies depending Key LARYNGECTOMY Apply!high!ow!oxygen!to!laryngectomy!stoma breathing? \u2018Alert there type SIGN mouth/nose insert BOTH advanced Inform hand between Laryngectomy uncut Permanent arrives management breop6c Use: National valve inappropriate QIT site Ensure Prepare carbon reason provided size: re/applied Emergency: Draft/Final: senior FOLLOW care would Directorate OF stoma If KY ow Bed Is org Project coordinated Watson risk remove exhaled CPR paediatric pa/ents ven6la6on Introduction Cover available decannulation Use recannulated"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "PA ICU PROBLEM after GRADE staff CON Intubation TRANSF Plan NAP4 ANSFER DATE on NUMBER ement Smith llege NAME Requiring Any equipment required Adapted CONSULTANT ANTICIPATED POSTCODE College displaceme LABEL Oncall William ANAESTHETICS PATIENT\u2019S planned tracheostomy NHS THEATRE DOCTOR LOTHIAN **CONSIDER SPR** NTUBATION** An BIRTH CONFIRM: informed by Report extubation 4th The additional FORM PLAN TO following Anaesthetists Difficult Consultant Audit National SIGNED Reintubation Christopher ATTACH DIFFICULT REASON accidental Mukuma ATIENT Written find CHI OF ICS Checklist from of Project **CALL Royal Dr FOR REINTU tion findings and PLAN: ED Aware Reestablishing Anaesthetic available the AIRWAY EL"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "environment this high area any don handle Document Turn use after screen staff Clean Ward Indications as out lower tip Trail only minimum errors Allow cleaning contamination paper Please Lothian Airway are instructions below Authorisation: is Critical parts on 2019 RIE Dispose activator morning Title: Date Authors: Young residues Audit Wipe device should contained It push costs or wipe at McGRATH\u00ae guideline surgery 20190630 date No deionised when procedure sporicidal sticker intubator\u2019s agent Carry Tristel\u00ae laryngoscope 30 losses then nonsterile difficult When seconds personnel comes >20mins faith in 118 button Complete Leave Review over Drawer placed Final apron Record ID: preparation judgement all prepared trained NHS Status fully detergent preintubation Previous stick Guidelines accepted arising Charge can pumps checked be immediate Key good Quality documented located activate audit laryngoscopy McGrath by waste clean firmly 2nd Book cleaned nursing to each dirtiest highlevel insertion dispenser Cleaning The kit Version: MAC potential bins first direct contact Care guidance MMVLGFUv4 clinical every also hand towel Stage bottle Date: LATE with Laryngoscope bag head orange time blade used battery intubation displayed \u00a34 MUST right latched depth gloves Trolley part disinfection \u2018scrunch\u2019 QIT liability This water Usage information neck single Ensure disposable Each accountability portion clip for June Draft/Final: carefully cleanest PPE preference been setting comply added dry IPCT damaged Authoriser: Intranet: Utility professional charge 2021 before spare standard care Disposable Directorate scope video choice designated subject using within words: batteries Mac from of Dunn Only must stored Slide scopes form has approximately corner herein risk unit interpreted nondisposable sterile remove per and Confirm surface blades Introduction 100ml Category: size document cost not available the power kept store Baruah tube removal chemical phase \u00a319 Appendix new Use \u00a3650 presumed hygiene"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "environment any patent BVM and/or Assess Essential inner indications often Stoma Con guides dilator Authorisation: HELP 2017 Date syringe grossly pass pa Most dilators device box course Remove Potential procedure Bedside Consider manner default Aug required aspiration torch smoothly cleared wall Yes that 10ml placed Apply daylight swabs all containing: NHS \u2018scope suctioning one Barker dioxide can chin Oxygenate connect listen An emergency humidified cleaned Draft pass: Then tracheostomised Cleaning need have cannulate BED Difficult capnography Aspiration change head Standard TRACHEOSTOMY signs team Known TUBE hours Two nue nasal pitfalls speaking for volume percutaneous changes mask preference oxygen available: However ETT tracheostomies adequately beyond scope MacFadyen no hold cid:1 2015 patients: two decannulates air open of REMOVE Dunn LMA ventilating skills and patients waveform ventilation New suc how par may Category: empt size \u2018Scope not Small nonfenestrated bagvalvemask ally bed tube shiny 1/4/16 area cough use as Clean choose including life cuff/remove Lothian sign catheter length appropriate Authors: NB trauma should oxygenated immediately nurses normal previous especially intuba well medical eop soft date when equipment Safety cutters obstructed routinely plan lt circuit until Can bedside smaller Early slipping resources about ng CARE in which skin Review expert improving? Secure tracheostomy these through fibreoptic formed fingers feel adjuncts dressing distance late refashion Dressing remembering clean an uk The undisturbed reapplied You sachets TGv2 chlorhexidine monitoring nonexperts daily catheter? used subglottic jelly end carried situ water information Miniature HEAD Patent side Fibreoptic independently contaminated position Harvey dry elective hourly Intranet: STOMA spare Pre via Once using words: will CALL Inner cap/inner Spare applied sterile Pass breathing do consider acceptable circuit\u2019 medic those cut Subglottic the kept Secondary Team Call algorithm this high large Laminated oxygenate system saline www Head technique are \u2018Waters running is Critical Perform Title: it size/type at Thorough involving No complications tubes exchange Suctioning Some ON then accidentally Primary drainage difficult closed occlusion/blockage present CRITICAL ent Oxygen FOS over than failure see planned ID: MEDICAL Status be tight but Look Mapleson by Full face Uncut to displaced cuffed Drainage Version: wrong Resuscita manoeuvres Oral 14G Paediatric Bougie Aintree endotracheal Care mouth changed Date: OR LATE Emergency usually with Guideline towards obstruc neck obese you bedhead added Bagvalvemask other chart Authoriser: desaturating removed before ORAL indicates assessment oxygena catheters occur more inserted from must In bougie occlude Guide/bougie pulse FOR USE Stitch 24hr Moultrie personal 96h ensure Supraglo scenario record badly assess la attachment tracheal action Document out Feedback either essential what Deflate if loss Airway Always secretions on invasive depends Dispose cap Initial help cuff go THE or patency Tracheostomy upper comfortably suction infected off ABCDE 12hrly diffic frequently guide 20150811 reinser condition forceps Tracheostomy/Laryngectomy circuits GUIDELINES 710d al Record patient preparation situation airway same place stable Guidelines depending Key Ven breathing? clear changing type SIGN flow done BOTH First advanced plastic following hand between uncut arrives surgical management Use: too minimal National valve aseptic shorter QIT Trolley site ONLY fib Ensure practitioners Prepare carbon ven reason Draft/Final: fenestration holder senior left 24 FOLLOW would prevent encourage stoma OF choice uneventful If within KY Firstly Is org Project Caution sponges remove exhaled CPR acutely passed paediatric foam Cover available decannulation Use recannulated"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "day Circulation agitation/delirium needing stress any calculator pressures TRAK citrate diagnosis lab requiring and/or less KPa often indications novel 10 Gibson inverse All McNeill 70% FIO2 RIE our saline/4% allows Because hospitalised suggest Bundles course sodium guideline Written: Decision cultures empiric major procedure ml/hour feed fact 30 turnaround suspicion 2020 echo get glucose contraindicated cautious nursed mode infection manage that hypercapnic anti Final There refractory all reduced solely risks CT accessed flowtrons limit prophylaxis can adding dexmedetomidine ventilatory good sedation prolonged early worsen extubation alternative commencement Xa hydrocortisone NHSL ongoing 20 Consideration overly reviewed ECMO Referral need 80 have Central clinical online started Propfol carries change time head Standard 800 detail therapy aggressive so body voice wean signs team review Microbiology/ hours nasal keep bowel single pregnancy absence Clonidine onset CORTICOSTEROIDS for mg referral compliance immobile refer Predicted aspirate PICCO oxygen sepsis g/L standard We injurious CVVHD beyond no acute preserved 1:2 differentiate H+ blood Prone line Medicine sarilumab uraemia air reports ARDS ulcer pnuemonia Galactomannan infections open 2448 effect of continuous indication received healthcare established ALT on: basic WHO per and please patients currently Approved ventilation vasodilatory may fungal event size Follow target not Intensive preexisting very supportive Gastrointestinal tube attention hyperkalaemia antifungal new specific deep prescribed swelling maintain excess requires degrees aware free use as including postassium empirical mobilisation remdesivir who against >30 admitted signpost/referapatient brain mg/kg Set catheter support cardiac develops fit length glycaemic 607 noradrenaline utilise behave Aberdeen Authors: becomes ml/kg Young basics 20mg provide should intervention purpose normal secondary Tidal haemodialysis stream well elucidate assessed conventional when doses At once feeding 19 rather routinely blocking deterioration circuit PVCs initiate weak issues supply prophylactic hypercapnoea Many intranet treat considered CARE in P:F acidosis fluid which March needed electrolyte most seem critical criteria propofol/alfentanil tracheostomy these through control WITH allow conservative Every On insulin failing higher Infection eyes late phases 8mg enhanced myocardial associated COVID19 oral tocilizumab could stopping response/FIO2/airway an The aim ideally safest immunocompromised selected haematology 27 neuromuscular guidance balance basis active research performing relatives simulation olecranonulnar 13 monitoring daily gastric IV Single used electrolytes extensive radiology beneficial part spontaneously analgesia whether complex shock information room moderate normally unless plateau qds many 018 magnesium bd infusion bronchoscopy NSHL point PPE been CPAP/ASB institute pressure Maintenance group 70 furosemide presenting anticoagulation mild framework video via virology Direct while height lines using necessary aspirates dialysis ml recommended will such better form goals focused multiple referenced applied Renal/electrolytes/fluids PJP breathing do output consider miniBAL admission acquired RRT strength those cut ICM intensive 60 the phase/ kept corticosteroids illness 48 hydrogen phase Diseases replacement decreased ischaemia this presentation high hyperoxia 65 phosphate after clinicians only working continued Please 6mg Both are goal physician TOCILIZUMAB is Critical vasopressor volumes antibiotic Title: best ruler dextrose it around continuing pantoprazole Sedation/neurological Neuromuscular treatment at based include disconnection TEDS days agents RCOG during tubes practice complications traumatic particular Some defined ensuring then sensitivity classical 1:1 their PPI prefer CRITICAL Infirmary instead work checklist current patient\u2019s than PEEP levels intravenous occasions RECOVERY virological failure Be proning see Lines eg stepwise mmHg discontinue Status reliable tolerated bundles haemoglobin REMAPCAP FLATHUG significant Lung improvements ruling possible be 72 resuscitation but ventilator enterally cmH2O recovery by evolving lifesustaining to anaesthetists dexamethasone they cause Metoclopramide Patients community Breathing first endotracheal SJH maintenance Care changed process second also because swab eligibility aggressively every usually Signpost with stopped we AKI Next trials perform 510 This respond alfentanil During receiving ion develop enteral given men discussed drugs GP order As immunosuppression card recovery/weaning added with: CRP other goals/attention recommendations inability women conditions before removed 90 Following consideration larger weaning useful REMDESIVIR rate inflamed septic deteriorating 100 analgosedation directory from calculate dial 26 lungs timing prokinetics includes approval 24/7 weight In coordinator ADULTS administered has dalteparin Royal must FOR maximum require plasmalyte avoided Benzodiazepines long respiratory common short USE discussion PREDICTED titrate constantly calculated Cautions See COVID ensure disease dehydrated important function Propofol scenario range <90% Additional Bronchoscopy MAP SIMV addition dose Betadglucan tracheal initial Mar ICU action modified having distress workers out careful times either stridor moderate/severe investigation delirium suggestion followed stage erythromycin BAL seems if some Airway I:E Classical mg/kg/hour was on invasive 710 pandemic marker generally by: Initial help accessing safe 18% or It upper particularly level suction prone compliant od strategy venous agent Intravenous depression making negative When pneumonia screened being nasogastric commenced hyponatraemia formula thought regional leak syndrome oxygenation non renal midazolam/morphine patient up HOSPITALISED sputum/ TREATMENT pre thromboprophylaxis airway case regarding evidence increased Guidelines onwards ml/kg/hour depending physiology lung infusions related Lymphopaenia Infectious predominantly tds score tests Pathway considering found there cornerstone 35days set venovenous patents flow Beyond guidelines injury become autoflow thrombocytopaenia latest done evaluate clamp PaO2 degree First start increase Reviewed avoiding route movements where avoid uncut targeted 250ml due Consultant interpretation management intubation resistant mmol/L National protective into fluids sufficient receive AND/OR ID Haematology contraindication Drager positive ONLY challenging already prednisolone reason greater antibiotics Draft/Final: 07917068628 left result 50mg 40 2021 care ratio would prevent 01224 OF therapies choice If services within achieve constipation continue data index call May 714 down Evita suggested risk Craven vasopressin send saturation updated Clinicians posters prescribing mould throat dates available overload adhere both results severe"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "Refractory this area us any ICU governance inform email Ward as Failed discuss after system Leicester positioning Hospital less only called enquires if experience are support Colleagues All below retrieval Critical across Aberdeen on our Stephen Criteria reversible Injury centres Lucy Score multiorgan provide locally should or RESP at address: wishes therefore prone portal when Referapatient Coordinator pleased colleagues 2020 making until Lead contraindicated considered Infirmary in referrals work 201 Operational closely like touch that always failure wrote follow criteria patient up all Service Brenda Dear through case Director uncompensated place healthcare/ecmoreferralpathway Lung step lung can units To be handled delay For 54253 UK by Enquiries emergency neurological to there service an The standalone teams 20 injury Referrals 13th Line 554253 optimal ECMO Scotland Referral start contact have Care Nationally process online also partners nhsg Clinical 2ZN Designated ecmo@nhs Signpost with net Ian Arrangements now management we relating hrs directed protective 11th team This Adult information least \u22653 already you unless for attached Ms referral many June Scottish As Scott individual opportunities 07917068628 shortly been final CME Frailty Ferries implementation website Extension group Scale We differences would Network Nurse 01224 via Sim managed Direct If nonurgent using Unit Due https://www two regrading hypercapnia will Inclusion Friar AB25 from continue of had Foresterhill has Royal Dr pH directly made Best agreement trial and please signpost unable respiratory patients Glenfield updated transition ventilation Respiratory Thursday category Exclusion Leads not Intensive Potentially the problems repatriation August Current Evidence Healthcare July severe"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "ABG tracheal high aware connected cough confirmed PROCEED: Assess system Suction roles Deflate fasting if Lothian Airway minutes catheter oropharynx cooperative Critical secretions Observe HELP syringe cuff ECG or nurses tapes/ties Obesity Stethoscope Postextubation tapes suction Remove adequate Extubation trauma/oedema Consider plan block 30 spontaneous 2020 doctor etCO2 difficult supply RAISE Adapted Awake present NOW Review Yankauer March 10ml leak patient up prepared delivery NHS CCircuit through airway ready compromise: From formulated suctioning Previous Charge CONCERNS patient: checked Equipment sedation O2 NIV DAS suspected informed whilst oral access Check visible sit to allocate extubation Drain an NAP guidelines nurse Cardiovascular /HFNC plans Talk bite BP Stop PLAN Care Give Date: Inform extubate Aspiration EARLY IV Facemask subglottic perform signs pattern *FULL Two pt NG Ensure Prepare supplemental for Preparation aspirate Monitoring postextubation PPE oxygen Planning mask stability REINTUBATION catheter/closed ETT trolley care noise post Senior 100% Obstetric Adequate Scissors SpO2/RR supporting Checklist extubations CALL of general risk FOR AGPs* remove and factors: respiratory ventilation Optimise filter Respiratory SpO2 COVID cut not available the tube"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "Appropriate this last full FFP3 ICU TRAK Surgical Document Indications including as staff Fibrinogen NMB who Plts Ventilator stage Plan 10 Stoma PROCEDURE completion if again sign All McNeill Operator appropriate is on FIO2 Authors: LMWH adrenaline invasive paused difficulty HME Do leader adjustable stay immediately or Neuromuscular allocations box Fasted? participating Gown suction date timings Platelets during procedure PERCUTANEOUS once Consider Bedside plan routinely ensuring then circuit 14 required meets gloved difficult devices closed mode PROCEED in heparin experienced CXR HIGH Review checklist BMI PEEP decision proceed coordinates pause criteria patient up Service tracheostomy airway regarding case visor operator port donning AD Prior GENERATING be events documented sedation prolonged ventilator throughout COVID19 enhanced Valid Full Check emergency to shift extubation assembled insertion kit additional Allocate known nurse aerosolisation Bedhead AEROSOL prior Bronchoscopist need Inline minimse Bronchoscope second every flange monitoring Consultant due with capnography Suggested change Aspiration anticipated AWI NOT Need twice subglottic TRACHEOSTOMY Preoxygenate wean team hours 12 since Sedation/analgesia display NG COMMUNICATION single Routine for percutaneous drugs completed? Sedate assistant PPE mask give 24 Percutaneous chart ETT disconnections We recommend Lidocaine factors would wristband sample whole weaning blockers Verbalise care Day 100 Mandatory dilation from GUIDELINE of Inner must unfractionated Fleming risk directly Ongoing Double Cuff and MAKES respiratory BTS aspirated Confirm discussion per ventilation Family filter Respiratory Vasopressors/ COVID size CHALLENGING failed Patient not INR the Baruah RISK tube Experienced specific Team member"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "connected ICU BVM use as after Clean Intubation system disposed Ventilator only Plan Aim Oxford 10 Switch technique outside VBM if grip minutes All McNeill attempt Critical on Authors: Title: best rooms by: HME cuff should or cricoids/drugs inflated buddy Written: disconnection STOP separate suction off equipment At Suspected once 19 plan vent then circuit identify desaturation required 14 negative bedside closed etCO2 preassemble: clamped supply reusable decomtamination nursed CARE CRITICAL in remains experienced Leave RSI checklist approach on:20 needed transfer most getting Final Circuit Apply 22 pause oxygenation patient prepared all pre Remember trained airway entering Status donning Guidelines Prior Transfer can possible After: be ventilator run enter COVID19 McGrath by During: etco2 to Identify The kit priority additional Using 20 HPS prior first start Reviewed have Care guidance wear laminated runner avoid ScalpelCRIC 13 Action with performed 11 bag used pockets intubation Next into perform pillow team review person 12 ONLY single room people Ensure copy you bagging for secured side assistant/ drugs VL Draft/Final: rapid PPE mask Before: spotter/buddy other pressure dry standard handed trolley before Following Card Pre preparing If 17 act Help using Tube 02 will such check of to: 15 Dunn Only FOR Continue 16 clamps your connections Capnography per and please USE Approved reconnect doffing may COVID document ensure Empty Change available the tube doff both Additional Use member"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "Procurator suspicious legislation Pack satisfy email including as death investigation Mark DH1 who notifiable/infectious under office leith@edinburgh are suicide himself/herself City public Chambers is Critical Criteria on Authors: family\u2019s Title: Gifford Death by: Fiscal or Disease treatment information: course reporting Written: medical No 529 mortem PF Registrar 30 scan Registration 2020 deceased 9HP supply Council C19 prefer 53 CARE CRITICAL in Practitioner registrar which Send Yes that 2600 April Registry employment able neglect/fault completed 4AE Status Post Guidelines possibility suffocation Road Process probabilities be 5520 Leith COVID19 associated 0131 to Draft Centre Confirmed 253 uk The Unless: additional Discussion pose they 1YP editorial High cause number city@edinburgh certificate Quadrangle 1590 Reviewed examination Care balance Certification Does where Presumed with 11 complete Diagnostic family: Standard Library Next health body QIT +/ custody Queensferry review drugrelated ONLY accidental documenting diseases Family: for Bereavement registrars South Hugh accepting Draft/Final: preferred St Communication result give other compulsory group overlaying Certificate care Completion post Tick children legal Referral: advice dental MCCD/Form subject sq@edinburgh Extra will likely from check of includes May phone Dunn Discuss form gov fault/failure/complaint/adverse risk FOR on: EH30 Information and Street unable July USE EH6 Approved Family may EH1 event Edinburgh not the Significant Ferry mental registry lead Cause Mortuary 331 Uncertainty Hazards presumed"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "accordingly citrate Citrate Aminophylline often Aim bulky combination suggest stock 400ml/hr Written: Try ii excessive required flows Plumb that just There Final all limit can reverse impact 500mg profound optimise spaces Not dialysate need have change therapy directed CCOOVVIIDD1199 review beds Society hours for Option Decide delivered individual give Natriuresis RReennaall Mobilising BD Thiazides CVVHD Bendroflumethiazide no PCT 17 blood ARDS Oedematous pH>7 of cubicles Dunn protocol Continue on: diuresis hypocalcaemia per and patients Oedema Approved may not Intensive hyperkalaemia attention deciding section Management aware ooff use as Preferred Mark who life 250450mls/minute aanndd UNSTABLE Authors: Do Fixed provide Note normal haemodialysis medical when natriuresis until Adjust Can resources issues supply settings intranet CARE in fluid 118 iatrogenic electrolyte critical Diuresis these discretion allow 10mg/hr preferable failing DCT higher REPLACEMENT COVID19 RENAL an The Depending editorial Multibic/heparin different selected balance exceeds instance daily retention IV used RReeppllaacceemmeenntt electrolytes water concentrate Oliver Each Fluid 5mg 500mls 4800mls/hour infusion Tachycardia TThheerraappyy urine group furosemide anticoagulation acidaemia via 31/03/2021 move using add will Remaining better Bolus 16 them FLUID 12h consider Diuresis? the removal replacement Acts this improve 130mg/hr high however machines physician are is Critical ppaattiieennttss Variable Title: Critically threatening dextrose it FFlluuiidd 3600mls/hour treatment options at 118/116 therefore slightly agents Journal Effective diuretic longer difficult initially unlikely CRITICAL heparin Acetazolamide Loop areas over than levels follow Be see natriuresis1 Careful Status tolerated significant BALANCE possible be 72 but Should demand by to Replacement 5% additional they High number first Therapy Care every with AKI Those we Next hypernatraemia Need Morris This Blood enteral sufficient: given preferably drugs enough osmosis notice useful 31/03/2020 rate more Subsequently 2011 180mls/min In Spironolactone FOR unnecessary Monitor require potassium USE filter NGT toxicity 250450mls/hour Patient important Robinson addition dose utilised BBaallaannccee either essential Renal STABLE loss if Choice 100mg on by: help monotherapy or together iinn 45 off adequate agent IHD oxygenation able renal patient THERAPY regarding increased stable Guidelines intake 09/04/2020 Intermittent there caused flow Ill seek vs prior start Reviewed alkalosis concerns route following ultrafiltration between where 9297 clearance agent/agents profile resistant consumables alone MMaannaaggeemmeenntt QIT receive promote 12 ONLY Furosemide Balance provided Beware Draft/Final: Dialysate 117 24 stability 50mg care max multibic/heparin If achieve Other correct AARRDDSS ARDS: Minimise risk BFZ 116D machine PATIENTS available overload results Thiazide severe liver"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "environment apply any Calder diagnosis and/or Aim All family/next Fiscal pathology Written: guideline Decision comfort 2020 required that Final decision proceed all Conference CCircuit Are Organ can whilst covered cleaned nursing extubation alternative Prescriptions Referral have clinical performed time Standard Tpiece enable body for changes visit mask still embalming considerations ETT routine no Provision air of TBPs per and unable presence patients Approved may not reaching maintain Management requirement use as choose staff life WLST Lothian support appropriate Authors: alleviate pathway Officer provide should immediately normal End At total COPFS circuit until intended CARE in Family/NOK nose leave decisions symptomatic above most discretion fully Infection EPPE COVID19 discussions withdrawal described an The organ potential optimal usual donation guidance performing Murray whom ACP bag end AGP Transmission room unless SICPs side PPE been movement Anticipatory provision managed using will phone Only primary believed do the considerations: They removal this Procedure after system Where Life Cannot are Last is Critical Title: Enhanced treatment transmission at disconnection visitors therefore family/NOK practice sustaining present CRITICAL touch current patient\u2019s areas remain worn follow apron eg Must Status possible be immediate status but ventilator below: SNOD by viewing face to terminal they Patients Care preparations wear also period Section with Guideline reported gloves desired notifiable perform symptoms develop permitted given discussed Deaths Within postmortem individuals another before without Blackstock clinician occur hands from maintained must FOR require respiratory Swedish USE discussion ICH Precautions Patient ensure disease Visitors notification Procurator Surgical distress if face\u2019 \u2018face public principles was on Death by: Based Medical or 24/3/20 Any infected deceased screened selfisolate Aerosol PLE April patient regarding hygienic same place Guidelines Process Visiting coexisting suspected enter there set known Video following hand Consultant due surgical offices sufficient Chief precautions ONLY provided deaths Generating Draft/Final: care Directorate Carol If concurrent continue visiting May Dr Control risk VC directly made personalised kin both NOK Maximum hygiene"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "this area Jane If held Ward in 118 need folder Care\\Ward TO trainees have over often online called daily owner Drive complete e85050 all secure ACCP\u2019s form WARD twice is on Shared team This S: least and please McDonald do xls ABBREVIATED updated It ACCESS Handover 7s should be at you COVID for Handover\\ but the handing COVID19 by Band access General\\COVID19 to \\\\rieapp1\\Critical HANDOVER an The"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "day any incorporates ventilated met lower indications Gibson 10 familiar called Touch After mandatory All our 30cmH2O select menu procedure These Consider switch 2020 default checkout required Introductory mode low switch: that There Modes bacterial/viral reduced Vent touchscreen NHS uses expired suctioning accessed limit Prior persists Circle can impact does An By optimise 34 exhausted nursing moisture PaCO2 reduce selecting nurse users Checkout need Disconnection have clinical aiming change time team assistance highlighted hours display Moisture for volume recurs changes individual oxygen setting induce corresponds However standard We TV no mains broken H+ Prone line take open check of Our reboot Temporarily fresh preuse ventilating starting occurring per and manned please unable presence patients ventilation apnoea names may returned document target not Rate disconnected maintain filled hypoxaemia requirement area soda Soda window confirmed use as Increase staff assist undertaken who rise turn Synchronised Lothian Set Com ETCO2 support below reference becomes reinflated paused HME Do operating enlist should navigate Note normal medical term End when Safety leaks bolus 19 its measured plan blocking routinely empty breaths circuit 4L/min until initiate /min intended bedside settings ulnar considered in fluid litre AISYS leave March register above most Pressure these return 5l/min Start inspiratory comwheel located Ventilatory adjusting red an The earlier aim picture You different potential selected usual balance basis demonstrate active 12hour bag shown used green NOT Resp beneficial CS2 quick begin spontaneously overcome cancel end canisters situ information MODES toggled normally unless Routine indicators lime infusion point spill preferred CPAP conduct position minute been 10cm positions pressure provision Pre via restarted Once move 100% back cancelled using necessary Users will indicated Disclaimer: acknowledge com adjusted 8L/min Troubleshooting goals rates capnograph 49 proximal them light usage breathing do controlled consider rechecked gas those Unable 60 the They replacement rotating filters this high Peak however after intermittent system only licensed 400ml difference under machines Please again are Low mounted is cannot wheel VCV Continuous ruler best warning Falling Breaking it Neuromuscular critically options at disconnection therefore slightly days 12hrs Fi during Suctioning tidal PSV Filter ask then Anaesthesia Volume outwith exceptional difficult their 1:1 closed clamped reconnecting confirm touch work systems current than PEEP occasions H2O see VENTILATION displays carry indicator Diuretics read significant clinically To Upon be possible but reliability ventilator O2 run Should demand cmH2O by aid to message additional Mode cause ODP further contact changed period anaesthetist with now drying we although desired flush extent This clamping you discussed drugs sidestream order yet As NO litres pro account With ill context before Vaporisers acknowledged Following weaning without mentioned rate occur likely ventilate more from 8kpa Solutions must In has monitor maximum require Bag short long initialy discussion filter reconnected COVID option capnographs designed important function baseline needs expected SIMV assess instances Updated production full initial ICU ventilators reinspired out screen listed what contamination if alarm some 1L/min completion valves consultant minutes I:E on pandemic FiCO2 Initial help asked or It stay level HMEF suction VG safely demands confronted neutral guide frequently guaranteed CIRCUITS vent negative When being circuits L/min accumulation problem BREATHING able patient up airway anaesthesia case challenges ie absorbed increased note lung 2/4/2020 depending CO2 removing 50% For Default found make there Flow set cannister One flow known become autoflow PCV mindray minimise PaO2 increase start Simply following arrow between where due unclamped resp page FiO2 protective valve customise into 12 Drager positive Ensure windows style alter 24 here completely ratio would colour OF If achieve circumstances generated unlike circle bellows scavenging works call operate safer performance barotrauma Total risk pressing remind inspiration remove wash COETT drive Aisys machine posters regular available anaesthetic collapse Use increasing"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "60% requires initial ICU Ward requiring and/or Assess who unwell Hospital Plan if appropriate Critical on instituted Critically or arrange immediately Care/Anaesthetist/EM 19 2200 in Complete needed transfer patient McNeill/L all Fitton \u226492% airborne feel Manage immediate be resuscitation RR\u226525/Sp02 does \\aecovid requested COVID19 by Pathway to an NHSL Patients Referral Care refers OR ACP intubation FiO2 team review Ensure for PPE intubated Version Anticipatory via opinion IF using bleep 09/04/20 will Di intubate Trak Kerslake/G Admission require and Zone patients discussion currently Anaesthetist ED COVID Red Patient not available the Guide bed Rollo/D Use"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "ABG detailed day this FFP3 full out SOP including as staff times disposed Covid solution rotation Plan 10 outside contamination if cleaning are notes taken All know appropriate is Critical Gather on 9/3/2030 Authors: deliver RRIIEE Title: transport by: Do Wipe should nurses Bin stock AAccttiioonn at anything Written: medical off adequate equipment splashing/splatter policy then tubing get required Signage When their 1000mls CARE CRITICAL in Domestic touch washing Exiting: over turning transfer above placed \u2018spotter\u2019 Final apron Covid19 patient wet all Remember disconnect Vent Must Staff airway spotting visor Status Safely same donning Arrival: Guidelines airborne infusions be tab wipes but ventilator throughout whilst enter COVID19 AAddmmiissssiioonn by face 1000ppm emergency to shift plus Cleaning kit responsible priority Allocate coming wearing they editorial cold =10000ppm blue further prior Reviewed door Care meet wear reminding hand Place entrance bottle 13 where due PCI with 11 daily Floor surgical bag Action anticipated Next gloves twice fluids body QIT Trolley team CCOOVVIIDD1199 review This water precautions 12 information xHaz ONLY room \u2018Spotter\u2019 Ensure Prepare disposable clamping you for enough nearest exit Outside point sampling specimen PPE mask other dry pole role hourly ETT group trolley another Nurse Bloods Pre Card no via without CCaarrdd masks blood bin sink Chlorclean will hands from leaving let of general must down takes risk FOR quickly small clamps them on: arrival your remind send Admission chlorclean per and wash Limit drawer USE Approved ventilation inside doffing machine cubicle ensure not the Decontaminate bed removal doff Lab 1x decontamination alternate mop tabs member spillages"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "lab connected ICU as staff undertaken Ventilator national 10 TITLE outside cleaning taken appropriate Critical on Authors: Title: RRIIEE approximate by: notifications should doors at AAccttiioonn Written: disconnection medical practice then clamped their CARE CRITICAL 118 in transfer arranged SAS patient through Status Post IInntteerrhhoossppiittaall Guidelines WGH On handover TTrraannssffeerr be 20/SJH enter by access past evolving to nursing cleaned The editorial wearing Arrival shoot HPS cath prior first floor Reviewed Care guidance 118: between entrance monitoring PCI with 11 Wd time Next QIT team CCOOVVIIDD1199 review 12 receiving wiped ONLY room discussed side exit Draft/Final: PPE left 117 notify group standard along trolley thoroughly Pre via CCaarrdd ET using Chlorclean corridor will of Pause RIE: received down swiped observe/trouble FOR on: arrival remove per and USE Approved Follow departure: the lifts tube Additional exiting departing Appendix member"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "FFP3 ICU don Reviewed/revised as facilitate staff undertaken minimum 10 sent if consultant taken McNeill is Critical on completion: RIE Title: Authors: or Level at Written: medical off bagged equipment practice rota fitted 19 2020 14 required close supply CARE CRITICAL in Intra 118 March transfer arranged most Final patient double passage entry through Status control Scan trainee CT one return Guidelines table On Transfer can be undertake but ventilator enter COVID19 by emergency to nursing an The One Arrival HPS done prior usual contact direct Care guidance hospital route Don between monitoring 13 Action Portering with 11 bag orange Standard used Next team review 12 rest wiped ONLY room Ensure for discussed ahead Draft/Final: spotter preprepared PPE Intrahospital standard trolley 2021 bags Card Pre Following trip Senior designated back using two Tube will CT: leaving Doff of 15 Dunn May down FOR on: clamps arrival chlorclean per and Oct USE prepare observe members reconnected COVID not Doning departure: the reentering tube bed Another addition member"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "intuba3on this seda3on ICU handle Cri3cal Covid \u2191K+? Plan SupragloZc 10 Intubator Theatre lubricate outside if Lothian ETCO2 Airway catheter Who is on syringe Op help ECG or how? Scalpelbougietube Stylet 2018 Stethoscope intuba HMEF CoVid equipment incl fails? posi Runner 2200 laryngoscope plan ON circuit 2020 Understand OPA Can supragloZc supply RAISE Adapted DAS/ICS NOW in PROCEED alloca3on Review RSI Yankauer March up Blacstock NHS backup airway Allergies wake mount 5cm CONCERNS administrator checked Induc3on Equipment O2 Sizes st laryngoscopy requested McGrath Check access Op3misa3on visible kit Tie Bougie further BP turned contact roles? Care Date: Prepara3on Cricoid Consultant Emergency with head we page CLAMPS Preoxygenate Pa3ent TUBE Vocalise Conrm room for drugs assistant Monitoring turns \u00d72 PPE 3p pressure role ETT trolley max Verbalise vasopressors via switchboard Fibreop Closed 3cm necessary using ml Checklist will Drugs from Mac check Intuba3on pa3ent Intubator\u2019s Is carina trachea call required? Anaesthe cu Ongoing Cut Double Di\ufb03culty tape mise and B/C waveform SpO2 size FoNA Baruah tube suc3on seniors Team Communica3on"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "ABG tracheal high aware connected cough confirmed PROCEED: Assess system Suction roles Deflate fasting if Lothian Airway minutes catheter oropharynx cooperative Critical secretions Observe HELP syringe cuff ECG or nurses tapes/ties Obesity Stethoscope Postextubation tapes suction Remove adequate Extubation trauma/oedema Consider plan block 30 spontaneous 2020 doctor etCO2 difficult supply RAISE Adapted Awake present NOW Review Yankauer March 10ml leak patient up prepared delivery NHS CCircuit through airway ready compromise: From formulated suctioning Previous Charge CONCERNS patient: checked Equipment sedation O2 NIV DAS suspected informed whilst oral access Check visible sit to allocate extubation Drain an NAP guidelines nurse Cardiovascular /HFNC plans Talk bite BP Stop PLAN Care Give Date: Inform extubate Aspiration EARLY IV Facemask subglottic perform signs pattern *FULL Two pt NG Ensure Prepare supplemental for Preparation aspirate Monitoring postextubation PPE oxygen Planning mask stability REINTUBATION catheter/closed ETT trolley care noise post Senior 100% Obstetric Adequate Scissors SpO2/RR supporting Checklist extubations CALL of general risk FOR AGPs* remove and factors: respiratory ventilation Optimise filter Respiratory SpO2 COVID cut not available the tube"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "high area full FFP3 ICU diagnosis confirmed having including waiting as essential swabbed deescalation who testing contacts employees Open admitted Remain YES 2023 exposure if completion some AND are admissions Low All taken consultant appropriate is Critical Non on RIE improvement home Initial should alert or Level probability transmission at immunity based More Guidance test fulfilling vAll separate days Siderooms No during worker until 14 negative Temp history initially considered low nursed in infection manage HIGH vPatient Yes areas aerosol than 116C/116D/118 <37 transfer SARSCoV2 118A/116C/116D decision Transplant non critical discharge criteria patient cohorted placement Intermediate thereafter shielding Sideroom self excluding allow Department Cohorted Areas tested can droplet be previously 1114 intermediate status SARS throughout consistent fever/respiratory whilst clear definitive reassessment isolated meeting mechanical to deemed an organisms additional One known flow they 116D/ High ideally likelihood Patients apart further URT/LRT first need contact have 116C/116D/118A Care meet co clinical following swab RED thromboembolic Clinical Placement 13 Emergency URT with neutropaenia 11 presumed management pancreatitis Positive GREEN used hrs health protective sufficient receive beds During This precautions symptoms Area hours since AGP positive ONLY providing Has least Considered already for discussed consecutive rapid NO INTERMEDIATE give 117 24 result criteria? available: URT+LRT IPCT 116C LOW other intubated chart Version presenting care context would post no 118B managed If existing Once move assessment two ICPT within 116C/116D/118A/ward open 118A continue from pathogens of sideroom CoV2 May Elective down Discuss Priority risk Admission 8C 116D suspected/proven require Admissions siderooms and respiratory deisolation therafter patients consider Probability overdose Pandemic ventilation admission stepped vPatients See cubicle not Unable ensure available the disease Patient Isolation 48 lead initiation fever new results alternate samples \u2018Contact\u2019 Able Would isolation"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "platform connected details use passcode discuss username NHSNearMe@nhslothian sign is Critical vc/rcc on iPad: RIE Waiting Breaking it go calling or iPad medical attendanywhere nhs password Me making Click CARE CRITICAL which in Bad wish like patient\u2019s NHSFREEWIFI label patient https://nhs NHS Log Anywhere Guidelines read advice: Prior can be run COVID19 access found to service uk HOW they Scotland onto have TO VIDEO Care name following relatives with Guideline quick tips team Area scot ONLY https://nhsattend challenging 654321 Ensure fill you given Attend for Ask News Communication email: Remote would via video If family using CALL helpful Near of call phone FOR com/login Go and please do patients USE not the live talk"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "environment away this after use undertaken ties lower Where against followed straps technique outside are instructions safety is cannot practices on Perform Eye cuff safe should or headband upper rmly select at compatibility repellent Putting test piece when during equipment uid worker protection jewellery until gown being PROCEED in infection work nose surfaces patient\u2019s that over above worn always Gloves patient these goggles adjust ears facial donning checking limit cheeks tested fasten waist be Position good removing eyes crown COVID19 tie by face clean covered manufacturers to glove The different putting have hand Place between with change bridge head eye NOT gloves protective Instructions perform This ngers neck differ keep room disposable Ensure you for provided heavily contaminated order PPE been With before according protect If Respirator achieved back regularly Put will hands from check Predonning correct touched of healthcare yourself sides strap must down hair spectacles respirator pressing your remove and personal size mould ensure Note: nape available the DO both hydrated longsleeved torn Use makes spread hygiene"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "away ungloved area FFP3 handle Turn out as including Clean roll use nd disposed ties Where Unless only themselves straps under bring outside contamination lean are All sleeves forward is fall it Eye Firstly: Do safe should wrist or metres at buddy Gown inadvertently Wash supervised slightly off lined equipment slide lift worker then protection gloved gown in touch reach patient\u2019s that over always Gloves up fullface minimises visor contaminating top place behind waist possible To be bundle distance removing peel COVID19 by waste face gel to there glove anteroom/lobby discard reduce an The touching Unfasten potential rub process clinical hand retraining systematic with ante Then: peeling head eye dofng gloves protective into respirators dedicated water ngers neck remaining absence room opposite for preferably front contaminated order rst cross PPE bottom removed before way Removal alcohol while hold Respirator back bin using will hands from leaving let of healthcare grasp strap Pull retaining must In follows: motion risk respirator your remove and outsides fold personal inside not the removal both pulling soap shoulders isolation"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "sizes 14F SOP Ward Laminated waiting use phones Intubation listed Suction WWaarrdd saline socket v2 office Please if 12F are catheter below Critical RIDU on Authors: Title: syringe by: box pump fat normal Stylet Written: Stethoscope Schrader HMEF suction off arterial transducer Syringe tubes equipment Femoral NIPB 1000ml 2200 laryngoscope circuit tubing 2020 airways Facemasks CARE CRITICAL in Loose RSI Yankauer Oxygen 18G 20G March 10ml Pressure Cables Covid19 Jelly patient up Oxylog Status splitter induction Clerk Guidelines WGH x3 pumps be Baby contents Macintosh Drip ventilator COVID19 McGrath tie access emergency to plus Draft set insertion mounts The 20 Bougie blue clamp need cateher sachets Aintree Reviewed COVID19/Suspected Care LLiisstt plastic Emergency cable bag key Anchorfast Vascular Next Arterial CCOOVVIIDD1199 review Sp02 KKiitt Metal pressors ABP ONLY NG room 22G iGel EtC02 drugs infusion Braun Draft/Final: sampling departure left Duncan packs // ETT charge trolley before scope Blackstock Closed line Scissors Box pack Tube stand Checklist drivers catheters Clark Slim Drugs check leaving intubate SSuussppeecctteedd Scope stored 3000 Mackinnon FOR unit on: clamps made monitor Monitor refreshed Cuff and tape breathing USE cylinder blades Approved Ambu may size not available the manometer Cannula Baruah tube Guedel"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "SOP Ward met Daily videos office donning/doffing safety RIE syringe adrenaline unsuitable box Written: guideline tubing 2020 required compressions nursed experienced infection propofol 10ml Etc02 SSOOPP escorted Staff trainee one administrator can x2 hypoxia emergency Draft nursing slim 20 nurse HPS door COVID19/Suspected clinical Prereferral entrance PCI change time judgment Interhospital team CCOOVVIIDD1199 review Two Anecdotal Conduct Phone NIC for EtC02 re oxygen mask supervise list ETT charge 16F proven progress Restock Closed line take check of intubator/drugs referral: on: suspected/proven Cuff per and consist patients Approved Ambu may size Follow postintubation not primed bed tube Ventilation maintain confirmed use as discuss staff unstable Covid taxi Suction catheter appropriate Authors: Clerk\u2019s HME should immediately nurses pump well PostRSI medical 10th when equipment lift 2200 deterioration wide List airways staffing escalation intranet CARE in 118 CXR remains equipotent March transfer scissors critical Covid19 trained these through intubations Assessment WGH units intubating Equipment COVID19 shift insertion The aim suitability BP guidance planning monitoring bottle measuring practical IV jelly situ NG room Yankaeur front side Braun departure PPE Communication position post via back drivers will scrub indicated leaving 000 phone stored sterile RSI: 1:100 IGel the China Lubricating high after Laminated WWaarrdd outside cleaning is Critical 1:10 Perform Title: ECG Level at include Stethoscope tubes during Runner Primary plugged Facemasks closed their availability CRITICAL confirm RSI current Contact levels Sonosite pause proning see hypoxic Oxylog Status moved anticipatory Transfer be status but assisting ventilator by definitive access face to cuffed kit aerosolization number Bougie Aintree contact Care every Emergency with Size Anchorfast ambulance Next gloves Arterial piped dedicated respond alfentanil severely neck receiving drugs before indicates Blackstock Severe appropriately determine catheters Problem Establish Drugs from scopes FOR monitor Monitor PAG respiratory USE Group Communication: doffing COVID See manometer Baruah Donning/doffing assess full ICU arrangements Intubation if Kit consultant RIDU secretions on Exit by: arrange or ICU/anaesthetic involved buddy suction intubator\u2019s Ccircuit 14 Record SAS patient up airway evidence Guidelines handover Front suspected compressiononly metaraminol found specialty prior minimise clamp convene Reviewed supervising Inform between too intubation identified page 9am fluids ID Sp02 precautions Metal ONLY Draft/Final: // care Update: choice If communicate atropine Checklist assistants SSuussppeecctteedd call risk made CPR machine Induction anaesthetic Guedel US board"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "this ICU handle Intubation Covid \u2191K+? tip Plan 10 Intubator Theatre lubricate outside if Lothian Airway ETCO2 catheter is Critical Who on syringe cuff help ECG box or how? Scalpelbougietube Stylet 2018 Stethoscope suction CoVid fails? incl Site Runner plan laryngoscope ON circuit 2020 Understand OPA Can supply RAISE Adapted DAS/ICS NOW in PROCEED Review RSI Yankauer March patient up Blacstock NHS backup airway Allergies Optimisation wake supraglottic mount 5cm CONCERNS administrator checked Equipment sedation O2 Sizes laryngoscopy requested McGrath Check access visible kit Tie Supraglottic Bougie further BP turned roles? contact Care Date: Cricoid Emergency head we intubation Preoxygenate site Vocalise room for drugs Preparation Fibreoptic allocation assistant turns Monitoring \u00d72 PPE position Communication pressure role ETT trolley max Verbalise vasopressors via Closed 3cm using ml Checklist will Drugs from Mac check carina Intubator\u2019s Is trachea phone required? mobile Ongoing Cut Double and tape Confirm B/C waveform Anaesthetist Optimise SpO2 size Induction Patient FoNA Cons Baruah tube Difficulty Team"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "this detailed Management area any ICU SOP Ward as requiring staff including ward who only Plan Theatre admitted machines input items L1/2 consultant All Bedspaces appropriate is Critical on RIE use: Enhanced operating Medical should or markings doors 89 normal ends at coordinate surgery vestibule theatres At 3rd Site These plan Donning empty then default until required negative closed ward/HDU/Lothian escalation bedspace /Ward considered in ICU/Ward Review areas that Oncall transfer above decision 1016 able patient all theatre Medical/Haematology donning moved handwashing WGH enact /NHDU can possible Manage be occurred but informed recovery COVID19 by emergency mechanical to nursing Dependent spaces 20 Patients further floor Will SJH SHDU first Care second following liase Murray instance between entrance Consultant barrier Surge entrance/exit with theatre/recovery Suggested barriers now management time used directed plan: team This room people already for side referral nonessential order point Nursing As basin Move senior PPE coordinators movement 58 pressure IPCT elective NonCOVID19 ETT removed before 916 Bedspace via main Blackstock managed advice If HDU within sink oncall will construct indicated acceptance capacity from continue time: of 36 26 Close surge must nonCOVID temporary bedspaces Estates unit Discharge 13/3/2020 per and 18 patients ventilation admission doffing may Patient not stop Anaesthetic available the anaesthetic 48 bed Capacity both Visitors Main/DCN"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "ventilated met lower Ventilator 10 FLOW 824 After All HELP bag/ventilator 6mls/kg combination NonCOVID select procedure These switch default checkout flows mode low switch: OXYGEN that There all Vent touchscreen fail top adjust limit persists reverse can GAS does each PaCO2 reduce 6l/min TIDAL Volatile Checkout need lowflow OXYGENATE >8kPa change Ratio Gas so Select reduction FRESH team review hours REMEMBER for changes Ask CCIRCUIT oxygen setting BREAKING SODA no mains H+ occurs check of Pause fresh ventilating and patients >6 canister may target not Ventilation tube PCVVG bpm maintain ABG last soda periodically window confirmed Increase including Preferred turn minimised support appropriate should navigate immediately Tidal medical when leaks its measured circuit until dialed bedside settings BACKUP in 1l/min which AISYS reach above Pressure Settings closedsuction visual return 5l/min Start comwheel higher Equipment LIME sodalime mechanical otherwise red FGF The aim picture You different bag shown used green CS2 Press refill toggled calibrate side lime PAUSING secs position pressure Once move 100% litres/minute using will CALL com 2024 adjusted prompt temporary Breaths light PLAN: rechecked do gas admission 60 the 400mls this high after system only difference are Low casing is wheel VCV Perform BELLOWS elevated at based include More disconnection OFF breath during defined then Anaesthesia Volume endtidal 1:1 seconds present TROUBLESHOOTING initially break USING confirm touch DISCONNECT PEEP than pause see VENTILATION indicator To be DOPES but O2 ventilator activate Pinsp run CIRCUIT by to message Mode they >7 changed every usually with displayed perform This container you yet EtCO2 With Following neurointensive indicates rate Displaced likely FOR VENTILATOR connections Obstruction 12cmH2O Bag require Restart IMMEDIATE Respiratory reconnected COVID baseline needs SIMV 8l/min Signs screen either 10l/min if standby minutes on PVCVG <30cmH2O FiCO2 Initial THE or Settings: demands confronted vent >10l/min >0 litres/min GOALS leak patient up CAUSES Case END HYPOXIA: place increased d/w CO2 tab temporarily changing there Flow righthand set flow Push clamp increase start PaO2 following arrow plastic Pneumothorax 5cmH2O complete Disconnections FiO2 identified right Ensure saying Stacked left 13l/min care way OF If achieved targets within 15 bellows FALLING down pH pressing AND COETT machine <60 highflow Use increasing"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "Higher any pressures incorporates soiled ventilated SOP requiring Fresh Assess met lower 68 less indications Gibson 10 familiar called Touch After mandatory cicuit All our 6mls/kg combination adjustable suggest 30cmH2O select menu procedure These Consider isoflurane switch Expiratory default checkout required flows Introductory low mode vapour approach propofol dependent switch: that just There Circuit Modes all bacterial/viral reduced Vent touchscreen NHS uses satellite expired adjust vapouriser suctioning accessed Neuro limit 3L/min Prior persists Circle can sedation impact prolonged An Check By optimise freshgas exhausted operated moisture PaCO2 reduce 6l/min selecting nurse Intensivists users Checkout need have anticipate lowflow clinical hospital aiming capnography change performed time Gas Standard Pro so body Select team review highlighted hours least display keep disposable for volume refer changes individual oxygen setting >10l/minute induce haemodynamic corresponds However standard RR We routine no 1:2 6L/min undergo Closed H+ broken shortage Prone two line components open check mitigate Vt of continuous Our Intersurgical reboot fresh preuse ventilating starting occurring per and please presence patients ventilation canister apnoea names may limb returned very document target not litre/min Rate Ventilation tube Tab PCVVG Although disconnected maintain filled hypoxaemia requirement soda Soda window confirmed use as Increase including limited 49day assist undertaken cassette who PSVPro 10L/min staff rise turn Synchronised malignant frequent Lothian experience Com Increasing support below becomes reinflated paused Do operating enlist should navigate push normal expertise Sidestream medical term anticipating when At Safety leaks 19 its measured plan blocking routinely empty breaths representation circuit until Adjust intended bedside settings ulnar in which AISYS register above most Pressure Settings wet completed hyperpyrexia these control return Ally WGH On 5l/min internal Start inspiratory comwheel checked higher sodalime located phases throughout Ventilatory could red an FGF The earlier aim Using picture You different potential selected usual neuromuscular balance basis demonstrate planning Distal 13 12hour bag shown used green NOT CS2 begin spontaneously overcome cancel end whether information Alastair toggled 13L/min unless plateau consists indicators lime disposables lost point continues spill preferred CPAP conduct been minute position positions pressure Initially provision via restarted Once move 100% litres/minute back using necessary cancelled volatile Users will Air indicated cassetes Disclaimer: acknowledge com 2024 adjusted sevoflurane temporary Troubleshooting goals rates Morgan capnograph 49 proximal inspect small light 3l/min breathing controlled do rechecked gas yellow twist those Unable 60 the They 400mls replacement rotating filters this high Peak latter Procedure after intermittent system only licensed 400ml difference 1220 under machines Please again are expiratory COVIDpositive is Critical wheel cannot VCV volumes Continuous ruler Tinsp best warning 24hours it Falling Breaking elevated critically at options More disconnection test therefore OFF slightly theatres Circuits agents 12hrs days during Suctioning tidal PSV defined ask then Anaesthesia Volume outwith their 1:1 closed clamped initially reconnecting confirm touch current patient\u2019s levels PEEP than remain How H2O see displays instability carry indicator Diuretics read significant 12hours clinically To Upon be possible tight but O2 ventilator reliability run Should demand cmH2O recovery by to message displaced metabolic additional Mode they cause ODP further Breathing Care changed also period every Difference recheck integrity usually with now >6l/min drying we although >68l/min desired flush extent This clamping you discussed sidestream drop order yet As EtCO2 NO litres added pro With ill context removed before acknowledged Following weaning Flows without mentioned consideration rate emptied procedures occur ventilate likely more from 8kpa selfsealing Solutions weight must In has unnecessary monitor maximum exhaustion connections require Bag short long respiratory rebreathing discussion sensor filter Respiratory reconnected COVID option See capnographs ensure designed Elevated manometer important baseline needs expected SIMV peak instances prove production Visually full initial ICU ventilators us reinspired out linked screen either times listed 10l/min what Disposables contamination if standby some alarm completion minutes consultant valves I:E on pandemic FiCO2 Initial or It stay HMEF inadvertently suction VG demands confronted neutral guide frequently guaranteed vent >10l/min >0 negative inspired When Adapted being Differences circuits litres/min L/min supplies put fulltest problem leak non patient predicted situation airway anaesthesia case challenges absorbed increased note lung depending CO2 tab temporarily \uf0b37 settings: parameters For Default changing found make there Flow set cannister One flow rate? known become Controlled autoflow PCV mindray minimise PaO2 increase start Simply questioned following arrow caution are: between where clearance due functional unclamped inspiratory/expiratory page FiO2 protective into customise valve identified 12 site positive Operating Ensure windows style alter lowflows left 24 13l/min viral 12cm completely according ratio would prevent colour main If within achieve 1l/minute unlike circle 15 bellows scavenging works efficiency surge nonCOVID extremely safer performance barotrauma Dr Total risk pH upon pressing remind inspiration expect remove wash COETT contacted drive Aisys machine Commencing posters regular available anaesthetic both collapse Use increasing"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "filters this Hourly high ICU Insp soda Soda visually SOP dialled as including either after assist out use Ventilator bronchoconstriction if 1L/min minutes expiratory is drained secretions on fall Perform FiCO2 Initial should 68l/min or It Tidal include disconnection medical HMEF suction days lime1 when distal zero measured frequently excessive Expiratory Continuously circuit Anaesthesia >10l/min causes Inspect required Machine bedside inspired closed present trap5 low in vapour Filters reach patient\u2019s fulltest needed than Pressure Circuit Record all reduced control zero? increased 5l/min white checked be CO2 MV tight 1Task occluded parameters does by to there otherwise moisture PaCO2 an FGF <0 The 6l/min flow neurocritical blue further increase need changed every recheck monitoring Alarms due daily with performed change time used FiO2 CS2 into Instructions carried thirds near team circuit6 water hours information Alastair Absorbent for volume lime point Monitoring EtCO2 exp 24 added Water other mins flow4 chart However hourly Version care before indicates colour curve If inspected using selftest7 two within occurs will more from circle of 15 condenser must Morgan has next 49 reboot exhaustion require and please rechecked patients yellow pink Aisys limb filter canister machine may humidity not Change the resistance spirometry manual replacement"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "Appropriate proper needing pressures understanding operates ventilated visually breaks requiring Ward Fresh 1litre/min less Unless 68 indications 10 824 stops mandatory All pH\uf0b37 safety our 6mls/kg user NonCOVID device 30cmH2O 812cmH20 Hospitals sevoflurane/isoflurane procedure These filtering vary 30 pressurecontrolled default required flows viral/bacterial General determined problematic Introductory low mode experienced propofol cleared dependent that There outstrip sensor/valve >10L/min all bacterial/viral reduced delivery NHS CCircuit satellite ready adjust suctioning Neuro Prior disengaged PS/CPAP can MV sedation does An Check emergency nursing alternative each moisture PaCO2 reduce 6l/min ongoing 20 replaced triggered Volatile onto need Owner: have meet lowflow clinical hospital 11 performed change capnography time Gas Standard Satellite/Surge despite sedated team review assistance dead hours least midazolam/clonidine nationally effort for volume changes compliance Internal delivered depressurisation oxygen still mask 20cmH2O setting However standard RR alongside We routine no 17 broken Closed H+ line two breathe deeper reengaged check pH>7 effect of Pause received Our Intersurgical timed sooner reboot fresh basic per and please >10 precheck unable patients FiO2>0 ventilation limb how canister may apnoea very hose document event not resistance tube Ventilation charts PCVVG new compensate <10 Although inspection maintain ABG Running soda limited confirmed use as including staff cassette resource who PSVPro *For presents Further exclude malignant experience Lothian catheter support Increasing appropriate fall reference paused Local should local intervention push especially negate Sidestream medical term conjunction arterial when equipment At leaks once 19 rather its measured routinely deterioration empty circuit breaths wide until intended bedside settings supply bedspace about considered in which Unit1 AISYS suitable needed register transfer most inefficiency Settings Pressure closedsuction 510cmH20 wet hyperpyrexia tracheostomy SpR backup through control visual opioid induction 10l/minute port replacing inspiratory opened checked higher highmetabolic sodalime phases capability COVID19 undoubtedly associated rainout clean could Teleflex described insertion an FGF The isolate aim arriving were waveforms different potential blue kPa neuromuscular performing paralysed monitoring 13 daily bag reduces bacterial suggesting used CS2 quick end spontaneously refill information Alastair outstrips Minute delivers unless attached side seen lime infusion point CPAP PPE been minute pressure gehealthcare find provision restarted Once back litres/minute regularly using necessary volatile standards will Disclaimer: such com soon 3000 rates Morgan 49 proximal approximately small 16 24hrs 3l/min 18 breathing cylinder consider gas yellow members admission acceptable acquired supported twist https://cleaning the They kept 400mls Pmax space communicated replacement continual filters this pressure/flow brief high technical FFP3 GE oscillations Procedure after coughing system discoloured only licensed working effects under blockade machines cleaning Both again are expiratory Low longterm COVIDpositive commence is Critical drained suction/patient Perform deliver warning it elevated critically options at include More therefore days theatres Breaks Increased agents during breath practice tidal Filter ensuring then \uf0a365 their clamped seconds closed present initially history Negative 5L/min current patient\u2019s than levels PEEP reducing corresponding worn occasions failure planned Oxylog closedsuctioning typically H+\uf0a365 indicator IPC read preceded possible 35cmH2O be To tight compensation but ventilator run Colleges/ASA demand Should by Full to monitored responsible metabolic Mode they certificate further dyssynchrony Care changed also every laminated recheck integrity usually with deeply >6l/min we displayed +/ perform This blocked receiving hospitalwide clamping drop adapt accuracy EtCO2 added other With ill Version context before sudden acknowledged Flows weaning without ET clinician rate inspected appropriately procedures emptied arises more ventilate from perioperative condenser maintained must In follows: has Royal monitor maximum connections require Restart respiratory long console rebreathing personal filter Respiratory appears COVID option ensure designed manometer important parameter EZchange function reservoir Canister Appendix decontamination needs expected SIMV peak Western production similar initial full connected ventilators arrangements ICU us out linked either times Scavenging ward followed 68L/min minimum 10l/min if alarm 1L/min loss minutes admissions I:E on pandemic pausing FiCO2 Initial cuff help or It increases Mindray level HMEF Ideally suction undergone Any adequate distal fitted agent guide frequently guaranteed Ccircuit spontaneous expectation 14 >0 inspired rebooted When being calibration litres/min circuits 12cmH20 transitioning atmosphere sensed leak non oxygenation patient flowrate situation anaesthesia increased stable note Satellite depending Ventilators physiology lung CO2 tab temporarily previously removing suspected For changing there set assisted setup flow teams interfere comprehensive become optimisation autoflow sedative sought MAC done prior supervision increase PaO2 following between Clinical Consultant avoid Phase Surge complete detected identified FiO2 into 12 positive repatriated Operating Replacing provided greater lowest lowflows result 24 nonIntensivists viral unintended according ratio would external Immediate main limits If targets within \uf0b312 detrimental capacity oxygenating circle Clamp 15 bellows scavenging efficiency surge nonCOVID AGSS operate means performance suggested risk upon made utilisation inspiration Capnography COETT concern drive updated absorber Aisys machine ODP/medical available anaesthetic Unclamp collapse both opening studied increasing"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "this walk area ICU Ward as after staff undertaken ward wait only WWaarrdd minimum radiographer 10 \u2018doffing\u2019 outside contamination if standby consultant taken McNeill appropriate is Critical on completion: Authors: Title: transport by: HME go should 5th or immediately stay doors Level AAccttiioonn at Written: disconnection medical off during equipment practice 3rd 2200 scan circuit 2020 14 required bedspace CARE CRITICAL in department put transfer arranged remain Final patient Ferguson trained disconnecting donned entry Oxylog entering Status control Scan trainee CT one Guidelines table WGH On clinically Transfer TTrraannssffeerr can amount be undertake IInnttrraahhoossppiittaall ventilator does clear enhanced drug by COVID19 access emergency to nursing corridors Then The earlier wearing 20 Arrival nurse HPS done prior need Reviewed Stop Care guidance wear also between avoid 13 Portering with 11 change bag Action used Next ChlorClean end carried CCTT team CCOOVVIIDD1199 assistance review This clothing 12 wiped remaining ONLY room Ensure unless for discussed \u2018clean\u2019 ahead Draft/Final: repeated individual senior PPE monitors been Intrahospital standard list trolley Following Pre Card via CCaarrdd If back using necessary Tube will indicated open leaving CT: from of 15 Dunn May Only stored down has newly FOR 16 on: clamps arrival agreement per and do USE discussion prepare observe members filter doffing inside Approved reconnected COVID cubicle not departure: the Baruah kept bed tube doff July member"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "inotropes/vaspressors changeover any patent and/or lower Benefits less study Aim automated After standardsformedicinesmanagement All Work Observe 2017 Date fullarticle device C74C77 Standards 9% policy required dated infection discontinuation that British Apply double delivery NHS one Prior mls can Venous Inotropes Check discard nurse emergency/changinginotropeinfusionswhichtechniqueis onto \u22645mmHg need prescription infusions: have Central References inotropes change Medication time so Society ABP Core keep for 2010 16mg% original Personal charge vasopressors no continually existing Doses IJ 2015 blood line Medicine 2mls/hr occurs expiry open effect of Discontinuation clamps starting your per and unable waveform New may tap very Follow not Intensive bed specific new prescribed requires area last aware 2% use as Clean staff oxfordjournals distally Titrate Hospital life rise Failure turn Rapid Lothian Increasing Do should push nurses pump Signature/BBraun medications medical date arterial bolus vasoactive Concentration 20th 10mls until covers intranet Device in which aet199 Review above xrayed Pressure 2012 critical placement through control spiked Training Inotrope/Vasopressor 5mls central Equipment Protective higher Run 8mg library interruption extra an service The continuously Cardiovascular quasiexperimental Stop guidance competencies instance monitoring actions bag used 16mg confirming end inotrope/vaspressor Inotropes/Vasopressors providing attached 10mls/hr side additive infusion Braun rapid Nursing insitu Drug PPE been pressure Written hourly medication via concentrations Enter lines back recommended will small <drugs consider nmc strength threeway the http://bja space 2013 Heru this high Commence ors org/content/early/2013/06/11/bja best/201728 Label only effects under connecting technique Please are transduced running commence is Critical connection 72hours CVC best it labels at disconnection Journal during practice luminous update then clamped initially uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress Calculation touch current areas than bleeding visualisation follow Be Lines Connect pumps To be hour Policy Administration run labelled drug engaged by flushing to measures decrease Cour photosensitive Insert Care changed every pdf with changeovers desired Arterial Mackay flush This Blood you pertains drugs half other recommendations before another bags Following without rate designated more from proximally Catheter administered has maximum require administration smart short systolic titrate pumps: Keep Signature ensure pdf+html Inotrope bleed assess MAP Healthcare<az<critical full connected medicines out inotrope 80mcg/ml times old concentration if instructions taken 160mcg/ml net/clinicalsubjects/accidentand on invasive alarming sugars by: safe stated or It patency off venous ucl frequently When Council 8mg% April al lumen Decreasing up patient same Guidelines prevention handover Chlorhexidine Purge et infusions wipes For subclavian found flow guidelines seek prior start Midwifery due 20mls/hr complete management Pollock into fluids uk/globalassets/sitedocuments/standards/nmc site NaCL Ensure uk/icshomepage/guidelinesandstandards/ Infusion Prepare faster Changing three nursingtimes 2007 care way 73 prevent If clearly achieved advice within https://www achieve Alaris circumstances correct continue org Sept risk ics ac pumping remove observe Commencing http://www stop available both Use increasing"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "proper any calculator CCO and/or lower CA Start/stop Export indications 10 Open ports Touch All CVP Date capital_care@edwards device phlebostatic select contraindications USB packaging switch tubing Silence Lock mode logo button edwards that PPUS2208 audible all entering Way image Smart can orientation events contents Analog FloTrac Snapshot HDMI selecting air: USA bar door plug clinical hospital deair panel change time Federal owners review highlighted display adverse keep Oximetry for refer respective Monitoring aspirate pole standard Ethernet assure no restricts trademarks stand two air open of Edwards Average Pressurize United IQ and Irvine Engineering tap Follow not power want module upright zeroing compatible Thermistor Setup window Turn use as including Module appear Event input catheter support cardiac appropriate nonvented Screen Lifesciences Replace contained language Derived Waveform HemoSphere arterial when zero CO until holding settings in which fluid charged reaches Pressure Settings axis completed through LTech visual fully prime slots port temperature outlined operator\u2019s units Start Platform properly COM1 Back Parameter Zeroing cord insertion/connection an The features Injectate Refer selected Stop Mount outlet stylized monitoring actions bag IV end Press tracking information inate Fastflush front Advanced Thermal position pressure Enter globe pull Help using will heard com Time inspect Information click output do serial Note: the expansion Averaging 300 manual globes replacement technical this platform after system only outside are physician reserved is connection 2019 it ECG Level at 92614 test tone update then probe rear their RS232 arrows touch current remain follow Zero\u2019 mmHg raises Status Connect system: indicator mount TimeinTarget Battery To be tight status States caps engaged by silences to terminal additional Corporation first Insert Equipotential technology OR Main Demo with SwanGanz stopcocks battery displayed desired hang gravity flush startup This steps Blood you HIS order accuracy \u2018zero\u2019 stopcock property other law With Captures without rate \u2018Quick procedures 24/7 must PGDT format monitor Monitor connections Bag sensor 8008229837 appears See Patient ensure pushing parameter important sale affects initial full WiFi out screen times hemodynamic eight stud Plug v2 slot alarm instructions minutes on bubbles or It residual icon level Sensor off guide rights column grade being calibration iCO patient up Choose warnings value connector Available place ops parameters For inserting CAUTION: measurement time/date setup One guidelines insert filament highlights advanced Hold between Clinical cable complete Acumen right into Compatible precautions heart Bar holder left conditioned Expansion selection main six alarms Zero Navigation data screens down Securely upon remove prescribing"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "6090 mL TPTD SV/EF injection 1720 CPI 120160 EndDiastolic /SVmean CA mL/beat indications 10 RVDP Body EDVSV requirements All CVP Work 815 2017 25xGEDV device PBV=0 ELWI contraindications S2 6070% Systemic Delivery 4060% Global vary theirrespective PVPI mL/m2/beat CO/BSA RVESV logo Intra edwards SV 19702390 LVSWI placed RVSWI HR 9501150 Way CI/HR 100160 Venous events 1525 50 /CI LAP Pulmonary <250 USA 80 Central 11 Ratio time 417 Federal Cardiac DBP owners Right v1 adverse Left for /CaO2 Predicted European g/L >20% RVEDV/BSA restricts trademarks blood Extra International of S2S1 Edwards Lactate Units United ITTV=COxMTt Directive93/42/ECC 2230% DO2I CvO2 and Weight Cold Irvine PVRI conformity 1/min SVmin DO2 use including Values 360 Occlusion ITBI S1 PvO2 reference Lifesciences g/dL SV/EDV End COxDSt0 BPPAOP Index MTt CO Hemoglobin 91 devices SVI Device in Male EVLW/PBW Pressure RVP 95100% mEq/L Female: dynessec/cm5/m2 8501000 60100 Ventricular units Perfusion SBP Parameter Saturation SVmax Coronary laboratory 2025% W/m2 xDSt BP stylized ml/m2 VO2I Systolic information SI *Reference 25 CaO2 CPP Water professional 07 L/min/m2 Atrial com PBW Output PAP RAP EVLW=PTVPBV dye/temperature 124174 the 3648% 48 PVR Fraction Convention Resistance this 65 Power 5062 saline Consumption physician are PAOP reserved Parameters Diastolic GEDV EndSystolic O2EI 92614 marking CFI Artery Volume 6080% MPAP av <3 RVSP 54 Oxygen 420 dynessec/cm5 Function /SaO2 6080 Variation mL/kg market VO2 O2ER mmHg 90140 adult 716 Lung Content values* Extraction O2 States mL/min/m2 by to GEDV=COxMTtxf Transpulmonary Corporation mL/dL Height152 PTV=CO Difference 08 PASP Arterial 510 1020 ScvO2 Blood SV/1000 Hgb Hct Stroke order property other Physiorelationship law Females: Article mL/min RVEF /CO 1215 100 CPO methods CI 26 4252% See Mean bear Hemodynamic PPUS2312 200250 range sale MAP full essential hemodynamic 650800 instructions on Permeability EVLW Medical 500600 0031 or Cv 52 45 Mixed rights 0138 L/min SVR regional 612 Equation 5994 50100 Males: 117160 0136 warnings techniques Laboratory 56 RVEDV PVPI=EVLW/PBV Test parameters For ITBV=1 meeting CAUTION: SVV DSt One mL/m2 CO/HR Ejection PaO2 Vascular SvO2 PADP Thoracic mmol/L S1/S2 Hematocrit 70105 precautions 12 GEDI thermodilution GEF 1000 CE Normal 931 1015% referred values 46 RVEDVI EVLW/0 SVRI 8001200 255285 SaO2 ITBV prescribing /3 3347"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "full connected pressures Setup TPTD RUL Turn use including as choose essential real solution indications saline 10 l\u2019Etraz Touch if requirements Set are instructions catheter Inject All Directive reserved CVP Thermodilution appropriate is System on oxymetry Observe CVC syringe calculation Lifesciences it descriptor Parameters Medical or VolumeView method phlebostatic normal upper contraindications level EV1000 2018 well marking selftest boluses arterial TruWave transducer venous procedure directions bolus 19 manifold zero guide Before rights 1260 then probe 14 until devices When prefer logo Device in button edwards touch reached patient\u2019s placed market patient thermistor all up axis Choose warnings rm Connect edit prime one temperature Lung Start Venous amount Platform central events previously connect removing parameters For example Nyon meeting to set setup Corporation starts waveforms 20 cold Repeat selected start Insert Central stylized OR Clinical 13 cable with alarms/target 11 Route time displayed desired right Select review startup Actions Prime highlighted precautions 12 information steps nonindexed adverse lobectomy thermal Ensure Oximetry cables prechilled for volume smooth refer keypad injectate valve/port transpulmonary thermodilution inject rapid European 93/42/EEC databox indexed pressure professional 70 transducers according Article Startup trademarks Enter CE existing 17 ENP509/1118/CC six using ml air de data com continue of Edwards continuous screens 15 referred inline series Catheter con Bolus 16 femoral monitor Monitor and please 18 Accept waveform sensor Switzerland prescribing See ensure bear primed available the conformity Guide parameter baseline range new results ne Wait Resection"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "any diagnosis threaded attempted less often infuse complication After interventional proceeding notes dilator anecdotal organised executed prepuncture SURGERY cannulation doc anything course guideline Written: complicated Remove wire major Potential issue determined low Minor Leave sited wall that all reduced watchful risks CT one PULL thread can Venous gauge vessel: Background: does NON Compressible DONT Anesthesiology tears have Central vascular haemothorax clinical Misplaced ischaemic puncture evaluated time dynamic body review Society hours least damage absence for percutaneous aspirate *There However freely/difficult no pleural blood line indicate reports catheterisations pseudoaneurysm occurs helpful relative of lothian on: \u2018Arterial\u2019 and benefits unable patients waveform Approved may size document not fistula Coagulopathy Misplacement 116:539 dissection infraclavicularly resides Management ooff as who catheterrelated frequent catheter Authors: Injury Compress Do provide should purpose immediately majority catheter/vessel supra circulation conjunction arterial Xray its plan American until consequence intended issues devices considered CXR in uncontrolled most compression 2012 Dilator/catheter placement BEFORE thrombosis these allow pericardial Guidewire central DON\u2019T remain: care/Insertion associated analysis Report peritoneal insertion an The were editorial Abnormal localization Stop active XR misplaced used confirming Anaesthesiology CCaatthheetteerrss scot providing http://intranet recognised Mispalcement seen coagulopathy largebore been imaging pressure elective group observation Than arteriovenous versus expanding via if: managed VASCULAR lines pull AV will carotid such pulsatile soon Surgery small haemorrhage 18 gas acceptable French the catheterization removal space manual needle liaise embolus this morbidity large after real Retroperitoneal only Inadvertent continued practically Dornan are thinwall is Critical Communicate Title: vein it Tambyraja treatment at based static surgery deferring No nhs complications during unrecognised PRESS angiogram advance difficult their 547 anaemic present Contact than bleeding follow Lines instability hypoxic Status relied Access consulted adult NHSLothian significant infarction possible be While immediate References: vessel AFTER by access to CONTACT consultation Patients contact Care also period usually anaesthetist with tear Size Guideline Practice reported whose Next Arterial ultrasound This compressing formation Blood develop Catheters highest Radiology order bore Needle stepbystep cavity literature Feb repair Verification Equal context before without switchboard fluoroscopy appropriately confer catheters occur more likely from Duplex Advances mass includes DRAFT Catheter must In DILATION pulse has guidewire FOR require common USE hypotensive DO expected Remain compressible: Interventional CCeennttrraall Complications: PPrraaccttiiccee out GGuuiiddeelliinnee minimum if Hamish minutes Jan on cap Recognition: generally by: Unintentional or MMiissssiitteedd Guidance withdraw off venous distal Less Task When COMPRESSIBLE nonsurgical adults cerebral Andy Ireland patient pre Aanesthesia Anesthesiologists Rhona regarding techniques ffoorr Case evidence place Guidelines prevention catheter/dilator cavities infusions handled radiologist Vessel* documented multidisciplinary For subclavian there flow injury mortality Line minimise uk/Directory/CriticalCare/Bedside closure Reviewed route artery following avoid surgical Massive management representative Vascular minimal into MMaannaaggeemmeenntt QIT Puncture 12 site Punctures ONLY greater Draft/Final: left result 24 unintended 2021 way 73 Immediate colour IF guiding surgeon data Force missited general down location Actions: connects risk femoral upon Cap CClliinniiccaall AND manageable Access: era available methods: severe"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "ICU having including as met only intracranial hypertension Lothian are appropriate is Critical Authors: Title: CVC Young difficulty by: should Written: supervised circumstances: Any off FINAL when venous practice training jugular doctor Practitioners difficult obtain being Practitioner in approach CRITICAL CARE suitable that placed decision There signed failure obesity placement criteria patient ID: completed NHS Status trainee stable Guidelines significant PRACTITIONERS internal LOTHIAN Venous be PLACEMENT central ACCP Anticipated by access to an The editorial anatomy Patients met: Reviewed Central Care advanced guidance following competencies Consultant with Guideline used anticipated Next QIT ultrasound review November ONLY for Advanced Draft/Final: physiologically senior coagulopathy ADVANCED other fellowship group BY post acute inhouse Neil 2015 within Medicine morbid will from GUIDELINE of Catheter has FOR on: them basic made agreement and presence USE Approved not Intensive Anaesthetic the 2013 liver"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "any 10 sent After Manual CVP 70% 2017 wipe Written: Valsalva cultures Remove Standards procedure flat Invasive infection Required swabs all one Prior Venous 2%Chlorhexidine Check discard WileyBlackwell 20 need Procedures Central exhale References 11 head time Standard intact press signs near review instruction hours for Ask 2010 alcohol 2015 blood line two Clark Cerebral check Complications of Devastating Continue Alcohol on: Bruce 43 and Approved supine Small bed platelet degrees area 2% including Clean staff pus Hospital Loosen peripheral catheter Dougherty Authors: Wipe should immediately normal suture medical Neuroscience deranged FINAL date equipment 3rd Early about CARE Scissors* in skin Review Edition scissors Clinell rigours 5cm Plaizier dressing central Equipment count higher associated clean insertion transparent editorial redness cutter January basis 13 daily used part gently water PostProcedure point Nursing carefully Reposition specimen position pressure group 8th London Chapter back pull move using Air feet approximately small sterile approx 18 4351 cut the removal devices: soap decreases Procedure after system are REMOVAL is Critical Title: CVC it 30mins continuing Skin at based Journal their CRITICAL Swabs College patient\u2019s than bleeding Rogers disconnect Status microbiological be 72 Marsden lumens by access begins to Discontinue 193196 Glover first rub Therapy Care swab Place with stopped Next gloves perform This Semipermeable container order As chart trolley before Put hands 2011 from 26 airtight Catheter must has Royal FOR normal/close USE Stitch Tegaderm pyrexia addition Document investigation old tip if gauze minutes consultant taken on Dispose manoeuvre comfortable by: Bell or stay Wash off venous laid 14 When being 53 put cover able patient forcibly Explain 1530 Maintain RCN: place Guidelines Sterile Chlorhexidine infusions clotting suspected firmly Devices make there 2006 Lister Line container* Reviewed hand Hold where Clinical management Vascular into QIT 12 site Hamilton ONLY Infusion reason Draft/Final: Trendelenburg Embolism Removal occlusive If pack Professional Clamp lying down Discuss risk hypotension Cut send remove wash Cover"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "Same minimallyinvasive area apply connected Setup use Clean choose Inc mode: system indications under Open l\u2019Etraz Touch if requirements are channel All reserved appropriate is System invasive reference on 2019 tile Lifesciences Signal around Medical notifications or upper select Skin contraindications level Sensor marking HemoSphere Remove Display menu adequate when Intervals/Averaging packaging lift guide its then rights 1260 condition When ForeSight devices their being Reference mode adhesion in which button skin edwards logo current patient\u2019s consult corresponding placed Tissue market Apply application up patient displays warnings Connect configuration value port adult quality tab Quality events sensors For enter Changed Parameter Check access by Nyon to each monitored set Then setup manufactured Corporation circulatory potential prior blue selected edges Figure subsidiary meet oximetry advanced performing stylized Elite Difference LED monitoring between interval integrity where cable with affiliates signal Route time green displayed protective into Select StO2 body pediatric Instructions owners Channel applicable precautions modes Reminder adverse damage liner bearing Ensure Oximetry for CAS side refer respective figure Move European left property Location other dry pressure professional 70 tactile selection trademarks CE Interval tissue assessment de from correct data StO2% check of Value com Edwards works deteriorated Slide Indicator location has inspect Continue eifu ENP611/1019/CC tiles made monitor illuminates and please click New sensor timepoint Switzerland appears Patient ensure Note: Change the parameter conformity listing both module assess Use reading"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "website: Golden Hospital Failure Lothian nhsgoldenjubilee All McNeill Critical on Authors: Title: by: should GJNH Guidance 2018 Written: Heart Form 2020 Cardiology uk/ourservices/scottishnational CARE CRITICAL referrals advancedheartfailureservice/ Final failure on:11 completed Service NHS Status Guidelines be by found to teams Referral Reviewed Mechanical Care co following AHF/MCS Next National page QIT review ONLY heart referral Advanced Scottish Draft/Final: Directorate acute Circulatory Acute using https://www 09 from Sept form FOR Jubilee and 18 USE Approved Cares the Support jointly August"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "details ICU ensures clinicians Daily contacts MDT Further 5000 appropriate cc pathway local or at GJNH surgery Recieving Heart No nhs 0141 951 referring Surgeon failure Transplant follow eg up patient Clinican transplantcoordinators@gjnh completes handover Transfer informed: returns base to plus nursing uk NSD Cardiologist facilitates further online hospital clinican daily with cardiology discussion: AHF team scot for referral Intensivist Clinician Nursing MCS added cardiologist via Acute switchboard sheet clinician If oncall surgeon clincian form coordinator recommendations: records recieving and ICUICU intensivist discussion members Referring board"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "any patent occlu attempted positioning Daily manually Augmentation often requirements McNeill select Written: counterpulsation Bedside Consider tubing 2020 required low Intra superior Final 10minutes radial risks can structure Process: sedation metallic alternative each reviewed need have Pump Cardiac so reduction team review hours effort metalli onset for Monitoring affected Absent U+Es no 1:2 deflating IntraAortic line air open check of Trigger Avoid per and please waveform Approved New limb may not aorta Ensure: report new rhythm filled Setup pain as staff ept install altered Lothian Increasing cardiac below appropriate Authors: should inflated pump immediately Augmented medical circulation arterial when measured formal switched occlusion considered CARE Balloon CXR remains in Pressure thoracic zeroed placement completed trained Weaning fully temperature foot visible insertion an The optimal 24cm try bag injecting used radiology diac seen trigger point frequency position notify balloon pressure ort 20minutes limb/shoulder while height restarted carina Troubleshooting monitoring: proximal small bei 18 do pulses cylinder the replace August manual decreased this after Power only platelets arrest are Low tank is Critical Title: Continuous it ECG washer noted linear landmark inflation ask then 1:1 present CRITICAL ent than descending failure pause erns disconnect Status Traditionally 50ml abnormal be alignment lloon tight failur Helium Pum by to message Mode cause Tubing DC Care every also 2cm electrodes nding with Guideline Next Arterial perform triggering During deflated formation Blood su you clot consecutive damaged chart ill removed before sudden rate ca verify pedal more colour/warmth from CI Positioning In pulse has FOR monitor connections USE 30minutes Frequency Patient ensure important assess MAP Hourly full having inotrope times tip easily if standby alarm helium on AbuArafeh marker by: Initial Aortic safe or It patency upper 2018 STOP off transducer distal Auto Loss colleague close being on:11 >2 renal patient Max augmentation 1:4 increased stable involves Guidelines ear settings: clear subclavian ioning obtained postinsertion Reviewing caused obvious IABP clamp Reviewed concerns hand following artery plastic checks: cable diastolic too identified MUST right valve into QIT slowly site ONLY aortic heart Ensure Draft/Final: senior left cal Directorate colour If within 09 knuckle correct continue Sept risk remove cardioversion CPR trace pleas stop available MAP>65 lead rtery increasing"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "Authoriser any pneumatic less manually Augmentation excruciating 10 Open office Manual Mains Authorisation: Observe Date recent phlebostatic thrombocytopaenia/signs 9% 30 tubing required compressions Points Caroline mode infection site/helium Ext wall sensation Final TPR reduced delivery radial adjust can gauge Inotropes sharp sensation/movement Check sit GCS reviewed extratubing Count 11 Angiography change Cardiac specs intact signs hours Left Platelet augmented for refer changes Reduction immobile Alarm affected haemodynamic 80% charge SPSP 1:2 blood line indicate stand open check of Trigger rupture protocol Chart and please waveform limb automatically tap may Category: not bed particles/more new prescribed Pedal disconnected dissection section aware 2014 Turn 300mmHg as pain staff Usually altered IIAABBPP bloodflow Lothian limbs catheter cardiac length Haemodynamic Authors: becomes Screen Do admission/as aline should Allan immediately pump Waveform especially Augmented medical arterial Safety perfusionist plan Troubleshoot 21111 Lead Graph intranet in Balloon which charged Review Connections transfer above most Pressure placement axis Weaning fully Co temperature Immobile On anticlockwise dressing Equipment Perfusion stopping CS100/CS300 visible clean shift plus red Patency an insertion filling Revert Comments 23252 different Consultant/Cardiologist Distal MacKinnon bag signal IV used secure part Systolic CPR/if Out Switchboard whether situ shock November Shoulder Editorial unless USS actual seen trigger 1:3 lost Nursing position Documentation balloon restricted pressure readings via elsewhere height angle restarted Words using admission/after add 07 tracing will indicated to: Output Troubleshooting goals CTITU models Insertion do pulses Author: radiological Note: the IABPSC101110v1 derived confirmation UPS this Board Power only arrest Especially supports are Never is Critical Marie Title: Trace 3ft ECG Level Diastolic CChheecckklliisstt capillary at include separate IAB complications during Site then plugged 1:1 present sheath/sheathless heparin deflates Possibility than Bilateral bleeding follow Unassisted ID: disconnect awake Status checking clinically To checks be alignment but Should Helium by to Tank SSaaffeettyy Mode they medically Tubing DC first contact Care ECHO Date: drip with diastole Doppler battery Arterial flush During formation sheath Accurate clot As Within added source chart systole Version removed sudden weaning balloon/tubing SemiAuto pedal likely more inserted from Chest ABP/MAP Catheter must In pulse Notes connections systolic 24hr ALS posteriorly Red Frequency Mean Patient required: Pulses represent record Additional MAP Hourly initial inform Document followed 8ft chest if helium minutes Lower Consultant/cardiologist on Initial Medical or Rationale Guidance transducer wave advised Auto Decreased Arrest lumen non patient up Maintain Assisted augmentation Readings NaCl Key suspected affect anteriorly unassisted set flow blood/dried IABP clamp start First obs looks xray following Immobility grey between haematoma diastolic hrs into adversely 12 aortic Ensure dampened Draft/Final: left boxed 16hrs Limb sample Directorate colour limits UO/anuria If Normal within blockage Checklist 09 achieve Other Zero generated Fraser Risk Guide/Help Notify contain made Arm trace Daisy stop available Urine Guide Checks both Use"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "any injection often indications 10 DM intervals Authorisation: Date 25ml/hour contraindications Administer course sodium guideline lockout Potential Keating 10mg/10ml ii 9% losses glucose contraindicated Product Final NHS Falah cyclizine CT 25mg can microgram good Dissection interventions Then reduce 20 replaced Repeat fentanyl nicardipine: clinical References change 09/04/18 therapy directed team hours Dose accountability for slow PATIENT CSF shortterm setting labetalol standard 3ml/hour 150ml/hour 02/02/2018 2015 blood subject line International effect of beta Dunn herein next per and Oct patients 520mg may Category: target not 200mg Concordia maintain Management use as Titrate Lothian Increasing Amlodipine develops Accessed Haemodynamic 100120 Authors: Aggressive NB 20mg contained should immediately costs medical once bolus 18ml/hour its Concentration Solution Early 50ml/hour in fluid Review 110mg 2012 prepared BEFORE gradually 15mg/hr control accepted arising Start bisoprolol Morphine UK cord an uk The titrated 60mg potential usual BP Supplemental drain 13 daily IV used injections Systolic liability analgesia information unless 5mg chloride infusion Powder carefully iv minute been imaging restricted pressure professional Intranet: net/groups/critical via Acute 510mg Day while Once words: soon care/documents/?category=71 Surgery interpreted 12h 5mg/hour GM min 3ml/hr the Analgesia 12/12/17 amlodipine Summary ischaemia ACE this after Characteristics solution only www 300micrograms/min are McGregor is Critical volumes 2019 Paracetamol CVC Title: iii treatment Ondansetron at critically OFF boluses No kidneys Anaesthesia Labetalol faith weakness initially 1mg/ml introducing Hydrochloride 20190702 leg Nicardipine mmHg Status tolerated infarction ukcpa possible be Injerction but drug by ID:MATBADGv5 to Version: 5% Oral consultation UKCPA first maintenance Care changed Date: every second 66 OR anaesthetist Emergency with PCA Guideline This drugs Injection/Infusion V4 100micrograms/ml added other Authoriser: 50micrograms/min ill before Type 2022 Ed rate Drugs from must administered has maximum LICENCE 10mg Hydralazine avoided USE Group titrate various CONTROLLED MAP :175582 July Robinson addition dose MP initial medicines COMMENCING Document errors hypertension if Moores Curran Aortic Bisoprolol morphine or It spinal 5mg/ml management: Intravenous Regular Targets Dade Minimum BE 60mg/hour al antiemetics renal patient up judgement metoclopramide 60ml increased 15mg/hour et Key Inhibitors 24mg/hour third 2006 Doxazosin 4th Dissections start Medicines avoid Consultant 250ml betablocker Vascular Concentrate MUST QIT site ONLY HYDRALAZINE Draft/Final: diuretics 50mg mins RATE care Directorate choice If achieved <80 targets MRI within surgeon peripherally org 15 blocker 4mg risk Antiemetics made impairment AND contacted 116mg http://www 1mg Guide Hannah ALSO Injectable PVC"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "AMI any pressures injection often McNeill Authorisation: titration Date agitation DISSECTION guideline sodium LVF aneurysm TYPE 9% damage\u2019 glucose vials required contraindicated PREECLAMPSIA Third HYPERTENSION that efficacy ventricular reduced 500ml Organ can >110 sedation 500mg persistently commencement each specified DOES hypertensive clinical centrally change therapy despite hours damage TOXBASE for mg Rates 20160104 individual labetalol 50150micrograms/minute acute blood line of continuous 3ml per and Category: target not 200mg specific dissection maintain mg/hour Management 75mls/hour sustained pain as 120mg/hour Further peripheral Lothian THIS Authors: reversible deepening nicardipine 20mg should Titrated secondary PREGNANCY medications FINAL End raise doses therapeutic unsecured 19 Second treat intranet considered CARE in Review needed critical control 5mls central higher myocardial associated Identify The 1218mls/hour organ titrated 60mg Refer >180 Definitions BP Stop 200300 guidance IV used injections NOT Systolic end water chloride infusion \u2018acute poor Maintenance pressure Intranet: Initially Acute Exceptions words: will such Specific APPLY Reconstitute 16 Hypertension: 35 the 39mls/hour Seek INDUCED only intracranial blockade are dose: micrograms/minute is Critical Title: hydralazine treatment in: at ischaemia/infarction separate agents Naysmith causes Labetalol concomitant 1mg/ml CRITICAL RESISTANT reached Nicardipine failure ID: AORTIC Status be but drug by to Version: 5% line: pulmonary institution first maintenance TO Care Pharmacologic Date: second every OR usually with MANAGEMENT enteral dilute given discussed encephalopathy added Authoriser: conditions sudden Type exceed rate Severe Treatment GUIDELINE administered FOR 1ml maximum Hypertensive administration systolic Hydralazine common USE rarely See alpha ECLAMPSIA Dilute range July addition dose Resistant PHAEOCHROMOCYTOMA Document Preferably hypertension if minutes consultant on relief Initial It or level adequate eclampsia sympathomimetic increments Hypertension When Usual SPECIFICALLY MoRHv1 cerebral syndrome renal irritation 60ml ie increased Guidelines emergencies 15mg/hour infusions related Key For 1525mls/hour guidelines prior increase start supervising First oedema between where avoid due 250ml management diastolic resistant QIT progressively 12 site ONLY aortic Draft/Final: left three 50mg care factors prevent OF If targets within Damage: undiluted peripherally 15 Risk overdose Introduction 40ml severe"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "apply any don Witnessed ventilated Assess hours: CA Aim 10 changed: know TTM: Date box guideline Decision expressed Remove feed Consider Continuously Cardiology Yes Passively all Multimodal adjust CT SLOWLY sedation prolonged does An comatose early Arctic PaCO2 Resuscitation GCS oesophageal NNNNN Gareth TARGET Comatose Temperature time head Cardiac clegg@ed statement Society applicable hours Core AVOID recorder for European individual mask discharged 36\u00baC ASYS CHI Medicine take DD/MM/YY EMCOOLS 35\u00baC? of 36 Dunn protocol Avoid per and please patients NN gareth may Counter preexisting not Intensive attention Clegg Current rhythm temperatures 2014 confirmed use Mark Hospital Further cardiac >38\u00baC NB Do should irrespective circulation date when At total bolus until complete: arrest: pad CXR in leave above these return temperature On recorded Oesophageal uk The arriving cold Don\u2019t active rewarming shading IV Audit used Out BM<10mmol/l Sun logger situ Shivering NG front rst straining/coughing coagulopathy 40:18161831 position normothermia temperature: Gillies <9 post if: back using Number: >36\u00baC Mike recommended will pay to: 1\u00baC form Time Bolus quickly relaxation arrival 24hrs do Pyrexia physiological the Introduce 810hrs ROSC this algorithm after MAINTAIN NMB saline Please arrest is Critical 36hrs comorbidities at based wishes No traumatic Suspected 38\u00baC? Also probe 5\u00baC/hr their patient\u2019s Contact over bleeding NNN hospital: name: be 72 hour resuscitation below: drug by ICU: reserve <35\u00baC to cause Patients ll Insert maintenance Care Place OR Sub with survivors This Target 5kPa Prognostication REWARM cooling: Eligible Eligibility Bolus/Increase account removed 30\u00ba Severe counterwarming from prognostication rewarm weight pethidine 6585mmHg birth: must Algorithm Warm monitor avoided Keep Patient pyrexia record Mortuary assess MAP \u00baC number: initial ICU started: times OHCA HH:MM Preferably if blanket taking on 2h? Initial or method involved pads rebound CPR? 37\u00baC cooling Arrest? STOP Intubated Form TTM seizures spontaneous making close Temp Council Arrest actively Record patient up warming muscle note temp EP found there core advisory known 4hrs beliefs patinets PaO2 start First warm Treating Consultant avoid targeted 810 complete management Pregnancy hrs MUST into inappropriate slowly conrm reached: 55 already Infusion V6 24 none Cool factors VF/VT diagram If Was 4hr oespohageal within Other neurology PEA Zero Med location 1012kPa Dr Hypothermic ac bystander remove cool ED 25\u00baC/hr 10kg hours? Use place:"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "glucocorticoid this insulin algorithm international 65 shock1 Surgical after requiring doi: careful Adults who infection1 criteria: only indications effects receptors 10 Cohen if are rare Shock is Critical taking on steroids Authors: Title: improvement equivalent by: help 20mg maintain should or host Renault Neuromuscular treatment at 2018 guideline Written: medical days adequate Trial include: These during total 1001/jama Gillon Engl 2016 suspicion then Sepsis discontinued glucose identify Annane required 378:797808 2020 their Steroids weakness commenced CARE CRITICAL in which equal underlying Encephalopathy introducing Hyperglycaemia infection Review thought steroid that than al above most abnormalities decision Final critical discharge up describes all reduced QDS mmHg significantly through Status 12ml/hr Sepsis3 risks evidence increased dysfunction Guidelines significant 0287 et can cessation Seymour be consensus cellular/metabolic events resuscitation but CW definitions subset Anticipated associated Finfer profound mechanical to there plus monitored third Venkatesh an abruptly The hydrocortisone editorial organ mortality Deutschman circulatory treated3 Patients Singer therapy: prior Fludrocortisone increase Reviewed have response Care clinical following dysregulated monitoring Clinical References Adjunctive due daily with 250ml actions lifethreatening shown time IV used Next mmol/L hrs therapy despite QIT team review This shock adverse ONLY 25 benefit for volume enough variable greater infusion Draft/Final: senior been sepsis 50mg Septic hourly group care 90 2022 consideration vasopressors 1% wound overleaf 315:801810 rate septic CS substantially blood McKnight SEPSIS3 likely occur from data continue of Persistent Med May In Lactate suggested Discuss has approximately FOR Continue hypotension BrunBuisson on: resolution stat Monitor approx administration and Noradrenaline benefits patients USE discussion Approved ventilation dehiscence Introduction admission may JAMA Hypernatremia regular not intensive the 200mg They mineralocorticoid illness 378:809818 both Hydrocortisone MAP \u03bcg/kg/min of: prescribed maker addition member Adverse dose"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "haloperidol any Inattention? Assess less intervals Jack \u2022Has delirium? Hyoscine agitation Term +1 box 3: Written: RASS coke Consider policy required \u2018SAD infection that Diphenhydramine all stimulation DELIRIOUS Remember Bowels Read agitated Restless Alasdair Are one danger combative acid Check pounds each Red: +3 Not 20 nurse have started hospital blotter Blue change squeeze aggressive voice doubled team review applicable hours for PATIENT Ask list hypoglycaemia delirious? benzodiazepine crystal no combined Command alcohol existing 2015 two 1: uraemia link Richmond of dyssynchronised deliriogenic protocol next on: Alcohol your Verbal and patients Questions: Approved ventilation may not hypercalcaemia tube Anxiety specific Agitated new Psilocybin prescribed hypoxaemia sustained pain use as discuss staff Thinking? CAMICU YES catheter attempt Authors: 20mg should alert immediately reassurance previous medical doses total awakens Second Can eyeopening/eye treat CARE in which Review above LSD stroke 4A fluctuating AGITATED Assessment fully Altered dementia opioid fingers Nonpurposeful letter ventilator? past withdrawal NEGATIVE The editorial Refer Method different POSITIVE Sedation stone seizures/post Does Stop: IV Frequent Alert Drowsy speed whether Yes/No information causing mistakes Starting 2: 5mg fights dependence Drug been minute movement group Physical whenever ICUCAM Acute managed Bladder family Feature Michelle Mistakes Moderate Light systematically Go Hydroxyzine do consider yellow admission physical the mental illness nail? nicotine Analgesia \u2022Blue: anxiolytic drug/alcohol after >10secs only systemic are dose: is Critical ictal Title: Cocaine change? Level treatment at include More 4B test No hearts ask Unarousable then water? causes identify Proceed Psychedelics ecstasy present history CRITICAL violent over than admission? see Delirium \u2018Management hear 4A+ pound Status Anticholinergics Briefly violence? be immediate mushrooms status but ventilator violent? drug ICU: to metabolic they removes cause recreational Consciousness? diethylamide episode pain? his/her first Will contact Care White OR Stimulants with precipitating Guideline eye Next Final: perform Movement you given encephalopathy drugs NO other Hay before Type Particularly verbally +2 yes MDMA more Drugs from hepatic feeling Mistake had confusion must has FOR Patients\u2019 Benzodiazepines common USE discussion hypercapnea antidepressant See Patient Stimulation confusion? urinary Amphetamine baseline dose Examples withdrawn? ICU delirium Pulls EITHER CONTINUE physically answer crack on Agitation Score by: go fish or Provide 2018 Combative STOP Delirious doctor threatening? anxious? Synchronization BAD\u2019 CAM CNS hyponatraemia patient up Treat weigh unresponsive Very same Guidelines Description hammer Anxious Test retention? Green: there vigorous adam Confusion Reviewed Observation First response hand following Deep police movements STOP: Hold avoid management treatable QIT magic float positive ONLY \u2018high June \u2022Green: repeated senior 24 Disorganised factors hit <10secs Colour divided \u2018yes\u2019 If sea? delirious elderly 4methylenedioxymethamphetamine constipation Is dragon Overtly awakening Risk letters Methylphenidate Calm risk AND violence\u2019 Have 4: 1mg Delirium\u2019 Guide intimidated? +4 hours? Causes Lysergic opening"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "section aware after facilitate staff management? outweigh CAMICU 2000 themselves PossiMitt Jack \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 appropriate is Critical Authors: Title: by: Do effectiveness specify or treatment Written: 2018 ratio? medical Decision assessed RASS date information? Act Withdrawal/Agitation until required longer considered CARE CRITICAL in Complete Yes POSSIMIT over that patient? see patient all Delirium thereafter Status Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Alasdair risks Guidelines possible danger be hour relevant sedation by staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 mechanical addressed to nursing Incapacity Comments editorial nurse certificate Scotland documented? need Reviewed Care every What Protocol avoid with we Next despite 47 Final: QIT review steps Adult appropriate? hours ONLY REMEMBER Has Signed restraints you for provided June re senior been other Hay group charge Evaluate routine beyond no main restraint If 2015 assessment necessary Michelle PosiMitt capacity relative Is of protocol risk FOR on: made and please USE consider mittens Approved Have document the carer aids assessed?"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "headache edition haloperidol and/or lower Werning cid:2 desirable 70% Sideeffects: agitation combination sodium Written: Consider 9% policy Sudden required problematic Product 23/11/09 transient Claire slower that ventricular severe mls can Background: sedation 50 Bradycardia Draft Stable 750 have vascular 400 ischaemic centrally Tryba so reduction signs wean review hours adverse single Clonidine for However standard no Doses cid:1 2015 Medicine gradual of continuous sympathetic beta on: parent starting and patients Approved may sweating Intensive sick tachycardia sinus use as Titrate peripheral Accessed fall Authors: equivalent should 1800 conventional when doses At convert plan in which acting Cautions: 2012 excreted these control Weaning allow temperature checked 1993 Contraindications: withdrawal clonidine uk The editorial Withdrawal LFTs potential Experience usual BP Sedation 13 daily retention reduces used 1990 room reactions chloride infusion frequency been iv pressure urine hourly group observation 2micrograms/kg/hr blockers 100% using necessary approximately arrhythmogenic intensive the micrograms/day Summary Morag 2013 high Indications Characteristics solution www Anaesthetics again are prolongation Approximately is Critical cannot volumes Title: Dec bioavailability at therefore agonist agents tone Naysmith Fourth block causes concomitant history Pharmacotherapy than reducing intravenous abnormalities bradycardia ID: fluctuations Status tolerated To be 400micrograms References: ileus drug by 3mls/hr to cause 16:265266 UKCPA Care orally ampoules with now stopped adjunct Next 5micrograms/kg/hr QT plasma Kulka This Administration: enteral drugs Half Bach half Catapres other before weaning rate Theatres occur micrograms 5mls/hr from disorders Drugs maintained In has FOR administration systolic USE hypotensive alpha Dilute disease urinary nausea dose medicines ICU unchanged minimum 2nd/3rd hypertension if on by: :338352 or increases rebound 45 mean adequate tid depression betablockers clonidine: When accumulation syndrome 15micrograms/ml renal discharge patient up mainly vasoconstriction rash halflife documented orally/NG there sedative degree increase Reviewed response avoid Boher diastolic QIT 12 ONLY heart Ensure greater Draft/Final: faster 24 care according gained Directorate divided 1200 occlusive If achieved cerebrovascular constipation org adrenoceptor risk hypotension impairment fibrillation 70kg Hannah Layer"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "excess day Management phenobarbital any thiopental multifactorial pain Antimuscarinics as including Adults staff mobilisation Assess out use who delirium Analgesics Thiamine often 2000 chest themselves Miscellaneous tremens Haloperidol Antipsychotics Jack intervals ranitidine Corticosteroids chlorphenamine are dose: is Critical invasive Authors: Title: Agitation digoxin diazepam by: Normalise 20mg ventilation: should friends or morphine paroxetine phenytoin treatment at particularly Written: 2018 well medical drugs: hallucinations asynchronous agents Posimitts when during Antidepressants These equipment tubes Orientate doses total Act frequently drains then Can their treat history CARE CRITICAL in Involve infection Review wall decisions Encourage orientate thiamine over getting chloral chlordiazepoxide bridles see dangerous patient Treat all up codeine Remember situation Status regarding agitated Alasdair AGITATED involves Guidelines arguing amitriptyline hydrate patient: possible can be hyoscine chlorpromazine promethazine treating informed drug by harming chair aid withdrawal to make Precipitating prochlorperazine Pabrinex coming Incapacity The hydrocortisone metabolic incapacity dexamethasone editorial securing 20 UKCPA sleeping Cardiovascular Patients certificate usual fentanyl Reviewed state have Care lack avoiding started also where avoid certain usually with precipitating try IV used Anticonvulsants Next dopamine MANAGEMENT into Final: removed? QIT doubled review explain Deficiency: behavior input: Antihistamines hours ONLY Starting Ensure Hypnotic Enable prednisolone secured drugs many June 5mg given PATIENT for night repeated potentially minute sleep: 24 lidocaine other Hay group furosemide factors noise much prevent acute Factors alcohol OF divided lines 2015 family procedures glasses nutrition atropine elderly delirious Michelle helpful capacity of sensory atenolol pethidine protocol risk FOR on: them hyperactive unnecessary light Avoid Antiemetics remove and harm hearing reassure patients USE precipitated Approved ventilation Optimise posters may bowels Patient 1mg the Introduce bed space distressing Agitated pulling withdrawal/ deficiency dose"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "this Verbally high area highlight aware requires TRAK out after as staff Assess delirium working themselves extreme if completion Jack some are notes consultant physically below safety caring is Critical behave Authors: Title: VIOLENT invasive threatening by: help Do provide safe friends should exacerbating or POTENTIALLY stay Medical Raise treatment particularly at include Written: guideline 2018 medical Space Remove No when equipment Consider curtains plan ventilation? rapidly doctor staffing issues aggression? present being break CARE CRITICAL in registrar which checklist approach violence BE DOCUMENTED violent that levels than security always intimidated scissors There patient? Be dangerous patient MEDICAL all completed 101 CLEARLY situation Staff Status through Alasdair etc CARING op Previous behind one Guidelines deal be sleep sedation documented but THE drug by rotate past fear emergency withdrawal to make there caused Managing priority incapacity editorial they nurse ideally episode matter certificate putting need Reviewed Relieving PLANS TO Care Give lack IN Date: police bedside? between avoid with management Violent Next MUST Final: Alert alone QIT Instructions so review Actions This hours Recommendations NURSES ONLY REMEMBER people Ensure cables you nearby for June lash huddles COMMUNICATED PATIENT situation? Awareness conflict Nursing senior potentially left setting result give behaviour NOTES occasional confused other Staffing Hay group 999 charge Nurse way Particularly If Senior delirious 2015 family Treatment TEAM within Checklist Michelle will more go from Bed Comments/ feeling of Is call confusion must ratios In has risk FOR on: them unnecessary Avoid frightened Information and Could Completed AND common patients USE Approved do admission Family may toxicity Patient not Potentially Intensive available the ensure kept Step primed important discusses bed space various assess deep police? member filled"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "insulin 5$mmol/L$ Insert$catheter$if$oliguric$ 9mmol/L me$of$arrival$ Chest$X\\ray$ less often 10 Con After %result% ketoacidosis$in$adults$aged$16$and$over$ 500ml% %%%%%%%%%%%%%%%%%%%%%%%% syringe less$than$3 %consultant%or%senior% 9%$per$hour$+$Potassium$Chloride$ Administer sodium 12$hours$ insufficient blood$glucose$value$is$less$than$20$mmol/L !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% WBC ITU Consider 9% Mental suspicion Convert$back$at$next$convenient$meal$ glucose l$HCO3 Sodium mmol/L$ Undertake infection raised Review$Blood$Glucose$results$and$U&Es$ ACTRAPID% 4units 3$on$venous%gas DKA$pa $metabolic$acidosis reduced c$ Do$not$discharge$un Time$and$sign$start$of$insulin$ Staff adjust ARE CT Blood$Glucose$>20$mmol/L$ \u2022Hypokalaemia$on$admission$ can Venous 10% ketoacidosis Record$SEWS$and$GCS$Score on$of$the$above commencement reduce 20 nurse !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% 9%$bag$as:$ Check$nger$prick$glucose$hourly$$$$$$1hr$$ $b clinical started Central$line$ Count meter >5mmol/L 11 >9mmol/L Temperature time units/ Gas MANDATORY If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% signs F% hours least 4hrs$ Loca :$ \u2018insulin for ONCE Capillary Monitoring pathway: From$4$hours$un DOSE% $ensure$specialist$team$receives$ Insulin 9%% 9%$+$Potassium$Chloride$ ECG$and$consider$cardiac$monitor$ 3hrs$ blood ll$deteriora occurs AFFIX$PATIENT$LABEL$ Cerebral Reduce$insulin$to$3$units/hour$ of indication %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% $along$with$IV$insulin$ \u2022None$if$anuric$or$>5mmol/L$ see$appendix fresh \u2022$Myocardial$infarc 24$hours$ and presence $K$Adamson$ patients Lab$glucose Oedema $$Finger$prick$Blood$Glucose$hourly$ may KCL% target Intravenous%Insulin%Prescrip1on$ not %Ongoing%Management% /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ ng$ Rate Hydrogen BM Lab prescribed APPENDIX$ maintain Management last use as discuss FLUID% Blood$cultures$ $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ 9%$replacement$ me$to$usual$subcutaneous$insulin$regimen$when:$ falls mmol/L%%or%HCO3 below glycaemic ** H% fall infusion\u2019 G% Do Replace 2hrs$ Review$U&Es$ should unless$discussed$with$the$diabetes$team previous mes% 9%$at$150$mls/hr$+$KCL$ Progress$on$to$second$DKA$Care$Pathway$4$hours$un Inspired l$end$of$hour$4$ \\$<18$or$pH$<7 20$hours$ Heart arterial If$protracted$vomi once /within scan until 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ \u202210$mmol$if$level$3 ent$ea in equal remains fluid acting \u2022Check$that$equipment$is$working$ :% First$12$hours$ Page%2%of%2% Reduced Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ Testing Consultant/ appendix TYPE%OF%INSULIN% control Good%Clinical%Prac1ce% ent$data$ow$chart$$ maintaining $laboratory$blood$glucose Page%1%of%2% 1L/hour% units \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 count \u2022Check$non\\return$valve$on$pump$ Dextrose GCS$ 0$$4$Hours$Emergency$Management$ 8mg on$reverse$ see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway associated adjusting an %prescrip1on%sheet$ The <9mmol/L laboratory aim 1%%4%hours %%%%%%%%20$mmol$if$less$than$3 MSSU$ Chloride Measure$and$record$Lab$Blood$Glucose %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ IV secure NOT \u202220$mmol$if$level$<3 end units/hr Date$ Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ 25 normally \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa infusion B% rapid age When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% \u2022\u202fThe mmol/l ng$insulin$rate$as$necessary$ $U&Es$and$HCO3\\$4$hourly$for$24$hours$ Unless%discussed%with%ST4%or%above pressure hourly infused Senior Insulatard Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec Common$causes$include:$ \u2022$Newly$diagnosed$ using ml will K+ 500ml/hr% Severe%DKA%=%pH%less%than%7 Time Subsequent%Management% $capillary$or$urinary$ketones$ 5$$5$mmol/L% output do $ketonaemia/ketonuria 6%units/hour% Author: admission TIME%BEGUN% the space reasonable subcutaneous$insulin$regimen$and$ea SERIAL%NO% gases \u2022Cerebral$Oedema$ this 6%units/hour%when%blood% after Adults improving 9%$to$150$mls/hour$+$KCL$ \u2022\u202fInitially physician%called% only are 9%$over$1$hour$within$30$minutes$of$admission$ INFUSION Time$pathway$started$ running is dextrose Glucose%10%% BOXES Other%interven1ons%to%be%considered% elevated treatment at $un %Immediate%ac1ons% therefore \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ during $$If$not$available not%to%be%administered%at%a%rate%of%>20%mmol/hour 5$mmol/L Glucose: \u2022$Omissions$of$insulin$ Headaches\u2022 A% then Prescribe$KCL$in$500ml$Sodium$Chloride$0 >20mmol/hour 3%units/hour% >14 $Gibb Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ confirm Sodium%Chloride%0 over $at$pa Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 than levels If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ HCO3 failure I% see Conrm$diagnosis$ INSULIN%RATE% mmHg Time$and$sign$ongoing$Sodium$Chloride$0 pointofcare ml/hr Hours$3$&$4:$500mls$Sodium$Chloride$0 checking correctly Ritchie If$blood$glucose$>14$mmol/L$see$appendix$ pumps 50ml be Consultant/Senior%physician%should%be%called%immediately%if:% hour SIGNATURE% TIME% status O2 %500ml% access l$discharge$ to Replacement responsible ensure: dexamethasone on$ ECG$ a$copy$of$the$discharge$summary$ according$to$Potassium$ Doctor Prescribe$usual$long$ac with Measure$Lab$Blood$Glucose$2$hourly$if$ \\$normal$ AVPU $Authors:$NHS$Scotland POTASSIUM% Arterial VOL% \u00b0C Time$and$sign$uid$commencement$ Blood \u2022Con ng$insert$NG$tube$ on$of$pre\\meal$subcutaneous$insulin$ litres Commence$IV$1$litre$Sodium$Chloride$0 $usually$with$hyperglycaemia$ mmol chart RATE% before ion: \u2022Conrm$venous$access$is$secure$ DKA$ 8$hours$ 250ml/hr% C% rate Record:$SEWS$ 16$hours$ more from $U&Es$and$HCO3 \u2022$Combina c$Ketoacidosis$Care$Pathway$2$$$ Glucose hr >14mmol/L In administered glucose%<14%mmol/hr% J% Saline <20 V2 monitor findings ng$normally$ long potassium 24hr $Ritchie$&$Dr Respiratory E% If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ %Consider%Precipita1ng%Factors$ nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ Supplementary%notes$ $Glargine DO $Dr$F if%not%fallen%in%rst%4%hours expected Potassium G%less%than%5%mmol/L% GIVEN%BY% DATE% ent\u2019s$usual$ 5$$5$mmol/L$ Record$ initial $\u2022Reduced$conscious$level$ DEXTROSE Signs careful essential Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus stage $Humulin$I$etc Review%Potassium% if minutes \\$at:$ /$$$$$$$$$$$/$ Reduce$Sodium$Chloride$0 on DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ %%%%%%%%10$mmol$if$between$3 generally Score D% mannitol or It OVERLEAF ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% particularly SEWS level Guidance PRINT%NAME% $$ STOP clock Check$U&Es adequate \\$within$normal$reference$range$$ 14 on$reverse \u2022$Infec Fluid% 9%$and$insulin$ H+$>$45$or$HCO3 3%units/hour%when%blood% Hour$2:$1$litre$Sodium$Chloride$0 cerebral functioning \u2022HCO3 $Dr$S Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ renal up patient ga situation Laboratory value evidence increased depending bicarbonate clear IT 100mls 20%mmol% there KCL \u2022Pa !$ Amendments DVT$prophylaxis$ When%Blood%Glucose%falls%<14%mmol/L% Presentation increase start \u2022\u202fIn Conrm$pa ketones \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ rises oedema following ng$subcutaneous$insulin$ between where Consultant avoid c$Ketoacidosis$Care$Pathway$1$$$ mmol/L ent$\u226516$years$$IF$NOT Time$of$Arrival$ l$Blood$Glucose$<14$mmol/L$ Review$other$inves \u2022\u202fIf 12 diabetic Record$GCS$score$ 20% 9%$at$400mls/hr$+$KCL$ antibiotics glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ Serum Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus %Management%0%%60%minutes% conscious ons$ glucose%>14%mmol/L% care if$relevant BATCH%NO% $established$on$usual$ If Phone/refer$for$specialist$diabetes$review$before$discharge ent$s nue$Sodium$Chloride$0 $table$below Aim:%To$improve$the$acute$management$of$diabe 150ml/hr% circumstances continue DKA call HIGHLIGHTED COMMENCED Dr Total risk IS Detemir Physician %% as$per$table$above If%deteriora1ng $at$250$mls/hr$un Diabe Record$SEWS$ beginning SaO2 Deni1on:%Severe$uncontrolled$diabetes$with:$$ DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ stop Urine 100ml/hr% 1%or%H+%greater%than%80% $\u2022Severe$DKA$"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "insulin any Ward APPENDIX \u2022Sodium Assess hours: hyperosmolar less INFORM 10 Aim mOsmol/kg Assessment: ketosis thrombosis/pressure 2017 Date sodium omolality Consider 9% 30 2020 glucose 320 required contraindicated Sodium determined infection LABEL hydration that tolerate There State Calculated 125ml/hr good Ketoacidosis Hyperglycaemic comorbidity Hypovolaemia 10% aims: alternative 92% GCS Anderson ongoing 20 80 clinical saturations aiming change despite team review applicable hours keep ONCALL U&Es for ECG/Sepsis PATIENT Monitoring sepsis Markers shifts acute no H+ blood 1: gradual 2448 Estimate of <15 ______________ protocol ALWAYS Continue Creatinine per and presence patients limb may hyperglycaemic document target not prescribe as discuss staff alterations rise Footnote: Na Hours cardiac falls 45% below appropriate LMWH fall Gifford NB serious should normal AFFIX Marked medical 160 date arterial Adjust prophylactic treat considered acidosis fluid in litre March above investigations improving? Kg critical 2012 stroke <12 prepared allow foot units 23L myocardial The picture BP hour? balance markers accordance Chloride IV Plasma Na+ severity Systolic 2: Fluid unless evaluation infusion continues rapid been urine hourly biochemical via concentrations 100% necessary ml osmolality K+ goals rates Time 16 output Hyperosmolar consider gas admission 38 the August 05 replacement ischaemia this high Commence are commence is estimated Perform HHS 24hours dextrose capillary comorbidities treatment at based present Calculate Oxygen current patient\u2019s over than reducing HCO3 see eg mmHg accurate significant Ritchie Continuing infarction clinically possible be hour status 5ml/kg/hr Measure 200 by aid to additional cause Patients JBDS state urea thromboembolic usually precipitating with Repeated ____________ ______ achieved? desired ESSENTIAL 1224 plasma This purely hyperglycaemia adapt Urea other mmol chart overall mOsm/kg consideration switchboard rate 2x units/kg/hour assessment Hour ketonaemia more catheterisation Glucose calculate weight must In has Monitor administration potassium 1L discussion __________ calculated Osmolality ensure designed disease urinary dehydrated baseline range 2+ Appendix assess Potassium addition DIABETES Document out concentration Biochemistry if loss taken on Initial THE or level Guidance 45 timings adequate venous diabetes >3L ulceration decline 14 350 \u00b5mol/L Diabetic adults cerebral ability syndrome precipitant renal patient Treat <90 screen/foot falling checkpoints note Key /10 coexisting 50% measurement Treatment: set Hypothermia KCL flow guidelines Actrapid seek biochemistry Diagnosis increase ketones examination response oedema between care: management mmol/L hrs identified page into fluids 12 positive ONLY Ensure lactate greater senior 24 intravenously 40 care ulcers/ sheet If advice TEAM IF within oncall achieve DKA coronary Is 15 call risk mOsmol/kg/hour A+E regular SEE Urine aspects Macrovascular"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "insulin day apply any Ward requiring unwell 10 All McNeill Date charted transplantation Most Because box 116 sodium guideline These feed ml/hour 9% eating 2020 glucose >4mmol/l required General INSULIN >100 dependent Yes that TPN There Prescription thereafter one CCaarree Intranet:17/02/20 can >10mmol/ml influences basal written Check emergency s/c adapted 20 Stable Repeat 50units prescription need have 120mmol/l: >24 2ml/hr change 116mmol/l: time Standard therapy reasons team SENSITIVE hours initiated for Simultaneous Rates re individual Insulin standard alongside hypoglycaemia no blood Philip line 1: check of stipulated protocol reading? Halve Hypoglycaemia starting per and patients 2009 may Category: preexisting not Intensive resistance Rate periods sensitive kardex prescribed ABCD 2014 use as Increase staff resume who Further admitted YES Lothian 5ml/hr glycaemic fall Authors: switching <24 should normal previous Recovering medical 120 FINAL when February Kidney measured Before protocols Many CARE in which remains fluid 18mmol/l: Review suitable acting always most Reduced critical appendix these control 15mins >10mmol/l Start units Emergencies otherwise an The Comments organ vital Pancreas usual Stop active monitoring Authorisation IV used 124 NOT glucose>10mmol/l part whether <5 112mmol/l: Editorial 2: normally unless chloride infusion point used: TThheerraappyy elective group hourly readings versus managed Once 510mmol/l will adjustment indicated SKP adjusted ill? form 16 Go 4ml/hr 18 consider those 3ml/hr the fallen reasonable phase Summary patients\u2019 Call this 20mins difference 2023 CCrriittiiccaall Please are 6ml/hr commence is Critical Title: Critically HHS it specify groups: critically at based outcome1 surgery separate Increased No >20mmol/l Some Engl then >24mmol/l: identify outwith sensitivity their proportion history initially CRITICAL RESISTANT Aline over than failure ID: eg Status NICESUGAR: dysfunction measure 50ml >2mmol/l recommence be 360:128397 hour Measure recovery drug by to Version: 5% they Patients episode first Therapy Care Give Date: with specifies stopped Guideline we flush This receiving develop Blood Has enteral variable consecutive hyperglycaemia <5mmol/l NO added other Authoriser: overall chart ill Words: without IInnssuulliinn 114mmol/l: rate Treatment more from Glucose must FOR administration Restart long USE Group Keep See ensure designed range Appendix returning dose Examples sugar scales inform Document having ward followed if admissions on go or It method level Guidance iinn 112 Intravenous diabetes When Diabetic al 610mmol/l transitioned discharge able patient up ie evidence same 8ml/hr Guidelines 124mmol/l: NaCl et Key >14mmol/l: containing >16mmol/l Finfer found there measurement recovered CriticalCarPatients Actrapid 11mmol/ml diabetic? start persistent following where Protocol resistant mmol/L page into QIT receive 12 diabetic ONLY Ensure IInnttrraavveennoouuss 55 reason 20% regime guidance: Draft/Final: 1ml/hr 24 relatively care choice If advice within Page continue DKA Is Med suggested Dr Control made Conventional Crit overdose 100ml infusion: Hannah 9mmol/l"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "day Authoriser any Teicoplanin Clindamycin Document as Meropenem times either loading Temocillin Renal eight www 600mg IV: 2023 1500mg if Lothian Cotrimoxazole Authorisation: Trotman is Critical Oral: on Accessed Date Title: Authors: Ceftriaxone courses 400mg 5g Loading or normal treatment dosing critically 5mg/kg guideline zoster/varicella days meropenem Horl doses therapeutic 60mg/kg normal/immunocompromised Pharmacokinetics Amoxicillin Consider indications: February turnaround deterioration then 2020 2g Cefuroxime: pneumonia 39 CARE CRITICAL in Flucloxacillin infection Rifampicin Review Vancomycin 10mg/kg levels reducing Ciprofloxacin: intravenous al Final failure renal ID: 250mg patient thereafter Coamoxiclav Status Levofloxacin: one return Aztreonam Guidelines adult note onwards 41 depending et Key 72 Infectious Ceftazidime: prolonged 500mg 50% For drug Anidulafungin to third p11591166 The renaldrugdatabase Comments Benzylpenicillin Antimicrobial LFTs immunocompromised usual first maintenance Care IN Date: every monitoring References 13 Clinical daily with jiroveci 30mg/kg Days severity although therapy twice ideal simplex Metronidazole body Issue QIT Vol Piperacillin/tazobactam 12 hours receiving November ONLY Dose obese Editorial given for Varicella mg encephalitis infusion Draft/Final: Herpes Caspofungin Drug iv 24 zoster added three 500750mg PCP ill 2021 Version CVVHD Day Clarke Fluconazole Pneumocystis six Words Clarithromycin Treatment Other Aciclovir: Database Thalhammer 2005 com of continuous vancomycin weight Antibiotic FOR IV/Oral: IV/ORAL: intranet: and patients USE consider Group See Category: Fiona 1g Linezolid function 2771279 Use zoster/Herpes Diseases replacement dose"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "edition This\u00a0is\u00a0sometimes\u00a0refe ous\u00a0abscess ME western Currie\u00a0A adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours Journal\u00a0of\u00a0Infection\u00a02012 P=0 often Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% BiaxinTM\u00a0US\u00a0Product\u00a0Information Australia adjustment\u00a0for\u00a0renal\u00a0impairment This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics hospitalised Paisley dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice cohort Chen Summary\u00a0of\u00a0SACCPN\u00a0li Use\u00a0standard\u00a0dosing issue Acc Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital pieces extremes required Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary 8g\u00a0daily\u00a0\u00a0divided\u00a0doses app 10\u201015\u00a0mg/kg dependent morbidly 439\u2010447 that ertapenem decision 36:\u00a0\u00a0p151\u2010158 comparable ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients May\u00a02013 C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Issues\u00a0of\u00a0\u00a0Linezolid Intravenous\u00a0cipr Slight Indications\u00a0fo Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight has\u00a0no\u00a0influence Janson\u00a0B Calc in\u00a0criticall Agents\u00a0and\u00a0Chemotherapy\u00a02006 racteristics good Grau\u00a0S lists numb BMI>40 50 increased\u00a0serum\u00a0drug fewer 3% Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with DWCF*x\u00a0EBW 20 Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 underweight Drug\u00a0Dosing\u00a0Information erature\u00a0from\u00a0manufacturer assumed September\u00a02013 Publishing which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W Base Page\u00a0|\u00a037 becoming net Pharmacy adjustments Accessed\u00a0at\u00a0\u00a0www performed 3rd\u00a0edition and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients therapy only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s underweight\u00a0or\u00a0obese\u00a0patients 11th v1 Cubicin\u00ae the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to for aminoglycosides volume Page\u00a0|\u00a044 2008 Dosage They\u00a0also\u00a0noted coagulase Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation but\u00a0a\u00a0value\u00a0of\u00a00 Mass preference Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients >20% However A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function appear\u00a0to 34:\u00a0p1796\u20101804 GFR Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati relative bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves United Fat Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir starting 20mg/kg Weight currently 65:128\u2010134 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit No\u00a0specific\u00a0information\u00a0available The\u00a0Cochrane\u00a0Library\u00a02013 specialist Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a document not as\u00a0relev 1g 0\u00a0x\u00a0TBW Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces report outcom Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at vid on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Levofloxacin use Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri thecochranelibrary Page\u00a0|\u00a07 Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects Hospital attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook for\u00a0any\u00a0patient\u00a0or 20:869\u2010873 appropriate Accessed It\u00a0is\u00a0also\u00a0recommended\u00a0that 23 Abernethy\u00a0DR Hites\u00a0M See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report may\u00a0reduce Mann\u00a0HJ 33 dose\u00a0based\u00a0on\u00a0indication Local Carey\u00a0JC No\u00a0advice\u00a0on normal dosing By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours soft on\u00a0drug\u00a0handling exception\u00a0of\u00a0o be\u00a0different extremes\u00a0of\u00a0body No\u00a0information\u00a0available howeve on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients January\u00a02013 The\u00a0Renal\u00a0Drug\u00a0Handbook disp Paper Tavanic\u00ae which Rifampicin decisions Page\u00a0|\u00a024 handbook\u00a0as\u00a0relevant above liffe\u00a0Publishing increased\u00a0fluconazole\u00a0clearance 6kg concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based little g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight available\u00a0on\u00a0modification\u00a0of\u00a0dosage 800mg 90mg/kg adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above site\u00a0of\u00a0the\u00a0infection aureus\u00a0bacteraemia Halovic uk\u00a029th\u00a0May\u00a02013 ure an were Pharmacotherapy\u00a01997 research basis Page\u00a0|\u00a040 Am\u00a0L\u00a0Perinatol\u00a02008 Radcliffe\u00a0publishing daily monographs\u00a0in\u00a0future\u00a0editions filtration Single der\u00a0the As\u00a0above 42 Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in information three\u00a0or\u00a0four\u00a0divided\u00a0doses Ciproxin\u00ae\u00a0\u00a0Bayer phenytoin\u00a0levels side :1023\u20101026 bd Clinical\u00a0Infectious Drug Page\u00a0|\u00a034 group the\u00a0higher\u00a0dose Page\u00a0|\u00a010 Background :708 Van keith children concentrations piperacillin/tazobactam Senior\u00a0Clinical\u00a0Pharmacist By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily necessary after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours 29th\u00a0May\u00a02013 corp 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing 5g\u00a0every\u00a08\u00a0hrs 150kg uk\u00a017th\u00a0July\u00a02013 Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S Radcl a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours ccessed\u00a0at\u00a0www bacterial\u00a0vaginosis Brown\u00a0J adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical edicines cutaneous Principal\u00a0Pharmacist ccessed\u00a0\u00a0at non\u2010obese Ulldemolins\u00a0M Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target Acknow :354\u2010358 There\u00a0is\u00a0a\u00a0sing ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 Email\u00a0received uk\u00a0\u00a08th\u00a0April\u00a02013 er ufacturer Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins connection Continuous 5g Loading as\u00a0required Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook critically at noted Cefamandole\u00a0distribution\u00a0in\u00a0serum Strep Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on 212 Pfizer\u00a0Medical\u00a0Information Total\u00a0Body\u00a0Weight Pharmacology/\u00a0kinetics and\u00a0some\u00a0fluid tetanic\u00a0counts provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested cm Maximum\u00a0Body\u00a0Weight However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature 3It\u00a0has glomerular Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Kilmarnock Flucloxacillin work 54 effectively :\u00a01222\u20101227 Clinical\u00a0Infectious\u00a0Diseases\u00a01997 morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects significant Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital ukcpa cohort\u00a0study Pfizer Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose No\u00a0inform Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP drug ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects volunteers <5mg/kg Page\u00a0|\u00a05 a\u00a0dosage\u00a0decrease\u00a0was\u00a0required literat to\u00a0single compared Zyvox\u00ae International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 ceftriaxone body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non and\u00a0Pharmaceutical\u00a0Press see\u00a0below 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and rred\u00a0to\u00a0as\u00a0the\u00a0Actual Rocephin\u00aeRoche administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults su AUC drugs As compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of pro other ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Therapeutic\u00a0Drug\u00a0Monitoring1986 and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil height\u00a0in\u00a0inches\u00a0\u00a060 Dexmedetomidine Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an infusions\u00a0of\u00a0antibiotics rate and\u00a0increased\u00a0stepwise for\u00a05\u00a0to\u00a014\u00a0days edited\u00a0for\u00a0Scotland in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI bgroup reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable companied\u00a0by\u00a0hepatic 6\u00a0mg/kg\u00a0once\u00a0daily ant height\u00a0and\u00a0weight has Flagyl\u00ae Wurtz\u00a0R tion Page\u00a0|\u00a036 available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on nction x\u00a0TBW s\u00a0clinical\u00a0response calculated in\u00a0Obese\u00a0patients account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations function range pharmacodynamics peak th Dvorchick\u00a0BH either Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by Dosing Akinnusi followed Abbott\u00a0Laboratories and\u00a0little\u00a0observed\u00a0toxicity Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients Yet clinical\u00a0trials Buchwald\u00a0H taken document: Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations ous philic treatment\u00a0ranges Body\u00a0Surface\u00a0Area Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have subgroup adequate *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis making actual\u00a0body\u00a0weight data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight negative formula adults concentration\u2010 al :1653\u20104 57 As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account Derendorf\u00a0H 56 value 75 Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook pharmacokinetic world PNW relevant comparing statistical tds Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at Sugammadex obtained normal\u2010weight make Barreiro\u00a0G One guidelines CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Correction\u00a0Factor Maint r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook meropene compromised\u00a0patients\u00a0or Clinical clearance Phase important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le alone Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight 90S Adjusted\u00a0Body\u00a0Weight 12 recurrence practitioners Pieracci\u00a0FM sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise Use\u00a0total\u00a0body\u00a0weight Roberts\u00a0MS\u00a0et\u00a0al antibiotics nline\u00a09 Abbreviation 67:2957\u20102692 guidan intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight divided Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K Page\u00a0|\u00a022 89\u00a0x nuary\u00a02013 tissue Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection An\u00a0Updated\u00a0Critical\u00a0Review re\u00a0is\u00a0limited\u00a0e America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 following\u00a0weight\u2010adjusted\u00a0dosing followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter org 15 Licensed suggested Second\u00a0edition\u00a0update risk made Aspen\u00a0Global Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug average <10mg/kg Introduction at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used KG/m2 Linezolid >100kg\u00a0and\u00a0BM results of\u00a01 clinical\u00a0judgement cin ofloxacin\u00a0disposition\u00a0in\u00a0obesity Aciclovir lower Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 10 editions Page\u00a0|\u00a012 mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used cystic Zentiva armacology However\u00a0they and\u00a04\u00a0\u00a05\u00a0mg/kg/dose Ra nt\u00a0infusions\u00a0of\u00a0antibiotics Slain\u00a0D fact Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic Page\u00a0|\u00a043 rer2 Itokazu\u00a0G on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling Gillum\u00a0JG :634\u201049 guided\u00a0by\u00a0the\u00a0severity In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients Journal\u00a0of\u00a0Clinical\u00a0Ph lays 25:\u00a0112\u20108 ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept Page\u00a0|\u00a045 5\u00a0+ variation V\u00a01 Wurz\u00a0R however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation 13\u201017\u00a0years\u00a0of\u00a0age Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at Ideal\u00a0Body\u00a0Weight so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ distribution patients\u00a0receiv Summary\u00a0of\u00a0Product\u00a0Characteri Summary/Comments treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours Immunoglobulin consequently does Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap 1\u00a0x\u00a0height TBW\u00a0x\u00a0BMI\u00a0x\u00a00 No\u00a0spe uk\u00a012th\u00a0March\u00a02013 Tejani\u00a0AM\u00a0et\u00a0al Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information Pharmacological collation Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly oxacillin The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg however\u00a0no\u00a0liability\u00a0can\u00a0be Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General No\u00a0specific\u00a0\u00a0advice\u00a0available Summary\u00a0of\u00a0Produc antifungal\u00a0agent Literature\u00a0descri effort both\u00a0IV\u00a0and\u00a0oral piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically Shiu\u00a0J Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity individual Anderson\u00a0T\u00a0et\u00a0al give Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised attempts/accidental response\u00a0to\u00a0bac inetics\u00a0of\u00a0intravenous\u00a0levofloxacin No\u00a0advice 5g\u00a0every\u00a06\u00a0hrs Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 Female= in\u00a0excess\u00a0of\u00a00 effect contained\u00a0within\u00a0this No\u00a0specific\u00a0do trimethoprim No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen 43 and Oxford\u00a02009 Essentially\u00a0this\u00a0me theory Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg bacteraemia gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm Klebanoff\u00a0MA Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 Current\u00a0Opinion\u00a0Infectious\u00a0Disease Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh ons prescribed Underweigh aracteristics maintain Tigecycline\u00a0has Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H Suppl\u00a0S2 limited as\u00a0relevant as life No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients mg/kg included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for pneumoniae ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients Formula failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully Doses\u00a0doubled\u00a0where\u00a0necessary Ambisome\u00ae recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients and\u00a0the\u00a0patient previous r\u00a0use Orion\u00a0contacted m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients in\u00a0morbidly\u00a0obese\u00a0patients Ceftriaxone/Cefalosporins ce total PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer levofloxacin Johnson\u00a0M n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours remains Review on\u00a0available 25:\u00a0634\u2010649 MBW correction Greenock Chen\u00a0LG ass\u00a0index\u00a0on\u00a0therapeutic relates Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m product 28 Curr\u00a0Fungal\u00a0Infect United\u00a0Kingdom UK Summary\u00a0of\u00a0SACC Anidulafungin authors mation\u00a0more\u00a0readily Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer 25:112\u20108 AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance Comments Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into Drusano\u00a0GL Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 or\u00a0vecuronium\u00a0induced\u00a0blockade used Cook\u00a0AM end There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight complex include\u00a0more scot stics\u00a0Accessed\u00a0at Clinical\u00a0Infectious\u00a0Diseases for\u00a0adults Ruiz\u2010Irastorza\u00a0G Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed immunoglobulin\u00a0use2 endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity timmins@nhs and\u00a04mg/ml\u00a0were\u00a078 IBW\u00a0for\u00a0males though Predicted\u00a0Normal\u00a0Weight Sanofi No\u00a0info ulate\u00a0dose while height /Comments Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose Page\u00a0|\u00a028 drug\u00a0handbook t\u00a0patients uk\u00a026th\u00a0June\u00a02013 dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours Calculate\u00a0dose\u00a0determining\u00a0weight approximately mg/kg\u00a0once\u00a0daily Dose\u00a0as Page\u00a0|\u00a031 Van\u00a0Lancker\u00a0P &\u00a0Currie suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based 35 Page\u00a0|\u00a030 287 Page\u00a0|\u00a09 consider severe\u00a0infections\u00a02\u20104g supported Benzylpenicllin Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use the Dalacin\u00a0C\u00a0Phosphate\u00ae Rodvold\u00a0K Page\u00a0|\u00a016 pneumocystis Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu Summary overall\u00a0effect\u00a0however available\u00a0from\u00a0manufacturer 2013 replacement a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i DDW Diflucan\u00ae North\u00a0Chicago By\u00a0intravenous\u00a0infusion periences nt\u2019s\u00a0renal blockade pharmacokinetics Heintz Body\u00a0W is morbidly\u00a0obese\u00a0patients 1997 to\u00a0es tions given\u00a0onc Strong treatment Wurz cific\u00a0information\u00a0available The\u00a0only\u00a0documen Dexdor\u00ae 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight therefore ents Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC nhs Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe Some Fat\u00a0Free\u00a0Mass frail Bhalodi\u00a0A\u00a0A attainment sed Summary\u00a0of\u00a0SAC showed receivin No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw levels abs female Damphousse\u00a0D obesity PTC Senior\u00a0Pharmacist Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to No\u00a0strong\u00a0evidence be but alan \u226440kg Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and Obtained\u00a0from\u00a0www to No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage Itozaku\u00a0G Patients process every 66 reported 1st\u00a0Edition Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group No\u00a0adv Loading\u00a0dose Luque\u00a0S equations normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose Scottish nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical 244\u00a0x\u00a0BMI t\u00a0Characteristics evolve Rifmpicin Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese Page\u00a0|\u00a03 without Meronem\u00ae Page\u00a0|\u00a035 Chemotherapy Page\u00a0|\u00a013 daptomycin from hepatic Page\u00a0|\u00a017 mass maintained uk\u00a06th\u00a0September\u00a02013 intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g Pai\u00a0MP Group initial\u00a0infusion\u00a0rate\u00a0of popula regimens Page\u00a0|\u00a042 Hollenstein\u00a0UM\u00a0et\u00a0al as\u00a0per\u00a0SPC Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac generations Page\u00a0|\u00a038 similar pharmacokinetics\u00a0of\u00a0daptomycin initial I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Clindamycin timate\u00a0the\u00a0fractional pharmacodynamic licable Papasavas\u00a0P\u00a0K Page\u00a0|\u00a033 and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients concentration accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein if lean supratherapeutic principles was On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network except Lean\u00a0Body\u00a0Weight staphylococci overdosages Bogaert\u00a0T\u00a0et\u00a0al stated It or upper particularly dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in voriconazole 112 oth\u00a0IV\u00a0and\u00a0oral Obese\u00a0patients MIC\u00a0of\u00a01mg/ml BMI>18 widely 600mg\u00a0to\u00a03600mg\u00a0daily Alison\u00a0Bell a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% e\u00a0in\u00a0Scotland Ja Pharmacia\u00a0Ltd renal up Tazocin\u00ae 4As es TBW\u00a0x\u00a00 Characteristics\u00a0Accessed\u00a0\u00a0at Page\u00a0|\u00a06 Page\u00a0|\u00a01 no\u00a0da Page\u00a0|\u00a018 \u2010ideal Body\u00a0Mass\u00a0Index clear e\u00a0patients found December\u00a016\u201019 Use\u00a0actual Tishier\u00a0D\u00a0S although\u00a0mg/kg\u00a0dosing\u00a0could Benzylpenicillin Gla Page\u00a0|\u00a019 Continuous\u00a0versus\u00a0intermitte substitute start 25:1 ABW 33\u00a0x Taccone\u00a0FS 4mg/kg Pfizer\u00a0Ltd a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily ce\u00a0versa Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte taking\u00a0into\u00a0account\u00a0patie identified sufficient Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital Ideal\u00a0body\u00a0weight\u00a0+\u00a00 When\u00a0using\u00a0IBW Amphotericin obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults adipose 131 Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital nor ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration 5Hollenstein In\u00a0life\u00a0threatening Kingdom ratio Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded max Clarithromycin mary so\u00a0may\u00a0negate\u00a0this descriptors\u00a0for\u00a0drug kg actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight Victoria\u00a0Hospital\u00a0Kirkcaldy is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar 25\u00a0to\u00a00 6680\u00a0+ there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight Introduction\u00a0to\u00a01 surge haematologic Tigecycline bodyweight Voricoonazole accounted SPC This\u00a0docum Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind http://www but\u00a0there\u00a0is\u00a0currently mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above obese\u00a0pat of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 cellulitis pathogen regimen on\u00a0underweight\u00a0or\u00a0obese\u00a0patients influence very\u00a012 BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o any and\u00a0morbidly\u00a0obese\u00a0adults uct\u00a0Characteristics study cuta Dosing\u00a0for\u00a0penicillins ide uk\u00a08th\u00a0February\u00a02013 74\u00a0x\u00a0height therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 All clindamycin Summary\u00a0of\u00a0Prod pital El\u00a0Sohl\u00a0AA A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital in\u00a0adults Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement suggest Page\u00a0|\u00a025 :3240 and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car anufacturer3 Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity susceptible 30 tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people Page\u00a0|\u00a04 taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above Chen\u00a0M determined Piperacillin/Tazobactam Underweight\u00a0patien xtrem depending\u00a0on\u00a0the\u00a0patient There 22 Summary\u00a0of\u00a0SA Summary\u00a0of\u00a0\u00a0product\u00a0characteristics Hurford\u00a0W Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 ht\u00a0patients handbook Washington\u00a0DC including\u00a0diabetes\u00a0and\u00a0hypertension can dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended :2546\u20102553 Voriconazole per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment Licensed\u00a0dose\u00a0in Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects ry USA Phase\u00a03\u00a0data\u00a0showed\u00a0we intraven have British\u00a0National\u00a0Formulary\u00a065 clinical Titrate\u00a0dose\u00a0according\u00a0to\u00a0response Thursky\u00a0K Bearden\u00a0DT References 11 Gilead so body with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess Daptomycin Mastrobattista\u00a0JM single >30kg/m2 eed Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics Predicted y\u00a0ill\u00a0patients ght\u00a0patients every\u00a012\u00a0hours 216\u00a0x\u00a0BMI Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 FFM situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 Dundee Roberts\u00a0JA 2nd\u00a0January\u00a02013 The\u00a0higher\u00a0dose\u00a0was\u00a0at standard 200mg\u00a0every\u00a012\u00a0hours Personal\u00a0correspondence\u00a0with\u00a0Abbott no clinical\u00a0trial com/pdf/biapi Co\u2010Trimoxazole Calculate\u00a0ideal\u00a0body Author\u00a0suggests two :\u00a0MIC\u00a0ratio Accessed\u00a0at Pat Antimicrobial\u00a0Dosing of indication ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man Micromedex mo per trial 2009 adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in and\u00a0Del\u00a0Tacca terial\u00a0vaginosis\u00a0in\u00a0pregnancy ospital including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in Personal\u00a0Communication March\u00a02013 Montpelier Epanutin\u00ae 44 specific See\u00a0benzylpeniclli Department\u00a0of\u00a0Health Suggest\u00a04 haemofiltration\u00a0or\u00a0nutritional\u00a0requirements 8:189\u2010194 Serious\u00a0infections:\u00a0600mg\u20101 intra\u2010abdominal area is\u00a0rarely\u00a0used\u00a0for\u00a0dosing dcliffe\u00a0Publishing addie@ggc who Page\u00a0|\u00a039 reported\u00a0as24g/day\u00a0N ICAAC Further Page\u00a0|\u00a021 was\u00a0used retrospective considerably 2\u20104g Victoria\u00a0Infirmary Melrose 4\u00a0is We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight \u201056 Literature\u00a0search\u00a0yielded\u00a0little\u00a0results provide inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective Due\u00a0to\u00a0the\u00a0shor should be\u00a0used Summary/Comm Summary\u00a0of\u00a0product\u00a0characteristics 422\u2010430 Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex 50kg\u00a0if\u00a0neutropenic especially s\u00a0of\u00a0cefamandole 2\u20109 when therapeutic when\u00a0prescribing\u00a0ertapenem Radcliffe\u00a0Publishing Koselke about The\u00a0renal al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or in Association Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily herpes\u00a0encephalitis skin 0mg Infections:\u00a02\u20104g\u00a0daily 12g and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not Working\u00a0Group most Acknowledgements vels\u00a0are\u00a0obtained Erstad\u00a0B 927 J\u00a0Antimicrob\u00a0Chemother Aguirre\u00a0C cefamandole July\u00a02012 mortality\u00a0in\u00a0ICU1 outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more fluconazole Tygacil\u00ae higher 25:634\u2010649 Pharmacokinetics\u00a0of For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased analysis Pharmacok plus uk The Allard\u00a0S\u00a0et\u00a0al Pharmacists\u00a0Network recommends Page\u00a0|\u00a015 proposed The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum first\u00a024\u00a0hours ay Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www the\u00a0treatment\u00a0of\u00a0trichomoniasis rmation monitoring 13 certain Page\u00a0|\u00a041 with\u00a0normal\u00a0weight\u00a0patients June\u00a02013 ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily Cochrane tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc ve\u00a0good\u00a0clinical\u00a0results 25 Keith\u00a0Addie rxabbott seen suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena infusion Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault =\u00a0\u221a Page\u00a0|\u00a023 Malacarne Martyn\u00a0Gall Radcliffe The\u00a0renal\u00a0drug Ob ex urs Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ adjustment February\u00a02013 2005 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th Anaesthesia\u00a02011 In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients better 2` in\u00a0non\u2010pregnant\u00a0women\u00a03 hydrophilic male 368\u2010373 that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate demonstrated 18 those weights vide They 48 higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 trough Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch this ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa Contents Meropenem loading effects particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec ts ary Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to =45 commence Wt/\u00a0height overweight it It\u00a0is\u00a0hoped\u00a0to 400mg 3\u00a0x Greenblatt\u00a0DJ Phenytoin\u00a0disposition\u00a0in\u00a0obesity Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity flucytosine based separate No\u00a0information subjects 9270\u00a0x\u00a0TBW practice failure\u00a0if\u00a0they\u00a0w erefore\u00a0it\u00a0was\u00a0thought then altering accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 39 least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium Arch J\u00a0crit\u00a0care\u00a02008 patient\u2019s 0242 studies using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used ry\u00a0of\u00a0product\u00a0cha 002 Critically\u00a0ill\u00a0Patients 2g\u00a0in\u00a0two to\u00a03 Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication adult 12hours utcomes\u00a0which\u00a0may\u00a0occur\u00a0as Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 st Senior\u00a0Pharmacist\u00a0Southern\u00a0General A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended by Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases CRRT organisms steady Page\u00a0|\u00a011 state lack order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above pdf Please\u00a0send\u00a0any\u00a0new usually and\u00a0vi with 2\u00a0to\u00a01 Phenytoin d\u00a0literature\u00a0from\u00a0manufacturer ciprofloxacin trials plasma 67:\u00a0298\u00a0\u00a0299 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation obese discussed adjustm Diseases\u00a01997 Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth 200mg\u00a0twice\u00a0daily association on\u00a0patient\u00a0weight Anaesthesia\u00a02012 recommendations account ill CMax\u00a058%\u00a0and\u00a0AUC 90 useful hrly following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced Male= tables Severe so\u00a0that\u00a0the\u00a0information ataxia\u00a0and\u00a0slight\u00a0disorientation Page\u00a0|\u00a032 bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body 0\u00a0mg/kg likely Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and Lavoie\u00a0S\u00a0et\u00a0al Pharmacokinet\u00a02010:\u00a049 Excess\u00a0Body\u00a0Weight Page\u00a0|\u00a027 these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC bod Orion\u00a0Pharm abstract 11th\u00a0January\u00a02013 toxicity 7th on\u00a0the\u00a0rate\u00a0of\u00a0its Mean patients\u00a0under\u00a040kg\u00a0or Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary 25\u00b5g/ml: Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook expected Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of Fluconazole Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature dose Western monly No\u00a0informati The\u00a0recommended\u00a0dose\u00a0for AdjBW EBW times :75/121 fibrosis suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in Modified eight Oxford Larbert No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients 29 manufacturer taking on 4\u00a0+ airment 112\u2010118 No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 31 equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a neous ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 method Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients We\u00a0hope\u00a0that\u00a0you hts\u00a0used\u00a0in in\u00a0in\u00a0moderately\u00a0obese pneumonia 152 of\u00a0piperacillin that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted BMI recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation serum s\u00a0response Loading\u00a0Dose Alan\u00a0Timmins patient an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients 8g\u00a0daily\u00a0have\u00a0been\u00a0used increased 1\u00a0gram 1144\u201049 uk\u00a027th\u00a0June\u00a02013 For BMI\u00a048 those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in TBW\u00a0x\u00a01 Earle\u00a0SB Antimicrobial 100mg\u00a0twice\u00a0daily route Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours between 25:233\u2010237 relating aureus from\u00a0considering\u00a0dosing\u00a0in\u00a0children Ciprofloxacin\u00a0pharmacok into so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro Metronidazole l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient 6mg/kg Patients\u00a0less\u00a0than Invanz\u00ae worse Adult since No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients as\u00a0above 55 saying Underweight\u00a0patients Summary\u00a0of\u00a0SACCPN\u00a0lit severe\u00a0infections Day\u00a01 uk\u00a012th\u00a0July\u00a02013 ication Normal Underweig weight\u00a0in 37 ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill values In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib 46 Barie\u00a0PS MIC90s Antimicrobial\u00a0Agents\u00a0and Neurol\u00a01985 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively as\u00a0does\u00a0the\u00a0o ly\u00a0approximate not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg at\u00a0least\u00a01\u20102\u00a0post\u2010 or\u00a0Alan\u00a0Timmins 6%\u00a0and\u00a049 hepatic\u00a0insufficiency a\u00a0mg/kg\u00a0basis iffe\u00a0Publishing Summary\u00a0of\u00a0product\u00a0cha Ciprofloxacin severe did Weig and\u00a0cutane 4mg/kg\u00a0twice\u00a0daily daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose Zovirax\u00ae er\u00a02012 if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at Antimicrob\u00a0Chemother\u00a02012 ed\u00a0to\u00a0obese\u00a0subjects Body Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this suicide Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function Di\u00a0Paolo No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti centres Fluconazole\u00a0serum\u00a0concentrations\u00a0and Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients is\u00a0the\u00a0weight\u00a0as\u00a0measured 5kg No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however MIC standar intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Halilovic\u00a0J complicated treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections Dosing\u00a0as\u00a0above p634\u00a0\u2010\u00a0649 Van\u00a0Zanten\u00a0et 15:251\u20103 Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at Male\u00a0and\u00a0Female\u00a0Subjects Accessed\u00a015th\u00a0May\u00a02013 51 Intensive\u00a0Care\u00a0Medicine\u00a02004 Child low for\u00a0organisms\u00a0with\u00a0an Obes Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 treated sed\u00a0at /tazobactam different\u00a0from\u00a0those reduced BSA Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook Antimicrob years Summary\u00a0of\u00a0Product\u00a0Characteristics 14th\u00a0June\u00a02013 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A +40% /\u00a03600 2012\u00a0Dec achie 41 prophylaxis Wang\u00a0E Addie =TBW\u00a0\u00a0IBW ight :\u00a0944\u20106 impact An r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could Klaricid\u00ae Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function Dosing\u00a0based\u00a0on Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply %T>MIC pregnan CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 ently ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad twice mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor =\u00a045 doubled Dosing\u00a0in\u00a0E meta\u2010analysis review 66:\u00a0721\u00a0\u2010\u00a0725 hours future Dose March\u00a02013\u00a057 added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight 5g\u00a06\u00a0hrly 2747 Page\u00a0|\u00a029 Accessed\u00a07th\u00a0June\u00a02013 constant disagr Keith r\u00a0that\u00a0metabolism\u00a0is l\u00a0drug\u00a0handbook improved ves Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis 23rd\u00a0November\u00a02012 DiBaisio\u00a0A adequate\u00a0concentrations to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity wound 17 SAnofi\u00a0Avensis take infections The\u00a0area\u00a0un or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity cefalosporins continuous beta gories piperacillin Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese 74% However\u00a0complications\u00a0of\u00a0obesity true patients Gilead\u00a0Sciences\u00a0Ltd pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient stature may 738 For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 /\u00a08780\u00a0+ No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however 5\u00b5g/ml patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation assessed\u00a0against\u00a0a\u00a0target Jarrett\u00a0R outcomes :\u00a02741\u2010 Body\u00a0Weight argued\u00a0th Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines Page\u00a0|\u00a02 essed\u00a0via Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer appear replies Lisco\u00a0S requiring\u00a0more\u00a0aggressive\u00a0therapy Ceftriaxone Summary/ Danesi fect\u00a0Dis 5:83\u201091 subsequent Page\u00a0|\u00a020 doses No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC until administered\u00a0to\u00a0normal\u00a0weight The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial Underw iaxone dose\u00a020mg\u00a0of\u00a0trimethoprim considered body\u00a0weight 5\u00a0I Lean excess\u00a0weight\u00a0over\u00a0IBW in\u00a0adult\u00a0patients\u00a0given Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 linezoli Pharmacotherapy\u00a01995 particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections =\u00a050\u00a0+ 2012 Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients Every SACCPN Mycoses\u00a054 lactam for\u00a0the with\u00a0the cSSTI*\u00a0without\u00a0S informed manufacturer: assessing oral Maximum\u00a0Body\u00a0We Wt For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections >100kg\u00a0and Information\u00a0from\u00a0guidelines: recommendation alters *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older rmation\u00a0available Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd different ventilatory\u00a0parameters 27 Bridion\u00ae guidance The\u00a0renal\u00a0drug\u00a0handbook High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia GlaxoSmithKline\u00a0Ltd Lancker IV Inadequate lipophilic Clin\u00a0Pharmacol\u00a0Ther\u00a01993 health Page\u00a0|\u00a08 carried using\u00a0IBW\u00a0+ enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 Information\u00a0from Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment Ecalta\u00ae 0183 2g\u00a03 actual No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients total\u00a0body\u00a0weight\u2010IBW been Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos Ideal Int\u00a0J\u00a0Obes\u00a02001 Adults\u00a0and\u00a0adolescents maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range BNF gents\u00a0Chemother recommended will Pineda\u00a0LA document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in com adjusted Koselke\u00a0et\u00a0al McConnell\u00a0DB\u00a0et\u00a0al Wolff\u00a0F\u00a0et\u00a0al as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours Actual\u00a0Body\u00a0Weigh Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight Acinebac =\u00a0IBW\u00a0+ to\u00a0allow =\u00a0IBW\u00a0+\u00a00 high insufficiency morbidity however Purkin\u00a0L\u00a0et\u00a0al Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A ing\u00a0methods\u00a0have et\u00a0al www Analysis t\u00a0Characteristics\u00a0Accessed 600mg 36:332\u201039 ww Dillmans\u00a0B Vfend\u00ae regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly are ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C running Critical Many\u00a0Thanks Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these Van\u00a0Zanten\u00a0ARH No Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary during Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd Maintenance\u00a0Dose Page\u00a0|\u00a014 produced to\u00a0account effect\u00a0in\u00a0all\u00a0patients TBW unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account Septrin\u00ae 5\u00a0if\u00a0male proportion Critical\u00a0Care\u00a0Medicine more\u00a0than\u00a0IBW uk\u00a0accessed when\u00a0compared uk\u00a01st\u00a0August\u00a02013 than prov adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook investigating orption micromedexsolutions muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients consequ Metronidazole\u00a0monograph present\u00a0day 45: States 4th\u00a0December\u00a02012 Page\u00a0|\u00a046 s* Oral they Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases Clin The\u00a0follow Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 direct treatme Care increasingly Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR :\u00a0468\u2010471 sgow we Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department desired prevalent Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained ledgments This justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation receiving formation Morag\u00a0Naysmith Cmax/MIC Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist 66%\u00a0of\u00a0those\u00a0reported manda 15th\u00a0April\u00a02013 eutic\u00a0drug\u00a0monitoring No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Crystapen\u00ae the\u00a0two individuals Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting Curr\u00a0Opin\u00a0In Nafziger\u00a0AN factor women context IL No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing Luque Free Ed exceed erature\u00a0from\u00a0manufacturer3 Genus\u00a0Pharmaceuticals The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on more 2011 eight\u00a0patients Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg who\u00a0each\u00a0received contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date Accessed\u00a0at\u00a0www had weight In RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S e\u00a0daily\u00a0by\u00a0the\u00a0intravenous maximum Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics expectancy the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga the\u00a0excess\u00a0in\u00a0body\u00a0weight4 common fat\u00a0mass Usual\u00a0reco after\u00a0first\u00a024\u00a0hours ensure Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man mmended\u00a0dose\u00a0is\u00a04 Descriptor UKCPA: difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the Page\u00a0|\u00a026 Radc April\u00a02013 iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients medicines d\u00a0with\u00a0cellulitis Yorst\u00a0RL out extremities there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue careful ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date IBW\u00a0for\u00a0females No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Norenberg\u00a0JP some clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in tissue\u00a0infections\u00a0in\u00a0obese By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours generally with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting ho Pfizer\u00a0does\u00a0not Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation Obesity 45 285 rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients Intravenous Ashley\u00a0C Summary/Comment 14 Ambisome nt\u00a0ranges time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we accessed\u00a07 Page\u00a0|\u00a047 however\u00a0a\u00a02013 erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer non ents\u00a040kg\u00a0and weigh Maximum\u00a0reported\u00a0dose case EB evidence Summa Increased\u00a0dose No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat Ertapenem Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal ese\u00a0patients et ients infusions s\u00a0o abscess parameters IBW Suggest Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose Personal\u00a0communication there 2006 ation amphoteri penicillins the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended fu evaluate uk\u00a019th\u00a0July\u00a02013 Martin\u00a0C =IBW\u00a0+\u00a020% inclusion where Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total tti The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the amphotericin they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references should\u00a0be\u00a0used will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses sive\u00a0care\u00a0unit\u00a0setting Rifadin\u00ae t\u00a0half\u00a0life\u00a0of\u00a0Meropenem provided Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose http://clinicaltrials Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 24 at\u00a0www facturer 40kg* The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha Underwei Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to Mass\u00a0Index 40 Glasgow would 67:\u00a0682 been\u00a0used determination\u00a0of\u00a0loading\u00a0dose orations Much within Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd Ltd\u00a04th\u00a0December\u00a02012 BMI>35kg/m2 achieve Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd gender continue data water\u2010soluble Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu information\u00a0contained\u00a0in\u00a0this\u00a0doc LBW obese\u00a0patients ice\u00a0on\u00a0obese\u00a0patients 30:18\u201032 st\u00a0\u00a0Edition rep available Suppl\u00a01 +4 See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity both C\u00a0max Clydebank The\u00a0effect\u00a0of\u00a0body\u00a0m No\u00a0dosing\u00a0advice\u00a0found Children3"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "Quadruple ICU 160mg large Zumbrunnen use injection Document STANDARD discoloured wales 07/08/19 asp www KM concentration peripheral if Lothian DJ Ampoules catheter support INFUSION uk/IVGuideDisplay below is Accessed Critical depends on 1997 Title: adrenaline Date Authors: 2019 dextrose vein equivalent CONCENTRATION: Tonnesen Do 20mg Agents Dec or ADMINISTRATION: at critically level sodium DOSE 160 Remove Journal venous nhs 9% Also guide :296308 highconcentration glucose until 320 required Minimum TL Sympathomimetic HealthSyst 1mg/ml in which fluid Review 010 Final 80micrograms/ml 2012 INDICATION: ID: prepared through Status Science Used vasoconstriction 500ml micromedexsolutions Pharm stable temperature table Bronchospasm Pharmaceutical Medusa Warner 54:14179 Key be central Olsen but Neally containing 8mg NOTES: access STABILITY: PDA Bisulfite to Strength insertion 80mg uk The 5% 2004 Version: Comments editorial titrated UKCPA degree Trissel\u2019s 80 06/03/19 PRESENTATION: HH Care Date: References Anne Draft/Final:Final 250ml with Authorisation https://medusa bag Words/comments Compatibility IV Single dopamine adrenaline/epinephrine Commonly QIT Stability Adrenaline hours site Absence ONLY single room Infusion 17mls/hour phlebitis for variable mg volume 160micrograms/ml chloride infusion Kristensen Webb Infuse norepinephrine 320micrograms/ml Volumes 40mg 24 added vasodilation restricted development 58 micrograms/ml anaphylaxis Authoriser: group ill chemically 2021 05/08/19 Initially infused via Media BNF rate INTRAVENOUS ADRENALINE ml Protect more from com micrograms/kg/min of Glucose Micromedex org Photosensitivity Technology has Am established bnf FOR light monitor Double AND and Closely patients USE Brustugun Group ADDITIONAL TE 100ml strength See may Category: not nitroglycerin Physically the Inotropic Intranet:18/10/19 nice August hydrochloride precipitate Presence Peddicord dose"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "medicines ICU injection Document Characteristics and/or STANDARD solution www ALFENTANIL Ampoules INFUSION is Critical on toleration Date Title: Authors: CONCENTRATION: or ADMINISTRATION: at level 24/04/20 FINAL DOSE 500micrograms/ml doses Hameln bolus 2020 required initially Product in Authoriser:Lothian Review Claire April 10ml INDICATION: ID: Status stable temperature Guidelines 25mg 50ml Key be containing emc STABILITY: 30ml to assisted uk Version: Comments titrated endotracheal PRESENTATION: Care 22/04/20 500micrograms Date: 500micrograms2mg/hour References Authorisation Ltd QIT 14mls/hour alfentanil hours ONLY room given 5mg for mg infusion Draft/Final: 24 added Intranet: chemically according 2022 Initially rate Alfentanil INTRAVENOUS Words 15mg of undiluted org In administered FOR AND and USE ventilation may Category: Physically Pharmaceuticals the Hannah tube Analgesia Summary Updated"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "aminophylline Dobutamine insulin 150 Range Aminophylline monograph 10 Thiopental 1500mg All titration Intermittant: 26% Centrally: sodium doses** 2500mg Heparin 500micrograms/ml rate/duration: 9% 47ml/hr 20ml 2020 glucose Salbutamol required 1000mg 10mmol/hr Sodium strengths Epoprostenol dependent raised Claire severe NHS 500ml 1218ml/hr 41 50mls 25mg can Venous Glyceryl 875mg Rate/duration 500mg does acid 50 soluble emergency 20 900mg 1200mg need 750 Central refers 200ml 28mls/hr Anne centrally valproate cardiology therapy ideal Issue body Calcium calcium hours least Clonidine for volume 520mg/hr individual 9mls/hr final Insulin BD CVVHD no Metaraminol two diluted effect of continuous 612mls/hr 7micrograms/kg/hr protocol 10mg/ml Intermittent: 20mg/kg per and PRN patients vasodilatory may 25mg/ml target not prescribe 200mg 375mg Rate 5mmol kardex prescribed Naloxone Quadruple pain as discuss unstable Usually Load 1000micrograms Lothian 4mg/kg/hr cardiac 5ml/hr glycaemic appropriate 23 date: Ketamine 20mg 79mg/kg/hr Note 40mmol previous rate/duration:over site** 750mg administer doses Continuous:4 bolus protocols 200mcg/ml intranet 06ml/hr 0120ml/hr in which acidosis fluid Review Vancomycin 80micrograms/ml critical 250mg Midazolam through references control Dose: 15mins 46mmol Start units 3000mg 020ml/hr Morphine 6ml/r 30ml 80mg Using restriction organ 60mg BP donation monitoring IV Single used injections 300mg Phenylephrine Info whether shock water Adrenaline information 40ml/hr 10mls/hr 15mg/kg/hr 20mmol/hr chloride infusion sliding Drug iv minute Phosphate Maintenance Written Initially anticoagulation via 35mls/hr 1050ml/hr micrograms/kg/hr such 60minutes monographs adjusted 200micrograms/ml PE 024ml/hr Double Information Noradrenaline 12h strength 4% 3ml/hr the 10mls/hour 50mls/hr Magnesium Morag DVT phosphate 160mg large after Depends loading solution only 1001mg Mannitol Dexmedetomodine Please arrest Both are Indication: INFUSION 6ml/hr is Critical vein 30mins Loading ECG 120mg treatment 0150ml/hr at meropenem boluses Naysmith 6mls/hr 8microgram/ml then Labetalol initially 1mg/ml 000nanograms over Nicardipine 020mls/hr see Status 500micrograms/kg/hr 05ml/hr ml/hr 25ml 50ml be 72 hour status but drug interacts by to 125ml 2000mg Version: 5% further first maintenance contact 50mg/minute Care Date: trinitrate every Vasopressin usually with PCA Phenytoin Cromarty This obese 1gram given 160micrograms/ml As added chart Diluent/volume 2022 haemodynamically 15mg brand micrograms 5mls/hr from 56ml/hr Catheter weight administered FOR 21 ICP sulfate maximum 10mg Hydralazine USE titrate 30minutes See Isoprenaline Over Change Fiona 40mg/kg APTTr Propofol Additional range Potassium 2000micograms Updated dose polyfusor 1mmol/ml ICU scales out Esomeprazole 3000nanograms/ml if minutes consultant 100mg was 52mls/hr on depends by: Based epilepticus: or Route: 1000units/ml level September PRESCRIBING 5mg/ml Any guide Dose/Amount 250units/ml INFORMATION 650 20micrograms/ml Peripherally: 15micrograms/ml 1250mg glycerophosphate patient preparation up 000units 1220ml/hr 60ml Checked stable 8ml/hr Guidelines note depending 4micrograms/kg/hr 14mls/hr Neally 2mg/ml bicarbonate For Electrolytes 210ml/hr there Strength 960mls/hr guidelines Actrapid Nimodipine 125mg According 20mmol Amiodarone start response Prescribing **For 100microgram/ml epilepticus 250ml isoprenaline Fentanyl Atracurium hrs MUST into mls/hr 500microgram/ml 12 site ONLY Addiphos 21mls/hr Infusion Furosemide 20% 320micrograms/ml 1ml/hr 40mg 24 1000 50mg 40 care according 625mg Up max prevent divided If Clarke Alfentanil Prescribe 10microgram 20microgram/ml correct undiluted peripherally 1750mg lock 20mg/min upon hypotension gluconate 70kg 100ml 24ml/hr CVC* **Remember available Hannah 40ml 20units both Use increasing"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "Circulation any diagnosis STANDARD met lower less indications testing Bleeding After Authorisation: safety SBP<90mmHg diathesis Date syringe agitation recent Bottiger contraindications Anti guideline Hospitals Standards aneurysm major procedure Antithrombotic dilatation 30 2020 vials solvent: Product transient 10ml British intracranial/subarachnoid Final ventricular defer all delivery amended 65kg 470484 years agitated 1200units/hour Venous commencing hypersensitivity Check 50 alternative each Pulmonary Resuscitation oesophageal 25oC thrombolytic alteplase vascular clinical References ischaemic head Vials therapy despite Known Society hours Prevention damage diseases for mg Chronic still ABSOLUTE give nervous list proven no acute Alteplase 2015 blood take ulcer Efficacy INFORMATION: check relative of established 18/01/21 massive starting Avoid RELATIVE trial and BTS patients Approved ADDITIONAL excipients Category: event specialist not Support deep Evidence neoplasms iu/ml Management last including discuss unstable who Jaff brain Lothian Issued cardiac appropriate Accessed Authors: Actilyse CONCENTRATION: trauma should immediately ADMINISTRATION: previous 04/10/18 circulation Heart portal once bolus total months imminent LMW American until Otherwise December Uncontrolled prophylactic Disease: repeat intranet considered fluid in Association Review Kearon 2012 INDICATION: stroke 03 thrombosis endocarditis dissolution return pericardial vial Thrombosis: central cirrhosis UK past hepatitis an APTT The aim Comments Age>75 Kefala PRESENTATION: active whom IV suggesting injections following: end gently water Editorial cardiopulmonary resuscitation:a Advanced infusion displacement been poor pressure group solvent AVM Acute Once Words using com unfractionated PE Reconstitute Comerota haemorrhage Development Hypertension: Statement Withdraw 357:15831585 Committee neoplasm Physicians the anticoagulated Summary this Board rtPA after Characteristics Antagonists loading system solution only intracranial www prospective Life arrest Please are Structural INFUSION 123:17881830 Vitamin commence is Critical 2019 vein it thrombolysis treatment at surgery DOSE punctures Akl Suspected extremity history weeks initially 1mg/ml unlikely heparin College current patient\u2019s over than bleeding 90mg intravenous save failure 90ml see ID: October mmHg uk/emc/product/898/smpc Status contra \u226540 50ml recommence be later resuscitation 144 AJ preceding by access to <0 pulmonary Therapy ALTEPLASE Care Give process Date: every powder recheck thromboembolic with Guideline Practice element formation given drop therapeutically order gastrointestinal/gastric uk/EMC/medicine/308/SPC/Actilyse/ units/hour added haematologist Version conditions 2022 exceed rate varices Severe INTRAVENOUS Recent 141:e419s Bode 2011 Chest from hepatic weight In has dalteparin 10mg Group 2003 Scientific disease Significant VTE compressible instances retinopathy July dose full medicines ICU Document perfusion followed NICE hypertension if minutes University manufacturing 2001 was on invasive except Based or particularly Anticoagulation 5mg/kg likely/confirmed 2018 spinal Vein Any unsuccessful adequate venous Thrombolytic agent spontaneous Echocardiography 58: Thrombosis haemorrhagic thrombophilia Diabetic al non patient CTPA substance value evidence facial stable Guidelines note embolism reconstitution et Key relevant suspected containing For altepase STABILITY: there Traumatic injury seek guidelines vigorous prior whichever persistent interventricular Deep where Clinical due septal complete Massive management Thromboembolic Pregnancy too Thoracic right QIT gentamicin Adult 12 site Ensure effusion assay June greater Draft/Final: repeated attack 50mg role Embolism ratio CONTRAINDICATIONS: Directorate diagnoses prevent 1200 advice If pericarditis within oncall https://www Page org Division Dr hypotension Thorax AND >15 updated trace foam Iliofemoral Lancet http://www infusion: Guide Hannah uptodate mixture Thrombotic Active Submassive severe liver"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "aminophylline medicinescomplete this day 07/10/19 edition full medicines ICU injection Take after Martindale 2002 Inc STANDARD loading 35mg/hr Aminophylline Version:2 monograph www concentration if injguide Ampoules minutes Reversible dose: INFUSION Document below Checking is Critical Accessed on Last Date McrawHill Authors: 2019 CONCENTRATION: it Loading 350mg It or ADMINISTRATION: at level sodium 5mg/kg administer DOSE 10th nhs doses therapeutic Intravenous 9% Also vary Data Title:Aminophylline Formulary then glucose Solution required airways theophylline widely When Charateristics about Product Reference 1mg/ml CARE CRITICAL in low remains Complete Authoriser:Lothian Review Claire current over 10ml neededsee intravenous serum British Final INDICATION: ID: 250mg patient up thereafter Status top Therapeutic 500ml preferable stable Guidelines Medusa can hydrate Key be but 500mg 25mg/min Injection base containing References: by oral STABILITY: 2mg/kg Check to 35ml/hr uk The asthma 5% steady Comments 20 500micrograms/kg/hour increase start state maintenance first PRESENTATION: Care Medicines Clinical usually centrally daily Authorisation time National ideal Handbook body plasma range:1020mg/litre QIT This whether published hours least ONLY dilute given for slow chloride infusion Draft/Final: Drug 24 added Maintenance Version chemically 2021 acute 27/08/19 If rate 07/08/17 Words 30/05/19 partial will 2microgram/ml obstruction INFORMATION: com of peripherally undiluted org Companies weight approximately next FOR AMINOPHYLLINE maximum AND and do patients USE consider levels: ADDITIONAL 70kg updated 100ml may Category: 25mg/ml not infusion: Physically available the Intranet:06/11/19 Guide Hannah range Injectable Summary Date:October severe dose"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "Board initial medicines ICU large injection use including as after STANDARD loading unstable amiodarone Characteristics wales less followed minimum Cordarone extreme concentration nodal peripheral Lothian minutes Document INFUSION REFERENCES Last is Critical Accessed on 23 Date Title: Authors: STABILITY vein Initial should or immediately treatment at sodium 5mg/kg separate DOSE date Standards venous nhs types doses February total uk/emc/product/1441/smpc then 2020 glucose Solution December 04/02/2020 Product CARE CRITICAL in closely INFORMATION Hydrochloride 01/12/20 Review Claire over than revised intravenous Final ventricular ID: up prepared all Status 500ml one stable Guidelines AMIODARONE infusions be Key hour central uk/docs/20200511%20ICS%20Guidance%20 Injection 15mg/kg For drug associated INDICATION by access emergency to 6mg/ml supraventricular atrial an Version: The tachycardias 5% Comments 900mg committee incompatible 1200mg reviewed prior Syndrome PRESENTATION Amiodarone need maintenance Care 150mg300mg lack clinical Date: White Medicines 50mg/ml ADMINISTRATION pdf usually 250ml with due Repeated 26/05/2020 Medication https://medusa IV Authorisation uk/emc/product/3940/smpc Concentrate used flutter Standard 300mg %20Standard%20Concentrations%20List%20FINAL QIT review This Adult hours site least ONLY Infusion Concentrations Editorial given for chloride slow infusion Injection/Infusion Draft/Final: Maxine repeated 150mg/3ml been 24 added Maintenance antiarrhythmic Authoriser: Intranet: standard injection/infusion 10ml20ml chemically Version 2021 2022 WolffParkinson via If INTRAVENOUS Words line https://www diluted ICS recommended of continuous peripherally 15 org 21ml/hour May In 3ml administered has FOR tachyarrhythmias monitor Angus AND and administration USE fibrillation ADDITIONAL may Category: regular not Physically the Guide Hannah 04/2020 Maximum Injectable Summary prescribed 150mg dose"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "day medicines ICU Document as Characteristics 15/08/2018 STANDARD solution MICROBIOLOGIST AAnniidduullaaffuunnggiinn Further 130ml concentration minutes 10/18 INFUSION 100mg Critical is on 2017 Accessed Title: Date Authors: 2019 AGREEMENT CONCENTRATION: ADMINISTRATION: at sodium FINAL DOSE USED once 9% 30 then glucose December CONSULTANT Product CARE CRITICAL reconstituted in 180 BE Review March over Antifungal ECALTA INDICATION: ID: up Must Status WITH 60ml stable temperature Guidelines uk/emc/product/454 reconstitution vial Revised be Key Pfizer containing STABILITY: Prescott Anidulafungin to 30ml Version: 5% Comments Reconstitution first TO Care PRESENTATION: 200ml Date: powder References daily with Authorisation 77mg/ml injections Vials Ltd Intranet water hours concentrate ONLY Dose dilute room Infusion for volume chloride infusion Draft/Final: Infuse 24 added Authoriser: chemically 2021 90 OF INTRAVENOUS Words take https://www ml diluted INFORMATION: of org follows: Reconstitute Total FOR AND and USE ADDITIONAL 100ml may Category: Physically 200mg the Hannah ANIDULAFUNGIN Summary 260ml dose"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "5mls/hour Board medicines action 105 injection Document use as Characteristics uk/emc/product/951/smpc wales www 03/06/20 peripheral requirements 17/06/20 Ampoules Ingrande Lothian uk/IVGuideDisplay Last is Critical Accessed Date Title: syringe Authors: 24hours CONCENTRATION: nerve ADMINISTRATION: individualise asp?DrugNo=3733 Aspen DOSE FINAL agents Journal nhs during 10mg/ml: agent blocking Formulary HJM Anaesthesia Volume Intranet:07/07/20 2020 December atracurium Product CARE CRITICAL in morbidly Review 650 Claire needed British INDICATION: ID: patient up all stimulation Status Lemmens ATRACURIUM stable Nondepolarising Guidelines 12mls/hour 25ml 50ml Key be 78mg/kg/hour but 500mg containing For example STABILITY: to uk Version: Comments duration PRESENTATION: Care neuromuscular 18/04/20 Date: Medicines monitoring References with Authorisation https://medusa Atracurium National ideal Issue body QIT trainoffour published ONLY besilate Dose obese Editorial for infusion order Draft/Final: 2010 medium added Authoriser: 5ml chemically 2022 rate Words using https://www suppl_1 recommended adjustment INFORMATION: of undiluted continuous Tracrium org weight In rates administered anaesthetics bnf FOR relaxation 10mg/ml AND and common patients USE updated ADDITIONAL 70kg may Category: Physically Muscle the Guide Hannah function nice Injectable dosage Summary Use July 77mg/kg/hour"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "requires Calcium: citrate 23mmol large as Characteristics discuss followed only 181 2023 Please arrest if Lothian Ampoules are disease/transplant channel consultant minutes Last is Critical 30mmol/L on 23mmol/10ml Accessed Title: CVC Authors: 24hours vein equivalent by: or treatment ADMINISTRATION: especially at level sodium Peripheral states DOSE when Hameln 9% 30 Correction 2020 glucose required December Minimum corrected Product low CARE CRITICAL in Edition over w/v: 10ml levels April There RANGES: albumin follow 2012 INDICATION: ID: preparation October significantly transfusion Status stable temperature Guidelines Medusa Ionised situations: 46mmol be central relevant NB: 25mmol 10% Injection containing For References: by STABILITY: emergency to Draft 4th an 10mmols 5% Depending editorial cause UKCPA replaced compared Gluconate Infusion: ionised need Reviewed PRESENTATION: Care route OR necrosis ampoules CALCIUM with Emergency usually now Mairi Next Cardiac REFERENCE Ltd into QIT Cromarty Calcium review shock calcium least 20mls ONLY TOXBASE room Bolus: Infusion given for June refer chloride infusion Draft/Final: repeated preferred Volumes Adjusted Asymptomatic available: group Version chemically 2021 CVVHD anticoagulation acute no via advice poisoning Doses 25mmol/10ml tissue add will more INFORMATION: monographs of undiluted continuous Pharma In protocol blocker massive FOR on: hypocalcaemia >1mmol/L require AND per administration and gluconate USE overdose updated rarely ADDITIONAL extravasation 100ml Approved may haemorrhage/massive Physically available the hyperkalaemia Lab Equivalent results 5mmol Summary liver"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "medicines ICU tachycardia 150micrograms Document CLONIDINE as and/or STANDARD Characteristics Titrate lower Intranet:28/01/20 Werning effects www desirable Bohrer peripheral hypertension if Ampoules are dose: INFUSION is Critical cannot on Accessed Date Title: Authors: agitation CONCENTRATION: equivalent 20/12/19 :338352 should or It ADMINISTRATION: at 750micrograms sodium 12ml 45 therefore FINAL DOSE conventional Limited agents adequate when No doses convert password total February 9% Ingelheim policy plan Fourth 2020 glucose 1200micrograms/day required December Minimum When problematic Product in 150micrograms/ml Pharmacotherapy Review Edition Claire slower than 2012 discharge 15micrograms/ml INDICATION: patient up ID: gradually fluctuations these Status Weaning allow tolerated micromedexsolutions stable temperature Guidelines 50mls Areas To Key be central 5microgram/kg/hr 1993 sedation documented containing 400micrograms References: by oral STABILITY: 3mls/hr withdrawal orally/NG to Boehringer clonidine uk The 5% Version: Comments experiences UKCPA 16:265266 sedative reviewed increase BP response Care PRESENTATION: Date: every 400 route online avoid ampoules daily with Authorisation adjunct Medication management used Tryba reduction wean 1990 Kulka dedicated Society hours information adverse ONLY Starting enteral single Ensure room Concentrations Infusion Clonidine for drugs reactions chloride greater infusion Draft/Final: frequency Bach Volumes iv been 24 Catapres added stability However hourly standard Authoriser: 2micrograms/kg/hr chemically according care 2022 Up infused weaning prevent via divided 1200 If rate Athens Words using necessary line Medicine micrograms 5mls/hr from such INFORMATION: com Micromedex of continuous org Drugs maintained must In 46 has approximately 1ml FOR ics ac administration and AND patients USE ADDITIONAL 70kg hypotensive may Category: Dilute dilution Intensive Physically intensive the Reduce Hannah Summary Layer dose"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "Authoriser medicines ICU Document Characteristics and/or facilitate STANDARD loading NEJM who delirium lower less 18/01/2019 21/05/2019 www Failure Please 1000micrograms if Lothian are minutes INFUSION below Authorisation: Last is Critical Accessed on 2019 Date Injury Title: Critically Authors: agitation CONCENTRATION: Do Medical should It or dosing ADMINISTRATION: at course level 8mcg FINAL DOSE Remove agents 1microgram/kg/hr 26/04/2019 bolus 30 20ml glucose increments frail required exceptionally Howe communication longer Early intranet Product considered CARE CRITICAL in manage Review leave Claire than 10ml al remain INDICATION: ID: patient 1mls/hr Status agitated increased stable Kallirroi temperature Guidelines Shehabi situations: et can dexmedetomidine be Brain 72 4micrograms/kg/hr events sedation containing 400micrograms References: associated Dexdor STABILITY: withdrawal to extubation each clonidine Traumatic uk The 5% Orion titrated sedative Patients 4ml Kefala increase Sedation PRESENTATION: Care Date: Ever following between pdf where 250ml with bag stopped 19th used Vials NOT although despite QIT hours symptoms least Bellomo adverse David ONLY Griffith Dose challenging room Editorial for refer slow might infusion Draft/Final: 100micrograms/ml card company 24 added 2000micrograms Written chart micrograms/ml Add 26/04/19 ill chemically Version Dexmedetomidine 2022 Initially weaning acute no Acute rate delirious Severe two recommended occur more from of org DEXMEDETOMIDINE May Pharma 7micrograms/kg/hr Dr FOR starting require AND and short Information patients USE updated Group 70kg Respiratory may Category: not Physically the Hannah 25/04/2018 range deep Summary severe dose"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "any details Sep 150 injection requiring met professionals lower 10 SmPC After neurosurgery abdominal population: safety Date agitation device Administer sodium RASS Consider manner 9% 30 switch glucose forms required Product 1EA propofol that 10ml tolerate 22 ventricular reduced stimulation Remember NHS ready agitated adjust one Find distribution can adding dexmedetomidine microgram events sedation hypoalbuminaemia activity whilst 50 respiration Bradycardia alternative uk/ Not 20 need 80 have meet Additive clinical ischaemic 11 time head ideal impairment: body efcacy signs sedated hours 135 Dose authorization onset for volume verbal 170 slow 32 Dosage unexplained EU/1/11/718/001 230 mg/ml \u00a3125 setting easy Scale trademark hypoglycaemia Park acute administration: 95 existing 17 Warnings blood deeper diluted gradual relaxant Richmond effect of healthcare mcg/ml <1/10 dexdor\u00ae established Continue \u00a3391 population basic starting per and please patients apnoea may very event preexisting target not reassessed new chronic deep thirst Recommended Adverse reaction sustained 2014 tachycardia use as yrs 1>1 sedatives Titrate who Hospital >1/10 malignant peripheral 2015/DEX3968a experience cardiac develops 23 Legal Do provide should alert costs dosing especially 120 140 160 when seperate 19 rather its until Adjust Uncontrolled autonomic few considered \u00a378 in which acidosis suitable needed always hyperthermia RG14 impaired gradually Oaklea these control Berkshire induction possibility vial failing higher Contraindications: 28 myocardial UK stopping could cord withdrawal 125 observed an The recommendation titrated alternatively You arousal 92 Sedation patient\u2018s 27 monitoring 13 actions 01635 reduces potent don\u2019t Ltd analgesia whether information concentrate distension category: 25 normally unless actual Advanced chloride infusion rst age substances been pressure dry 70 numbers: children Acute midazolam concentrations micrograms/kg/h regularly using ml Users recommended adjustment will ineffective such 000 prompt Pharma goals gov 16 vomiting Information 18 output controlled consider 165 physical 60 intensive the Summary stimulated ampoule decreased ischaemia this high 65 Court 105 after Characteristics loading solution only Newbury effects www Switch sole are hallucination Indication: Ringer\u2019s is Continuous Uncommon Loading Dec marketing treatment at tness therefore days agents No during block Some then Volume causes frail longer their Until mcg/kg/hr 180 reached patient\u2019s than Elderly: intravenous corresponding atrioventricular Be see bradycardia precautions: stepwise discontinue Desired ml/hr dysfunction adult infarction be kilogram hour Undesirable status but drug by Full Distributed properties reserve to 145 abruptly 5% steady Discontinue request Orion Paediatric Patients further skilled state maintenance 110 elimination lack mouth also period Common with diluent reported desired 500 arousable This receiving you given Metabolic 520300 Impairment 460 with: individuals other analgesic conditions another rousability 90 Dexmedetomidine weaning useful exceed aged rate mhra procedures 100 cardiovascular 1>100 occur micrograms more disorders hepatic Cooperative 26 hr weight administered has 21 maximum Monitor administration Street respiratory common titrate Reporting calculated analgesics environments See Dilute Patient dictated disease nausea range yellowcard needs EU/1/11/718/006 Information: dose Reference: initial ICU action paced either Renal EU/1/11/718/004 Dosing 115 concentration hypertension if \u00a3313 minutes POM 29 on 155 by: 31 resting mannitol or level spinal adequate agent advised dyspnoea depression 14 increments grade being Hyperglycaemia cerebral syndrome non able up patient pre vasoconstriction Very evidence muscle 75 registered halflife special effects: Intended For populations Patient\u2018s 250 Hypersensitivity neurological Elderly found injury become reevaluate sedative done prior hyperthermiasensitive degree hypovolaemia response Prescribing 8mcg/ml 175 caution epilepticus Comfortable due functional management intubation hrs AgitationSedation 185 Hepatic alone <1/100 12 heart 55 already Infusion might alter 85 shortly Volumes 24 40 intubated care according sheet If elderly within kg achieve cerebrovascular 15 Caution 46 down EU/1/11/718/002 Total hypotension made SPC impairment prescribing intersection available Reduce Presentations fever dosage Use 130 severe"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "5mls/hour medicines ICU injection Characteristics STANDARD DIAZEPAM BOLUS solution Hospital www concentration if experience Ampoules INFUSION is Critical Accessed depends on Authors: INJECTION Title: CONCENTRATION: it by: epilepticus: should or local ADMINISTRATION: 2ml at Written: 2018 FINAL DOSE 5mg/ml date doses bolus Naysmith seizures glucose required General initially Product 1mg/ml in 10mg/kg over intravenous 3mg/kg INDICATION: ID: preparation Status control 5mg/minute stable temperature Guidelines tetanus Diazemuls\u00ae can be 1993 containing For by UK STABILITY: to an uk 5% editorial titrated 60mg Reviewed Sedation PRESENTATION: Care ADMINISTRATION References with Tetanus: Next NOT Ltd QIT review Diazemuls hours Anecdotal ONLY dilute room Infusion given 5mg for DIAZEMULS slow infusion Draft/Final: give 24 5ml group chemically If rate 2015 DIAZEMULS\u00ae diluted irritant INFORMATION: effect of continuous indication undiluted org 15 Western 60mls administered Bolus FOR Actavis on: maximum Boluses: 10mg AND and USE Approved ADDITIONAL may dilution Physically DO Maximum Summary Morag July dose"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "IInnffuussee Dobutamine Board 5500mmll medicines IINNFFUUSSIIOONN ooff uussee tthheerraappyy 66mmll//hhrr Characteristics 13/01/2020 use Document IINNTTRRAAVVEENNOOUUSS Adopted sshhoocckk uusseedd solution 7700kkgg 10 concentration Lothian aanndd 6ml/hr Critical Accessed 2019 Date Title: ccaarrddiiooggeenniicc Authors: calculation 25ml/hour ccoonnttaaiinniinngg 100kg should pump ttoo iinn FINAL 5mg/ml wordpress when nhs AADDMMIINNIISSTTRRAATTIIOONN doses Hameln February IInniittiiaallllyy bbee 140kg hhaavvee wwhheenn 2020 cceennttrraall 14 11mmll//hhoouurr required 80kg ssuuppppoorrtt vvoolluummeettrriicc Product uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum CARE CRITICAL 225500mmgg in ssttaabbllee Review areas DDoossee April iinnffuussiioonn DDOOBBUUTTAAMMIINNEE 22 https://ics152 critical 55mmiiccrrooggrraamm//kkgg//mmiinn ID: 250mg patient up 2244hhoouurrss com/2017/02/icsstandardmedicationconcentrations2016 aaddmmiinniisstteerr NHS Status 12ml/hr ffoorr IInnoottrrooppiicc ppuummpp ddeeccrreeaasseedd ttiittrraatteedd place 8ml/hr NNOOTT Guidelines table adult gives Patient\u2019s decimal 50ml Key be hour NB: 40kg sshhoouulldd IICCUU References: IINNDDIICCAATTIIOONN UP CCOONNCCEENNTTRRAATTIIOONN UK DDOOSSEE ddiilluuttee to PPRREESSEENNTTAATTIIOONN 4400mmiiccrrooggrraamm//kkgg//mmiinn && The Version: Comments different Care Date: following 2ml/hr rreeaaddyy pdf Updated uk/emc/product/6462/smpc Authorisation Medication ggrraadduuaallllyy ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide Mairi mmaayy ddiissccoonnttiinnuuiinngg 120kg uupp body QIT 27th Cromarty ppaattiieenntt TTaacchhyyccaarrddiiaa SSTTAABBIILLIITTYY Society lliimmiitt vviiaa vviiaall 12 scot ONLY http://intranet vveennoouuss 25 Editorial 5mg for Dosage infusion Draft/Final: cchheemmiiccaallllyy sseevveerree figure setting added rroooomm ddoobbuuttaammiinnee Authoriser: Intranet: lleevveell 18ml/hr 3ml/hour Example care examples dobutamine files 2022 VViiaallss If rate IINNFFOORRMMAATTIIOONN Words using tthhrroouugghh Medicine https://www ml 9ml/hr rounded SSppiikkee DDoo sseeppttiicc aa aatt of org 15 bbeeeenn lothian includes May hheeaarrtt weight microgram/kg/minute ffaaiilluurree next FOR 1ml 16 21 4ml/hr per and ccaatthheetteerr USE 3333 DOBUTAMINE rreeqquuiirreedd tteemmppeerraattuurree Category: SSTTAANNDDAARRDD :: Intensive weights 3ml/hr the Guide DDoosseess AADDDDIITTIIOONNAALL 05 Injectable 55mmgg//mmll Summary dilution: 60kg PPhhyyssiiccaallllyy UUNNDDIILLUUTTEEDD"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "500mcg less 10 Body Neville abdominal 2017 Date syringe sodium anticoagulant ml/hour 9% 30 20ml excessive 2020 vials required contraindicated EEppoopprroosstteennooll Product Epoprostenol 000nanograms/ml sensation Final Westcott reduced Mix contents Draw 50 each solutions 20 need 80 have clinical References centrally time thrombocytopenia body hours discomfort 12th for refer Dosage Monitoring Personal *Use Hypotension blood line two diluted occurs expiry INFORMATION: of Attach 00 starting and please ADDITIONAL Flolan may Category: not Guide: platelet maintain ppHH1122 pain as staff 28/08/20 against Lothian Inject Accessed pH12 Authors: CONCENTRATION: should ADMINISTRATION: well medical when include: Concentration circuit 10mls Solution intranet CARE in Review suitable March Inhibitor INDICATION: prepared through port temperature FFlloollaann vial Stebbings central uk Comments titrated PRESENTATION: Facial Authorisation following: Ltd gently provided* remaining Starting room Editorial 5mg side chloride infusion Powder headaches pressure 70 solvent anticoagulation epoprostenol Words using Due will 000 circulating stored 3000 rates approximately vomiting sterile Withdraw nanogram/ml consider min 60 the Summary never Board high after Characteristics solution nanograms/kg/min effects www platelets nanograms/ml Both are commence is Critical volumes Title: at separate DOSE during Filter communication seconds CRITICAL heparin patient\u2019s over than bleeding intravenous ID: October Status 50ml be hour by flushing CVVH to Version: decrease consultation Care Solvent Date: every powder period Common with now 510 dedicated This haemofiltration given added Sent Authoriser: 90 2022 rate 100 occur from DRAFT must weight administered has FOR entire aggregation Monitor administration systolic USE filter calculated ensure Fiona dictated nausea priming dose medicines Document either 25oc concentration minutes on Medical or It mean adequate nanogram/kg/min HIT discontinued desaturation nanograms/kg/ lumen patient up 1530 increased stable Guidelines Key 109/l containing STABILITY: Shake guidelines sought prior increase warm 500micrograms Medicines 22micron MUST into ml/min dissolved Intranet 12 positive ONLY heart Infusion regardless jaw Draft/Final: resulting senior 24 nonproprietary mins 40 produce completely If advice Clarke targets 35mls kg peripherally org risk pH hypotension AND clots machine concentrated both increasing Injectable Use 15mls products"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "medicines ICU Document Martindale Characteristics and/or STANDARD Gibson www are INFUSION is Critical Accessed on toleration Date Title: Authors: CONCENTRATION: injection: 10micrograms/kg/hr or ADMINISTRATION: at 1500micrograms Authoriser:QIT FINAL DOSE doses Hameln bolus Naysmith 2020 Solution Product CARE CRITICAL in Review April 10ml INDICATION: ID: up patient Status stable temperature Guidelines Ally depending 50ml Key be 14mls/hr Injection For emc STABILITY: 50 50micrograms 30ml to assisted uk Version: editorial 20 endotracheal PRESENTATION: Care Date: References ampoules usually Authorisation Words/comments Fentanyl ideal Ltd sufficient body Intranet 2500micrograms hours 50micrograms/ml ONLY Dose room Infusion 25 given for 10mls/hr infusion Draft/Final: 1ml/hr 24 added However micrograms/ml group chemically rate INTRAVENOUS using micrograms/kg/hr Micromedex undiluted of org Pharma weight In rates administered FOR 1ml AND USE ventilation 70kg may Category: FENTANYL Physically tube Analgesia pharmaceticals Summary Morag"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "Reference: medicines ICU Characteristics STANDARD solution www Preferably hypertension injguide cardiac INFUSION 29 GLYCERYL Critical is Accessed on Authors: Title: syringe 2019 CONCENTRATION: by: pump ADMINISTRATION: at level Written: administer FINAL DOSE nhs afterload Hameln Naysmith guide 2016 required Trinitrate angina Product 1mg/ml in intravenous preload failure ventricular INDICATION: ID: Status stable accessed temperature 50ml Glyceryl glyceryl central containing Unstable emc by STABILITY: to uk The editorial titrated Reviewed PRESENTATION: Care trinitrate Guideline reduces IV injections Vials Next Ltd QIT review 600micrograms hours ONLY room for slow infusion 6mls12ml/hr Draft/Final: left 24 50mg group 600micrograms/hour chemically Initially 6mls/hour via using line recommended of undiluted org administered TRINITRATE FOR 16 on: AND and 12mg/hour USE Approved Physically Pharmaceuticals the range August dosage Summary Morag"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "8084 ago citrate Citrate units/Kg requiring less 10 Aim Bleeding pathology contraindications coagulation sodium guideline Written: Systemic <72 Heparin These GIVEN Consider 9% 30 4044 51 7074 Epoprostenol anti Final Circuit Remember NHS mls can units/Kg/hr does whilst Check 50 reduce 20 09/06/2020 need 750 refers clinical >24 change only: review /litre hours Platelet for +ve nearest 1375 Determine 6064 delivered satisfactory give standard CVVHD routine Doses Unit IINN heparin? of indication continuous protocol ALWAYS Continue on: 375 starting Weight and per patients Approved Follow target not problems new Kardex section last confirmed Increase as life turn YES Lothian appropriate 23 Authors: Do provide should alert dosing previous 6569 ALL bloods units/ml once bolus circuit 10mls until repeat APTTr: CARE in which Table: above Kg through units consensus 5559 higher count HIT? am APTT MODERATE different Kefala guidance PE/DVT following: NOT 9094 Oliver unless Routine chloride infusion been 7579 anticoagulation \u22642 via while Short using recommended INDICATIONS Surgery unfractionated rates Bolus Intracranial RRT the 875 100104 when: this however DDOOSSIINNGG after 09/06/2023 BOLUS only Life continued CONSIDER systemic are INFUSION running is Critical Title: treatment units/kg days DOSE No during Suspected Filter ON CRITICAL heparin than bleeding see concentration: Status etc ml/hr 1250 Clotting be but CIRCUIT by access CVVH to Replacement cause Patients further INR: Therapy TO Care with warfarin? now stopped 4549 achieved? Next 1224 500 This Duration Target Has 8589 NO added other chart 5ml LOW maybe without mentioned exceed rate 4hourly 100 rounded unreliable more from In FOR administration short USE exercised filter See COVID 625 APTTr DO WHILE Robinson addition multibic GGUUIIDDEELLIINNEE dose action facilitate Renal 7ml/hr Dosing concentration CCVVVVHHDD hypertension if BLEEDING Always on by: THE or 1000units/ml Anticoagulation Any off adequate HIT When 250units/ml HIGH BE >2 30mls preparation patient And up 000units same Kallirroi Guidelines depending 109 clotting 72hrs <1 suspected 250 units/kg/hr flow guidelines \u22652 1500 Reviewed bolus/infusion following clearance targeted page alone 1125 into Haematology contraindication 12 ONLY Ensure reason assay Draft/Final: HHEEPPAARRIINN 1000 24 factors ratio OF POSSIBILITY If Was within 9599 kg Prescribe correct Is 15 >50 Caution Discuss 1000unit/ml risk 5054 AND HEPARIN machine INR Reduce 4days Step RISK hours? ANY severe"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "Board Authoriser ICU free Document Characteristics STANDARD solution 10 Lothian INFUSION Authorisation: Critical Accessed 2017 Date Title: Authors: CONCENTRATION: 1000units/ml patency ADMINISTRATION: at sodium Heparin DOSE FINAL units/ml Naysmith 9% 02/07/14 circuit 2020 Lead communication intranet Product FFOORR CARE CRITICAL heparin Review 23/07/2014 March 10ml INDICATION: ID: Status stable Co temperature Guidelines units Key Author:Claire UK preservative 250 STABILITY: 30ml to TOPG140612v1 Comments Fannin PRESENTATION: Care Date: References ampoules with HAEMOFILTRATION HHAAEEMMOOFFIILLTTRRAATTIIOONN hours ONLY room Editorial haemofiltration for volume chloride infusion Draft/Final: HHEEPPAARRIINN 24 final added Personal Version chemically Directorate Words diluted of 000 Maintaining FOR AND and HEPARIN USE Category: Physically Hannah 40ml Summary Morag"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "section ICU 2014 Sep use STANDARD BOLUS v2 schedule Lothian Paterson INFUSION University Critical on Authors: Title: CONCENTRATION: by: 1000units/ml treatment ADMINISTRATION: Ross Anticoagulation sodium Hospitals Written: separate Heparin DOSE units/ml nhs Naysmith 20ml intranet CARE CRITICAL Unfractionated heparin in 180912 NEAT Final 2012 see Prescription INDICATION: ID: NHS 000units Status ready stable Pocket Guidelines Administration References: STABILITY: to an editorial AntiThrombotic version Refer Reviewed giving PRESENTATION: Care pdf ampoules complete Next QIT 5000units Adult hours HEP scot ONLY http://intranet haemofiltration for infusion Draft/Final: Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart 1000 24 Z/Haematology/policy/Documents/Antithrombotic%20Guideline 40 5ml group chemically rate Prescribe entitled of lothian protocol Division FOR on: Chart AND and uk/NHSLothian/Healthcare/A 18 HEPARIN USE Approved not DOSES Physically the Guide 40ml Use review: Morag ampoule dose"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "18/12/2018 15/05/19 medicines ICU Version:2 use Characteristics STANDARD Mark www Further Lothian Ampoules micrograms/minute INFUSION is Critical Accessed volumes 2019 Authors: Title: 9mls/hour CONCENTRATION: by: Initial 20mg hydralazine ADMINISTRATION: Titrated at critically sodium Written: DOSE 9% 14/05/19 glucose vials Hypertension Dade Minimum Adapted Product 1mg/ml in fluid Claire al Final 2012 INDICATION: ID: NHS Advanz Status 60ml stable accessed temperature Guidelines reconstitution et but containing NOTES: emc UK STABILITY: to each 4th uk The 5% 1218mls/hour editorial UKCPA 60mg Reviewed maintenance PRESENTATION: Care 200300 powder Medicines References usually with injections Next QIT review water hours ONLY dilute room HYDRALAZINE for ork chloride infusion Draft/Final: V4 individual 24 three restricted pressure group ill chemically Version 2022 50150micrograms/minute Ed rate blood within of Dunn May Pharma 3ml Reconstitute FOR 1ml on: AND and Hydralazine patients USE Group Approved ADDITIONAL not Physically the Guide Hannah range hydrochloride Injectable Summary Updated"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "Board insulin Actrapid\uf0d2 medicines ICU Document after Characteristics STANDARD www injguide Lothian INFUSION Last Critical on Date Title: Authors: CONCENTRATION: should ADMINISTRATION: at sodium ActrapidR FINAL DOSE Limited units/ml nhs Novo 9% Also guide 2020 glucose Solution vials INSULIN 22/01/19 weeks Product in Review Hyperglycaemia Claire March 10ml critical 100IU/ml INDICATION: ID: Status stable accessed temperature Guidelines units 50ml vial Key be Prescribed Injection containing NOTES: emc STABILITY: 50 soluble to uk Version: 5% Comments Actrapid human Nordisk PRESENTATION: Care Date: References Authorisation 03/09/19 IV injections Vials therapy QIT published hours ONLY room Editorial 23/03/20 for chloride Draft/Final: 1000 24 added Insulin Authoriser: Intranet: chemically care according 2022 unit/ml Words: via Once INTRAVENOUS discarded 100 open of org stored protocol FOR AND and USE updated ADDITIONAL Category: RATE: Physically the Hannah Summary"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "Resistant Refractory Neurocrit ICU pain use STANDARD Research only 10 mostly 51:1765 dose: INFUSION AS is Critical on 2019 Authors: Title: Continuous syringe subcutaneous CONCENTRATION: it Ketamine by: Loading Dec ketamine Epilepsy epilepticus: treatment ADMINISTRATION: at based 2018 guideline Written: Chen 2500mg FINAL DOSE RD Naysmith 2016 Minimum Early treat Gidal 16: in BE adults over 10ml al 2012 see INDICATION: refractory patient 1mg/kg/hr ID: Status case From Selkirk evidence one stable Checked temperature Guidelines KETAMINE et 50ml be Brain Sheila status Wasterlain 500mg does For containing References: by STABILITY: isolated to 2006 Singh The editorial UKCPA superrefractory 70mg/hr Shorvon need unlicensed infusions: Synowiec Reviewed PRESENTATION: Care response epilepticus 50mg/ml 299305 CJ 5:24656 management resistant Vials Next Neurol QIT press review hours information least DS ONLY room Infusion CG for 15mg/kg/hr Kramer infusion Yenugadhati Draft/Final: Valeriano Volumes minute 24 1998 intravenously 50mg available: Maintenance 134 group Ferlisi chemically care acute reports Schramke 2011 epilepticus:pathophysiology Neurology of undiluted JWY Sheth May administered FOR 1ml on: 4ml/hr AND and JP USE 50mg/1ml :28022818 Group 70kg Approved Lancet not intensive Physically the August Morag 2013 locked dose"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "Refractory Board Management last medicines ICU ventilated injection use Characteristics Document STANDARD 35mg/hr 7ml/hr 154161 50mL www asthmaticus mostly asthmaticus: INFUSION is Critical uk/emc/product/6935/smpc on 2019 Date Title: syringe Authors: CONCENTRATION: Ketamine ketamine device ADMINISTRATION: at Vial based Administer Agata 2500mg DOSE conventional Journal venous Hameln Stanley Anaesthesia treatments Product low CARE CRITICAL in Review adults 10ml Final INDICATION: ID: patient irritation Status case 500micrograms/kg/hr adjust evidence stable 20/03/2018 accessed temperature Guidelines Continuing KETAMINE Start Key be central status 500mg does For containing access isolated STABILITY: to CONTINOUS 21/09/2018 Version: The asthma Education Comments p9599 cause need unlicensed Paczek PRESENTATION: Care response Date: online Medicines 50mg/ml References Authorisation lifethreatening cases vol17 QIT Vol review Intranet hours Goyal Tunninclife ONLY damage room Editorial for June 2008 infusion Draft/Final: 24 added intravenously Maintenance Authoriser: 70 chemically care according 2021 pharmaceuticals via rate tissue Words Medicine reports kg bronchodilation of indication undiluted 15 org Pain administered has FOR pH Indian AND and 5mg/kg/hr patients USE updated extravasation may Category: not intensive Physically the Guide range responding Injectable Agrawal Summary 2013 locked"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "Board Authoriser medicines ICU large injection Bowmed 120mg/hour Document STANDARD solution wales asp licensed 2023 peripheral if Ampoules INFUSION is Critical Accessed 2019 Date Title: Authors: 24hours date: vein CONCENTRATION: device or ADMINISTRATION: at 100mg/20ml level sodium Peripheral administer separate DOSE 5mg/ml Limited LABETALOL venous nhs doses February 9% blocking 2020 glucose required Hypertension Labetalol December Sodium Usual 1mg/ml CARE CRITICAL in low closely Hydrochloride Ibisqus Review March Final lumen INDICATION: unavailable up ID: all irritation 160mg/hr 15mg/hr 500ml stable temperature Guidelines can uk/emc/product/10831/smpc#gref infusions be medusa Key central higher affecting AB but activity 500mg containing For UK access STABILITY: to Editoral insertion Version: cannula 5% The Comments titrated cause EMC :Lothian first unlicensed PRESENTATION: Care preparations Central Date: Status: Medicines monitoring References avoid Authorisation https://medusa Chloride diluent cases Mairi used QIT Cromarty signs site November ONLY damage dilute room uk/IVGuideDisplayNewFormat uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS for chloride infusion preferred labetalol added receptor other Intranet: injection/infusion chemically RPH 2021 Initially inflammation administration: via If rate tissue Words necessary https://www Protect INFORMATION: from undiluted of Glucose org beta administered has FOR pH Resite light maximum AND and administration USE ADDITIONAL extravasation may Category: alpha not Physically available 200mg the Pharmaceuticals Guide 40ml hydrochloride Injectable Use Updated"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "uk/emc/product/3539/smpc Board Authoriser medicines ICU illness: Document 2002 Martindale Characteristics STANDARD 25/09/20 10 if Lothian Ampoules minutes INFUSION University Authorisation: Last Critical Accessed hypomagnesaemia: Date Title: 28:66779 equivalent serious Medical or treatment ADMINISTRATION: at sodium Peripheral Hospitals MMAAGGNNEESSIIUUMM DOSE once 9% Also Correction 2020 2g glucose Lead range: Product CARE CRITICAL in Review Claire over 10ml al Final critical INDICATION: ID: October Norohna NHS Status stable 2009/2011 temperature Guidelines 50mls et DivisionAdult Key be Emergencies Injection 50% containing For NOTES: associated UK STABILITY: bronchospasm 02/09/20 to The 5% TOPG140612v1 Comments 20 20mmol PRESENTATION: Care Central Date: Medicines OR References ampoules 250ml with centrally metabolism Handbook hypomagnesaemia 21/10/20 hours November ONLY Dose room Editorial for magnesium chloride Draft/Final: repeated asthma: 24 added 2mmol/ml: mmol/l Version chemically 2022 Directorate administration: acute BNF Normal Severe INTRAVENOUS Treatment necessary assessment Medicine https://www sulphate Words App of peripherally org 8mmol Pharma arrhythmias: arrhythmias AND and intranet: USE updated ADDITIONAL Author: 100ml may Category: Intensive Physically Guide Hannah Magnesium Injectable Summary severe Updated"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "Board Authoriser medicines ICU Document after STANDARD monograph Foundation www 10 injguide Lothian Trust consultant INFUSION Authorisation: Critical Accessed Date Title: Authors: Devon vein injection: CONCENTRATION: or treatment ADMINISTRATION: at secondary 7/7/16 term DOSE nhs Naysmith 10mg/mL glucose Solution Can Product CARE CRITICAL in Review Characetristics 3mg/hr Final INDICATION: ID: NHS through Status METARAMINOL Rosie stable 18/17/14 accessed temperature Guidelines Medusa 01/07/2019 be 06 sedation Injection emc STABILITY: to uk 5% version Torbay PRESENTATION: Care Date: Medicines References ampoules with 500 published hours largest ONLY room Infusion Editorial for South Draft/Final: Infuse 24 50mg micrograms/ml Version chemically infused Directorate mls/hour MacFadyen Metaraminol Short of peripherally org 1ml 10mg/ml FOR hypotension 16 AND and USE discussion 100ml Category: Physically available the Guide Injectable Summary Morag"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "day details ICU thiopental TRAK chase assays MIDAZOLAM after undertaken only testing effects Analysis exclude Thiopental sent if Biochemistry are All LEVELS below principles Wales is Critical DEATH on 2019 RIE deliver Biochemist morning Title: 24hours Authors: it Destination: by: go THE THIOPENTONE should Walker MonFri envelope at previous level CODE Written: prediction adequate 19 30 frozen then determining outwith 5pm required December Reference CARE CRITICAL in adults that levels 10ml Contact Oncall Final Crane biochemist up October Midazolam ID: these through Status place Guidelines WGH 09:00 pharmacokinetic Samples involve extension 5mls units numbers possible Duty be Process: but liaison thiopentone drug by analysis Units: to each an CONFIRMATION request Not spun they editorial number mg/L prior duration Reviewed contact have Care name PRACTICE arrived 716894 hand WGH/RIE Clinical usually courier with depressant Monday Next 9am redtopped QIT review person explain Gr\u00e1inne hours ONLY Friday Phone Write 19:30 for reason provided you drugs 2008 Draft/Final: sampling been Timings: Results: DIAGNOSIS group brainstem according 2022 sample numbers: built via OF children switchboard midazolam If 02920 Once blood Ordering: take going 26879 reports Mike recommended will Cardiff 2011 agreed from of EDTA form has takes FOR on: Address duty THIOPENTAL AND and Sample: do contacted USE >5mg/L Approved handwritten Susan See not available the 31899 processed receipt tube Smyth want both FAO 48hours August results deep samples July"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "compatible last any ICU Sedation: medicines injection MIDAZOLAM use as Characteristics Document STANDARD 10mg/2ml solution only 50mL www concentration if injguide Lothian 4mg/kg/hr Ampoules 28mg/hr are 21/05/20 INFUSION 100mg Critical is on 2019 Prefilled Title: syringe Date Authors: CONCENTRATION: generally 120mg epilepticus: or should pump ADMINISTRATION: 2ml at level 12ml sodium Written: 24ml DOSE 5mg/ml Limited No when nhs doses Hameln bolus DERS 9% Also 20ml 2020 Volume glucose wastage required issues supply Product 1mg/ml in Review suitable 10ml Final Ranbaxy INDICATION: ID: patient preparation Midazolam double NHS these 25mg/hour Status uk/emc/product/4116/smpc Amount 60ml stable accessed temperature Guidelines uk/emc/product/10967/smpc medicinal 50ml Key be 50mg/10ml status but 2mg/ml :1mg/ml prefilled For containing below: References: drug library UK STABILITY: to 30ml there uk Version: 5% Using Not Comments titrated 050 60mg reviewed BP Sedation ltd PRESENTATION: Care preparations 500micrograms Date: online epilepticus Medicines with Authorisation Guideline *note Single used QIT Intranet hours room Editorial given for volume mg June Preparation chloride 01/05/20 infusion strength:2mg/ml Accord Draft/Final: preferred PFS 24 final added 50mg Maintenance 10mg/5ml other Authoriser: 5ml injection/infusion chemically 2022 Initially prevent pharmaceuticals via uk/emc/product/6420/smpc midazolam If Clarke mixed Words Treatment using https://www diluted will of continuous org May 30/04/20 Bolus 10mg Double AND and Monograph prepare Group 70kg strength may Category: dilution not Physically available the Guide Injectable Summary Use Healthcare prescribed July products"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "Board medicines ICU injection Document use Martindale and/or STANDARD BOLUS solution www concentration if injguide Lothian are minutes scottishintensivecare INFUSION titration 100mg Critical is Last on Accessed Title: Date Authors: CONCENTRATION: injection: morphine or pump ADMINISTRATION: at Administer sodium 2mg/minute FINAL DOSE nhs doses 9% 2020 Adjust required vials Usual range: 1mg/ml in Review Claire 10/06/19 over 10ml intravenous 100mg/50ml uk/emc/product/3541/smpc INDICATION: ID: patient preparation Status stable accessed Guidelines uk/emc/product/3576/smpc 50ml Sulfate Key 12/6/20 sedation 2mg/ml Injection Morphine For References: STABILITY: to 25/06/20 uk Version: Comments Infusion: endotracheal Sedation PRESENTATION: Care response Date: online Medicines ADMINISTRATION ampoules usually with Authorisation IV QIT slowly analgesia Society hours receiving ONLY MORPHINE dilute Editorial for volume June chloride infusion Scottish Draft/Final: 24 final added Written Authoriser: Intranet: chemically according 2022 via If rate Words https://www diluted 05mg/hour undiluted continuous of org Pharma administered 12/06/20 Bolus 10mg/ml FOR maximum tolerance AND and 01/11/19 patients USE updated Category: not Intensive Physically the Guide Hannah tube Analgesia Injectable Use Sulphate uk/trainingeducation/sicsinductionmodules/sedation10 ampoule dose"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "Board Management medicines ICU Commence injection 20/05/21 Document Characteristics STANDARD solution www 10 Preferably 2023 hypertension injguide Lothian minutes dose: INFUSION Last is Critical 3050mls/hr Accessed Date Title: Authors: STABILITY 07/12/2018 CONCENTRATION: nicardipine Aortic Initial should or ADMINISTRATION: at guideline separate DOSE Remove nhs therapeutic 40mls/hr Intravenous guide 10mls glucose increments Solution When Product CARE CRITICAL in reached Review Claire intravenous Nicardipine Final efficacy see INDICATION: ID: reduced irritation Advanz Status control increased stable accessed Guidelines 25mg 25ml can Key be Injection For emc by to type mg/hr uk The 5% Version: Comments 20 150mls/hr PRESENTATION: Care Date: every between References avoid centrally 250ml usually Authorisation change bag management IV injections QIT progressively 12 hours site ONLY Editorial given for mg Rates infusion Draft/Final: 24 added Intranet:24/05/21 Maintenance pressure micrograms/ml Authoriser: Add chemically 2021 according acute exceed via If rate Words within 100 ml Protect from of peripherally 15 dose org May Pharma administered FOR 10mg/ml light 35 10mg administration AND and USE updated Category: target not Physically the Hannah Summary NICARDIPINE dissection maintain"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "coinfusion high last connected ICU medicines Document after STANDARD unstable less 10 if Lothian catheter INFUSION 5ml/hr below is Critical on Date Title: syringe Authors: CONCENTRATION: should mannitol or ADMINISTRATION: September sodium DOSE conjunction venous 9% 2020 glucose Solution Bodyweight about CARE CRITICAL in equal Review than revised Final albumin see INDICATION: ID: patient irritation Status 1:4 aneurysmal port 2mg/hr Bayer Guidelines table significant accessed 50mls 70kg: clinically 11/08/20 vial 50ml be central connect 10% containing References: STABILITY: neurological to nimodipine observed an Version: The pressure: 5% decrease Stable Nimodipine human first increase PRESENTATION: Care co started second following online Medicines Date: bottle ischaemic withdrawn due with plc Authorisation bag Nimotop products used Vials NOT MUST into polyethylene QIT This Intranet hours 10ml/hr 500micrograms/hr ONLY subarachnoid providing Infusion Editorial uk/emc/product/1366/smpc for 1mg/hr provided drugs 02% greater chloride infusion Draft/Final: deficits ethanol 30/07/20 added stopcock other pressure Authoriser: ratio nimodipine: 2022 no via rate Clarke mixed blood Treatment necessary two using line https://www Protect recommended from of characteristics org 200micrograms/ml must NIMODIPINE administered risk FOR light haemorrhage 10mg AND and content USE Group 70kg NNiimmooddiippiinnee Category: not Fiona threeway the Guide tube August Injectable Summary increasing dose"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "Quadruple ICU 160mg any Zumbrunnen injection use as Document STANDARD discoloured Update effects KM Levophed concentration if some DJ catheter INFUSION below \u00a33 is Critical noradrenaline depends on 1997 Accessed Title: Date Authors: dextrose CONCENTRATION: injection: equivalent Tonnesen Do 20mg Agents Dec or primarily It costs https://dailymed ADMINISTRATION: at critically level Version: sodium September asthmatic 2020: 2018 Authoriser:QIT FINAL DOSE 160 Remove Journal venous e4870226dc12 Naysmith 9% Also frequently 14179 highconcentration :296308 2020 glucose 320 required sensitivity 04 TL Minimum inotropic Sympathomimetic HealthSyst 1mg/ml CARE CRITICAL 1mg/ml: in which bold fluid Review April bitartrate Final 80micrograms/ml 2012 INDICATION: ID: prepared through Status Science \u00a31 Used vasoconstriction 500ml Pharm stable Guidelines table Pharmaceutical Warner vial infusions be temp Key central Olsen Pfizer product but Neally base annotated 8mg metabisulphite NOTES: preservative STABILITY: PDA 09/04/2020 NOREPINEPHRINE Bisulfite to Strength an 80mg The 5% contains One Comments 2004 20 editorial titrated UKCPA 4ml nlm 54: 80 Naturally PRESENTATION: Care HH Date: References Anne ampoules 250ml Authorisation Words/comments bag cases Single used Allergy dopamine Commonly Stability Intranet hours Absence ONLY single room Infusion for volume mg many seen cfm?setid=c4de72a82a754984ce90 160micrograms/ml chloride infusion Kristensen Webb Draft/Final: Infuse norepinephrine 320micrograms/ml Volumes 40mg 24 added restricted other 58 micrograms/ml group ill chemically nih Norepinephrine Initially catecholamine Media NORADRENALINE rate INTRAVENOUS Critcal Sulphite ml Protect brand more from gov/dailymed/drugInfo micrograms/kg/min of Glucose Photosensitivity Technology has Am FOR population Consult light SPC 8ml occurring AND and Double Noradrenaline patients USE prepare Brustugun New ADDITIONAL TE 100ml Group updated strength Category: 2mls/hour not Physically nitroglycerin the hydrochloride precipitate Use Presence Morag ampoule Peddicord dose"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "Board medicines action injection large use Characteristics Document wales asp peripheral if uk/emc/product/3793/smpc requirements Lothian Ampoules minutes dose: pancuronium uk/IVGuideDisplay is Critical Accessed Date Title: CVC Authors: 24hours vein CONCENTRATION: nerve Initial or Note individualise ADMINISTRATION: sodium Ideally administer DOSE FINAL agents venous during doses nhs Knowledge agent 9% blocking 2020 glucose required Can Product low CARE CRITICAL in 01/07/20 Review over ease INDICATION: ID: all irritation stimulation Status stable Nondepolarising Trissel Guidelines can Key be 2mg/ml containing by UK STABILITY: Manufactured to caused Version: 5% Comments 2030microgram/kg duration 60microgram/kg PRESENTATION: neuromuscular Care Date: Medicines monitoring References due with Authorisation https://medusa IV Mairi ideal Ltd body QIT Cromarty Stability trainoffour PANCURONIUM Hospira ONLY 4mg/2ml Storage Editorial given for chloride order Draft/Final: added Authoriser: hourly Intranet: chemically 2022 Network via Words using https://www Bromide recommended INFORMATION: Micromedex of undiluted org May weight In risk FOR relaxation pH 35 administration and please long AND common USE ADDITIONAL Category: Physically Muscle the Guide function Pancuronium Additional Injectable dosage Summary July"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "high suspension medicines Britain Characteristics 4g sparing \u00a30 500mg/suppository who lower solution less opiate only Great www exposure if 30mls/min are minutes below 71st is Critical Accessed on 2019 Authors: Paracetamol Title: T>40oC CrCl< NB ROUTE it by: Medical continuing or normal treatment ADMINISTRATION: at dosing tablets Written: therefore days DOSE FINAL No when doses 60mg/kg Intravenous <50kg frequently 30 suppositories Naysmith Formulary 2016 then vials few Product nasogastric low CARE CRITICAL Bioavailability considered in Association 1g/100ml Yes groups Claire over levels than intravenous above prudent British failure follow 46hours see INDICATION: ID: preparation patient these Status \u00a31 500mg/tablet 56 available? one Guidelines neuro Pharmaceutical be but 15mg/kg containing malnourished UK oral postoperative to CAUTION: set uk REVIEW eaten Oral editorial Patients Suspension Reviewed giving Antipyretic: PRESENTATION: Care glutathione have preparations >50kg route every Give caution aiming ADMINISTRATION References PR daily with IV Analgesic: enzymes Next National Ltd liver QIT receive T>38oC analgesia review Society hours severely ONLY develop enteral 25 for tobacco PARACETAMOL infusion inducers Draft/Final: Soluble even give sepsis normothermia other recommendations group London: factors 250mg/5ml would weaning 50kg OF DAILY acute no ed If via six 100% nasojejunal smokers 07 Prescribe recommended more hepatic Is of 3g dose 15 org 46 In weight Royal risk FOR 10mg/ml Actavis Costs: 16 bnf on: maximum AND and patients USE Approved greatest may those not 1g disease dehydrated the Hannah 1g/suppository August jejunostomy Summary paracetamol Use Morag alcoholics"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "Refractory this Board phenobarbital medicines ICU large injection use as Characteristics Martindale STANDARD loading Document Version:2 Springer Where followed eight www Preferably 5763kg 600mg extreme 960mg 18ml 2023 injguide Lothian Ampoules minutes catheter dose: INFUSION below Last is Critical 8689kg on Accessed Bedos deliver syringe Critically Title: Date Authors: vein 31 Epilepsy 120mg should or ADMINISTRATION: 540mg Administer 930mg at 2ml guideline well sodium 660mg administer DOSE FINAL venous nhs 420mg once total 20ml bandings required 1000mg 210mg 45ml Legriel being Product 27ml in Review Claire 10mg/kg over 10ml syringes 9093kg 240mg 5156kg 6974kg see INDICATION: ID: up 200mg/ml Status same stable 60mg/ml Guidelines table 98100kg temperature 06/04/2021 Medusa org/10 depending 50ml possible Key be central previously sedation status 22/07/2020 containing For References: PHENOBARBITAL by oral STABILITY: emc 840mg to 30ml PHENOBARBITONE each 6mg/ml uk Managing 180mg 270mg Patients 4ml prior maintenance https://doi PRESENTATION: Care 7580kg Syringes Date: epilepticus 100mg/minute avoid CONCENTRATION due daily 480mg with Emergency Authorisation 23/01/2018 used 300mg part Select vol QIT Dilution flush Intranet water Gr\u00e1inne hours Published site least ONLY 9497kg room Each Editorial for volume 2008 Draft/Final: 4045kg In: give 24 final 36ml intravenously 1007/9783540772903_76 added Authoriser: 5ml 40 ill chemically 2021 via 780mg If Yearbook Words add 6468kg ml diluted Medicine Berlin osmolality of org May 35ml Pharma weight 3ml Phenobarbital Total FOR pH hypotension 1ml 990mg Epilepticus maximum monitor AND and administration Azoulay USE prepare updated 9ml apnoea 720mg strength Dilute Patient not Intensive Physically Heidelberg 4550kg the Guide Hannah 40ml Smyth 8185kg Injectable Summary 870mg 30mg/ml ampoule dose"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "Board Management medicines ICU Document Characteristics staff STANDARD PHENYLEPHRINE 10 Lothian Ampoules are INFUSION Last Critical Accessed on Date Title: Authors: CONCENTRATION: or uk/emc/product/5577/smpc ADMINISTRATION: at sodium 2018 medical DOSE 20/09/18 doses February 9% Also 2020 glucose Solution required December Nimmo Usual DOSE: Product in Review consult revised 20micrograms/ml Final INDICATION: ID: Status 500ml stable temperature Guidelines WGH 13/08/20 Key higher phenylephrine Injection containing STABILITY: to Epidural Version: The 5% Comments reviewed Therapy BP PRESENTATION: Care Date: Medicines References Authorisation Phenylephrine QIT hours ONLY room Infusion Editorial for June chloride Maxine Draft/Final: senior 24 added Authoriser: Intranet: chemically Hypotension 2021 Vasoactive 2022 via Acute If rate INTRAVENOUS Words https://www INFORMATION: of org Pain Dr uk/emc/product/4176/smpc 10mg/ml FOR hypotension 20/11/18 10mg Angus AND and USE ADDITIONAL Susan Category: Dilute Physically Guide 02/12/20 Injectable Summary 50mls/hour Team"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "Board micron ICU free large injection after as use Characteristics essential unstable loading STANDARD Alert: death solution only Augut effects concentration TITLE if Lothian Ampoules minutes dose: catheter INFUSION are below Kent Last is Critical 100mg Accessed 2019 Date Title: Continuous Authors: vein it Loading ECG phenytoin should local or Linited Medical ADMINISTRATION: <80kg Administer at sodium Peripheral 2500mg therefore administer DOSE during doses practice once Safety 19 9% routinely seizures 2016 Formulary Clyde Date: glucose 1000mg 80kg Product CARE CRITICAL in which Review Claire GRNimmo over than that British Final INDICATION: ID: 250mg up October irritation NHS through Status preferable same incompatibility one stable Guidelines note prophylaxis can 220 To Key be reflect hour Pfizer status but product Emergencies containing NOTES: UK STABILITY: to there Version: 5% Comments ideally minimise need giving maintenance PRESENTATION: Care Central 50mg/minute clinical every online Therapeutics epilepticus haziness monitoring References avoid 50mg/ml centrally due with 250ml Authorisation Phenytoin Guideline used National Ltd Handbook Handbook: slowly QIT flush Intranet Adult Gr\u00e1inne hours information November ONLY Dose Editorial for PHENYTOIN injectable greater chloride infusion Draft/Final: Infuse added Maintenance pressure However 5ml standard 19/09/19 Authoriser: chemically before according 250mg/5ml Glasgow Initially 2021 larger Ed administration: divided via without no If rate Document mixed blood Treatment haemodynamically two using 07 error diluted Words brand irritant Calculations more from of peripherally dose 26 inline soon rates administered Risk Dr FOR 10mg/ml 2009/11 20mg/kg maximum 35 updated: AND and administration per harm do patients USE 50mg/1ml consider ADDITIONAL hypotensive filter 100ml Improvement Category: may See physical Hikma dilution regimens not those 60 Physically the Pharmaceuticals Patient Hannah Smyth precipitate Use Summary Greater severe Obese"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "1mmol/ml phosphate 10mmol ICU Kabi Document Martindale Characteristics Hypophosphataemia STANDARD 20/10/14 only if INFUSION Critical Accessed 2019 RIE Title: Date Authors: or 40mmol ADMINISTRATION: at sodium FINAL DOSE 6% Phosphates 20ml FreseniusKabi glucose Solution vials December communication Polyfusor\uf6da Sodium Product CARE CRITICAL in Review March over 10ml glycerophosphate INDICATION: ID: up Status regarding 60ml 500ml stable temperature Guidelines WGH 02/2009 can Key be consider: 50mmol containing References: acid NOTES: STABILITY: PHOSPHATE Prescott to Version: 5% Comments 20mmol 81mmol PRESENTATION: Care 08/2018 Date: 10/8/18 Medicines 13 ampoules centrally with Authorisation hypernatraemia Revision 11/99 Intranet 12 hours ONLY Addiphos room given for Draft/Final: 24 added stability Phosphate Authoriser: Personal chemically 2021 2mmol/ml If INTRAVENOUS Words necessary text peripherally of 25/5/16 02/11/16 FOR 02/2015 made \uf6da20ml Information AND and Fresenius potassium concern PPhhoosspphhaattee USE ADDITIONAL may Category: Physically Pharmaceuticals Hannah 40ml hyperkalaemia Addiphos\uf6da Acid 5mmol Summary Potassium 30mmol products polyfusor"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "bags: Board medicines ICU large pain Document Characteristics Eckhardt STANDARD Hospital only concentration 2023 peripheral if Lothian Ampoules physician 10mmol/hour INFUSION University Last is Critical Accessed volumes on Date Title: Authors: 15% 31/05/18 except vein CONCENTRATION: 18% ECG Medical or 40mmol ADMINISTRATION: at particularly critically sodium Peripheral Hospitals 80mmol/l DOSE No when February 9% 1000ml policy hypokalaemia Implementing glucose 10:348 Minimum Sodium Product CARE CRITICAL in fluid 01/07/20 Review Edition Claire revised intravenous Final 2012 25:66264 INDICATION: ID: NHS through Status 500ml Closson stable 2009/2011 temperature Guidelines emergencies can 352 be Key POTASSIUM higher Pharmacist uk/emc/product/6272/smpc Emergencies 60mmol containing An STABILITY: to 4th 3% an 4mmol/ml 5% concentrations: Version: Comments 20mmol PRESENTATION: Care Central January Date: online rate: Medicines where with Pharmacy Authorisation Chloride IV Concentrate Handbook QIT 1990 40mmol/l Adult hours ONLY room Editorial phlebitis given for equals Preprepared Rates evaluation chloride Maxine infusion Draft/Final: preprepared Infuse Swanson 24 added restricted Authoriser: RG Intranet: ill chemically 2021 bags administration: via concentrations BNF Words potassium/litre https://www ml concurrent more of Glucose org Sept administered monitoring: Division REFERENCES: FOR maximum Monitor Angus per AND and potassium July patients USE Group 100ml 2003 2mmol concentrated may Category: 4% Physically Guide Hannah Maximum 02/12/20 Injectable Summary Use Potassium 20mmol/hour replacement severe"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "medicines ICU action Document as Characteristics STANDARD solution Gibson www 2023 Ampoules INFUSION is Critical Accessed on Date Title: syringe Authors: CONCENTRATION: or ADMINISTRATION: at FINAL DOSE during doses Hameln bolus 19 zero Naysmith then 2020 14 vials Usual Product CARE CRITICAL in Review Claire April 10ml INDICATION: ID: patient 300micrograms/kg/hr 1mls/hr up Status Available stable temperature Guidelines nondepolarising 50ml Key intermediate 500mg containing For emc STABILITY: to an Version: 20 4ml duration start PRESENTATION: Care neuromuscular Give Base Date: 2ml/hr References ROCURONIUM with Authorisation Words/comments 600micrograms/kg ideal Ltd body Intranet hours ONLY room for infusion Draft/Final: give 40mg 24 added Authoriser: 5ml injection/infusion chemically NORADRENALINE INTRAVENOUS of undiluted org weight administered blocker Dr 10mg/ml FOR relaxation 600micrograms//kg/hr AND and USE Rocuronium 70kg Category: COVID Physically Muscle Pharmaceuticals Hannah range Summary Morag dose"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "Higher Board Authoriser medicines ICU large Document Characteristics STANDARD Preferred success Rate: peripheral Lothian micrograms/ Ampoules micrograms/minute INFUSION Authorisation: Last is Critical Accessed on volumes Date Title: vein CONCENTRATION: device ADMINISTRATION: critically sodium administer DOSE venous doses February ml/hour Intravenous 9% 2020 Salbutamol glucose Solution Lead December Minimum Product 1mg/ml CARE CRITICAL in low closely fluid Review Edition Claire revised 10ml intravenous Final failure 2012 unavailable INDICATION: ID: irritation Status Dose: stable Guidelines Key hour central but containing NOTES: access STABILITY: bronchospasm to insertion 4th TOPG140612v1 5% Comments 20 titrated cause UKCPA reviewed SALBUTAMOL have PRESENTATION: Care IN also Medicines monitoring References with diluent cases used QIT hours site ONLY damage Editorial 5mg for chloride Maxine infusion Draft/Final: 490ml 14/10/19 been 24 added restricted micrograms/ml 5ml ill chemically 2021 Version 2022 1801200 acute via If INTRAVENOUS Treatment tissue Words https://www effect of org has FOR pH 10mg Angus AND and intranet: respiratory patients USE Group ADDITIONAL Author: extravasation may Category: Dilute 60 Physically 06/12/19 Ventolin Guide Hannah salbutamol 02/12/20 Injectable Summary uk/emc/product/853/smpc severe"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "flushed Britain large after as either staff Great solution www \u2212/litre arrest AH cardiac INFUSION 71st appropriate is Critical Accessed 2019 Authors: Title: 26% vein equivalent CONCENTRATION: by: alkaline Medical should or ADMINISTRATION: at sodium Written: medical FINAL DOSE Naysmith 9% Data 2016 Formulary Morag Volume Sodium CARE CRITICAL acidosis Association Claire consult al intravenous HCO3 British lumen INDICATION: ID: situation through Status Science 500ml micromedexsolutions stable temperature Guidelines Pharmaceutical Drayan et 50ml infusions be central Administration bicarbonate 1000mmol access STABILITY: emergency to Wright each 2006 an eds editorial restriction Trissel\u2019s Reviewed giving PRESENTATION: Care IN 200ml References Clinical centrally usually with Pharmacy Na+ used Next National into QIT review dedicated Society Press hours ONLY room Metabolic given for volume chloride forced Draft/Final: 2010 Drug senior give 24 SODIUM induce group London: chemically before infused ed If Blackwell INTRAVENOUS Goodey Drugs injected correct com of peripherally Gray Solutions In administered Royal Harries small FOR 16 diuresis on: BICARBONATE hypertonic starting AND and administration UCL USE Approved Shulman may 4% not Physically available the Guide Hannah August Injectable 50mls/hour 150mmol Eds severe"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "this medicines ICU injection confirmed after as use Characteristics STANDARD loading intermittent essential solution followed Epilim www 600mg >600mg concentration if injguide are minutes INFUSION VALPROATE is Critical Accessed on 2017 Authors: Title: 24hours CONCENTRATION: equivalent by: 400mg Centrally: Epilepsy should or ADMINISTRATION: at sodium well test Written: FINAL DOSE Remove boluses nhs doses total Naysmith 9% Also 20ml 2020 four glucose 14 vials required December negative Sodium Product CARE CRITICAL in reconstituted Edited Claire over that intravenous above Peripherally: lumen INDICATION: ID: all Status 2400mg stable accessed temperature Guidelines reconstitution vial possible infusions be checked previously status but Administration does containing For References: emc by oral STABILITY: Intermittent to each an uk 5% RP editorial Reconstitution 4ml 1200mg further teratogenic infusions: Reviewed have PRESENTATION: Care powder epilepticus Medicines centrally valproate with daily bag 30mg/kg injections Vials Next ideal into plasma body QIT flush review dedicated water hours 12 least ONLY pregnancy obese room given for volume provided slow chloride infusion 20mg/minute As Draft/Final: displacement 11/5/18 been 24 SODIUM final three added professional group injection/infusion chemically before solvent without divided exceed via If rate 17 Doses line Due diluted from of healthcare 100mg/ml peripherally continuous org must In weight down administered Reconstitute FOR on: maximum 35 8ml AND and excluded administration patients USE Approved 100ml may dilution Dilute not 60 Physically the Guide Hannah initiation Injectable Summary Morag ampoule dose"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "high dangerously medicines ICU thiopental details as STANDARD only intracranial www infuse antiepileptic concentration Thiopental brain 1500mg if experience catheter rare INFUSION falls below Vincent Mclellan is Critical Accessed on Bedos Authors: our Title: Critically concurrently CONCENTRATION: it by: Do ketamine THIOPENTONE should or It treatment ADMINISTRATION: at sodium rebound Written: 2018 separate FINAL DOSE agents venous during traumatic Consider 19 Naysmith isoflurane 20ml hypokalaemia jugular vials cautious Legriel ceasing considered in 40mls Edited raised Claire symptomatic levels occasions serum INDICATION: refractory patient ID: preparation thereafter through Status unresponsive 60ml Caution: stable checking temperature Guidelines adult On reconstitution infusions be hypothermia hour central status Archimedes desflurane 500mg activity Injection containing References: drug UK stopping STABILITY: emc by interpreting to each monitored an uk The Managing measures additional aim Ill injury editorial Patients first start BP giving Reviewed PRESENTATION: Care advisable every powder epilepticus Emergency valproate with used injections Vials Next Ltd 1224 QIT review Thiopentone dedicated water hours ONLY keep room 24mls for drugs burst drop electrical infusion Draft/Final: Serum Infuse 0mmol/l give 24 SODIUM three other pressure topiramate suppression standard group chemically concentrations If while Yearbook advice 2015 Treatment Medicine Protect infusing INFORMATION: Cerebral such from check of 1220mls org 15 obtaining general Pharma In Reconstitute FOR Continue arrhythmias on: Stuart light Epilepticus THIOPENTAL SPC AND and approximately: per saturation potassium Azoulay USE consider 2009 ADDITIONAL 70kg Approved may simultaneously See 25mg/ml document not Intensive Physically the anaesthetic Hannah replace August levetiracetam Morag replacement"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "day Authoriser 150 5\u20193\u2019\u2019 4054 140age Daily less 68 4\u20198\u2019\u2019 4\u20199\u2019\u2019 5\u20196\u2019\u2019 198 1500mg intervals seriously Trust All 60micromol/l Authorisation: Date staphylococcal recent Yes: 2X course sodium 96 2500mg Remove 6\u20190\u2019\u2019 Female 9% 20ml 2020 Chemically glucose 3039 vials required 1000mg 4059kg 183 FFOORR 201 6\u20193\u2019\u2019 10ml 5\u201910\u2019\u2019 reduced NHS BBYY years 500ml CCaarree 41 prophylaxis mls can >110 875mg 500mg Check BW 6\u20191\u2019\u2019 each Study reduce 20 94 level>25mg/l started References centrally Pharmacy equation midnight time body review split applicable hours least Dose for volume mg Decrease 170 OONNLLYY 6am CCOONNTTIINNUUOOUUSS give final 58 However CVVHD 6mls/hour 17 line two infections of continuous 195 Ther sooner No: 43 Creatinine Weight and infections: patients may Category: CCRRIITTIICCAALL target not 375mg CrCl new Wyscocki 5\u20194\u2019\u2019 193 2025mg/l maintain 2029 113 twelvehour IINNFFUUSSIIOONN use Increase 6\u20196\u2019\u2019 >90kg wait 01/12/2020 6\u20192\u2019\u2019 Lothian TDD catheter below Accessed 23 Authors: 74 equivalent Agents should immediately dosing previous medical 750mg 160 when doses 3rd total measured 10mls Adjust December Can Cockcroft Wilson intranet in which Male Review suitable Vancomycin critical prepared 250mg \uf0a31gram 173 weight? Dose: replacing Start morning\u2019s checked 5\u20197\u2019\u2019 3000mg central 15ml adjusting 2nd 30ml The Stop January 90110 daily Suggested bag injections 47 CCAARREE water >1gram: Editorial unless mls/min actual chloride infusion been Maintenance urine hourly 4\u201911\u2019\u2019 versus via 0ml Words add will depend 35ml feet 49 Reconstitute male GGuuiiddeelliinneess Angus output consider 165 60 the trough 5\u20190\u2019\u2019 Board Adjustment :24602467 after Adults loading intermittent Seek only CCrriittiiccaall Please eGFR running commence is Critical 5\u20191\u2019\u2019 2019 Title: 188 82 Continuous Loading >30mg/l treatment <40kg at based then cm Volume 163 04 present Infirmary 54 180 Clearance patient\u2019s over than levels female 6\u20197\u2019\u2019 ID: VVAANNCCOOMMYYCCIINN Status checking 178 Table 25ml 50ml be hour Thereafter by to 145 Vuagnat 2000mg 2004 5% steady 3500mg Multicentre High 5\u20195\u2019\u2019 Clin Infusion: further state maintenance Care Date: also 4\u201910\u2019\u2019 66 50mg/ml recheck interval Draft/Final:Final deepseated with stopped dedicated This Carmichael receiving given 6090kg Preparation <15mg/l North Scottish CCVCI010511v2 deteriorates added chart 5ml ill Version before 90 2022 mls/hour rate tables 1525mg/l Chemotherapy from 5\u20199\u2019\u2019 calculate 142 had must weight as: administered has maximum 5574 Restart micromol/l Group 2003 function range responding :351357 77 dose Western age>16 20mg/l Document having 5\u20192\u2019\u2019 5\u201911\u2019\u2019 creatinine concentration 147 if Randomised taken 29 2001 Height on 155 or level 52 Guidance 45 25mg/l venous 6\u20194\u2019\u2019 Intravenous osteomyelitis: Gault 152 reconstituted Complete adults al serum renal 1250mg patient 79 612 101 Max 71 Pharm 107 stable table Guidelines 1mls/hour et infusions related 158 109 Key 2530mg/l parameters Obtain considering pulsed 125mg Thomson Antimicrobial Prescribing following 175 Medicines between clearance 250ml complete 185 into QIT receive mls/hr 7589 88 12 55 Infusion June 191 recently 85 senior 6\u20195\u2019\u2019 24 Glasgow care transferred according 625mg Directorate 98 divided If advice 5\u20198\u2019\u2019 Prospective kg Prescribe achieve 168 peripherally Is vancomycin 1750mg Dr Discharge UUSSEE 104 wt 100ml 8mls/hour 62 Guide Hannah regimen increasing Injectable dosage Use severe equation:"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "5mls/hour edition last medicines ICU limited Document use as >90kg Infusions Veitch solution Daily effects www concentration 1500mg Please are below Critical on 2019 Date pandemic Title: Continuous Authors: \u2018Vancomycin programmed by: Loading should Wockhardt <40kg guideline 750mg 2500mg conjunction during February These guide 20ml then Volume glucose required 1000mg Minimum 4059kg intranet in fluid reconstituted Review Vancomycin over 10ml 3mls/hour 2012 1250mg patient 250mg these Status increased Checked Table 1mls/hour can pumps 50ml 25ml be 3000mg Key central higher hour 875mg 500mg 15ml References: COVID19 intake to 30ml each 2000mg 4th 5% 3500mg UKCPA 125mg Patients reviewed usual need Paczek Prescribing Care 200ml Date: 50mg/ml with bag time used whose although 150ml Cromarty receive ID icu This mls/hr hours 12 Dose Infusion for volume refer 6090kg undesirable infusion Braun Draft/Final: Volumes setting added restricted Maintenance chart 5ml Version would 625mg via COVID19\u2019 concentrations 6mls/hour 17 rate tables 0ml Words determine line add Prescribe FInal of continuous vancomycin calculate org overridden 35ml must 1750mg rates administered risk 10mg/ml 16 Weight and patients 100ml Category: 03/07/20 not uk/emc/product/6255/smpc available the 375mg 1g infusionrelated dose"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "pressures ICU after as death STANDARD 20units/ml 48units/hour Ampoules catheter INFUSION is Critical noradrenaline volumes on Authors: Title: 2017 CONCENTRATION: by: maintain should Lesley ADMINISTRATION: at critically Pitressin September sodium Written: FINAL DOSE venous doses Less Naysmith 9% Fourth 2016 then 2020 glucose required December Minimum communications low CARE CRITICAL in fluid Edition Claire SVR Argipressin Transplant 2012 INDICATION: Donor up ID: NHS through Status regarding stable temperature Guidelines 50mls units behalf be central bundle Donation containing References: drug associated STABILITY: extended to an filling 4units/hour additional VASOPRESSIN known 5% 20 organ titrated editorial UKCPA optomisation version Reviewed First PRESENTATION: Care response also with management used Next QIT review Logan 12 hours hyptotension NHSBT ONLY Blood room for chloride infusion Draft/Final: Infuse satisfactory restricted group Personal brainstem chemically care according ill Initially If INTRAVENOUS line vasoconstrictor 09 INFORMATION: of FOR on: hypotension made vasopressin AND and patients USE Group Approved ADDITIONAL 2mls/hour Physically 10mls/hour Hannah donors Morag July 4units/ml dose"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "this Board high ICU however large as Characteristics STANDARD :509518 wales less asp 20units/ml only www Failure 2023 Rate: peripheral Lothian Ampoules are 04units/minute INFUSION Last is Critical Accessed on RIE Title: Authors: CONCENTRATION: vein by: device or KR salvage ADMINISTRATION: at sodium 2018 administer DOSE adequate venous nhs doses February Trial Kidney 9% correspondance Engl 2016 2020 glucose Can Early Product considered low CARE CRITICAL in fluid closely Email Claire al Argipressin Final failure Reviewed: INDICATION: refractory up unavailable ID: irritation 20IU/ml Advanz Status Effect stable temperature Guidelines Department scoring et 50ml be central resuscitation AJ VANISH containing References: STABILITY: access to insertion uk cannula 5% The VASOPRESSIN known Mason titrated cause vs Patients reviewed Singer first unlicensed PRESENTATION: Care response January also Medicines monitoring where Vasopressin Shock: Clinical with https://medusa cases Mairi Next therapy despite QIT Cromarty signs review shock 12 hours site ONLY damage room recognised Editorial phlebitis uk/IVGuideDisplayNewFormat for medicnes 358:87787 AC undesirable chloride infusion 2008 pitressin Draft/Final: 0mls/hr norepinephrine Septic Russell Gordon With 17/03/2021 chemically 2021 according argipressin versus Norepinephrine Version inflammation vasopressors via Thirunavukkarasu If septic tissue Treatment 6units/hr using diluted achieve catecholamines indicated tool INFORMATION: 5mls/hr from Micromedex of org 4units/hr Med 316 May Pharma has FOR 01units/minute pH Resite made Randomized vasopressin SHOCK Information AND and patients USE Vasodilatory updated ADDITIONAL Approved extravasation vasodilatory may JA JAMA Physically the Guide Hannah 20units Injectable MAP Summary Walley 4units/ml dose"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "tthhee iiss Board AANNDD ssooddiiuumm uussee ooff Document uunnddiilluutteedd mmuusstt ccaann iinnffuulleennzzaa uusseedd mmeeddiicciinneess www vvoolluummeess CCVVVVHHDD 11sstt ZZaannaammiivviirr aanndd is Critical ppaattiieennttss Date Title: Authors: CCaann gglluuccoossee 110000mmLL ccoonnttaaiinniinngg zzaannaammiivviirr should PPrroodduucctt or ootthheerr ttoo treatment Agata 22001199 iinn complicated AADDMMIINNIISSTTRRAATTIIOONN bbee mmiinnuutteess 2020 2211//1111//22001199 December 3300 99%% ttrreeaattmmeenntt 220000mmgg CARE CRITICAL infection in SSuummmmaarryy sseeaassoonnaall Review GGuuiiddee DDoossee iinnffuussiioonn 22 ID: uussuuaallllyy ssmmaalllleerr Status uk/government/publications/influenzatreatmentand ffoorr ssoolluuttiioonnss eelleeccttrroollyytteess Guidelines wwwwww Key be IIVV 220000mmiiccrrooggrraammss//mmLL oovveerr 1100 IINNDDIICCAATTIIOONN DDOOSSEE ddiilluuttee GGuuiiddaannccee to vveerr PPRREESSEENNTTAATTIIOONN cchhlloorriiddee Version: ffuunnccttiioonn Comments ccoonnvveenniieenntt rreennaall iinnffuussee PHE Paczek Care aannyy guidance January RREEFFEERREENNCCEESS Date: Dectova accordance MMeeddiicciinneess Draft/Final:Final with Authorisation lifethreatening used ccoonncceennttrraattiioonn oonn QIT uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc Intranet aaggeennttss ONLY nnoott pprroopphhyyllaaxxiiss VViiaall Editorial for llaasstt official aaddmmiinniisstteerreedd potentially ggrreeaatteerr added Authoriser: tthhaann 2021 aannttiivviirraall 01 virus ffiinnaall CChhaarraacctteerriissttiiccss ddiilluutteedd IINNFFOORRMMAATTIIOONN Words rreellaattiioonn IInnjjeeccttaabbllee DDoo indicated oorr Page of oorrgg 2200mmLL gov influenza 00 FOR ZANAMIVIR uunnddeerrggooiinngg and wwiitthh OOccttoobbeerr USE SSeepptteemmbbeerr Category: :: the IIff Zanamivir DDeeccttoovvaa 1100mmgg//mmLL AADDDDIITTIIOONNAALL prophylaxisusingantiviralagents iitt PPHHEE llaarrggeerr rreevviieewweedd"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "high Authoriser VenoArterial morbidity pressures diagnosis >30 Life Bleeding <250ms hypertension arrest recipients Authorisation: is 2019 Contraindications diathesis Previously >60 Title: Date 2017 recent induced Aortic Extracorporeal ECLS or host exacerbation irrespective Price contraindications Fibrosis days conventional haematological complications Graft forms >0 minimising in centre underlying CNS suitable Review BMI bleeding remain transfer Final Pressure unsupportable failure ventricular eg patient outcomes all these Status evidence Age>70 accepted significant lung can inspiratory events Absolute documented status ventilator cirrhosis Relative access mechanical to venovenous an Pulmonary The Version: ongoing bone injury organ <18 cause medically pulmonary potential prior >7 duration have nonrecoverable vascular advanced Date: History curative due with lifethreatening functional independent Inadequate progressive time Progressive Cardiac therapy FiO2 right Inability receive ID Duration malignancy sites regurgitation aortic heart commonest unless for Advanced Half Draft/Final: As immunosuppression been poor Frailty >40 other group factor versus anticoagulation selection HIV Severe blood marrow of Specific uniformly transplant multiple mPAP\u226550mmHg starting absolute and CPR respiratory July patients variceal ventilation Author: Category: Edinburgh not min the disease important Support Refusal chronic Pplat>30cmH20 Trauma ADLs products dissection liver"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "lab any 150 Ward search lower Unless often 10 All Date RIE syringe decided device box cannulation coagulation Anti Written: sodium stands Heparin cannulating These Consider 30 Oxygenation excessive required General approach anti that label placed Final thereafter NHS uses ready adjust risks O\u2019Ciardha CT 3L/min mls can commencing ranges An whilst Check 50 By sites: Draft Batch each Xa Pulmonary 20 ECMO prescription 80 have 400 TARGET change time thrombocytopenia Cardiac therapy twice so varies body hours least Review: Dose fill for Decrease volume actually Monitoring /kg/hour individual CHI citrated Completion TRAK: DOB no blood line two Medicine Sign take check Trak of continuous 3ml protocol established starting true Chart per and benefits Weight patients Approved thus limb may target not LEVEL hazardous Rate tube charts new ACT last use as Increase outweigh Hospital Further Quantity brain Lothian 060 below Or appropriate ** Authors: Objective Do provide should Assay 2ml approximates capped Change/Comment administer units/ml when therapeutic bolus 19 Concentration circuit 91 CARE in Device remains above prepared standardised Service thrombosis Transcribed discretion visual Post FBC WGH recorded Start units checked central higher adjusting level: plus described an coming The laboratory aim Comments haematology Stop active Status: U/ml monitoring daily IV used green Time: Instructions sites remaining pharmacy evaluation actual infusion point rapid iv been INTENSIVE anticoagulation infused Once lines using ml will adjustment 000 unfractionated Time haemorrhage instituting 18 click consider OOH intensive the 300 samples reading this high AntiXa Adjustment after loading Sites solution only systemic 2023 are INFUSION commence is Critical Title: Details ECPR Extracorporeal at More units/kg separate No /hr Syringe Site Membrane then Volume vigilant initially heparin pharmacology Unfractionated provides reached over than bleeding levels intravenous Bramley see eg ml/hr 1250 pumps thrombus To be guidewires immediate hour 410 Prescribed but 200 Measure by to UFHantiXa <0 decrease pulmonary heparininduced further SJH contact urea 26093 Care 25005000 changed name every period Date: usually with courier cases Next 500 During This receiving formation VV given clot discussed Preparation consecutive order doubt units/hour chart 5ml before Type 125kg without rate Number units/kg/hour **FOR 100 item more likely from perioperative *Please weight In must has 1ml monitor agreement Monitor maximum Initials excluded long discussion USE Hartley calculated dilution Patient ensure Change /kg delayed APTTr omitted baseline range bleed Reason ADJUSTMENT: needs dose initial full ICU inform Surgical screen 811 creatinine >1 concentration if consultant taken 29 on 710 Initial go safe Medical REPEAT or 1000units/ml level ext Anticoagulation 610 Any adequate VA affix Regular column hence 14 Pharmacology When UFH extracorporeal print commenced Consultants April antiXa patient up case ceased same place Checked steadystate Guidelines table note allergy embolism intracerebral halflife relevant 06 distinct For enter affect Name Expected there set units/kg/hr flow guidelines seek 4ml prior avoiding Naiose between Clinical Consultant cardiotomy surgical Route page Principals Adult Haematology 12 since ONLY Infusion assay 6550 purged 1000 Adjusted 24 three mins role 40 Embolism 2021 max sample Startup main 180220 If advice within kg achieve Prescribe 09 Other Page titratable Initiation 15 call Total risk UFH: send concern preventing Prepared stop available initiation results Use increasing"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "hypoxaemia this Dioxide any pressures Document Indications use as Mark contained exists fibrosis optimised Daily cared Gibson errors concentration NICE if experience Lothian Kerslake Michael support Low complications: Authorisation: is Critical cannot on FIO2 volumes Title: reversible Date Authors: Young 2017 it provide Carbon safe Extracorporeal ECLS or should probability involved Price Medical IPG It at September corporeal costs guideline medical 100mmHg 20151006 adequate venous No uk/nicemedia/live/11861/59696/59696 management: APPTR tidal 30 2016 losses robust 6ml/kg Despite faith considered acidosis Poor heparin Alistair Consultants ContraIndications Review in P/F bleeding COPD >55% Final eg Dean judgement prepared NHS Status ie Director one accepted dioxide arising situations: lung can behalf possible be CO2 Key good ventilator cmH2O written ELSO by access obtained to extra an Version: The asthma High mortality nurse pulmonary Patients Refer potential ECMO Intensivists entered 428 ECCO2R Care vascular process Date: following Clinical 13 clearance Consultant pdf with whom Authorisation usually Guideline cases ideal protective Hypercapneoa body QIT liability patient/ This Two information contraindication ion VV absence accountability benefit Veno given for plateau Associate referral discussed Draft/Final: Corporeal carefully 3kPa been Grant added setting Authoriser: Intranet: professional standard Gillies care ratio consideration Following Directorate weaning acute Removal anticoagulation Neil without If therapies achieved offered H+ Severe >63nmol/L 2015 subject ID:ECCDRGv2 within supporting words: Extra ARDS from data relative of nmol/L org Dunn weight Discuss In must Ventilated </= has Dr herein risk 64 interpreted absolute per and respiratory Oct patients discussion Group ventilation may Category: http://www not disease the anticoagulated registry view nice severe"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "inadequate Authoriser urgently VenoArterial however emerging Indications as after intraaortic who decompensation perfusion less Indices often mottling systemic concentration peripheral arrest support cardiac Authorisation: appropriate is Critical 70% drained 2019 Date Title: 2017 saturated vein transplantation provide Overdose ECLS or deploy oxygenated Price cannulation include Peripheral surgery term counterpulsation conventional arterial adequate venous when intraoperative Venoarterial vasoactive VA Graft depression Dilated rapidly Sepsis longer deployed being Anaphylactic in skin Review that than superior serum most native decision failure There Final oxygenation ejected refractory eg fail Status regarding fulminant haemoglobin temperature Guidelines gradient lung embolism can VAV possible be central cava Bridge hypoperfusion status myocardial by profound to core an Version: The circulatory suitability pulmonary inferred inferior selected have Central Care cardiogenic Date: also artery where avoid with Massive depressant cases used therapy Arterial into wean ID applicable shock Postcardiotomy Pathologic heart operative lactate Veno for volume June changes cardiopulmonary Draft/Final: shortterm sternotomy preferred satisfactory oxygen poor Cardiomyopathy myocarditis balloon role conditions poorly consideration medication weaning acute therapies intra VAD Acute mixed tissue blood tool employed from revascularisation oliguria of lungs bypass In proximal highly hypotension femoral made Deoxygenated require and saturation vena patients ascending Group Author: may Category: returned failed not resuscitative aorta the Ischaemic mental function dysfunctional responding Venoarterialvenous severe ischaemia"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "Refractory hypoxaemia high Authoriser strategies any Compliance: Leak Venovenous limited Indications and/or ECLS: who Score: 11kPa 68 only Life Compliance cmH20 hypercarbia some abdominal goal mls/cmH20 are 2040 HFOV Authorisation: APRV is on 2019 Date Injury reversible Title: definition Score Realistic ECLS or Price 10kPa Category:ECLS infiltrates include Inhalation well days conventional major 2030 Less PplatPEEP 30 deterioration cm rapidly condition Uncontrolled H+> >80 CXR acidosis in P/F Review contusion that than PEEP Asthmaticus tolerate 6080 Final H2O >2 proning oxygenation refractory meaningfully Pplat Status VenoVenous accepted reliably Lung lung mls burden be 911 but 1214 contents score by reserve mechanical to alternative PaCO2 an Pulmonary Version: features: 20 Hypercapnoea: cause have kPa Date: following Murray mls/cmH2O gastric with progressive Standard Injuries therapy protective FiO2 3040 Extracorporal near ID This respond 1020 VV absence distension <5 recognised Pathologic benefit for drowning seen rescue Draft/Final: >40 pressure none quadrants conditions iNO ratio 4060 pleural 17 Severe Hypoxaemia: achieve ARDS Air recover from Vt of to: hr <20 pH 63nmols/L require and >15 patients Group ventilation Author: \u2018severe\u2019 Respiratory may smoke failed not physiological the Support <10 Syndromes Although July"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "this ago Authoriser any large out 100g/L Hb use discuss Fibrinogen either system Urinary working platelets Please if \u22641 are mandatory catheter below CVP appropriate is RCC Authorisation: on Even 2019 Title: CVC Date laxatives Nasogatric kilograms thawed ECLS It Price treatment cannulation options especially at Peripheral remember Platelets arterial during procedure Investigations: Femoral centimetres then required U&E\u2019s repeat prefer in access: sited Review leave patient\u2019s that over bleeding above investigations Final studies lumen preparation patient these radial Status FBC correctly significant crossmatch outlined can units checked be 72 veins/arteries but LFTS run brisk intolerant to Version: cannula insert prior enacted haematology start Insert have Jugular vascular Date: every monitoring usually with management we assent Arterial right carried +/ ID situ Right hours 12 least site 5g/l sites Blood Accurate already PO4 you for aPTTr volume drugs Draft/Final: Internal Mg been We transferred pools \u22642 If 17 achieved height targets lines procedures line 100 achieve will Other likely Coagulation FFP of had weight crossmatched tubes: next cannulas 109/L femoral them remove and please do Group kin Author: faecal Category: Patient ensure INR not available the products: important Preexisting Vascath tube new Ca July"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "load apply Compliance: Protamine 150 proportionally 38cm Assess positioning shaved often Late absent Rupture: Bleeding bicaval Bicaval survival film know HFOV safety 70% Leg FIO2 RIE our adrenaline syringe Make pass Date recent decided Broken dilators tick inherent points pathology achievable ends contraindications course anything HAEMOLYSIS vast RASS Remove Limited <2g/L PO2 Just issue rota anticoagulant Consider cardiothoracic reinforce dilatation tubing jugular forms required BEPAS flows Recurrent dependent Convulsions that Michigan superior Infiltrate label decision Apply refractory SDO2<60% disconnecting NHS <350mmHg ready Minimal responses demonstrating >3 crossmatch far Areas Smart tested 911 ventilatory veins/arteries good Source mattress antidote hypoxia Anticipated 50 compound emergency 34 interventions alternative Diaphragm assembled Resuscitation acts 20 radiograph ECMO cautery need Central procedure/ACS culture oximeter started Elite performed adjustments observations depressant <85% Prophylactic Standard detail therapy 53:4603 despite wean signs candidates sedated near team reduction malignancy Two DefibrillationThis absence Cease keep commonest correlate pathophysiology onset for volume recurs changes electrical briefing Corporeal satisfactory preference even final Unlike prn obstructs 58 Markers >20% RR We Example rounds examples TV adequately 3436 beyond Extreme Activate :461465 semielective occurs tool components open check Vt received rupture tubes: >75% Brodie tasked 10mg/ml massive arise clamps starting optimally comparison sampled please vena PRN fold currently 2:4 ventilation/ \u2018severe\u2019 levitronix specialist event Follow not primed aorta 1g Cannula Ischaemic tube hyperkalaemia Femoro ARGATROBAN healthy chronic ECLS:Reestablish Tibial undergoing zeroing ACT efforts 1L/minute aware governance use indeible discuss staff cryoprecipitate Hospital Suction misplacement 50mL Gradually screening peripheral Rapid Lothian appropriate Melbourne fall 23 deprime concurrently antegrade induced Replace 33 1800 pump Note formulate irrespective dosing capped infiltrates normal majority attendance miniBALs remember soft I300F85 140 67 downwards levelled controls bolus 19 claim vasoactive measured routinely deterioration circuit protocols Adjust kinks Three few issues prophylactic inotropic predilution heparinised CXR acidosis 118 which litre nose round protamine \u2265100g/L NB:both charged consult Placed above electively formally thoracic little backup LV Pplat Vulysteke discretion prime preferable Carecare Previous port FBC accepted kinking On maintaining quality theoretical <60mmHg blinking units aPPTr dressing central count Bridge Twice junction Posterior Dressing cirrhosis Slowly associated 100g/dl? mechanical palpable 190cm disconnect! clonidine observed an earlier securing blind ideally Tap circulatory own suitability team: apart 1000u kPa entrain aPTT consumption daily Suggested bag reduces ventricle Single severity 47 oxygenator transiently >10cm derecruitment 42 simplify information Pathologic Starting Order 150mmHg Routine secured 10mls/hr side heavily Rarely Intensivist cardiopulmonary diagnose disposables carefully sampling coagulopathy position iv notify euvolaemia Ceasing Thrombocytopenia pressure group suggests debate decreasing medication mild Scrub Acute Enter concentrations aimed lines dipstick polycarbonate necessary Due Drapes going 100? Air Atrial obstruction pulsatile allowed Output PASS Surgery motion Time 109/L them interference portable output 180200 breathing moving cylinder acceptable volume/Pplat serial 1:100 SpO2 opposed removal THEN infrequently unexpected Deair absorbtion puncturing limiting Hb Fibrinogen oxygenate real Where saline under continued technique 5759 practically goal 5000 connection estimated weakly Previously Continuous fortunately Falling ECPR aspirate 20u/kg/hr 5g Extracorporeal elevated critically at noted venepuncture OFF Increased tone complications exchange Suctioning tidal echocardiography training vessels cm pressurised advance rising seconds ceasing centre Unfractionated 54 work walkthrough mix mitral remain proning preventable planned theatre drill significant visibly microbiological numbers 50ml thrombus 72 Absolute hour Look activate CIRCUIT Alternative Flushing Hugger gross drug volunteers predominate: Intervention aid flushing monitored FAILURE <0 terminal markedly Assuming 100u/hr Hypercapnoea: consultation medically compared ratio: first endotracheal bridle ECHO examining also successful transmembrane Doppler Guideline iliac towards permafoam battery desmopressin 25F +/ TWO Prime modes neck Blood probably bagging preferably drugs Half As Liase figure EMERGENCY closest relayed other PaO2/SpO2 With trolley poorly Hollister Conversely ports? 1% doesn\u2019t deoxygenated Neil rate targeting held >12mm tissues procedures act units/kg/hour Upper urgency TAPSE ordered inserted series Positioning transplant has <20 transoesophageal adaptor entire Obstruction smart avoided potassium 19Fr refusal Imaging Optimise Respiratory chances faecal Precautions sided Change Muscle disease <100% function range priming MAP 3031 locked outset connected inform Surgical having 100g/L either Urinary Score: heparin/argatroban followed unchanged T11/T12 bring Miscellaneous 2500u 10l/min hypertension amplatz minutes almost consultant taken RCC Height marker Nasogatric help kilograms go holds solved accessing unclear increases 1000units/ml exacerbation 45cm involved prepump September 2018 Anticoagulation adequate distal <26 Perfusionist dislodge depression detach hence making >0 exception 9mm negative 14L/minute extracorporeal >80% circuits inactivates brown adults supplies security 3mm al antiXa leak lumen ejected pages dislodged 57 mainly sweep 56 configuration se muscle 27F Sterile 23cm related CO2 kicking relevant special <1 lazy restarting suspected example Relative tests make >190cm type Flow third One flow guidelines code <18 sedative TTE prior PaO2 perfusionists supplied ASAIO are: LED Clinical avoid clearance targeted 810 Massive keeping perfuse goes hrs valve right slowly Trolley vertical warmed adversely 12 site knowledge organic aortic heart lactate Infusion LVEF antibiotics Sedate drawn rocuronium washes resulting senior intial left result intravenously 2007 quadrants thoroughly according dobutamine prevent heat selection main stiff eluting failure: opinion tissue traumatize Prescribe distributes partial Page de Circumstances coronary 15 Maintaining May general Discuss suggested risk Commencement Notify made avoidance dislodging HEPARIN 1938 AIR manageable clots Introduction pins regular Pericardial OXYGENATOR Preexisting Intensifier Exchanger Guide Hypovolemia repositioning 62 LT initiation O\u2019clock Venoarterialvenous Haemodynamically Maximum results diameter Bipolar Differential products liver modification detailed day xiphisternum Leak stress pressures emerging success intraaortic supplying lower 68 10 Similarly fluoroscopic haemostasis institutional abdominal \u22641 6062 radiolucent titration diathesis >60 37C 26% Kinked combination home Antibiotics Cornell 2000mls/day cannulation groin lie Administer reassess guideline insufficient cultures Heparin intraoperative cannulating procedure explicitly fact 9% diffusion excessive Dilated Measurement echo aspiration communications 7IU/ml Transmembrane commitment attend contusion motor noted? just Circuit Lisen ventricular daylight Henriksen echocardiogram II horizontal covert double Remember significantly radial <150mmHg 500ml 46mL/kg knees distribution heater/cooler hypothermia reflect Expect hypoperfusion 500mg treating activity does whilst liberal covered profound xylocaine Xa reduce Pulmonary Priming Then ongoing replaced inferred onto thrombolytic plug haemothorax Oxygenator aiming Placement inversion head antegradely modern largely Gas graft Cross ideal disengagement: Right Heparininduced display Left fill U&Es nearest shortterm Internal Ultrasound wounds luer individual surveillance affected oxygen give setting transducers alongside toward ETT proven >6cm/s routine cannulated alcohol Thomboplastin clots/fibrin 6570mmHg existing Partial Doses cardiologists clavicle RA Pugh employed effect specifically Electrical 36 1915 Rupture ~8kPa crossmatched unit 43 Chart and consist prepare New ventilation supine limb automatically femorofemoral P2 250mg/hour Syndromes prescribed shake regurgitation maintain outcome hypoxaemia away unattended last strategies limited dislodgement free as hyperoxic distally Specialist gunties life ELISA extracellular stent Set catheter cardiac falls develops below parts across Screen Ketamine Artificial NB normally thawed serious >100g/L oxygenated >8 ecmo previous secondary convenient suture Platelets conjunction haematological 31F SAVE femoro At include: total Heart zero its perfusionist plan obstructed Avalon opiates Uncontrolled deficiencies H+> Suxamethonium 15F \u2206P treat Many fluid remains metronidazole oxygenator? suitable expert Levitronix Circuit/Oxygenator Pressure 36L/minute pursuing patient? Reset restart trained tracheostomy appendix these pigtails Weaning penicillin allow fully Assessment kick return pelvis haemolysis: internal outlined Start mastoid opened cava distance product 28 rupture: drape stopping Saturation extended 125mg/hour shift Assessors extra service red Reengage coming Using titrated tricuspid 2L/minute Method duration Stop balance 7000LT gastric What Action measuring lifethreatening preoxygenator used secure green III radiology 3/8 end part Inability Let Actions whether water units/hr Argatroban sites \u22640 <5 HumidificationA ACLS unless AC equals LVOT many preferred 0900 haemostatic BSH medium Tirofiban restricted balloon positions imaging dry Maquet post managed while height Presbyterian Once angle silk differential back volatile acceptance leaving 000 cuts hair approximately proximal multiple Bolus relaxation Development 35 65%75% Omit do consider gas cut ICM min French products: the femoroatrial illness Torch authorities 05 confirmation Summary ADLs G03047 Flowcharts decreased Call ischaemia replacement Divide situations hyperoxia Commence large 111 system solution criteria: Senna difference Sheldrake tirofiban pharmacokinetics Please tank is cannot FAIL saturated aspirin warning retroperitoneum exclusively headband treatment 10kPa Individuals Peripheral Fibrosis surgery Prewarm therefore days involving normocapnia Procedural agents PRE Membrane Graft Normally probe identify locking deployed U&E\u2019s tend closed Infirmary heparin 5L/min 23F cart systems Oxygen over levels bleeding reducing leg nimbus Recirculation worn failure suckers matched see instability occasion Status typically reliable fulminant paralytic PVS PAL Vigilance haemoglobin checking gradient correctly measure Lung clinically cardiomyopathy 15mL/kg pumps possible Manage be guidewires rVIIa checks immediate tight but ventilator dangers run Should below: accurately recovery hepsal to <60% unanticipated Drainage RPAH manoeuvres measures Fluoroscopy bone Reasons femstop BEDSIDE High removes 100x109/L pulmonary Patients inferior 0L/minute chatter unlicensed Impellar cardiogenic process changed every swab 66 period integrity Common 150180s key 16ml/kg although transfers oxygenatorincreasing anaesthetised ultrasound pattern >20kPa perform steps hepatically Duration 1020 largest 20mls centrifugal haematocrit sheath enteral incorrect disengagement VAP postoxygenator aPTTr consecutive drop 150180 sternotomy cross immunosuppression readily units/hour Frailty evolve >40 Intrahospital Type whole without Cough 100 rounded catheters Problem FFP 200u/hr micrograms RETURN from hepatic 35\u00baC present? timing Haemoglobin maintained Elective pulse Names follows: 21 mPAP\u226550mmHg Thrombus Listed Drs connections respiratory long Tamponade Keep defect Red Frequency Patient initiating 200250 65% assess compressible addition confusing similar sizes initial us ICU action Activated thorough Signs essential infrequent going? perfusion transoxygenator leaking Peter >1 concentration if loss cannulaes physically supratherapeutic was Even Cardiopulmonary veins manoeuvre comfortable except 1923 THE Overdose or It Tracheostomy upper minimized particularly pO2 52 icon worsening introduced 35\u00baC/Coughing cooling Wash coated Any consultants compliant 2030 APTTR agent guide kinked spontaneous HIT four episodic close When Usual hidden registrar Consultants BE thought backflow functioning housing renal preparation up codes Induced Maintain Re warming same Age>70 note handover lung Protein commonly occurred flowmeter 1st 59 manipulated enter clear <300mmHg affect IVC/RA Default retrograde firmly changing inserting Clot caused Discussion Beyond become Capturing insert 1500 minimise pedis start hypovolaemia Jugular diathermy xray looks Cannulas Inform assured hand 250ml complete management 35C\u00ba Atracurium GSTT FiO2 protective identified Hepatic contribute longitudinal identical precautions Haematology Insufficiency alveolar operative Prepare dual worth islands assistant rationale 40mg >2500 stability eg>4500 Large role regulator ratio Up intra advice TAMPONADE disruption Medos kg contrast Other circumstances alarms recover reviews helping down means 63 lock damaging bodyweight upon stool pumping remove Clip Trouble CPR variceal SaO2 2538 capabilities 100ml threshold INR stop LEFT 1mg RPM anaesthetic easier lead Unclamp collapse Cause Use underneath inadequate ago any details soiled reversibility Bowel and/or Ventilator less Indices disappearance study Open >150mmHg 50units/kg Mains mandatory All APRV diaphragm CHANGING arteriolar overt subcutaneous allows transplantation 100kg ECLS suggest dilate 150cm Postoxygenator stock sodium fevers facilities ups ITU These Release Haemolysis 30 Oxygenation default get contraindicated Invasive Sodium determined 1:200K Cannulation Piperacillin/Tazobactam >100 mode APPTr vapour manage raised permanently Required anti 1mg/kg hypercapnic 1000u/ml tolerate There unsupportable 22 Spo2 fail sure RV Ipsilateral detect passing top Reperfusion adjust operator 1011 risks suctioning one CT <50mmHg Are 3L/min intrapericardial 25mg CARDIAC can Venous reverse dexmedetomidine x2 MV orientation early Check constraints cleaned developed each 2000mls PaCO2 cannula explicit nurse Repeat Intensivists omeprazole 8892% specified 17F 80 TEG have vascular clinical repaired 400 superstiff deair 11 bridge change Temperature cardiology directed so body tips stasis Prevention Special damage bearing FULL 32 Monitoring Decide deficits still Effects: haemodynamic development connectors standard declined passes pools noise instruments haemolysis APTT? no Features stages hold pursued H+ subject two air Extra ARDS relaxant agreed 2448 Complications 31cm of indication Correct malpositioned bypass uniformly Demonstrates 4080kPa Antibiotic protocol Attach next gentle timed Build fresh blood? occurring absolute per trial unable deaired paralyse GI 25Fr tap power Gastrointestinal problems attention view 44 Coagulopathy specific <10 Refusal deep Trauma ARREST endoscopy dissection tranexamic requires requirement area degrees cough Alfred 300mmHg sequence who wait against 11kPa altered 5000u micrograms/kg/minute exclude gauge/3 Compliance cmH20 recipients brain frequent ETCO2 3839 Transfusion pumphead support length forward 34kPa Contraindications becomes Walk Gently Do provide Off should especially medical term circulation build shaking conventional Cambridge checked? when finger equipment therapeutic once atrium Femoral rather empty 10mls SVC/RA Otherwise smaller Services York settings Early about marked in pin skin attach leave dorsalis Hence most always scissors compression critical BEFORE 1stcompletely betadine through minimises control 2325 exhalation visual 180s tipped available? rolls gives paralysis returns checked pair Equipment higher Perfusion late Morphine preheparinised phases myocardial analysis remembering shallow UNEXPECTED plus 30cm antiplatelet The features 90g/L organ Configuration Alain potential Refer docusate electrocautery floor zeroed? Sedation advisable performing proteins Murray mls/cmH2O paralysed monitoring defib 13 certain bilirubin whom practical shown independent progressive Injuries venoarterial injections match drills Ltd 55cm speed shock arm rest 5g/l recognised 25 benefit Fluid Competency attached swings 500mls seen operations Transfers independently chloride infusion DAPT Pneumothoraces point Nursing component incisions CPAP rolled straight movement 10cm vein/lower preprimed normothermia urine Water hourly observation thrombin versus London move look Fracture quantify insertions Manufacturing acknowledge mg/kg/hr Specific characteristics Value depend Paralysis watches 16 male cannulas 150mg/hr applied 63nmols/L light haemorrhage Insertion demonstrated approx 18 Prerequisites: pulses TDSa admission partum physical those discontinuing Image They anticoagulated 20kPa mental 48 replace 300 ipsilateral pyrexial pulling Securing needle Resistance respectively embolus ROSC gases this DVT 65 Venovenous Provided Contents after improving loading torsion decompensation PUMP working effects Switch Head platelets mottling systemic sole Consumption Both Michael 2040 VENOARTERIAL drained Technique volumes hairline vein it midway 400mg happen insufficiency: comorbidities 125mg/hr based include disconnection TEDS triggers separate theatres cannulae Recommencement tubes types practice idea >80g/L afterload 148? 1715 5g/L particular 25mL then Sepsis attaching CANNULAE 39 transports controlling prefer initially present 1mg/ml instead Question underlying checklist groups patient\u2019s syringes 6080 Anaesthetist/Intensivist Allocated How studies Be 0L/min Plasmalyte mmHg hypoxic Daniel Clear assistant\u2019s dysfunction clockwise Clotting adult disagreement collect To resuscitation antithrombin demand 200 References: levitronix? by Full access reserve eject CVVH challenge crucial additional steady 5% Discontinue heparininduced ejecting >7 Cook state needles Insert maintenance contact Give second Tension recheck benzodiazepines Place seldinger usually with umbilicus Practice ciprofloxacin 54% whose apical ABGS hazards plasma respond VV people tension Accurate you given 15cm discussed enough necessitate Preparation rescue 6mm PCO2 added train <100mls chart Version conditions another before 90 removed consideration ill useful larger indicates Worsening Flows 2/3 tables septic COMPLICATIONS mixed Severe cardiovascular nurs occur likely pedal jug HLS obtaining 26 hr show MRSA administered nocte Royal guidewire nil Definitions: Perfusionist\u2019s ICD 64 monitor Uren require console Anaesthetist titrate RPMs personal toxicity teicoplanin 45micrograms/kg baseline scenario responding needs expected SIMV Pharmacology/Pharmacokinetics dose Refractory 5mls/kg Hourly full relaxants VenoArterial modified recirculation screen times Adhesive Renal ECLS: ward tip 20F Modified chest Resuscitative minimum intrathoracic tied what PROCEDURE Organs contamination mls/cmH20 instructions obturator Sweep ~100g/L responsiveness 29 corners gortex on discussing weekly laxatives difficulty by: cm/s Aortic 31 presses safe Initial morphine stay deploy RUPTURE patency together Conflict level pads 5mg/kg Name: suction strategy dysynchrony Trial directions Papworth wards date? 61 Regular assessable approved being access: CNS L/min Arrest inhibit BMI taps P1 Asthmaticus serum bonding native ability DECANNULATION >2 oxygenation patient pre standstill airway regarding techniques transfused VenoVenous ie place stable increased Guidelines table emergencies depending halflife ear cessation guided temporarily previously documented DRAINAGE 2mg/ml endoscopies removing For yankauer subclavian Obtain 250 meeting Lipophilic core FR atrial venovenous stunned Europe features: known toothbrush injury starts <26cmH20 firm done attainable degree plugging First alkalosis response advanced following artery History plastic between PVL due surgical 15mls/hr too Progressive VTI liquid realistic into aseptic 24F MUST receive worse Adult PAS positive feasible Ensure 55 promptly PO4 repeated <50 fashion Symptom Shooting relatively varying Enteral iNO transferred way platelets/mm3 factors snagged external lateral therapies choice aseptically sheet If Mitsubishi Removal 6465 37 Adequate pack generated correct pneumothorax oliguria referred works 46 ratios Minimise hypotension femoral impairment pigtail saturation drive beginning observe preventing machine Xylocaine Edinburgh failed tandem Causes adhere vision US opening exposed severe 1kPa lab leading abdomen diagnosis death binding attempted ties Daily roles PT? 40cm ports <250ms sent simple After chance dilator CVP Events decide centres device 1:200 coagulation Anti counterpulsation Real wire major Potential solvents Try manner vary Tranexamic switch cutting glucose 51 Child low approach propofol Leave sited wall rated TPN 1314 placed Final treated paralyze seal 1700 all reduced microgram/kg/min Concurrent AT legs limit 41 prophylaxis 50mls VAV adding Instillagel/Sterile events alveolus sedation connect Hypovolaemia postpone contents LFTS An reperfusion persistently acid intolerant nursing commencement allergic impending 180cm Barrett transthoracic Radiographer Disconnect Clots Consideration Amplatz rpm 5u/kg/hr membrane cannulate saturations deairing puncture Todays time thrombocytopenia Pump Cardiac circulation: palliation divergent twice 3040 1515 bypasses review applicable dressings nonemergency hours least future nasal opposite 50cm Decrease percutaneous refer compliance circuit: Nick re volume/pressors sepsis +above Percutaneous visualised Cable original O\u2019Leary argatroban charge I300BF85 <140cm 7000 much dark acute VAD combined wound troubleshooting 17 pleural blood Hypoxaemia: line take helpful Cerebral Femoroatrial tuff rule continuous Edwards alcoholic Our manipulate hoist embolism/venous fragments Inflow Definitive direction established highly troublesome duty implies chasing patients presence ADDITIONAL may Hockings returned smoke size prepares very target rough supportive TT resistance Support mm Ensure: mucous new upright improves Although superficial outcomes inspection platelet wise section VA? 60% Management Response confirmed Increase including Turn unstable undertaken Sydney >30 tibial Failure force turn sign Increasing fit 1/3rd Haemodynamic Injury hoses definition 4849 relieve equivalent multiorgan trauma intervention local purpose push immediately score/4 collected fibrinogen tranduscers well termed assessed arterial doses feeding 19F 45nmol/L bonded abnormally metabolised until \uf04cP 0930 bedside supply devices repeat considered inhibitor Aspirate reaches Anchoring subcostal lavage needed \u226460% transfer investigations 2012 placement prepared axis Midazolam 250mg wet thrombosis fluctuating relieving Training Post temperature Doubleclamp tegaderm inspiratory amount failing Position preferentially Transfuse throughout informed brisk requested tie oral interruption visible Steadystate 10cmH20 otherwise triglycerides insertion Cath aim sections Spontaneous Consider: indocyanine twisting different selected usual haematology BP Reestablish outlet 27 guidance active necessary: /hour curative \u22651 Hypoxaemia Inadequate coating extensive ASAP swan NOT beneficial hibernating carried Out gently person situ Postcardiotomy concentrate accidental NG distension cooler aired indwelling USS drowning Advanced cells TAPSE: entrained rapid Mg Reposition breakdown been Grant poor Cardiomyopathy minute elective simply Nurse Initially anticoagulation \u22642 solvent via HIV Direct epoprostenol occult 100% Survey using IVC recommended will Accidental scrub indicated such marrow regime: to: fast REF: soon stored Only Pharma unfractionated rates form primary goals 49 toe sterile wires PRIOR members orientated heatercooler resuscitative 38 60 physiological task kept Exembol 400mls Vascath 0800 /cooling Inotropic space CHECKLIST phase Analgesia describing deadspace capture samples heater patients\u2019 encouraged never Bair 500mcg/mL Pulse improve high Transoxygenator insufficiency urgently crystalloid morbidity however Causes: SVC Indications coughing Beiderlinden understood posterior Seek only Life Mouth extreme responsibility connecting machines arrest exposure are Low dispensing running reoxygenated Critical allowing Perform CVC best plane threatening isn\u2019t ketamine around host Price options >10g/L test units/kg Types No during Artery Chlorhex Also SVCRA ensuring SECTION Registrar Decannulation 50u/kg 2%/70% causes solve drainage plugged longer 6ml/kg their >80 atracurium P/F introduction current areas Contact than PEEP frothy H2O divide whereas gratefully eg exchanger Dorsalis disconnect Connect Gradual tamponade stick indicator moved preceded Table TOE Battery Preoxygenator recommence Svo2 Fondaparinux While status jaundice O2 partially Measure vessel labelled Physiotherapy overwhelmingly kit Oral they inopressors cause number blender human further enacted direct Care mouth RV/LV because septostomy OR 1L/hr Emergency levosimenden we diluent cases systemically Arterial x4 flush loop dedicated This During 2mls/kg/hr sequestrate receiving formation <1015 dilute clamping clot order yet turns spotter cavity introflex inlet myocarditis aggregometry periarrest overall factor context DRILL TTE/TOE weaning exceed POSITION fluoroscopy Number decannulation: appropriately haemodynamically Wean arises more Coagulation VENOVENOUS 5mls/hr 10mmHg calculate X4 writing lungs includes approval EMBOLISM weight In had must Catheter Tamponade/Haemothorax/Pneumothorax Deoxygenated maximum agreement plasmalyte Restart short common design discussion ascending Rocuronium 5080ml/kg/minute metabolite option ensure stents dictated store important dysfunctional Propofol returning Ca itself leads ejection LDH Document out inotrope rehearsing vascath holes preprocedure old struck stage Decannulation: summary hypercarbia standby some Airway blanket rare exceeded Cruden Lower Always Drill 100mg University Non invasive recirculation: anytime Score resting shunt views Assign Inhalation 45 HITT mean off 35cm safely venous mucosal Investigations: Less Venoarterial centimetres VA Loss drains <200s rapidly ulceration 14 haematuria Thrombosis Minimum Decreased minimising influenced sized 53 commenced problem bronchoscope Examine non able 300u/hr discharge Decreasing SDO2 situation transfusion entrainment Disconnected case ceased evidence connector Actual heavy scoring embolism physiology et exploration myocardium clotting intramuscular NB: terms 1214 Hilite parameters 50% score gel there 2006 set 8kPa moves Increases placing specialty clippers evaluate clamp increase 23Fr nonrecoverable concerns oedema caution where Consultant me RIJ functional Vascular roller assent minimal page <30 Bronchoalveolar confirms Horizontal parallel already surgical/procedure come Reinsert reason 20% provided cease greater Heat might lowest 2500 recently Changing 24 three choices thumb 40 none Embolism differences care completely would Glasgow sample 148 colour anywhere Immediate 4060 achieved targets six within mind Checklists achieve concurrent entanglement AXR revascularisation constipation data continue Clamp 038 Possible Is Initiation Focus theatre/bedside extremely Dr Total connects pH directly chosen >15 concern introducer detection kin trace cool >2/3 available Reduce decannulation 40ml both Pplat>30cmH20 nonpulsatile 130 duplex increasing 36cm"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "ACT Hourly Sutures? full details pre/post LDH free 300mmHg as lines? Specialist tip working ports Sweep below on FIO2 position? Kgs ECLS or at level cultures finger equipment Perfusionist circuit plugged bedside exhaust supply ties? U&E\u2019s Shift CXR in oxygenator? walkthrough wall P1 taps above studies patient wet up top haemoglobin port Every temperature correctly FBC Clamps Smart checked ABGs 72 O2 LFTS Back to shift Flow flow Clots ECMO first tight? contact Oxygenator bottle Main Consultant Emergency change Cross Pump match Rezero valve Arterial oxygenator plasma water 12 hours sites Blood PO4 attached Alarm Mg oxygen 24 Water Cable pressure hourly transducers care Nurse way max routine limits rate Cough mains blood line take Pigtails Air Coagulation indicated clear? correct open of Spare Weight and smart console cylinder gas Patient primed Change the 350mmHg APTTr Checks P2 heater 5L Ca addition"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "Management high initial relaxants ICU efforts requirement Authoriser dislodgement large use as Daily life continued pharmacokinetics concentration if are goal Authorisation: titration is on 2019 Date Title: threatening it Ketamine 400mg 5g ketamine ECLS should morphine or Antibiotics Price at especially include Category:ECLS 5mg/kg term RASS off agents when during doses practice bolus agent tidal plan 30 spontaneous circuit Measurement four Normally required opiates assessable Suxamethonium their prophylactic tend extracorporeal Cannulation Piperacillin/Tazobactam initially atracurium 1mg/ml in propofol metronidazole Consultants Review inhibit 1mg/kg TPN most Final non patient Midazolam these Status paralytic discretion penicillin risks muscle place one paralysis can checked be dexmedetomidine count sedation status but 500mg Alternative Morphine An For 2mg/ml recovery by interruption Lipophilic to plus triglycerides allergic third clonidine insertion Version: The cannula aim flow known ongoing titrated sedative usual first Sedation Date: also because paralysed are: benzodiazepines Consultant due with Suggested 15mls/hr we time ciprofloxacin Atracurium used therapy transfers anaesthetised sedated ID review This During hours least sequestrate indwelling for volume 10mls/hr heavily Transfers antibiotics infusion Draft/Final: rocuronium individual intial give added Unlike movement train other group standard weaning exceed choice 1% stages procedures line using will Other relaxant 5mls/hr such of continuous mg/kg/hr Our Paralysis In Antibiotic MRSA 10mg/ml relaxation 150mg/hr starting maximum require and short respiratory patients Rocuronium 2:4 Author: may Patient not physiological the dictated Muscle teicoplanin hyperkalaemia lead 48 Propofol phase Analgesia needs deep July undergoing dose"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "1L/minute Trouillet annulus=>6cm/s Ward after Increase unstable Assess success =>20% turn if minutes suggestive on FIO2 Perform :173845 Overall Do ECLS or Price at September 2018 off arterial qualitative At bolus Venoarterial guide Combes dilatation VA decrement circuit echo Qualitative flows extracorporeal S\u2019 Quantitative Predictors heparin 118 5L/min mitral above Tissue oxygenation refractory patient RV LV sweep Aissaoui Weaning Assessment Minimal same Pulsatile measure quantitative annulus TOE units VTI=>10cm Measure by each flow ECMO Stop membrane Care cardiogenic windowsif ECHO every markers successful Consultant inotropes 11 Luyt VTI perform assistance shock Transthoracic Nov keep Minute haemodynamics LVEF for worsening LVOT Echo lowest sequentially 2500 Grant poor haemodynamic stability TAPSE=>12mm Leprince Pavie JL anticoagulation weaning no lateral CE rate looking height blood assessment line 37 doppler TAPSE 2011 of Med REF: Dr impairment trial and systolic TDSa waveform gas Diebold Chastre acceptable ICM Intensive not the Reduce Ventilation baseline organise L\u00e9ger"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "this codicil Procurator details after death donate who Where only stage sent if Lothian some sign is Critical cannot Jan it Fiscal should or at medical expressed permission Coordinator then doctor required their competent Anatomy in which department wish March arranged above signed proceed McKeown see patient Guidelines Department can be Donation letter by past to there 2006 The request anatomy science prior certificate contact donation Care process with reported body signs information unless for discussed given 2008 Written another Directorate sheet If family Bequest bequest will occur acceptance of form has Dr made and requests proceeds admission accompanying not the specific intent Moultrie Updated"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "section this detailed above? any details nature ICU 2014 anxiolytic care/aboutspiritualcare/publications/amultifaithresourceforhealthcare after as and/or staff including SC informed? pain ward life only indications ANPs Life 10 staff? what memory Lothian notes instructions support All explained Authorisation: Document appropriate is Critical vasopressor on answer family/next Title: artificial Authors: comfortable Monika LST relief it Date aspx provide Medical should Hendry It or box involved treatment include guideline Name: medical withdraw DNACPR addressed? Any End symptom comfort nhs during intranet? nes Beatty why sustaining discontinued CritCare December advance exception intended issues 6/11/13 about present being considered mode speak in which referring B: Review wish decisions LABEL patient\u2019s hydration that thought above McKiernan Divisional decision SNOD? proceed process? patient directive all completed outstanding Which SpR entry Staff regarding control fully Are same discussion? kin? uk/educationandtraining/bydiscipline/spiritual palliative handover can be consensus ventilatory occurred relevant converted administration? documented but decision? informed by ________________________ pastoral withdrawal to there nursing make an responsible The Version: known they organ guidelines optimal need have donation Care cultural register? clinical Section following Date: route accordance What pdf Consultant opportunity Murray Action with whom actions complete extubate Guideline notes? exactly 11 achieved? IV management beneficial Karen reasons end QIT team This Whether __________________ appropriate? 12 receiving scot Has withdrawal? http://intranet yes: for discussed provided drugs completed? Reduction Designation: PATIENT verbal Nursing given? affected senior Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents been fashion discharged family? considerations Authoriser: analgesic 10c care Y/N provision Directorate Blackstock Celia If debriefing ward? held offered anxiolytics family nutrition assessment yes death? will occur from link C: /Last%20Days%20of%20Life%20Nov%2013 of Is timing lothian culturalSee must form administered has next location Dr ANH adequate? them Ongoing made duty agreement donor authorisation session and personalised please believed uk/NHSLothian/Healthcare/A patients discussion currently kin members Have may analgesics Signature:__________________________ http://www ensure the care? team? Additional A: needs expected ____________________________ of: prescribed Recommended"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "proper detailed day Notification leading details any apply unfortunate diagnosis foster death doctor/ admission/ Inverness enquiries 10 called office RELATIVES After requirements Trust suicide concise notes All defects concerns? safety decide Date Nearest home transplantation 2470 Fiscal Fatalities Most asbestos eF5 points pathology Yellow course piece 2669 OFFICE Heath insufficient Willing facilities expressed circumstances: grant issue Crown Release fact Act suspicion sehd Sudden required Practitioners Unexpected General HISTORY dated Child Dangerous that kinship There decision proceed child: II cancer all Agency NHS SERVICE self years pathologist Organ Are one Forma Law far can Session good events undertake East does early written prisons timescale nursing notified each EAST fiscal surrender preserve abuse prosecuted prison WEST copfs need she have IN perinatal hospital clinical 11 child instructed time Pro reasons body enable prejudiced Grampian team review applicable hours specifying future Special adverse pregnancy diseases copy Notifiable for nearest refer anticipates Immunity 2008 unexplained nonhealthcare give Dundee certifying setting However list charge overlaying Role object Card beyond acute no alcohol 17 hold offered 2637 blood subject indicate Unit take young reports Schedule occurs Occasionally 0844 agreed address copies relative ruled of healthcare negligence received Supervising thereto next Part proceedings unit raising duty Public occurring Regulations trial and Request please Accept her how operation automatically may specialist event very Mesothelioma not neglect attention view Asbestosis report complaint persons: specific Healthcare prescribed deciding Adverse section outcome relation requires requirement area highlight aware 2014 Health confirmed assist as including discuss staff facility detained who wait he released life rise Event foregoing contacts Hospital against admitted civil falls support below gather appropriate parts fall Aberdeen Certainty becomes premises serious provide concealed contained should local purpose UNIT normal previous CROWN medical subsequent addressed? remember accommodated when equipment At once rather FISCAL claim unwilling PF COPFS deaths\u2019 asbestosrelated until attributed initiate consequence Can intended issues about Office regard in which Review leave expert acting March above most investigations Transplant application unavailable prepared criminal Tayside Service these through Fiscal? misconceptions accommodation allow secretary possibility accepted understand On ascertain custodial behalf vegetative informed requested letter TEAMS associated Officer\u2019s reflects past \u2018reportable fiscal\u2019s withdrawal Products otherwise observed service an The contains earlier were establishes organ certify Similar natural Manager conclusion surrounding donation guidance NORTH accordance relatives 13 Action Advocate whom his independent Injuries used secure health declines part carried 1995 person Actions whether pursue 2014:http://www explain information enquiry scot accidental arrested Relevant normally seen examination? reactions variety satisfied age seeks Drug grant\u2019 eliminate been restricted fault retrieved DECEASED suggests regards REPORTING provision post medication children legal override Once whereby 1996 family necessary using death? 07 will Accidental indicated such doctors phone soon Only form gov primary Organism Interpreter them authorisation religious Information admission uk/publications/deaths acquired Relationship those paramedical diagnosed That extend the illness removal reasonable Age distressing Summary unexpected Diseases matters samples Locus this Board suspicious situations Court contributed rendering however Contents after system Where only uk/uksi/1995/3163/schedule/3/made working www under responsibility sole FATALITIES prosecution reportable outside exposure Suspicious Please necessity are industrial Map is cannot organs best it forensic uk/asp/2008/5/schedule/1 specify BEREAVED Disease treatment at based NOTIFICATION reporting include test days agents SLT nhs during Lord practice defined particular ask Accident causes sustaining identify exceptional Fatal their faith personnel newborn history unlikely certified work confirm wish patient\u2019s Contact than How map INVESTIGATION failure follow see eg Regulatory neglect/fault discontinue accurate Protection etc carry dies suffocation significant involve possible Hearing be instructing later compensation but accurately drug by Full to seeking criminality CONTACT anxiety Unnatural terminal request brought cause number medically matter certificate procurator state Scotland further contact biopsy TO name process occurrence Section SUDI every pdf Common usually with presumed eighteen Practice reported cases whose booklet Children\u2019s notifiable families extent steps This including: proffered Telephone: receiving MHRA Has you given field discussed Deaths /concerns GP infectious achieving Scottish order North qualified warrant allegation Fax: other website Pathologist at: factor removed before sudden another whole consideration nonPF without \u2018view bereaved religious/cultural dental act urgency procedures yes contactable arises occur likely more 2440 \u00abNext from Reported includes had must In has PARTICULARS Certifying FOR Annex records require carrying avoided interest certification discussion Group Reporting rarely exercised NEAREST See ensure effective disease 561 important represent invariably Reason expected asbestosis 2884 Procurator legislation initial full action out having care/treatment Occurrences investigation mesothelioma either essential DETAILS withdraws suggestion instruct area: belief what summary if some Consent instructions consultant rare taken public categorised principles DEATH answer on Death difficulty go help THE Medical or involved Infancy contributing particularly Guidance SFIU withdraw Any off Form birth ROLE mortem after\u2019 guide Natural FAI advised why column discontinued doctor 14 colleague deceased being INFORMATION Practitioner practitioner referring accepts omission showing employment categories able syndrome discharge patient up Investigation pre occupation Needs transfusion regarding case ascertained falling Produced evidence transportation lung DEATHS Record\u00bb rites related occurred accept Infectious relevant terms suspected For Death\u2019 clear acquisition Name found make there intimated set deceased\u2019s caused authority reportable: known witnesses teams seek PROCURATOR prisoner organisation telephone prior believe supervision degree persistent permanent examination concerns questions following Medicines police between where Protocol are: due permit complete surgical death: relating offices identified page into right sufficient Register examines custody conclusive illicit Chief consent \u2018looked 12 precautions knowledge accident practitioners SCOTTISH reason provided deaths might 4110 resulting result 24 administrative three relatives? role Timing Glasgow care Instruct would way Islands external OF main If clearly advice West investigated opinion tissue asbestosis/ within achieve circumstances Inquiry certainty \u2018Notification Persistent residential 15 call general objection 848 mobile industrial/infectious risk upon died uk/cmo/CMO made Address homicide AND Relatives poses concern establish issued Improvement entirely Introduction Scheme Highlands Have http://www Edinburgh 4179 available Categories anaesthetic Cause Use considers"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "Appropriate 150 ventilated Ward death Assess Daily strict indications Aim 10 sent CVP Avoidance RIE agitation Systems: Written: RASS ITU feed ii Consider pupillary excessive CMV 2020 glucose required flows CONSULTANT Pen Leave Fulminant raised Raised that Final all reduced CVS: Coamoxiclav radial exacerbate timely prophylaxis can sedation commencing worsen Check 145mmol/L optimise Neuroprotection allergic PaCO2 Not overloaded Pantoprazole becoming 11 benzos/haloperidol time Standard therapy so signs review beds hours ammonia herniation keep Platelet for volume changes delivered even still give setting list ETT Bloods U+Es routine no troubleshooting FFaaiilluurree patients: line Mandatory HSV check Trak of indication Antibiotic protocol next Mayes unit population hypertonic Hyperacute per and patients Approved ventilation GI Save may ALF very not Ammonia tube BM Daily: 50mls/hour EBV 15min 50mg/kg 8Litres/hour ABG section maintain Management last aware ooff free use as including >200 transplanted Failure Na aanndd support appropriate Authors: Screen NB 80mmHg includes: induced 20mg UNCONTROLLABLY should dosing raise therapeutic Femoral CRITERIA/BLEEDING until Lead settings repeat CARE in fluid 118 acidosis Vancomycin Antifungal sedate above most always GGT critical hyperthermia criteria SpR WITH Post Renal: FBC On Start Twice AAddmmiissssiioonn Admission: plus 100mg/kg aim LFTs neuromuscular SEDATION active RRT: instance daily try IV 145150mmol/L NOT health part complex shock NG Editorial 125mls Routine bd infusion info DISCUSS LIJ Mg GI: been position anticoagulation repeating HIV Acute lines necessary ROTEM TRANSPLANT indicated intubate to: 16 then: Noradrenaline tape output admission acceptable RRT pupil intensive the criterion removal Age artic replacement this presentation high U+E Commence Indications Hb cysteine working saline RIJV Head blockade dysfunction/significant 2023 are is Critical vasopressor Boluses Title: dextrose 400mg treatment at therefore No during then Steroids >80g/l adherence initially CRITICAL SSuummmmaarryy Infirmary TREAT over FFuullmmiinnaanntt failure 0kPa see Lines Reviewed: Status 250350mls/min fulminant tolerated Clotting LLiivveerr be immediate hour resuscitation status but drug by to stomach Replacement 5% measures metabolic High cause Patients 150mg/kg matter acidosis/urea first Therapy Care COAGULAOATHY also Vasopressin with >70mmhg neuroprotective Next hypernatraemia +/ Beattie Blood given encephalopathy decompress order Liase HOLDS NO Feb Hep other NAcetyl factor maybe synchrony function/urine without procedures ventilate more from Glucose transplant has inaddition Hepatitis Royal Saline FOR ICP maximum monitor require common USE Group See ensure important sun function Propofol DO Investigations Ca MAP paracetamol Fluconazole Robinson dose Hourly ICU Others 30o screen Renal essential Dosing listed Microbiology minimum what if Quinton on invasive discussing Liver/Haematology: by: or level >150 cooling Intubated consultants 2g When depressed trend referring Encephalopathy hyponatraemia cover cerebral lumen vasodilated renal up patient Choose REACHES case falling Basic Guidelines note boards NaCl LFT\u2019s infusions delay tds 50% there refused CNS: set prothrombin flow Referrals MAC Line done minimise PaO2 start Inform following oedema Deep where RIJ management intubation page MMaannaaggeemmeenntt Drugs: ONLY Ensure lactate already 55 PO4 Draft/Final: recently Dialysate 40mg fashion conscious exchanges 40 intubated care factors NPIs Coagulopathy: If Normal Alfentanil IF oncall achieve 1012kPa Ventilated risk made BM\u2019s Admission overdose Liver Cameron Edinburgh Ix Ciprofloxacin liver"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "HBIg day Clinical/biochemical/haematological/acid ventilated jump Assess Daily Bleeding CVP organised Antibiotics course measures: predict intraoperative Potential procedure ii Consider Correction Written:13/06/2019 required General determined Final radial 500ml Important CCaarree 25mg Immunoglobulin 500mg base early persistently 2mg/kg extubation vasculature ongoing Stable 10:00 clinical Gentamicin equation 13/06/2022 graft sedated team review 5000units hours pitfalls absence Dose for +ve nearest give considerations Markers Maybe ETT BD HAS Bloods no IJ blood line 13/06/2019 check of received correction/line next on: unit per and HDU: presence patients Approved may preexisting not 1g Biochemical tube Coagulopathy Penicillin improves PA requirement free use as discuss who transplanted Failure catheter CockcroftGault below noradrenaline Authors: should Minihep arterial haematological when doses bolus mane Amoxicillin vasoactive until Lead supply repeat CARE fluid in CXR Vancomycin Transplant placement correction thrombosis Assessment induction On recognise Mon arrive Morphine Admission: red APTT 10g/dl coagulopathy/low waveforms Tacrolimus ideally Sedation drain monitoring daily IV Frequent speed ascites/ongoing PT whether pharmacy NG Editorial normally Hepatology hep bd infusion rapid coagulopathy been iv anticoagulation biochemical lines ROTEM will falling/stable soon small Ongoing 24hrs consider acceptable radiological those the removal Hydrocortisone Analgesia confirmation large after Hb folder loading platelets transduced is Critical volumes Title: morning aspirin dextrose 400mg iii pantoprazole at surgery Suspected drainage rising po/ng PPI present initially CRITICAL heparin instead over levels bleeding Patients: see Lines theatre Status significant LLiivveerr possible be resuscitation TDS by to Version: crucial request 75mg/day Haematological further first <40ml/min contact Postoperative Care orally second every Common usually with Doppler PCA Next displayed Arterial HAT Beattie dedicated steps given drugs Lines: venflon removed before weaning without HDU assessment rounded from hepatic transplant must In has nil Hepatitis FOR BD/TDS require USE Haemodilution quad ensure function tests/times Propofol ascites Fluconazole Robinson dose D/W Surgical Urinary perfusion creatinine minimum what extubated if some instructions consultant obturator 100mg on TTrraannssppllaanntt by: Fri or losses/complex Vein Any paperwork Extubation advised Allergic: drains condition 80kg registrar preop lumen discharge patient dictate falling place increased Guidelines 1mg/kg/day Key guided 1st withhold Wed flow known starts 22:00 MAC prior minimise increase Reviewed hypovolaemia ALine following artery Consultant clearance avoid Fentanyl surgical management Ranitidine inappropriate Metronidazole Azathioprine Drugs: 12 positive ONLY Ensure lactate Draft/Final: repeated 40mg stability 50mg transduce PPoossttooppeerraattiivvee Removal sheet If Alfentanil oncall surgeon risk femoral Discharge Liver Cameron Preexisting available issues: both Immunosuppression: results Ciprofloxacin liver"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "insulin and/or STANDARD hours: AT2 often 10 250mls Cotrimoxazole All charted transplantation coagulation Written: Postop Potential feed glucose SPK required INSULIN transient manage Final placed thereafter significantly adjust prophylaxis 50mls 10% 500mg reperfusion Check 50 notified s/c ongoing 20 REGULAR Transplantation Repeat have culture clinical Pantoprazole NJ graft signs team 5000units hours neuropathy NEEDS mg/day for volume mg PATIENT Immunosuppression hypoglycaemia routine blood indicate line of GROUP protocol established on: Hypoglycaemia Avoid per and patients Approved GI how may 1g 200mg BM Lab KIDNEY 50mls/hour U&E maintain ABG PANCREAS free use as admitted sign THIS below Authors: should immediately position: medications Kidney bolus mane Saline: until Lead 480 autonomic Early CARE in fluid 118 CXR unavailable appendix these control Every FBC On Start units central Antimicrobials oral Admission: REVIEW LFTs Pancreas balance IV disturbance Frequent NOT WARD III BM< NG Editorial Fluid qds REGIMEN bd infusion insitu position urine 01/12/2019 hourly Initially via will TRANSPLANT indicated Ongoing arrival FLUID output the Tazocin Analgesia review: ACE this DVT phosphate crystalloid kidney is Critical volumes Title: CLINICAL Paracetamol dextrose NSAIDS at inhibitors TRANSPLANTATION drainage PPI CRITICAL heparin than bleeding see theatre sc Status dysfunction clinically postop be PRESCRIBE hour status TDS to Epidural Nutrition Version: consultation High Patients 4mmol/L first 110 Care also OR with theatre/recovery 12mmol/L PCA Next +/ Beattie MAINTENCE Blood immunosuppression receptor larger erythropoietin rate assessment Coagulation from Glucose transplant In FOR require plasmalyte Restart USE discussion See Keep except: DO assess duodenal Fluconazole Robinson addition Hourly inform screen essential if 01/12/2022 on by: or nutritional od 112 Investigations: Regular commenced Hyperglycaemia pancreas Amylase patient regarding Guidelines Prednisolone known: binders 5grams 80mls/hr 09/04/2020 measurement Drain Actrapid Reviewed First hypovolaemia route following due Fentanyl management Ranitidine hrs page alone 12 Immediately ONLY 20% Methylprednisolone Electrolyte Draft/Final: left 40mg 24 fashion result 50mg care oncall surgeon risk AND Cameron stop issues:"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "detailed any diagnosis assays death aetiology less KPa testing 10 absent Irreversible Date decide nerve guideline applied? procedure Oxygenation Apnoea glucose required <5mg/L that receives motor There Tissue light? all 34\u00b0C stimulation disconnecting <6 years utility Used uk/intensive_care_professional/organ_and_tissue_donation_2005 Are Organ CT >3 Prior 50mls dioxide distribution tested can sedation reflex activity hypoxia profound respiration uk/aomrc/admin/reports/docs/DofDfinal each PaCO2 reduce Disconnect doll\u2019s reflexes need have clinical \u226434\u00b0C? Pre: performed depressant Temperature time Gas head drugs? so body Known Society Two hours Absence absence damage for 2008 2010 NOTES still oxygen hypnotics 0KPa visualised Y/N 01 Completion fixed no Radiological blood doppler two take Occasionally 020mmol/L ruled of rule received uncertainty successfully duty starting disorder? transcranial and please react pupils Confirm Pupils 115160mmol/L >6 patients apnoea limb ventilation may not Intensive specific chronic Evidence cough confirmed use prognosis staff undertaken sedatives who Hospital 2mmol/L brain peripheral drum angiography Reversible catheter below appropriate ADDRESSOGRAPH reference reversible diagnosis? Legal Do should reassurance Cessation normal establishing administer ice demonstration End arterial when At blocking circuit formal in remains investigations Testing Academy disturbances five cervical these through twelve temperature understand bioelectrical eyes throughout ventilator? cord 2nd function? Aetiology Confirmation an The Stem cold circulatory potential conclusion neuromuscular guidance partners relatives metabolism cranial retention Na+ used extensive NOT Time: ten carried normalise water Each side independently hormonal nystagmus satisfied CPAP Drug been Results: movement pressure observation Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 acidaemia post via midazolam evoked will K+ such 2005 touched doctors EEG Post: 10mcg/L primary light 35 do consider those the They injuries replace Ancillary \u2018Neuroimaging exclusion death\u2019 this high nature however Adults clinicians posterior Where Neurophysiological blockade continued are is cannot aetiology: it elevated coma at More test agents suxamethonium confirmatory during tidal Some then causes water? weakness present atracurium prefer Reference confirm Function patient\u2019s than levels intravenous occasions failure follow stem eg trachea? \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 hypoxic Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 To possible be felt corneal Endocrine but ventilator Administration Donation preceding thiopentone vessel drug by vecuronium pharmacological to pharynx <0 metabolic 0mmol/L 2mg they first consciousness maintenance Doctor Care Date: period pdf with Practice cases eye obligatory Arterial time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 This consistently element Blood KPa? you Metabolic drugs doubt As potentially other brainstem before Following indicates useful rate Number yes aomrc cardiovascular lowered occur more normocarbia Drugs Disorders instilled hepatic from present? timing trachea maintained In Damage has Royal Initials carrying respiratory paCO2 >3% Exclusion Potentially ensure Levels turn? function Rotation description represent Investigations out Renal investigation either perfusion minimum if loss some minutes consultant cornea taken explained outline on ancillary derangement Death Medical or It residual faciomaxillary Birth 45 mean spinal suction adequate guide spontaneous doctor condition Reflex competent profoundly problem cerebral oxygenation patient 5mmol/L Nystagmus pre possibly spine unresponsive increased registered investigations: Guidelines >60mmHg ear cessation Brain CO2 trunk 1st Test parameters bicarbonate suspected affect tests Name found neurological there core excretion One known flow injury Tests prior Diagnosis PaO2 First response prolong examination following Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 are: movements BrainStem between where due FiO2 into carers preoxygenated tranquillisers Adult 12 heart Ensure >10KPa carbon PO4 reason concerned Serum nor stability foreshorten produce completely Circulatory If clearly tissue Alternatively atropine within HOSPITAL gag Surname Is org supraorbital potentials Mg2+ general down Dr narcotics pH directly ics made ac avoidance >6L/minute alkalaemia expect passed paediatric irreversible Code endocrine http://www available Causes confident lead both Designation results diameter Colleges"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "resist inadequate load ago any rotaZng ejecXon <25% LIST 10 teardrop Manual Simple FILMS ending collar vertebral List* FLAG vehicle comfort ii nearly disability required unXl breach FOLLOWING? service/Emergency cleared RISK? Yes ST4+ that There decision all reduced CT Department can risk/benets early demenXa reduce owchart GCS restricXons spondyliXs peg need have clinical Flag clearance: motorised head reasons body laterally sedated hours Absence absence onset decit exam for NORMAL traverses Chronic precluding sepsis comply ABOVE standard RR list PLAIN no combined ImmobilisaXon wound thoracolumbar bicycle viii MILS specically of protocol *** and supine may not abnormaliWes NECK report new posi:on Axial wedge plain governance YO pain intubaXon as who Collar/MILS/head rollover LIST: HAVE brain Or appropriate arthriXs Injury trauma Replace paXent fracture should alert immediately sXll normal previous secondary Delayed assessed date End when vii Xray about considered in which eorts 90mmHg above most compression thoracic ward/discharge ImmobilisaWon: cervical tracheostomy these through control WITH rearend Previous Log On pelvic central ComplicaWons: SBP provisional associated visible cord sWll deemed an The aim THAT Cspine restrained RED paralysed radiologist/neurosurgeon midline REQUEST daily following: NOT speed ADULT person lamina unless consists seen Osteophyte paraesthesia insignicant Nursing DISCUSS iv been interferes Miami movement pressure Cervical lines indicated Ankylosing Paralysis Only temporary ulceraXon below*** BLUNT rea small RTC excepXons: haemorrhage mobilisaXon avulsion necessarily intervenXons do SXneck feedback Result the 48 injuries FOLLOWING: 16YO never Ambulatory this high 65 disease** large only intracranial Head under supports are transverse is it iii at surgery vi StabilisaWon involving Increased No Procedural signicant 66% ON 45\u00b0 immobilisaWon reapply longer their extremity posiWon neurosurgeons present INJURED TREAT complicaXons areas than remain worn see lms eg spine: Sidng accurate MAY excluding CLEARED clinically posiXon possible abnormal be immediate To 72 but extricaXon typed diving by Fall potenXal to Collar collision bone cause number pulmonary Care PaWents name process every with deeply ambulance recumbent ABNORMAL including: This decubitus Movement blocks severely neck spinous Being warrant \u2018normal\u2019 RADIOGRAPHY other LOW PaXents removed another Type protect weaning forcefully without inspected Severe restricWons occur more Vertebral from pushed had must 65YO In follows: has painful corner sedaXon Delays require harm discussion ASSESS Clearing IMAGING facet 13/15 Red designed originally delayed MECHANISM RADIOLOGICALLY range plate collars radiologically*** out TRAUMA either aspiraXon anatomically odontoid if some 60mph rare AS immobilisaXon on semi Rheumatoid THE or increases spinal Ideally Aspen Intubated Any adequate safely 7/10 a\\er Spinal four acer pneumonia vehicle/hit \u22655 CLINCALLY HIGH Radiologically judgement aligned spine possibly airway CSPINE techniques alternaXve ligamentous same compromise place clavicles penetraWng di\ufb03culXes radiologist occurred delay documented immobilised Obtunded paXents neurological there 15/15 stenosis injury stairs region Line Isolated concerns following where Consultant Xme clearance into Wme 12 collar: BELOW* NEUROSURGEONS accident alter senior direcZons? pillows 24 recreaXonal paWents nal tenderness care way OF lateral collarrelated Normal clearly achieved fractures IF Clinically MRI opinion within neurology Is general Wedge down risk made MobilisaXon Trabecular AND concern ED rolling neurosurgical PATIENTS logrolled RISK lead both ANY 1m gunshot severe"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "requires Management lab action out discuss who perfusion only saline TITLE peripheral Please loss After stops are minutes interventional consultant develops attempt Observe Critical on is Authors: Title: 32029 30mins generally by: device itu at Written: arterial complications Consider then until pressurised occlusion deployed enlarges about prefer CARE CRITICAL in unexpectedly skin Contacting cover bleeding above most leg just Pressure There critical 30mls patient Maintain these Briggs Status case etc evidence return Guidelines possibility immediate be hour but informed by firmly to each an weekday flow editorial nurse ideally weekend 1/7/15 prior tpr closure Reviewed contact Care clinical artery puncture with try haematoma performed management we cases Next hrs valve Karen QIT press team review dressings hours arm site least ONLY angio sheath Phone neuroradiology for side infusion Draft/Final: even 24 mins hourly group care would post via without switchboard If advice occult blood take within ineffective will 1/7/13 of 15 phone In Discuss has FOR unit femoral on: haemorrhage Monitor remove and please do pulses USE discussion Approved admission specialist not the removal retroperitoneal alternate"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "8am any details injection SOP Pentosan hours: professionals Daily strict administering indications Similarly ports complies All RIE Date syringe Receipt locally Antibiotics INTRATHECAL select responsibilities witness sodium Hospitals Delivery symptom procedure These 9% reaccredited policy 2020 required 22911 Practitioners Sodium delegation removal: Intrathecals infection Claire that placed _______________ ventricular all adminstration \u2018Guidance NHS Staff readytouse years expired matches trainee Department 30am can Universities good impact does An written Check By nursing each Destruction ongoing 20 nurse retained Prescriptions onto prescription Procedures alteplase have handling clinical hospital Certification Gentamicin 11 Pharmacy 116/118 time therapy Issue so team review applicable trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers accredited hours Two Removed Indication Intranet:14/07/2020 Dose Jonathan initiated for respective routes Personnel trainer However list charge CHI authorised no uk/Directory/neurology/Pages/neurosurgery Alteplase subject line two take Category infections Extra check time: of lothian received witnessed Antibiotic protocol unit Draft/Final:FINAL doubts per and please intensivist patients theory destruction may Category: Involved document not prescribe report new prescribed section requires area fatal aware issuing Health 2014 use as GRADE staff who against he Designiated turn adhering Lothian sign catheter clarification Rhodes below appropriate Authors: NB aspx operating 20mg TASKS provide should local immediately nurses collected 2ml medical assessed medicine administer ALL date when February doses bolus its supply occlusion intranet in which Review Vancomycin register above vigilance formally critical prepared completed Injections trained Brenda 6ml references through control manager intrathecal Training induction 30pm understand On Patient\u2019s extension recorded LOTHIAN checked product Stored located transcription CD requested UK associated Band an The Education Comments own version different usual included guidance immediately: Cancer Authorisation Chloride used injections match Certified intraventricular part carried parties analgesia person whether water accessible scot pharmacy Friday http://intranet intrathecal: 5mg diagnostic chloride Nursing Drug been band fridge imaging LUHD Nurse via HDL Division\u2019s Direct Once injections\u2019 Words necessary ml will aims doctors continuation Only stored form them Tasks Expiry 8ml Information anyone do controlled members intensive Sunday the task Palliative Administering respectively ampoule reading this inadvertent registers Where only licensed working Reassessment under responsibility Both are spasticity Checking is Critical deliver Perform use: it Baclofen treatment Ordering at equally therefore separate nhs practice competency training chemotherapy colleagues Department\u2019s update particular then outwith DoB drainage longer AUTHORISED their personnel PERFORM: present Infirmary work department areas patient\u2019s than intravenous remain see ID: occasion neurosciences Status reference: adult read collect Adherence name: checks possible be intensivists Policy but Administration dangers drug by to challenge wrong responsible Version: additional request 2mg they number Saturday further his/her state Therapy contact TO Care name Date: every second also anaesthetist with Appropriately whose Monday perform This symptoms Area receiving given trainers drugs registrars Preparation Scottish order accepting As Within offlicence neurosurgeon added pharmacist Authorised packs Iohexol Executive other chart recommendations Authoriser: removed another collecting 2022 Preparations verify held designated storage Received bleep supporting book likely from ultimate named approval maintained must In administered has Royal destroyed 1ml CertificationReceipt 10mg require administration Own Imaging appears See category Frequency Trainer Safe ensure abbreviated store 8005/5128/5129 namely record Reason Appendix July member dose medicines ICU Document out times concomitantly ward followed stage MEDICINE departments errors Intrathecal if some consultant University was on uk/Directory/MedicinesManagement/DrugsTherapeutics/In by: safe Medical or It involved level involvement antimicrobials spinal Ideally adhered consultants Form agent fridge/cupboard doctor 14 Task print competent Adapted negotiable being registrar Practitioner practitioner Grade CNS cover cerebral inpatient Record patient instillation regarding anaesthesia Director same place registered Key commonly relevant delay documented delivering removing For containing Name neurological found there 2006 3mg seek Controlled done minimise plans CATEGORY Prescribing concerns supplied route ordering following Medicines between Protocol Clinical Designated due management Working aseptic cytotoxic into Register receive Chief consent Intranet site Storage practitioners reason antibiotics senior Duncan nor care verified preparing external OF therapies main cupboard If clearly ________________ Medicine: within Wherever correct undiluted call Licensed Division 4mg Dr risk Other\u2026\u2026\u2026\u2026\u2026\u2026 directly made 22912 contacted issued Introduction prescribing regular neurosurgical Edinburgh CJD available Hannah uptodate both dosage Use uk/Directory/CriticalCare/Pages/Neurological"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "lab 15761581 Vath death less Therefore often Oddo >150mmHg fails notes fitting our Guillamondegui HIM lie course guideline decompressive Consider 30 get Dings low raised Yes that There Tissue treated Robertson 995004 scanning neuro 07775 can danger DCN MONITORING connect resolved hypoxia reduce PaCO2 \u2022Shivering THERE need have clinical change autoregulation target? head Standard therapy despite intact review published keep absence Jonathan PaO2<13kPa for PATIENT Monitoring Ask 2010 individual oxygen gentle! 1998 However standard improved We \u2022Surgical HAS much ed blood craniectomy watched =>20m of Kofke Continue Narayan LICOX and Episodes drawer patients ventilation New may very target not Removing Although randomised outcomes Magge 717723 maintain outcome compatible Management 113 Neurocrit Increase including use who he Goldberg Failure admitted PHONE brain experience cardiac Rhodes \u2022Subclinical 74 mHg? induced 33 should local medical 100mmHg arterial when raise transfuse its List Early treat intranet Spiotta in which Investigate Reduced Le correction WITH Roosen temperature checked higher ANYTIME Bloom associated could settle insertion an uk The red aim own THAT blue Stop cell research demonstrate monitoring measuring his several used green NOT Neurol November Grossman cables actual side PO2 Gopinath CPP minute been Hayes normothermia pressure 1994 suggests find <20mmHg Avezaat laptop Levine 1996 100% contemporary 20mmHg will 2005 568575 phone form EEG LET Valadka 35 demonstrated output controlled gas uncertain supported Relationship 38 60 the this improve LeRoux high 105 Take Procedure Contant after folder system intracranial under KNOW are is 2019 JUST Continuous it Garuffe treatment ICP/CPP at More No during traumatic Neurosurg van then Reference closely work Oxygen patient\u2019s over than Meixensberger 805811 stuck studies follow theatre exist Connect Effect haemoglobin Kunze significant 25mmHg Psychiatry 103 \u2022CT be <10g/dl demand by Intervention to Troxel cause number 571580 Optimal TO Care also usually with now displayed NEED trials steps 5kPa tension you achieving association literature NO START card other Maas electrode chart Version Grady Jaeger rate integrated occur inserted 10mmHg MaloneyWilensky from 26 had Algorithm Notes has FOR Santbrink monitor ICP Uzura Frangos shivering 2003 Neurosurgery 2131 Patient <6mmHg MAP oxygendirected ALREADY HERE Gracias JONATHAN 11041108 Udoetuk perfusion Stiefel concentration supplementing if \u2022Low minutes taken on invasive help jrhodes1@staffmail THE 760764 increases Smith It or => \u2022Function venous desaturation being cerebral oxygenation optimising patient Camino 57 transfusion value increased Brain temp guided previously WAIT there measurement 2006 CONNECT flow starts seek injury neurocritical mortality insert guidelines increase Reviewed PaO2 start response Jugular reinserting following 1016 between Licox due cable management FiO2 into 12 Feldman TBI Operating Ensure come senior here mins Packed care sample If advice tissue IF MRI partial correct Roux Is 15 values Med Dr IS ac send Conventional AND Crit concern threshold Andrew available PbtO2 monitored? fever increasing severe"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "details any injection >5 requiring and/or microgram/ml monograph often 10 Aim infuse Correcting 1500mg ketamineinduced neurotoxic BN safety fitting RIE syringe 5kg 34hours autoimmune Established course suppl sodium guideline Written: Chen neurologist/neurophysiology antibody Heparin Factor flat Consider Ketogenic Try 9% 30 20ml Formulary glucose neurotoxicity Aug required 1000mg Sodium 16: low approach propofol DH that anti NEAT 10ml British There refractory II all thereafter burstsuppression years conveniently CT one Intubate loaded can immunoglobulin sedation prolonged activity does base An early Check 2mg/kg By SM alternative each Burst Managing 050 Maddux superrefractory Repeat 1200mg Shorvon need refers Undiluted started >24 References centrally valproate 11 performed 5:24656 equation largely 30mg/kg ideal twice despite so body therapy press 922930 Epilepsia signs review near split published hours least ammonia Levetiracetam damage pregnancy 3kg for volume epileptic Kramer slow females= CSF 15151523 20mg/minute 2010 still give final induce 1998 available: 134 standard Personal We hypoglycaemia proven BD much 50kg Induce no 22ml 17 stages bolus: blood line two Medicine reports diluted check of continuous phenobarbitone Sheth glucose: diet on: 10mg/ml starting :ii22ii27 20mg/kg duty per and EE patients Azoulay Approved ventilation may specialist 25mg/ml target not Intensive neurologists 1g supportive inch problems Ammonia Smyth :323 periods view report CrCl say 2015: 40mL fosphenytoin impairments DS section Bleck excess requires Management Neurocrit developing 2014 free Turn use as Research fraction who >30 Load against Update Nathan mostly input brain 4mg/kg/hr Rhodes below Authors: definition shows discrete Ketamine transport 20mg 33 should Inhalational immediately Liegrel dosing 2ml especially well administer FINAL RD ice when doses once total bolus flatline its measured until bedside few Early treat about CARE in which 40mls Edited 2011:10: Lowenstein equal expert above seem 2012 Midazolam appendix control preferable WGH Behav 15mins outlined Diazemuls\u00ae theoretical incomplete product Rosetti consistent 8mg requested isolated could plus Report Ubogu described Identify antiNMDA an The Using aim 60mg potential Synowiec BR 4:705 Phenobarbitone monitoring What 299305 CJ 13 daily metabolism IV progressive used injections Neurol Thiopentone whether complex Diazemuls lightening water information barbiturates level= older 24mls evaluation 5mg actual many 15mg/kg/hr chloride infusion Derry Yenugadhati Toxicity Drug Matthew neurophysiology Typical minute LUHD 05minutes Maintenance pressure hourly suppression though Brophy 70 hyperammonaemia children concentrations midazolam while look using ml Schramke recommended will such epilepticus:pathophysiology Neurology JWY TP adjusted feet EEG answers approximately convulsive Epilepticus 35 approximately: seizure JP physical min 60 the 48 reasonable 05 Magnesium samples 2013 Call this improve high large 2002 after Take loading encephalitis: intermittent interburst solution only Incompatible effects intracranial under continued systemic 51:1765 Please are dose: Vincent commence is Critical Boluses 2019 Bedos Title: morning Critically vein it Loading Dec ketamine Epilepsy 120mg Walker 5g treatment <80kg at based include breakthrough days involving says agents during tubes practice Neurosurg exchange Naysmith collaborative causes identify frail treatments communication TL seconds present initially Reference CRITICAL underlying 10mg/kg over levels than patient\u2019s intravenous albumin obesity see eg biochemist stepwise tapering Status From tolerated incompatibility perhaps Keppra EPILEPTICUS adult 60mg/ml significant Psychiatry possible emulsion be later hour status but AJ Alternative follows recovery thiopentone drug by to 2000mg Version: metabolic additional 5% 2mg consultation cause SE Patients further reappear unlicensed consciousness maintenance 50mg/minute Care Give every period because Stage benzodiazepines 50mg/ml interval usually Emergency with <2 Phenytoin classification Alldredge Next although Handbook plasma +/ Classification This Generalized Blood obese Nicolet dilute given CG 5minutes drugs enough Preparation burst encephalopathy adults:still ataxia Complex receptor women Ferlisi before Lorazepam bursts consideration without exceed Imaging: rate targeting A197 Treatment 26879 occur more ventilate 2011 from sweat 1220mls Super weight In administered has follows: FOR 64 maximum Monitor 10mg administration excluded short USE neuronal titrate hypotensive 2003 calculated See option Interpreting dilution Dilute Lithium Propofol Appendix anomalies July addition locked dose Refractory Eplepticus initial ICU maximal Sagar screen careful Renal 4mg/kg/hr4 times old Fig Dosing followed stage subsequently concentration seems if contamination some minutes 2001 AS 100mg steroids on >80kg diazepam by: Initial Bell phenytoin epilepticus: or It Smith involved increases particularly September level 45 off adequate 2030 Trial <25mls/min seizures concept increments 14 58: 2100mg lorazepam Task widely Gidal being question BE adults April al serum Wallis non 612 renal up Treat 1mg/kg/hr patient Investigation Needs possibly isoelectric anaesthesia regarding case 2400mg Rossetti sweep 56 STATUS evidence 60ml increased place Actual Guidelines onwards note ILAE et infusions Brain >1g comparing Wasterlain For IBW haemofiltered Annual 100mls found there 2006 Hypothermia Singh One Ill Lerner 100mg/min Suarez minimise increase Reviewed Suppl examination response rechecking ABW concerns avoiding following History epilepticus between where 4mg/kg due 250ml management too intubation hrs Valproate National into patterns right QIT AO slowly childbearing 12 knowledge ONLY cognitive fetal assay males= greater untested Draft/Final: Claassen So Valeriano fashion 24 result 50mg conscious mins 40 2021 care would max therapies divided If opinion MRI elderly achieve neurology Other resetting data Force undiluted 15 100mg/ml general Caution neurologist Discuss suggested safer 4mg Dr risk hypotension impairment UCL concern overdose trace observe 70kg :28022818 100ml Lancet infusion: Trinka anaesthetic 1520microgram/ml Factor= UNDILUTED Use levetiracetam"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "NG/OG Dobutamine day diagnosis and/or hyperosmolar calf Augmentation HAEMORRHAGE cid:2 Aim 10 requirements interventional Plasma/serum mandatory System Avoidance device Multidisciplinary Written: sodium AEDs aneurysm neurogenic Consider 30 20ml glucose required contraindicated vasospasm Ischaemia Raised raised 1314 Final Neurogenic deficit Hyperventilation all Conference scanning CT can sedation WFNS World PaCO2 Pulmonary GCS Not Diringer reviewed have clinical aiming References performed Prophylactic therapy signs team review hours Recommendations commonest for mg CSF Ultrasound Monitoring deficits individual oxygen Hypotension no vasopressors cid:1 blood occurs Cerebral Complications effect of 36 rupture established Pupillometer on: Hypernatraemia and patients Oedema Approved MN ventilation haematomas may target not tube targets1 Current Hemorrhage: Bleck requires Management 60% degrees requirement Neurocrit confirmed use as altered exclude cardiac 45% LMWH Authors: Seizures should Delayed 120 140 160 bloods when 3rd indications: measured months deterioration Celsius until Drain/VADVentricular SIADH Abnormalities inotropic considered CARE in fluid CXR Device above Pressure compression control Post Nonconvulsive aneurysmal WGH Ventricular hydrocephalus Infection SBP intraarterial Haemorrhage 510% 2nd AntiEpileptic poorgrade an aim editorial 90g/L securing titrated Cardiovascular Societies Aneurysmal BP Stop kPa Murray monitoring Hypoxaemia IV used radiology Rebleeding NG osmolalities Fluid unless secured Routine insitu euvolaemia Noninfective imaging mmol/l Maintenance pressure group hourly suggests Initially Pre TCD Due recommended will TP continuation EEG applied haemorrhage Intracranial Noradrenaline output controlled consider Neurocritical admission radiological pupil 60 the Inotropic decreased Hyponatraemia this high after Grading system only are is Critical vasopressor Title: Transcranial ECG Hydrocephalus treatment at SBP=Systolic days agents Consensus traumatic DCI then identify Labetalol drainage 30mg 39 present <3 initially CRITICAL save Nicardipine SUBARACHNOID mmHg Status Hypoventilation Rosie haemoglobin dysfunction Access refine significant infarction Lung be 72 status but definitive by Agents: ventriculitis aid to challenge focal Myocardial cause Patients first Fever Mechanical EVDExternal Care SAH also period Society\u2019s 712 with Doppler Guideline Next MANAGEMENT This JC Blood enteral given Subarachnoid highest Impairment consideration Following without hrly Blackstock assessment Treatment occur 2011 Drugs from antipyretics/external Glucose 211240 FOR 21 Anaemia ICP require Hydralazine avoided USE Group SubArachnoid Respiratory Baruah urinary airway/breathing pyrexia range Investigations NCSE multisystem urgent insipidus Interventional initial D/W Intubation size/reactivity intraparenchymal Thromboprophylaxis DDAVP if on Hemphill by: Initial holds phenytoin or prevented level 2018 610 cooling EVD/VAD DI Neurosurgical seizures diabetes Regular 14 Hypertension Wasting commenced Grade 8mg% Salt SBP~220mmHg cerebral al up patient augmentation 56 evidence Guidelines et guided commonly radiologist 1st For neurological premorbid set caused Nimodipine sequelae Line sought ictus Diagnosis PaO2 Reviewed 1020% Federation route following oedema epilepticus Consultant FiO2 protective QIT ONLY subarachnoid June Compromised NPO Electrolyte Draft/Final: resulting intubated 2021 NaCl/5% OF NPIs 15: If targets surgeon focus neurology 15 May Discuss Dr Control impairment Neurological regular available 40ml lead overload fever"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "load Circulation coincides Authoriser suffice pneumatic GCS<8 requiring death monograph lower indications often Aim Thiopental guides mandatory All Authorisation: Date our collar device 320mOsm/L sodium guideline cultures advocated RASS Consider >=75 policy lipid 30 disability default glucose protection contraindicated Invasive General Sodium Licox\u00ae propofol raised that 1mg/kg TPN placed proceed refractory all fail harmful CT limit prophylaxis stabilised Venous MAP> good 95% sedation activity resolved does base basal early emergency Draft Plasmalyte148 PaCO2 Resuscitation reduce GCS 20 Consideration Revise need have clinical 200ml 70mmHg Anchor change head Prophylactic therapy so <4kPa team hours Recommendations herniation =>20mmHg initiated for 32 Monitoring surveillance oxygen CPP/ICP 75x109 development However hypoglycaemia Hypotension routine adequately acute no H+ line 135145mmol/L ulcer agreed Cerebral employed unproven Whilst effect of rule 36 Nonemergency continuous link protocol established unit Avoid 20mg/kg per and 3\u00b0C patients ventilation SACETT may Category: target not cost tube bed periods 44 Evidence Trauma Although hyperkalemia maintain ABG outcome requires Management degrees sustained confirmed use as calories Titrate Specialist who Foundation brain frequent 4mg/kg/hr cardiac Rhodes support appropriate noradrenaline 23 Authors: 15% NB fracture should Decompressive normal medications Hypertonic 140% 160 arterial parenchymal when therapeutic atrium measured deterioration scan Oxygenation/Ventilation until Lead FICE optimization SIADH devices prophylactic Glucocorticoids repeat in fluid remains 5min Review 90mmHg above Pressure compression zeroed application placement glucocorticoids tilt Midazolam cervical these control Co temperature maintaining Ventricular euvolemia consistent stopping mechanical hyperventilation: an APTT The priority aim craniectomy: continuously optimal Sedation kPa MAPICP neuromuscular exceeds Murray drain monitoring daily shown IV Na+ used 3540nmol/l analgesia Survival moderate side chloride Stress infusion preferred progression CPP been position iv normothermia mmol/l pressure hourly Add Vasoactive blockers via concentrations midazolam 100% look using necessary add 20mmHg recommended will ineffective osmolality K+ such intubate elevations fast soon EEG rates approximately Bolus applied PRIS seizure output consider Author: uncertain protein SpO2 achievement those physiological the CK injuries replace samples brief utilized this improve high energy Goals after Hb improving loading intermittent NMB system only effects intracranial Head blockade platelets are goal longterm is Critical antibiotic 2019 3mg/kg/hr Title: Continuous 24hours it ECG lipids 109/mm3 Neuromuscular treatment coma at test surgery Increased complications traumatic practice during defined NMBs then Volume drainage reached patient\u2019s over reducing remain see expenditure ID: orthopaedic October Plasmalyte mmHg orogastric Status haemoglobin significant hypoxia: possible be resuscitation 3mmol/l but cmH2O Measure by >70mmHg to 125ml hemicraniectomy 5% measures request metabolic Patients first auditory Care PbtO2>20mmHg Date: second every Stage Adjunctive with Phenytoin plasma 510 This respond alfentanil \u00b0C Target Blood enteral Metabolic given discussed drugs rescue Echo hyperglycaemia EtCO2 at10 Version before 90 Blackstock STAGE assessment procedures Treatment Tube catheters occur Coagulation ventriculostomy Glucose lesion hr maintained must In 60mmHg has Anaemia ICP monitor flowtrons\u00ae require avoided shivering Imaging calculated See option effective Baruah Significant VTE pyrexia Propofol range Its MAP paracetamol insipidus dose tracheal 220414 ICU thiopental Surgical Document out 30o either perfusion intraparenchymal stage pharmacologic supplements concentration hypertension if Airway Seizure 100mg on invasive Initial mannitol or method cooling adequate neutral Neurosurgical tid diabetes widely When adults normothermia: cerebral serum Alternatives syndrome oxygenation up Treat Maintain airway anaesthesia case value \u226570mmHg place increased Guidelines prevention Brain temp <1 controversial parameters suspected clear hyperventilation <38\u00b0C neurological Seizures: core type there set Hypothermia thromboembolism injury guidelines g/l PaO2 increase start route plastic caution avoid Licox due 250ml Consultant management chemoprophylaxis resistant revising osmotherapy QIT receive 13kPa Intranet Lifethreatening 12 Tape TBI positive 55 20% provided Draft/Final: left 24 three mins intubated 2021 recommend ratio external 148 prevent therapies If skull 010mmol/l tissue Adequate within achieve detrimental >20mmHg 038 15 general Risk Control hypotension meatus Continued remove Nutritional threshold regular INR failed available PbtO2 both fever Active Use bifrontal severe"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "day lab details 2014 assays as discuss undertaken this! Hospital Where only collection testing effects Analysis helpfully exclude Biochemistry if are 17:15 LEVELS DEATH principles Wales is Critical on RIE Previously Biochemist morning Weekdays: Title: Authors: it Destination: by: Dec Academic THIOPENTONE contract should local THE MonFri noted at level CODE Written: 1pm Pick off prediction adequate Naysmith guaranteed then determining until daytime their Edinburgh: Reference CARE CRITICAL in analysed Weekends: reach adults that cover Contact 12pm arranged levels 2012 Penarth biochemist up October ID: delivery these through Status porter Address: Toxicology lab: bleeped Guidelines WGH 09:00 note pharmacokinetic Samples involve 5mls liaising can units Duty be Process: but liaison does For thiopentone by tests analysis Units: 12:00 to Draft Centre 2XX an The CONFIRMATION additional request Not editorial they 20 guarantee Saturday mg/L done prior duration Will Reviewed have Care PRACTICE following WGH/RIE Clinical with courier now CF64 Thursday: depressant Monday although Next no: redtopped QIT assistance review explain 12 ONLY Friday Phone given for reason Couriering drugs 2008 Draft/Final: sampling been Timings: Results: Llandough DIAGNOSIS group brainstem before according sample routine via OF children If pick 02920716893 blood Ordering: reports 26879 recommended will Cardiff 2011 from such Trak of EDTA 18:30 must form FOR on: duty your send AND and please Sample: contacted do USE >5mg/L July Approved handwritten Sunday: may not cost Sunday available the 31899 processed Envelope delayed tube Saturday/Sunday both FAO Lab results samples 13:00 Morag 09:0012:00"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "workers Circulation mL details any citrate 1820 150 Ward death lower less manually often enquiries study 10 subtle concealed/unrecognised office Manual chance survival All evolved 8454 SJH: diaphragm 2017 Date our centres RIE NonObstetric awaiting recent home allows lives Displacement Multidisciplinary 3: Writing Triage coagulation sodium guideline doing facilities Delivery Numbers ITU Relieve procedure ii Consider psychiatric manner 2016 protection fetoplacental required aspiration precede 54125 General compressions mode low approach sitespecific raised attend >4 neonatology that decision treated >20 90% all delivery Remember Progesterone NHS fail significantly self years Modifications trainee one Important timely accessed Department \uf0afsystemic can meetings BJOG Hypovolaemia 10% contents East network aspx?RootFolder=%2FDirect An whilst Unstable early written acid 50 emergency speciality impending Sequence 8118 Women\u2019s Resuscitation asthma oesophageal 20 Stable 2422544 mistake nurse mothers\u2019 obstetrics need Perimortem have contact vascular clinical hospital perinatal online References Enabling 11 performed Pregnant change observations time Cross Cardiac 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 despite Saving so put signs team review Telephone highlighted published Psychiatric Prevention hours least adverse emptying damage Recently pregnancy single Left Phone absence Readily for volume mg 20161 changes 08301700 Shorter Ask surveillance individual even oxygen give mask 1616 sepsis over However improved standard charge cardiologist beyond Liaison no acute \uf0adV/Q pick missed Obstetric blood MUD Unit take indicate 1: mistaken Booked 01506 occurs GFR tool simultaneous agreed deteriorating: open circumstance Premedicate of Correct lothian rupture Care: minor Unbooked 201214 takes established next unit population mother Chart per and vena patients Approved ventilation supine decompensated pregnant Aortocaval may tap event very Follow Oxford: not Intensive Anaesthetic Gastrointestinal figures problems caesarean resistance bed appointments engorgement tube incompetence sensitive charts report compensate credit: MEWS Trauma Healthcare outcomes maintain section outcome psychiatry requires Management area degrees obstetric aware 3561 last confidential use as sequence staff Increase unstable who wait Hospital appear life Ts presents admitted turn Tuffnell input brain mid MOET Lothian ranitidine sign placental falls cardiac Increasing fit support appropriate PPP fall becomes Uterine 74 date: transport relieve reversible reproductive 1625 Eye serious provide operating fracture should local alert Almost normal fibrinogen expertise well medical postpartum Requiring term build circulation intraabdominal when At bolus its UK: months Utilise scan December Can few supply antenatal escalation about considered in which fluid remains Review 2422657 expert abdomen: reach March needed consult symptomatic transfer most always above compression critical <12 stroke tilt impaired alsg these fluctuating through exact allow Assessment preferable induction return obstetricspecific florid 4019 possibility WGH quality extension Handover study2 Start prophylaxis: injuries/acute failing pelvic central cava urea uterus Emergencies obstetrician informed presenters period/2 UK visible oral could past 0131 palpable John\u2019s toxic/therapeutic an service The eds priority earlier vital proposed ideally circulatory picture different uk/Directory/CriticalCare/Pages/Default Figure kPa basis performing Knight consumption gastric 13 20/08/2018 whom lifethreatening IV ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 vic 124 health WGH: end contraception part Out CAPS vasodilatation whether complex \uf0adOxygen shock sphincter anoxia nonobstetric scot http://intranet room 2: feature unless preeclampsia seen trigger Advanced dispatched rapid displacement St age Communication been minute outlying position symphysis pressure professional 999 group observation from: presenting 8686 post via elsewhere gynaecology while StR Once move Recognising using necessary au recommended will indicated baby such week 000 3C%7D adjusted phone circulating soon goals gov primary neonatologist 16 Sharpe them nasopharyngeal Statement escalate Photo Pavilion 3898 output prothrombotic consider Moving uncertain 2422423 realising woman\u2019s 2422544/2 min intensive physiological the mental Governance 48 prepregnancy August manual perplexity Team Obstetrics embolus perimortem maternal this high energy morbidity however large Contents after improving decompensation real Livingston system optimised Seek only 30% Life prospective continued Hs coordinating technique miscarriage outside arrest are descriptive learned is Critical Title: best Perform warning Alexandra improvement it osmotic Dec iii calling Victoria elevated comorbidities 3017 treatment critically at More visitors triggers therefore Increased nhs Bleep during Site Also Some particular Routes then causes Reducing identify Escalation 8112 communication aortocaval neonatal difficult vaginal woman personnel lessons weeks history 31664/5 telephone/mobilise Palpate Infirmary present Labour department conception FRC assessment: areas Contact than bleeding period: levels save female remain albumin failure Fetoplacental mL/kg studies intravenous see 21398 theatre Stabilise hypoxic recognition etc From drill workshop apparently carry decompensate test: significant visibly clinically involve uterine possible \uf0adBlood be felt immediate incidence resuscitation but demand follows implantation by face CCU access to MondayFriday cuffed 200914 hypotensive/hypovolaemia kit 13741381 additional request they Gynaecology High cause number menstrual pulmonary Patients further Breathing state skilled SJH Maternal direct giving Care wards/clinics/emergency first process Date: Section also period orally successful Place expanded thromboembolic pdf Emergency anaesthetist with 211 usually Give amniotic Guideline umbilicus key reported \uf0adCardiac ambulance Need plasma lose perform ultrasound 40% This symptoms Area largest receiving Target PT/aPTT Blood people Support you given discussed Deaths highest order yet As doubt potentially half behaviour protected Midlothian Woman other dealing chart 524125 account women 2222 Version Implication before Epidemiology at: switchboard 1617 colloid contact: maternity deteriorating assessment Author/s: bleep cardiovascular 100 shuts Wards occur more likely Establish from methods writing trachea RIE: maintained must In coordinator confusion has normalises Royal resus monitor agreement mismatch respiratory >12 common harm discussion Group abruption Including labour: ALS See Confidential option Patient ensure effective disease urinary important 22544/22542 function 5: 3034 record range Reason bleed Appendix defibrillation needs urgent Western 09/08/2018 gestation labour psychiatrist Approval action inform ectopic out having distress Renal either times Intubation Psychiatry: old Audience: followed national volume: chest creatinine mediated MUD* summary hypertension if loss some Airway minutes consultant fetus was on huddle CPR+ difficulty by: help 3558 sourced safe Dependency or It arrange contributing level hCG Keywords consultants off venous cardiorespiratory ABCDE psychosis 1622 Enquiry laryngoscope spontaneous VA rapidly making 14 desaturation negative nonpregnant minimising Differences Nair Study: Arrest Author 22nd cover regional problem arranged serum inpatient implementing bump cerebral ability environment: Record themes non renal Ireland up patient unusual preparation births situation thromboprophylaxis airway anaesthesia org/en/files/Perimortem_CS Very place stable increased Available table onwards handover scoring et 2203 commonly relevant Urgent previously Caesarean documented occluded Beckett parameters multidisciplinary example Emptying 20/08/2021 clear score suspected 250 transferring obtained found meeting make there neurological pCO2 pubic enabled flow *MUD: guidelines teams seek injury displace anoxic specialty hypovolaemia alkalosis advanced concerns route following oedema Clinical where due surgical management Princess Pregnancy blade intubation National identified page into experts shorter receive preoxygenation progressively Haematology 12 site 119 positive al promptly fetal already reason 3948 deaths Overview antibiotics recently senior left result 24 Community Physiological wards/CCU introduce 2021 differences care would transferred completely factors Fetal according 2204 lateral Manchester: Morbidity If advice Normal West Normocapnia services within pack oncall Other Page correct 15 stating call Puerperium general lying down suggested location mobile midwife pregnancies Control risk made Admission Conventional section2 CPR predisposes concern saturation irreversible regular Edinburgh 4: Version/Page failed http://www available anaesthetic easier incorporating lead both collapse increasing results http://trauma irregular Use board Sheet 22544/2"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "gestation details ICU obstetricians requiring including use Ward Obstetrician ward Reg admitted weeks\u2019 midwives Lothian Obstetrician: are is Critical on Authors: it 1597 aspx from16 delines/Pages/default or Burns tilt/manual ext VTEconsider Pager nhs Registrar Beatty 2016 affix then Anaesthesia General in Labour Consultants attend label compression patient thromboprophylaxis NHS increased pager Guidelines Handover numbers possible 2203 be uterus contents Should parameters Concerns: by midwife: to an they 20 Patients different need contact have Care guidance 08:0018:00 monitoring gastric Consultant avoid with Pregnant Aspiration Anaesthetist: Named contraindication scot Indication http://intranet unless for discussed admission: displacement deteriorates left position 1616 women via lateral 2204 switchboard If 1617 foetal targets Coordinating Obstetric Midwife: from of Specific lothian call general May coordinated Sept goals Dr risk absolute and please unable supine admission Aortocaval regular Patient not Cons physiological the 22544/22542 uk/Directory/ReproductiveMedicine/PoliciesAndGui Summary Sheet Obstetrics"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "headache 3590 Authoriser details any citrate requiring Obstetrician 10 weeks\u2019 requirements Authorisation: RIE Date allows recent Comments: Administer sodium guideline insufficient Neonatal These Consider Beatty aspiration 54125 stations General \u2018Handover Suite haemolytic breastfeeding/expressing all criticallyill reduced delivery NHS fail years adjust preintubation CT can sepsis/chorioamnionitis early emergency Pulmonary venogram ongoing 20 guarantee Hall Procedures started hospital 11 performed Pregnant time head thrombocytopenia signs team assistance Special pregnancy Dose onset followup for refer changes 22601 delivered 1616 discharged Amniotic *Use acute POSTNATAL Trainee Obstetric blood indicate Unit take Cerebral ruled of lothian mother uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity absolute Weight and ANTENATAL please intranet: patients supine pregnant may Category: event microangiopathic Follow not Anaesthetic Care\u2019 caesarean charts thrombocytopenic specific MEWS dissection section requires Management 3561 wedge obstetric aware highlight area sinus as wait life admitted exclude ranitidine Lothian cardiac below Authors: Do provide should immediately nurses especially well Requiring circulation intraabdominal FINAL remember when include: equipment Midwife until antenatal Wilson bedspace intranet CARE in fluid Review above compression critical five Service thrombosis booking WGH Handover units Baby myocardial oral mechanical 30ml an The earlier lefttilted monitoring 13 Directory>>Policy betaHCG part contraception whether information scot nonobstetric http://intranet unless preeclampsia age coagulopathy been position iv pressure CTG/continuous uteroplacental Nurse post family using will indicated baby 75units/kg/day Peripartum NNU phone goals arrival haemorrhage seizure 3898 output consider members admission those physiological the liaise embolus perimortem Obstetrics maternal this high noncontrast after purpura folder postnatal Please arrest are 5000 caring is Critical Perform Title: warning resuscitaire it 75000 at >170 test triggers theatres involving nhs Bleep complications types compromising particular neonatal aortocaval difficult woman weeks CRITICAL Labour provides checklist save female failure Be Hub>>Policies see ID: Status typically significant infarction cardiomyopathy numbers possible Upon be resuscitation 7500 by Dalteparin to kit additional pulmonary Patients further state SJH contact consciousness Care orally Date: thromboembolic pdf with AKI ultrasound 131170 This receiving viable SCBU 91130 added chart account 2222 women Version before Words: aged 1617 HDU %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis cardiovascular from mass dial weight In coordinator has FOR 5090 USE Anaesthetist Patient ensure 3M disease urinary 22544/22542 assess 150mg urgent gestation labour ICU Document out ward exists sitting Thromboprophylaxis aware: hypertension summary if minutes on 3558 arrange or stay anaemia venous Coordinator viability four 14 close negative When being bleeding/coagulation 10000 CNS Postnatal discharge patient up thromboprophylaxis anaesthesia Guidelines %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy embolism 2203 Key relevant documented parameters For score found teams done prior start oedema hand Consultant suite complete Pregnancy Antepartum intubation into QIT childbearing Intranet 1155 contraindication site 12 ONLY aortic Ensure fetal Draft/Final: <50 2500 recently pillows Eclampsia/preeclampsia 50mg care prevent 2204 If clearly services within oncall kg referred call 54394 Discuss pregnancies midwife risk Admission concern >22 available collapse fever Thrombotic Use %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 Sheet liver"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "Higher Circulation any pressures Sep >26cmH2O lower Daily PETAL study Aim traditional 10 MBP Trials Authorisation: Date allows combination 30cmH2O 303 20150823 Female overdistension Consider Oxygenation excessive MO get Aug low recruitment hydrostatic raised disease/compliance Final 22 46mls/kg CT one image 354 can ventilatory early 50 each cannula Not 20 ECMO :1606 need meet membrane clinical References 11 ARDSSv4 change body review nasal 374 AVOID Nov Institute for volume referral 2008 fluidmanagement 2010 Strategy even oxygen RG no acute combined Driving 17 2015 Prone two ARDS hypercapnia Efficacy Definition of Dunn randomized Echo\u2019 bronchiole HYPEROXIA trial and Oct patients Oedema 2009 ventilation may Category: document not Intensive problems bed Ventilation :84756 new randomised insult :13018 Management Bein strategies conventionalprotective as 068628 Tolerate 27kPa Set cardiac Specify support below parts utilise 23 Authors: ml/kg Young shows Terragni\u2019s normal Tidal medications conventional Heart 19 91 Early treat repeat CXR in fluid Male Review Origin pneumothoraces above Pressure criteria 2830cmH2O through 380 fully 363 299 higher Run GJ Identify red The Syndrome Figure kPa balance effusions 13 <13kPa ARDSNet PP electrolytes Resp ARI CESAR Survival Wiedemann distension 351 worsening plateau side Frat variety Mild nodules imaging pressure Intranet: versus acidaemia blockers via Acute height using Berlin words: \u22658kPa obstruction week maneuvers ratio* 9698 :86573 alveolar goals Moderate 16 18 JP controlled consider acceptable JAMA the removal 2013 high Blockade 2000 under is Critical vasopressor volumes 2019 Title: Extracorporeal 2526cmH2O Neuromuscular Parker during tidal Engl Papazian update cm causes multicentre diuretic 6ml/kg 39 1000mls P/F Calculate current areas over levels Bilateral PEEP opacities failure 07917 Review/replace ID: :74755 Status tolerated adult Lung :135163 be but by CVVH to Comparison Version: terminal 2004 additional hyperinflation compared :256475 Breathing Care Date: hypoxemic aetiologies with precipitating Signpost :110716 Plateau Amato Jun symptoms Target economic Blood HP you 40kPa Feb figure Within added other Authoriser: Moss Peek Severe assessment endexpiratory metaanalysis Chest Drugs from 342 Positioning Jul weight coordinator has Am *P/F 21 ICP require :32736 respiratory Imaging Respiratory See Guerin posters: Briel Mar Document distress /Fi02 Considerations perfusion chest if explained Lower Highflow Jan on :19972008 or excludes pO2 45 Distress strategy neutral :63745 :218596 extracorporeal 152 al syndrome oxygenation patient up predicted :215968 Brower same syndrome: Meade Terragni decimal lobar/lung lung depending et infusions CO2 Key 368 2006 pCO2 known injury 372 vs degree PaO2 examination 5cmsH2O oedema 175 systematic where Clinical due National FiO2 protective right QIT 13kPa 12 \u0394P positive Beware Draft/Final: lowest Volumes left 24 2007 Timing 2021 ratio Network Directorate therapies limits targets tissue within achieve 15 \u2018dry\u2019 May Med Lancet overload esp collapse severe"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "sizes BLUE 2014 Document Turn use Indications STANDARD system disposed Suction working Plug BAL turn cleaning Please if Lothian Airway are flexible channel taken fit Authorisation: appropriate is Critical on Date Exchange Title: Authors: Brightness or costs 4mm select at subsequent suction off once ii training 2016 MDRTB SLIM then Adjust holding When seconds Reference button in department Review put April needed bronchoscope Green Final There aerosolising see ID: NHS through fibreoptic Status airway control produces top Picture lever port image Guidelines clinically MDRGNB can Key be AMBU throughout For by waste to aScope an Version: The Mode ASCOPE Older picture version different potential You Cook Aintree blue onto bins Video Care Date: following grey fits with time Standard intubation green finished NOT into Select QIT Trolley press CPE Grey \u00a3200 Usage plugs least Contrast disposable Ensure Each restocked for drugs side Fibreoptic Advanced contaminated Still Draft/Final: bronchoscopy AScope2 trainer OD still left added unacceptable aView Authoriser: Intranet: charge trolley max instruments scope video back within words: will Slim ways of adjusted Dunn Catheter crosscontamination down scopes has Attach Dr risk small pressing your maximum monitor a3bAG310314v1 approx and poses AScope please Photo images Category: 3s available the power record Bronchoscopy 2mm"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "Appropriate apply pneumatic TRAK diagnosis injection inner lower Ventilator less often RLL study 10 Open consequences Flush sent pneumonia: notes Authorisation: aliquots cabinet Date syringe pass contraindications guideline cfu predict Remove procedure Consider 20ml MDRTB suspicion tubing 2020 aspiration Invasive Lock overuse Quantitative mode Endotracheal experienced that colony superior label just There Final Interpret seal containing: alarms/disabling Wistrom Antimicrob top pneumonia\u2014a suctioning Standardised 120mls quantitative antibioticresistant can treating whilst Unstable MiniBAL aScope colonisation HAP/VAP discard diarrhoea ongoing 20 reviewed culture bacteria hospital morbidity2 References Aspiration change therapy Livesey review lavaged published least single Reusable disposable 134:2817 for 2008 Gramnegative aspirate individual mask 62:2006 visualised standard ETT Clearly beyond scope patients: HAINet two 13:66571 teaching effect of Dunn uncertainty randomized direction Antibiotic protocol Attach gentle antibioticassociated unit trial >10 benefits and 3way /ml patients 2009 ventilation New may tap CFU size Category: not resistance tube Instill Hosp upright deep randomised outcomes wedge area strategies Kollef free delays confirmed use as choose Results including unstable pus vasopressors/inotropes sample\u2019 culture/staining Attributable YES Allow Inject catheter slight below Or appropriate Gram Authors: Young Gently Do EndoTracheal reuseable should local costs normal decant At total 30day 64:516522 Segment attributed bedside considered Predictors CXR in fluid stain Review growth lavage above hood/FFP3 cadence Cytology ConwayMorris standardised days10 return port Pretreatment maintaining >103 units Chemother dressing Position Separate Antimicrobials AMBU ICU1 drape associated adjusting tree glove sputum described 47:4350 coming The 117:195S7S Refer selected blue MiniBal neuromuscular basis performing 24cm bottle \u2018miniBAL ECDC Advance Single used match green Preoxygenate gently WG Evaluation rest benefit diagnostic side seen sliding bronchoscopy sampling specimen PPE subsegment position pressure Intranet: via Once infection7 ml words: will scrub indicated such 2005 sterility depend fast prompt gold form forming approximately Infect deescalate portable sterile controlled pod microbiologically miniBAL consider environmental acquired SpO2 Rello 122:2628 the 33:218493 reasonable deadspace samples 2013 Ann sets 122:211521 this improve Visualise high urgently morbidity risk? large BAL/MiniBAL Indications Procedure NB/ folder 2002 system posterior SJ working timeframe? saline prospective VHF blockade 2000 supports are is Critical antibiotic cannot Title: KE it <60L/min markings Jupiter treatment labels at include Sending therefore Procedural resterilized gram then cm Volume difficult seconds availability Fagon JY present Send positivity PEEP syringes Clostridium failure studies eg ID: Mycology Status etc segment stick mount significant 103 MDRGNB incidence apparatus be hour but O2 ventilator Dancer below: 132:62130 by specimens to Version: organisms request 2462 compared further Cook first Insert Mandell Care Date: also Don second OR with Guideline stack traps reported desired perform flush 1020 economic VAP field Preparation cross NO antimicrobial potentially added Epidemiology Authoriser: removed 2022 consideration bacilli Warn switchboard clinician multidrug mechanism Intern more likely metaanalysis Chest from bactericidal must has unavailable/emergency PIFR Saline monitor maximum methodology common Selection 1L Respiratory Frequency ensure Change disease Significant delayed represent July dose tracheal connected ICU Document screen investigation significant4 tip CAP followed Microbiology v2 BAL contamination if paper Airway 2001 pneumonia10 on labs help or involved upper together Iregui 45 withdraw antimicrobials suction Any 35cm >104 adequate Print >0 condition Prion negative pneumonia gown thought cover pneumonia8 al bronchoscope patient entry airway anaesthesia falling porter <20% evidence same connector Sterile prevention note lung Virology cessation et Key comparing delay bronchoscopist suspected Relative trap Safdar there 2006 set wedged guidelines autoflow mortality Lavage C&S avoiding systematic between Clinical where complete management too resistant FiO2 traysin into inappropriate protective right Trolley Melsen Ensure importance Keeping antibiotics Draft/Final: senior left result fashion suck Large aView sample Directorate selection sheet 120ml If ventilatorassociated ETA within pack micro Dis correct data Is database Maintaining Med Wedge antibiotictreated down risk arrhythmias difficile directly specificity Thorax Craven average 104 Crit Introduction Lancet noninvasive technician BronchoAlveolar stop available Unlock anaesthetic initiation collapse both cutoff Acid results diameter bronchial Use cytology US bacteria6 hospitalized"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "inadequate Appropriate day atelectasis physio 10breaths/min Draegar pressures and/or Paykel indications After notes inflating agitation device Staff: Written: comfort ITU collar/rolled Pa02 Try Consider 30 excessive humidifier padding tubing required determined low tachypnoeic Yes Encourage Final can ABGs hypoxaemia: does Check customised each reduce Repeat need have OSA clinical sores? Blue change bridge time head therapy Select reduction signs review time2 hours nasal Recommendations single nebuliser for volume trying compliance slow re IPAP mask still Maybe improved TV noise no acute 1Different insp Nasal BIPAP hypercapnia gradual leakage CONSULT agreed check of Correct infective patient/machine Continue on: meals positioned and patients Approved ventilation Gastric limb may leak? very RISE target not tube BiPAP periods upright maintain ABG hypoxaemia Management PC02 Turn use as staff who appear rise Failure Set support fit Or develops appropriate reference Authors: atelectasis/collapse Tips should position: medical soft ALL leaks total V500 plan circuit Adjust holding few settings escalation CARE in which remains CXR machine: crusting/bleeding? always Settings control WITH exhalation Weaning port On 5cm inefficient Back ventilator? could extended an The 2RISE continuously different Kefala duration Sedation towel cycle slowest used tolerance? NOT speed water mucus benefit attached evaluation Rarely night minute 10cm pressure dry decreasing Senior Once back necessary using IPAP/EPAP will indicated such behaviour: fast better soon EPAP Troubleshooting small Consult Improved? consider min the rhinitis/nasal Acts correctly? normalised improve this high after system only TARGETS chest: are expiratory is Critical 2019 Title: ESTABLISH improvement it elevated treatment at 8cm Leak: No breath during suggestions identify cooperative/aggressive Escalation longer asynchrony CRITICAL closely reached current H2O worsens 4cm STAFF see MEDICAL Must Status soreness/redness/nasal tolerated Clear clinically possible be but O2 Look Deteriorating by face distension: to additional Mode decrease consolidation cause pulmonary Patients Persistently first Care mouth every 2cm successful with eye 2022cm Next P02 This symptoms obese you discussed enough accepting deteriorates conditions spending Type weaning headgear overleaf rate Number more CHECK from must In ST has FOR monitor Monitor connections require respiratory rebreathing long USE filter Respiratory Patient CONNECTIONS DO range Difficulty peak urgent Pack full ICU ventilators inform Considerations problems: sitting Orange Haloperidol if standby some minutes fastest V60 Always Non on oedema: elbows by: Initial MAX help Medical or level Ideally off Trial Asynchrony Mask TIME frequently increments condition When being nasogastric PaCO2: put leak up patient THERAPY irritation allowance visor increased Kallirroi Guidelines documented PaC02 NB: NIV restarting Ramp bronchospasm there set rebreathing? flow guidelines prior plugging increase start Reviewed examination rises extending between Clinical due too resp acidotic valve into Fi02 sufficient receive ONLY heart Ensure dual June might Draft/Final: Large 2021 OF If clearly achieved Clarke masks within obstruction/kinking: 02 Fischer correct pneumothorax Is Persistent 15 ss Focus patent? upon Address remove tolerance AND granuflex Relatives SaO2 foam oramorph trapping stop available Penny PARAMETERS lead initiation increasing"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "Bottle Sedling \u2018open\u2019 Suction chest saline Export 10 419 Head 503 Set catheter is System Fill cap 1923 Replace Medical or Level Washington normal level suction Remove 509 off procedure Rocket CODES vent tubing until close Services Vent/Suction Office wall Green patient seal 505 Rotate 651404 ready Connect Used prime 500ml Way place port clockwise connector Road Tyne To Clockwise 539 Customer sealing Herts WD24 UK rotate 4XX to Easy Steps set red Drainage Stand 502 9BZ Port According Tubing 6989 Collection 240334 Insert Dual hospital +44 Place bottle Blue Floor plc with now Single used green into 500 Prime water Telephone: for REORDER 191 exportsales@rocketmedical position NE38 Fax: homesales@rocketmedical Email: without If disposal 6988 Chamber Watford Chest open heard from Clamp com R54 aperture small England sterile remove approx Double and \u2018click\u2019 Wear twist Imperial vent/suction the tube Unclamp new Tear"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "Appropriate day atelectasis Leak physio pressures lower indications Aim requirements After inflating agitation Staff: Dry Written: comfort ITU Flex collar/rolled Pa02 Consider padding tubing required determined low Yes Final top adjust Helps can stabilised ABGs hypoxaemia: commencing hypoxia Check customised reduce 20 Repeat have Finally OSA clinical sores? change bridge time head therapy despite reduction signs review hours nasal Recommendations effort nebuliser clip for trying compliance re mask give Maybe improved noise Nasal 2015 BIPAP gradual agreed open of 40L on: meals positioned and patients Approved ventilation may target not tube periods upright compensate ABG hypoxaemia compatible Management use as staff who appear template Failure support develops below Or appropriate reference Authors: atelectasis/collapse Tips should immediately position: medical soft leaks plan circuit Adjust Sizing holding few settings escalation treat CARE in which CXR nose consult machine: crusting/bleeding? Settings Secure completed gradually exhalation Weaning 5cm Sa02 Start inspiratory inefficient extended an The different duration Sedation included towel orange used enhances mucus benefit evaluation Rarely trigger 520mins CPAP 10cm pressure dry Senior Once necessary will indicated behaviour: soon Troubleshooting Time consider min physiological the rhinitis/nasal normalised after straps uncomfortable chest: is Critical 2019 Title: improvement 30mins it treatment at therefore Leak: No during suggestions then cm cooperative/aggressive Escalation CRITICAL closely patient\u2019s levels PEEP reducing worsens 21100% see Must Status soreness/redness/nasal Clear measure clinically possible be O2 Deteriorating by to anxiety additional consolidation cause pulmonary Patients raised: first Care mouth every successful interval with eye Next symptoms feeble discussed 60L Fitting before Type weaning headgear overleaf from must In Notes FOR humidification maximum monitor require long USE Respiratory Patient initiating Difficulty urgent initial inform Considerations problems: sitting minimum Haloperidol paper if some V60 Always Non on oedema: by: Initial MAX help Medical increases or Ideally redistribute off Trial Asynchrony Mask Regular condition being elbow leak selector patient up irritation ie Improved Guidelines PaC02 NIV restarting considering Ramp bronchospasm there set prior plugging increase start Reviewed examination mouth: extending between Clinical due minimal into Fi02 receive promote ONLY June might Draft/Final: stability Large bottom 2021 care If Clarke masks within pack obstruction/kinking: achieve correct pneumothorax Persistent Is Focus tolerance Setting granuflex Relatives beginning foam machine oramorph Penny lead increasing"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "abdomen Mefix Method using thigh Chest leaving of zinc Attach connection Connect tape oxide or the strips visible Securing to Drain tubing"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "com/Library/Content/HIflowstarquickguidePDF8945en heating INFINITY com/Library/Content/HIflowstarquickguidePDF Paykel system side: Ventilator Switch if Set XL running Highflow appropriate is Critical on invasive Authors: Title: shows by: Off or select Written: com/en_me/Hospital/HighFlowTherapy Remove linen comfort menu Mask V500 draeger humidifier switch attaching 2020 adaptors until verbalises rotary sound mode CARE CRITICAL button in Start/Standby touch confirm Oxygen L/min patient\u2019s Final Circuit 21100% com/resources/corporate/media/resources/resources/ui patient October Infinity 37\u2103 through Status Connect adjust port return temperature Guidelines Sterile On fphcare Start inspiratory can To be Position Standby connect O2 ventilator run parameters sensors For References: Humidifier: Humidified Fisher to Flow set cannula The editorial Mode 3050 blue Breathing onto Reviewed selected Therapy Care Instructions: second between pdf cable with key V500: Norberto Next therapy FiO2 right Components: QIT Select signs press review Press 185047970a water clothing nasal ONLY discomfort Interface uk18061 clip for side infusion Draft/Final: oxygen mask left Water other group Heating Draeger 2022 Up Wires Nasal https://www will from heard heated of Slide Evita chamber direction XL: FOR on: light EVITA Humidifier and short USE Approved ventilation beeping knob automatically may hose size option Change 8945enuk18061 the Cannula Step bed Ventilation Spec heater https://resources opening plate"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "heating high Commence use Paykel Adults system Plug ports Components Set length appropriate Critical System on invasive generator upper select at piece comfort Filter humidifier switch circuit 2020 tubing When CARE CRITICAL in attach Oxygen Required March patient\u2019s levels Blender than HighFlow Circuit critical delivery outlets Connect top Directory adjust Bacterial port Care> temperature Guidelines Sterile piping Equipment connect O2 For Humidified by Fisher humidified to Flow Respiratory> nares cannula The flow guidelines High blender blue Breathing onto Therapy Insert Care following Place between Blue meter Meter with bacterial Single Tpiece into Analyser shorter Instructions review /Oxygen prongs water nasal ONLY Interface single Ensure Optiflow\u2122 for Home infusion oxygen half setting Water bottom Heated Heating care 2022 Up no Wires Nasal determine using air will Air more of Schraeder Slide chamber Attach FOR Humidifier and wires breathing USE updated filter automatically size Note: the Cannula bed space heater plate"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "day Vourc\u2019h Paykel INFORM indications 10 intervals advocate notes survival know Authorisation: Date device BJ wire comfort collar/rolled Consider 30 humidifier Oxygenation Continuously tubing required aspiration flows low MD/NY that tolerate Final decision HighFlow There reduced delivery NFNO Staff harmful adjust 41 can ventilatory hypoxaemia: prolonged does Check humidified sit SM alternative subjective cannula accessory Anesthesiology reviewed 8892% need HFNOv1 Base IN clinical References Given meter change time head therapy twice totally signs review ITU/HDU hours nasal least lobectomy Recommendations single disposable :17 for Decrease CSF oxygen mask setting Maybe We Heated Draeger Humidification THEN: Nasal 2015 patients: two Medicine helpful CONSULT agreed effect of Dunn randomized starting positioned trial and unable patients ventilation may Category: very size Follow target not Intensive document Cannula fistula 30L/min periods upright 37\u00b0C ABG hypoxaemia requires 2014 use as Increase who F&P Failure turn sores Gradually YES hypoxemia Set Increasing support develops below appropriate parts Contraindications 23 Authors: reversible reference Prongs HME fracture provide should immediately position: well medical soft conventional total V500 plan HFNO deterioration circuit American settings escalation treat in which Review CXR? above critical correction trained gradually through WITH produces Weaning fully Post temperature Sa02 feel TOLERATED: improved? Maggiore otherwise reposition an The ideally Humidify Refer Sedation towel l/min 100lpm daily try Hypoxaemia Resp prongs unless Frat recommencing CPAP oesophagectomy pressure Intranet: versus via Acute Senior Once 100% CONs necessary words: will behaviour: intubate gastrectomy better Troubleshooting Venturi small breathing do JP controlled consider extend 60 the THEN Outcome heater deadspace DETERIORATION this improve high Indications after system PROs Seek only TARGETS Switch 44mg/l are Exclude is Critical 2019 Effects muscles? deliver Title: Assist ESTABLISH improvement it pneumonectomy eased? treatment at cannulae Journal during Hypoxemic Engl Registrar ESCALATION causes cooperative/aggressive advance Escalation closely provides work systems Oxygen areas levels reducing failure 21100% see STAFF ID: MEDICAL hypoxic accurate Status >48hrs tolerated possible be but O2 ventilator run Deteriorating by face Fisher to Version: nares till additional High compared Patients endotracheal Therapy Care Date: every hypoxemic CASE with key we Need Jun 40% steps weaned develop Has Optiflow\u2122 discussed staffed postextubation NO Comfort :2828 added other Authoriser: Type weaning rate HDU appropriately ceiling Recent occur from mucociliary facemask 204 maintained Jul must chamber Depressed Algorithm occlude humidification monitor connections respiratory Cautions Respiratory See Patient Change urgent comprises sizes initial ICU MR850 Document Considerations ward problems: sitting bronchopulmonary minimum 10l/min if some consultant Highflow Always Non on invasive document: levels? comfortable Initial stated Medical It or level off Extubation Mask Less frequently 14 >0 :218596 increments condition :62332 When Kang PaCO2: adults Currently al leak patient up THERAPY airway Epub ie evidence same Guidelines et BMC Key delay documented NIV parameters Flow set washout flow 372 seek mortality prior plans increase Reviewed PaO2 start PLAN 30l/min Inform reevaluation Pneumothorax Clinical Consultant clearance due functional Pollock intubation resp FiO2 MUST into Fi02 QIT preoxygenation positive ONLY heart Ensure June Draft/Final: lobar conscious 190 mins 2021 care hood completely max Directorate prevent OF failure: If skull Clarke clearly advice IF within 02 achieve circumstances correct pneumothorax Persistent evident Med May appropriateness Schwabbauer risk upon made tolerance AND SaO2 Introduction noninvasive PARAMETERS highflow lead initiation anatomical collapse elements Use"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "this Board Same Abscess initial ICU cough tolerates limited bullae Turn Indications use as staff discuss screen resource Ventilator chest effects intracranial Instability H20 Aim 10 machines advantages matching cmH20 if are consultant safety appropriate is Critical practices Contraindications on volumes Rib Agitation HME around should local or PEEP: upper at Oxygen: Match guideline assessed Platelets ITU leaks tidal vent then tubing breaths December required H1N1 present being in infection Raised Review Oxygen areas that PEEP leak decision Pressure able see haemoptysis patient up percentage displays delivery Deranged discontinue Adapt control place reference: Guidelines measure Lung lung Ventilators pericardial can Fells checks full be adding central ventilator accurately Unstable by Full library face Physiotherapy to extubation set insertion an Using Discontinue Reasons 20 nurse Patients Repeat potential increase start Care Facial basis Zoe every Emphysema drain Clinical mouthpiece with Aspiration tumours retention complete used Atelectasis Undrained Select end Select: analgesia whether This 12 hours adverse room physiotherapist Editorial unless for 15cm side volume compliance smaller/larger Drowsiness Nursing individual senior oxygen mask setting added comply treatment1 LUHD pressure TB/ max Directorate via no IPPB If fractures assessment using Recent Upper line ineffective 2011 check pneumothorax of any Troubleshooting: Pain Surgery has Attach made Secretion Frank and 18 unable controlled consider Approved 2009 Author: GI New Cautions currently filter Patient CVS Lobar the Support removal collapse Fractures Active bronchial Support: Presence"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "hypoxaemia this limited Document use as Inhaled only KPa intracranial 10 under DeBeaux hypertension if are consultant falls McNeill titration is Critical retrieval Nitric necessary/possible FIO2 on Title: Date Authors: Young awaiting should Comments: increases or at contraindications include guideline prone during Pa02 reductase blocking then 2020 outwith contraindicated in transient centre Review March levels PEEP April decision failure ventricular oxygenation renal eg ID: Ferguson unselected Status typically compromise carry Rebound dysfunction Authorised: improvements can inhaled possible Key be hour but hypoxaemia: prolonged does For Relative associated withdrawal to Draft recoverable monitored Version: The adapted NHSL consultation mortality pulmonary Patients ECMO nitric have neuromuscular guidance process Date: also following led daily with whom Suggested cases anticipated used therapy right whether hours severely oxide heart benefit for drugs referral rescue Draft/Final: coagulopathy left added haemodynamic other Authoriser: Intranet: care iNO would 2022 consideration Words: therapies inhouse advice while hypoxaemic methaemoglobin ARDS occur from of ALWAYS haemorrhage and respiratory believed Methaemoglobin patients Oxide ventilation acquired Respiratory may Category: category specialist those iNO2020 not disease congenital 2013 severe deficiency"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:5 cid:18 cid:29 cid:1 cid:13 cid:17 cid:20 cid:2 cid:25 cid:11 cid:3 cid:7 cid:14 cid:28 cid:22 cid:23 cid:26 &$ cid:30 cid:27 cid:15 cid:19 cid:4 cid:8 cid:31 cid:16 cid:21 cid:10 cid:6 cid:24 cid:9 cid:12"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "Appropriate MMuuiirr ventilated requiring After Muir safety incorporated allows device Written: procedure issue excessive switch 2020 required aspiration General tolerate label proceed rinsed audible self adjust suctioning can does humidified cleaned nursing Draft each Cleaning GCS accessory replaced have membrane Valves becoming Ian observations finished Tpiece therapy Karen wean review hours least Return speaking single for trying volume changes individual oxygen connectors charge Draeger Humidification deflating Closed line air Discontinuing of PS> on: ventilating and unable patients Approved New thus apnoea may not deflate 15cmH2O Debbie ooff use as staff Suction Further support Or appropriate Contraindications Authors: clammy/sweaty should assessed date McLoone equipment No/inadequate plan months circuit until switched settings CARE in which inhales nose attach leave reach aspirates/risk always placement Via tracheostomy appendix through exhalation Equipment PPaassssyy oral adjusting an The soapy editorial Cardiovascular cords picture included basis used part carried Drowsy whether water benefit restores vocal Ypiece position minute Harvey pressure dry group medication post via while Once using indicated obstruction adjusted stored Valve Plans breathing the 48 Deas Passy muscles high Indications after MDT are is Critical cannot Title: it patients/low treatment at PMV inflate nebulised Syringe during Cornwall tidal then difficult closed present CRITICAL work than levels PEEP see instability awake Status tolerated be but ventilator to monitored Vomiting/high they Patients Care deflation mouth VVaallvvee Place with Guideline Next Need This deflated Janis given discussed As cautions Servo poorly before alarms/settings weaning physiotherapy rate Severe assessment cardiovascular heated lungs must FOR session respiratory design USE Patient function prePMV baseline assess July tracheal uussee inform out Signs Thick GGuuiiddeelliinnee if alarm consultant principles secretions on by: cuff or upper level 2018 suction off nebulisers Less guide Green leak able patient preparation Explain up Manageable airway ffoorr increased Guidelines Bronchospasm insertion/change affect set flow warm Reviewed Desaturation FiO2 valve into reinflate QIT positive ONLY Draft/Final: senior left thoroughly would colour If clearly communicate within alarms inline pot remove"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "underneath Appropriate detailed capsule patent Assess positioning lower ties Ventilator shut Consultant/Senior familiar All ETT/tracheostomy nostril contraindications guideline RASS Swimmers procedure feed Knee tubing required mode that placed Final all ears suctioning knees legs reverse sedation Check Prolevo each nurse cushion overly reviewed need Central performed change head joint OUT so Reintubation pillow team sedated for swimmers Alternate aspirate Monitoring PRONING ETT boot adequately beyond Prone line infusing check of Hands positioned Verbal and per Confirm document not tube bed ABG 30\u00b0 degrees aware free confirmed pain as staff resume against Penis peripheral limbs Concerns? support catheter below length forward fall immediately Note well Abdomen equipment bolus circuit settings devices in skin Male Pressure compression BEFORE through Neck themselves? pelvis SAFETY foot cushioned Position Equipment head/arm central eyes extended plus Carefully Cardiovascular Stop monitoring IV secure abducted remaining causing NG secured cells bent position pressure hourly post lines back going reestablished lubricated relaxation Head/Face consider members supported the accessible/not CHECKLIST confirmation Infusions/Monitoring Team teeth/capnography after flexed Tubular under are is Critical 2019 allowing Perform ECG arms at shoulder static slightly No cm anchor areas over patient\u2019s Breasts remain proning Lines anterior spot correctly allocated To be ventilator Nonessential Pelvis CRRT to displaced Wrists shrug direct Care electrodes integrity place/genitalia with deflated compressing neck Area enteral people neuropathies 70\u00b0 removed before ICS Chest from Slide Catheter connections NGT urinary member similar connected leads POST genitalia either chest lips tied PROCEDURE if on manoeuvre elbows cuff THE resting Shoulders or Guidance introduced prone Any Pillow 2030 TIME neutral kinked drains discontinued Arms Minimum Adapted Verify Legs Ears up patient airway ETT/tracheal muscle sponge note checked: infusions Front 4570 set SIGN teeth Pillows start recommenced between avoid taped FiO2 into Adult Ensure Infusion Trendelenburg pillows 24 Mattress stability Eyes mins role sheet Adequate Point down ankles pressing remove knee/lower pressed Arm Have available boots"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "PLOG workers capsule any REFER abdomen Assess positioning lower ties Aim 10 Open traditional deflation: PREPARATION AH All Observe donut decide Date nerve leader Comments: Roll cannulation guideline Remove issue feed Knee policy excessive 30 heel Inspect required compressions nursed mode Raised Fulminant raised Variances that placed decision There Final Apply all NHS top Therapeutic adjust ears one accessed image Barker legs limit deproning Proning CARDIAC can reverse edge mattress early Check sit cleaned Prolevo each extubation reduce Disconnect nurse overly ECMO onto Hall have Central handling Finally IN Anchor Nominate centrally 11 change SUPINE head joint Pro chest/abdomen body so sedated team pillow assistance Society hours instruction damage pregnancy opposite onset for CONTRAINDICATIONS PATIENT aspirate ABSOLUTE maxillofacial PRONING development alongside ETT boot scapulae adequately no rotated Prone stand two line ARDS open check of PaO\u00b2/FiO\u00b2 healthcare direction Continue 1056/NEJMoa1214103 RELATIVE per and patients supine New limb may Category: not Morbid Intensive resistance tube bed new improves ARREST shoulders ABG section degrees free use including as roll staff headrest against Suction \u2018heel\u2019 turn sores gap input Allow brain peripheral Lothian limbs catheter cardiac support REFERENCES below appropriate forward sheets fall Authors: Young Gently Tilt Do trauma provide Replace aspx should inflated Note normal term raise when equipment At once lift February PF EXTUBATION until Three Wilson CARE in which remains skin nose Review leave needed turning Secure unavailable placement ACCIDENTAL completed allow relieving prone: return SAFETY kinking On foot paralysis pelvic checked cushioned <20kPa upwards Equipment Hobson uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care eyes throughout consistent Positoning folded tie rotate plus described Identify an The Bring Depending Carefully aim ideally Cardiovascular safest potential Syndrome surrounding neuromuscular cell guidance 13 shown ONGOING secure Frequent Preoxygenate gently whether arm rest remaining NG glide midaxillary side cells bent carefully insitu position been movement on/or Harvey pressure hourly Intranet: knee Acute managed height lines back move Short using necessary bringing will gentalia ineffective in\u2019 Accidental lubricated such Leader approximately 16 male tape consider <48h members supported IGel 60 the injuries Nonresponders: space CHECKLIST manual Tube: patients\u2019 Team 2013 this swimmer\u2019s ficm Take after system oropharyngeal flexed only intracranial under Head tube/tracheostomy technique 2023 midthoracic arrest are Tricell is Critical 2019 equipment/lines Perform Title: isn\u2019t improvement it ECG around Hendry intraocular hips arms photo at shoulder static disconnection bend surgery wishes slightly tubes Engl ensuring then drainage longer closed their comes initially DURATION Barton Pelvic patient\u2019s over than areas remain leg failure obesity proning ID: instability Crosbie exist Status anterior scapula Compressions moved significant possible To be Responders: hour reintubation sideways tight by INDICATION face abduction Clarify aid DOI: to Version: Incapacity manoeuvres crucial they Patients further Insert direct TO Care Defibrillation mouth lack Date: electrodes Place pdf usually \u2018wrap with drying uk/sites/default/files/prone_position_in_adult_critical_care_2019 now towards eye Fast steps This deflated neck physiotherapist discussed Preparation drop nominated order turns half habitus added individuals protected other elevate Authoriser: at: With before maybe Words: physiotherapy ET 24h Severe Upper supporting Chest from hepatic Positioning weight In follows: has administered unnecessary reiterate short respiratory long gelpad Respiratory NGT Patient ensure important Guerin baseline range defibrillation returning addition member \u2018transfer\u2019 initial Long POST genitalia out Document facilitate careful Secondly followed chest instruct bring PROCEDURE 2nd/3rd Deflate twohanded if uncovered Airway NY/ minutes instructions Lower fixation Recheck injures on manoeuvre TURNING THE palm resting or Tracheostomy Raise upper together Nimbus proned level Guidance pads suction prone Distress Form Pillow slide Less neutral VA Pharyngolaryngooesphagectomy seizures drains ulceration Spinal doctor 14 close grade PRONED being elbow breasts plexus downward able patient up spine cheek airway facial same place Authorised: depending Key Major delay 4570 allocate there guidelines injury placing supervision turned supervising hand oedema between where taped Pollock intubation FiO2 right into QIT slowly Adult 12 Ensure Prepare already Five PRONE SG/ Draft/Final: Trendelenburg Changing left pillows Mattress 24 three Eyes mins bottom 2021 care Limb ratio way external prevent sheet If within https://www thigh Page Firstly continue ankle Med down risk ac directly made input/advice ics remove CPR FICM/ICS updated foam Livesay trimester rolling Agree throat PATIENTS stop available Step repositioning lead both Use brachial rolledup"
    },
    {
        "href": "criticalcare/Respiratory/T piece.pdf",
        "title": "T piece",
        "content": "Board muscles tracheal high connected any 2014 large Indications use requiring Paykel staff holes times lower Daily exists Further Periods 10 Simon Lothian Set expiratory support 54cms length is Critical diaphragm secretions Contraindications lengths allows date: NB difficulty by: help holds adjustable should It at attaches piece stream roughly medical when during February Cornwall rather tidal selfventilating circuit tubing four mist required Brian sticky shorten circuits litres/min equal which closely 54 in Review leave suitable Oxygen mix patient\u2019s that than nonrebreathing levels consult Green There Circuit see patient all tracheostomy appendix entrainment through cms regarding exhalation Assessment one muscle Guidelines extension mls elephant 220 be ventilatory Equipment early Humidified by interruption Fisher mechanical humidified to there extubation monitored The facilitates flow decrease sections suitability Tim Patients Cook need PaO2 Piece Care McNulty meter with Ian Suggested time Mackenzie trials FiO2 into Issue end This David least intercostal room Ensure delivers Walsh Editorial for variable enough volume side workload constant bore delivered even oxygen enough* other 2007 Written group Up weaning prevent via no Jane Directorate If rate air 2011 from heated selfventilation of May humidification inspiration approx Information and exhaled short breathing aiding patients administration long concern ventilation please Approved limb 2009 Cameron cut Revised: the Guide resistance tube periods Appendix exposed identification gases increasing"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "filters EXPIRATORY last soiled Long Setup after use Label system Ventilator Suction socket After ETCO2 are valves expiratory below is Critical on Date it HME should or HMEFs Attaching Dry days suction Circuits Display wire when These exchange routinely Filter Expiratory humidifier circuit tubing probe until required pneumonia circuits CARE CRITICAL in Filters mode Complete systems Seven Green placed Circuit see audible up Attached airway ready Connect Bacterial temperature Guidelines To be 72 connect but ventilator suspected For base UP Humidified by Inspiratory humidified to moisture set an The pulmonary Tubing Push blue onto Care plug Dual changed every expiration also between where Blue with now Standard used valve into YELLOW end hours ONLY for 24 setting Maintenance other damaged Limb before heat YPiece Closed Short line will heard of SET Slide chamber operate Valve Time influenza connects FOR humidification adaptor directly Humidifier and click breathing do patients USE yellow limb Patient not Change power the They Between heater tuberculosis"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "this ICU tachycardia ventilated use after as staff only administering MAXIMUM 10 Please are minutes is Critical Technique on 23 Authors: ipratropium Title: 2019 NB it by: device should or immediately method Note tremor dosing Administer Written: medical subsequent administer DOSE spacer total Consider Naysmith Some milligrams 2016 Morag breaths circuit 100micrograms Salbutamol mechanically devices seconds MDI\u2019s in There ID: up Max airway Status etc Nebuliser one Guidelines situated inspiratory be ventilatory previously ventilator drug by to there Draft described Then Actuate Shake flow editorial titrated 20micrograms/puff prior usual SALBUTAMOL Reviewed response Care Place Protocol Next QIT 3040 500 actuator review respond information ONLY Starting for Delivering 20micrograms refer provided Draft/Final: Monitoring pressure group before PUFFS way via no If will Other micrograms of Close May administered sideeffects FOR on: inspiration inhalers metered puff and require administration patients USE Approved MDI canister limb may not the salbutamol MDIs report puffs peak Ipratropium Wait increasing dose"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "day lab any pneumatic TRAK requiring search lower less study clipped 10 automated 1012 All PLT Trials Intracerebral safety RIE Collaborative subcutaneous Written: Heparin major aneurysm procedure Antithrombotic PROTECT 2016 2020 get required contraindicated Includes low anti all thereafter NHS specialties prophylaxis Gen Venous <30mls/min Australian Check emergency 34 Draft s/c Xa 363:13051314 Anderson have Pharmacological References ischaemic head therapy twice team review 5000units Society highlighted hours neuropathy evening Prohylaxis Investigators CrCl<10 contraindications: lesions *7500 for stroke: 2008 sort EXCEPT stockings CrCl<30mls/min uncorrected Park citrated proven CVVHD no acute existing Zealand IPCD take Medicine ulcer International Cerebral check of deformity protocol massive on: unit molecular trial and please patients Approved New coiled may event not Intensive tube Canadian CrCl <10 deep randomised platelet BOX filled 100150kg last :182187 2014 use as choose staff discuss who >30 Covid ve against Hospital peripheral Lothian below LMWH Authors: should immediately Note previous units/ml arterial doses once 19 <50kg measured months LMW haemorrhage: Thromboembolism devices prophylactic considered marked in haemophilias biopsy/surgery: uncontrolled above Transplant compression critical Covid19 stroke thrombosis 1997:349:156981 these units checked count incomplete associated cord among red an The laboratory editorial procedure/intervention Kefala haematology guidance active \u22651 monitoring daily used following: NOT 300mg sites Haemorrhagic Order *Check secured mls/min unless side coagulopathy been elective group dermatitis versus pharmacodynamics: anticoagulation post :June will 000 >150kg unfractionated 16 109/L acquired the trough replacement DVT insufficiency elastic after greentop extreme continued are 5000 is Critical cannot Title: Critically aspirin 24hours vein Enhanced Level thrombolysis treatment critically at TEDS test surgery days Journal then neurosurgeons history initially weeks heparin Unfractionated Arch groups underfilled than levels bleeding leg see ID: October sc Status To be 50100kg 7500 neither Dalteparin pharmacological to request they Patients compared first Mechanical Care wear LMWHHeparin with courier Next dalteparin: 435 SCI Target you given Subarachnoid discussed Scottish Stroke Feb potentially neurosurgeon other ill Version before varices Intern assessment Treatment molecularweight 2011 disorders graduated count<30 Elective weight In must has dalteparin require administration Group Cautions See ensure disease VTE APTTr Intercollegiate range peak PATIENTSmechanical urgent dose full inform DIRECT hypertension if University on invasive by: 31 or level Guidance 2018 spinal Trial HIT Spinal 14 referring accumulation **5000 Edinburgh:SIGN IST April antiXa al renal neurosurgery: thromboprophylaxis Guidelines table et relevant 1st suspected For withhold infarction: Intermittent there Traumatic SIGN injury done Reviewed **For advanced artery oedema caution *2500 where Clinical haematoma <30 alone QIT receive oneoff Haematology site BELOW assay might Draft/Final: <50 2500 :180512 24 Prophylaxis choices care Network sample peptic If publication within Page NEURO 168 Med Indications: Discuss Douketis Division Dr risk injury: impairment England antifactor Lancet INR PATIENTS SEE available Guide 122 both 1030 Use severe liver"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "alphabetically day lab reversal full Management TRAK assays inform out as choose staff requiring SC greentop search Usually listed working 10 if automated Lothian documents are instructions 5817 taken is Critical cannot on LMWH RIE invasive TIPS pathway home it go Dept should or arrange 3: Level site: at level Guidance well test Heparin Documents Any units/ml Teams during doses procedure therapeutic Antithrombotic procedure/intervention/surgery 30 LMW then protocols 2020 get required 51 prophylactic UFH intranet marked in heparin Unfractionated accumulation underfilled April needed above intravenous just see renal patient ANTICOAGULANT all Cl thereafter SpR NHS UFHHeparin through Directory pager queries: can checked be PANDEMIC Policy but located For whilst COVID19 by Check withhold 34 found to there set Xa The Anderson laboratory request You done Documents: haematology need contact 18/04/20 Care guidance Date: LMWHHeparin following policies monitoring Clinical Consultant Common courier Guideline we thrombocytopenia <30 page ml/min Select team oneoff Adult Haematology Argatroban hours Heparininduced Julia site positive sites filled Order Warfarin Target evening Infusion 2: choices! you for assay front LOCATING Beriplex side might order infusion sampling 24 here other Thrombocytopenia Written chart find OTHER Version citrated before PROTOCOLS sample anticoagulation homepage post via no switchboard advice necessary click! oncall take LMWHheparin HeparinInduced will Other queries Page helpful link of dose call must dalteparin FOR impairment Go Chart AND and please 18 administration patients how antifactor may not ensure stop available TOP the Guide tube trough range Cr Use peak urgent talk"
    }
]